Microrna and use thereof in identification of B cell malignancies

ABSTRACT

Disclosed are nucleic acid sequences, including microRNA sequences and cDNA sequences, as well as vectors, DNA libraries, microarrays, and recombinant cells comprising the nucleic acid sequences described herein. Methods of determining the B cell stage from which a B cell malignancy is derived. Methods of identifying B cell malignancies are also provided. Methods of diagnosing B cell malignancies are provided. Such methods comprise, in certain embodiments, detecting one or more microRNAs or cDNAs as disclosed herein.

CROSS REFERENCE TO RELATED APPLICATIONS

This patent application is a divisional of U.S. patent application Ser. No. 13/513,757, filed on Aug. 13, 2012, which is a national stage filing under 35 U.S.C. 371 of International Patent Application No. PCT/US2010/058952, filed Dec. 3, 2010, which claims the benefit of priority of U.S. Provisional Patent Application No. 61/266,733, filed Dec. 4, 2009, the contents of all of which are incorporated herein by reference. Priority to each application is hereby claimed.

STATEMENT OF GOVERNMENT SUPPORT

This invention was made with United States government support from the National Institutes of Health grant no. K12-CA-100639. The United States government has certain rights in this invention.

SEQUENCE LISTING

The sequence listing is filed with the application in electronic format only and is incorporated by reference herein. The sequence listing text file “WO_ASFILED_SequenceListing.txt” was created on Dec. 3, 2010, and is 262,254 bytes in size.

BACKGROUND

Naive B cells migrate through the circulation to lymphoid organs where they undergo the T cell-dependent germinal center reaction. Adaptive immunity is acquired as specific antigen-reactive germinal center B cells differentiate into the major effector B cells of the adaptive immune system: memory cells and plasma cells. See, e.g., FIG. 1A. Although the role of specific transcription factors in mature B cell differentiation has been examined (see Nutt et al. Nature. 1999; 401:556-562; Chang et al. Proc Natl Acad Sci USA. 1996; 93:6947-6952; Turner et al. Cell. 1994; 77:297-306; Shaffer et al., Immunity. 2004; 21:81-93; and Schebesta et al. Curr Opin Immunol. 2002; 14:216-223), mechanisms regulating such transcription factors during mature B cell differentiation are largely unknown.

Many malignancies derived from mature B cells are known and are believed to constitute the majority of leukemias and lymphomas. Such malignancies appear to reflect defined stages of normal B cell differentiation. Diagnosis of leukemias and lymphomas can be particularly difficult because of their shared lineage. These cancers frequently display overlapping morphologies, genetic abnormalities, and expression of surface markers, which can complicate the diagnosis. However, the distinction of these tumors is clinically important because there are important differences in the treatments and expected response to treatment. Thus methods that improve the accuracy of their diagnosis should provide to improved outcomes for these patients.

MicroRNAs are commonly 18-22 nucleotide-long RNA molecules that regulate expression of genes. There is an increasing recognition of the role of microRNAs in oncogenesis, lineage-selection, and immune cell function, including early B cell differentiation. See Calin et al. N Engl J Med. 2005; 353:1793-1801; O'Donnell et al. Nature. 2005; 435:839-843; Chen et al. Science. 2004; 303:83-86; Lim et al. Nature. 2005; 433:769-773; Li et al. Cell. 2007; 129:147-161; Xiao et al., Nat Immunol. 2008; 9:405-414; Baltimore et al. Nat Immunol. 2008; 9:839-845; and Ventura et al. Cell. 2008; 132:875-886. However, the full extent and function of microRNA expression during mature B cell differentiation and in B cell malignancies are not known.

Correct diagnosis of B cell malignancies is important from both a clinical standpoint and from the standpoint of setting appropriate patient expectations. A misdiagnosed B cell malignancy may lead to an inappropriate therapy, which can unnecessarily endanger the patient's life and/or be an ineffective treatment for the B cell malignancy. As an example, the diagnostic distinction of Burkitt lymphoma (BL) from diffuse large B cell lymphomas (DLBCLs) can be difficult because of overlapping morphology, immunophenotype and cytogenetics. Burkitt lymphoma tumors are molecularly distinct from DLBCL, however. The difficulty and importance of obtaining the correct diagnosis in BL was highlighted by the experience of a multicenter clinical trial, CALGB trial#925119, in which nearly half of the 100 patients with an assigned diagnosis of BL were found to have another diagnosis upon further pathology review.

If diagnosed and treated appropriately, nearly 80% of patients with BL can be cured with intensive (high dose) chemotherapy regimens. Thus, a misclassification of BL as DLBCL can result in a missed opportunity to cure the malignancy. On the other hand, misclassification of DLBCL as BL leads to unnecessarily morbidity from intensive chemotherapy regimens. Thus, methods that improve the diagnosis of BL, and other B cell malignancies, can provide better outcomes in patients.

DLBCLs can also be subclassified into two different B cell malignancies, activated B-cell (ABC) DLBCL and germinal center B cell like (GCB) DLBCL. There are at least two important clinical applications for the molecular sub-grouping of DLBCL patients. First, the prognostic information could inform the choices and expectations of patients and their physicians. Second, the important molecular differences in these subgroups form the basis of testing different targeted therapies in these patients. The possibility of a differential response to therapy among ABC and GCB DLBCLs is supported by data that suggest that the benefit of receiving a proteosome inhibitor, bortozemib, is predominantly limited to those patients who have ABC DLBCL. However, the clinical distinction of the subgroups of DLBCL using immunohistochemistry is difficult with current methods distinguishing GCB DLBCL from non-GCB DLBCL with limited success.

Mature B cell differentiation is important for the development of adaptive immunity. The process is also of interest because B cell malignancies are common and retain a number of features derived from their normal counterpart B cell subsets. Unlike other maturation pathways in the hematopoietic and other cell lineages, successive stages of mature B cells do not simply signify progressive differentiation away from the stem cell stage. Rather, each stage represents a specialized state with specific functions. Thus, germinal center (GC) cells interact with CD4 T cells and dendritic cells and undergo somatic hypermutation and Ig-heavy chain class-switching. On the other hand, plasma cells secrete immunoglobulin, while memory cells are primed to proliferate and differentiate into plasma cells upon repeat contact with antigen. The specialized functions demand a finely tuned program of gene regulation.

MicroRNAs represent a novel class of biomarkers that provide new opportunities for clinical translation. First, intact microRNAs can be isolated from tissues preserved using standard methods, such as formalin fixed, paraffin embedded (FFPE) tissue. Thus, microRNA-based biomarkers could be easy to translate to clinical use. Second, microRNAs can be readily assayed using real-time PCR and other methods available in conventional pathology.

SUMMARY

In an aspect the disclosure provides an isolated nucleic acid molecule having at least 80% sequence identity to any one of SEQ ID NOs: 763-1350 or 1565 or a complementary sequence thereof. Embodiments provide for sequence identity of at least 90% or 95%.

In an aspect the disclosure provides an isolated nucleic acid molecule comprises any one of SEQ ID NOs: 763-1350 or 1565 or a complementary sequence thereof. Embodiments provide for isolated nucleic acid molecules comprising a primary miRNA, a precursor miRNA, a mature miRNA, or a DNA molecule coding therefore. Embodiments further provide for a cDNA molecule comprising sequence that corresponds to a miRNA sequence of any one of SEQ ID NOs: 763-1350 or 1565.

Aspects of the disclosure provide compositions, pharmaceutical compositions, vectors, host cells, and DNA libraries comprising at least one nucleic acid molecule described herein.

In an aspect the disclosure provides a method of determining the B cell stage of a B cell malignancy in a subject comprising determining the level of expression of at least one microRNA in a sample comprising a B cell taken from the subject relative the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in Table 4.

In an aspect the disclosure provides a method of identifying a B cell malignancy in a subject comprising determining the level of expression of at least one microRNA in a sample comprising a B cell taken from the subject relative the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in Table 4.

In an aspect the disclosure provides a method of diagnosing a B cell malignancy in a subject comprising determining the level of expression of at least one microRNA in a sample comprising a B cell taken from the subject relative the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in Table 4.

In an aspect the disclosure provides a method of identifying a B cell malignancy in a subject comprising determining the level of expression of at least one microRNA in a sample comprising a B cell taken from the subject relative the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in any one of Tables 7 to 35.

In an aspect the disclosure provides a method of diagnosing a B cell malignancy in a subject comprising determining the level of expression of at least one microRNA in a sample comprising a B cell taken from the subject relative to the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in any one of Tables 7 to 35.

Embodiments of these aspects provide for identification or diagnosis of a B cell malignancy selected from chronic lymphocytic leukemia, follicular lymphoma, Hodgkin's lymphoma, activated B-cell diffuse large B cell lymphoma (DLBCL), germinal center-like DLBCL, and Burkitt lymphoma.

In an aspect the disclosure provides a method of determining whether a B cell malignancy in a sample is Burkitt lymphoma, activated B cell-like diffuse large B cell lymphoma (DLBCL), or germinal center-like DLBCL, comprising determining the level of expression of at least one microRNA in the sample relative to the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in Table 10, column “BL miRNA list”; Table 14, column “BL High”; Table 11; Table 14, column “ABC High”; Table 10, column “GCB miRNA list”; Table 14, column “GCB High”; Table 32, or Table 35.

In an aspect the disclosure provides a method of determining whether a B cell malignancy in a sample is Burkitt lymphoma, activated B cell-like diffuse large B cell lymphoma (DLBCL), or germinal center-like DLBCL, comprising determining the level of expression of at least one microRNA in the sample relative to the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in at least one column labeled “GCBvsBL” or “GCBvsABC” in Table 7 or “ABCvsBL” in Table 8.

In an aspect the disclosure provides a method of determining whether a B cell malignancy in a sample is activated B cell-like diffuse large B cell lymphoma (DLBCL), or germinal center-like DLBCL, comprising determining the level of expression of at least one microRNA in the sample relative to the level of expression of the at least one microRNA in a control sample, wherein the at least one microRNA is selected from the microRNAs listed in Table 35.

In an aspect the disclosure provides a microarray comprising miRNA-specific probe oligonucleotides wherein at least one miRNA-specific probe oligonucleotide is specific for a sequence of SEQ ID NOs: 763-1350 or 1565, or any combination thereof.

In an aspect the disclosure provides a kit comprising at least one primer sequence that can detect any one of SEQ ID NOs: 763-1350 or 1565, or a combination thereof.

In an aspect the disclosure provides a kit comprising at least one isolated nucleic acid molecule having a sequence of any one of SEQ ID NOs: 1351-1564.

In an aspect, the disclosure provides a method of identifying a B cell malignancy comprising determining the level of expression of at least one microRNA selected from the microRNAs listed in Table 4. In certain embodiments, a method comprises determining the level of expression of at least one microRNA selected from the microRNAs listed in Tables 7-35.

Other aspects and embodiments will be apparent to one of skill in the art in light of the following detailed description.

DESCRIPTION OF THE FIGURES

FIG. 1 shows that mature B cell subsets demonstrate distinct microRNA profiles. FIG. 1A is a diagram showing the overall schema of mature B cell differentiation. FIG. 1B shows selection of B cell subsets using flow cytometry. FIG. 1C shows the distinction between naive and memory B cells based on IgD and CD27 expression using flow cytometry. FIG. 1D shows relative expression of microRNA in the naive to germinal center B cell transition. FIG. 1E shows relative expression of mRNA in the naive to germinal center B cell transition. FIG. 1F shows relative expression of microRNA in the germinal center B cell to plasma cell transition. FIG. 1G shows relative expression of mRNA in the germinal center B cell to plasma cell transition. FIG. 1H shows relative expression of microRNA in the germinal center B cell to memory B cell transition. FIG. 1I shows relative expression of mRNA in the germinal center B cell to memory B cell transition. In FIGS. 1D, 1F, and 1H, miRNAs that were, on average, at least 2-fold differentially expressed at a false discovery rate of less than 5% are shown according to the color scale. In FIGS. and 1E, 1G, and 1I, mRNAs that were, on average, at least 2-fold differentially expressed at a false discovery rate of less than 1% are shown according to the color scale. FIG. 1J shows that expression of certain microRNA processing genes, DGCR8, DICER1, EIF2C2, DROSHA, and XP05 is unchanged among the B cell subsets (P>0.1 in all cases).

FIG. 2 shows experimental validation of the interaction of miR-223, which is expressed highly in naive and memory B cells compared to germinal center B cells, and targets the transcription factor LM02. FIG. 2A shows base-pairing of the 3′UTR of the LM02 gene with nucleotides 1-8 of miR-223. This 8-mer is highly conserved across a number of species and serves as a potential binding site for miR-223. FIG. 2B shows the effects of over-expression of miR-223 in germinal center lymphoma-derived BJAB cells in 3 separate experiments. FIG. 2C shows the relative LM02 protein expression from a representative experiment (from 3 replicates) transfecting a scrambled control versus a precursor for miR-223 in BJAB cells. FIG. 2D shows average expression of LM02 relative to Actin over three Western blots of BJAB cells transfected with a scrambled control versus a precursor for miR-223. FIG. 2E shows luciferase activity in BJAB cells transfected with a vector comprising either a luciferase gene coupled to the 3′UTR of the LM02 gene or a luciferase gene coupled to the 3′UTR of the LM02 gene with the miR-223 binding site mutated, and cotransfected with miR-223.

FIG. 3 shows experimental validation of the interaction of miR-9 and miR-30, which are expressed highly in germinal center B cells compared to plasma cells and target the transcription factor PRDMI. FIG. 3A shows base-pairing of the 3′UTR of the PRDM1 gene with the 5′ seed region of miR-9 and the miR-30 family. FIG. 3B shows the effects of over-expressing miR-9 and 2 members of the miR-30 family, miR-30b and miR-30d, in plasma cell myeloma-derived U266 cells in 3 separate experiments. FIG. 3C shows the relative PRDM1 protein expression from a representative experiment (from 3 replicates) transfecting a scrambled control versus a precursor for miR-9, miR-30b, or miR-30d in U266 cells. FIG. 3D shows the average expression of PRDM1 relative to Actin over three Western blots of U266 cells transfected with a scrambled control versus a precursor for miR-9, miR-30b, or miR-30d. (P<0.05 for miR-30b and miR-30d, P=0.08 for miR-9.) FIG. 3E shows repression of luciferase activity from the PRDM1 3′UTR construct by overexpression of miR-9, miR-30b, and miR-30d wild-type and mutant sequences.

FIG. 4 shows that expression of microRNAs in normal B cells is conserved in certain B cell malignancies. FIG. 4A shows lineage prediction of both IgV mutated and unmutated chronic lymphocytic leukemia, germinal center B cell derived DLBCL, and Burkitt lymphoma based on differential expression of microRNAs in normal naïve B cells and germinal center B cells (microRNAs depicted in FIG. 1D). FIG. 4B shows miRNAs that were found to be differentially expressed (P<0.05) in malignant cells and normal cells as discussed in Example 5. FIG. 4C shows cloning frequency of miRNAs in unselected mature B cells (N=3) and certain B cell malignancies (N=42) from a previously published study (“sequencing data”), as discussed in Example 5. FIG. 4D shows differentially expressed miRNAs that distinguish Burkitt lymphoma, activated B cell-like (ABC) diffuse large B cell lymphoma (DLBCL), germinal center-like DLBCL (GCB DLBCL), and chronic lymphocytic leukemia. Predictor miRNAs from each pair-wise comparison that distinguish each entity are shown in the boxes.

FIG. 5 shows the distribution of miRNAs present in B-cell subsets.

FIG. 6 shows that certain microRNA targets are expressed at lower levels. FIG. 6A shows density plots of the expression frequency of predicted mRNA targets of miRNAs expressed highly in germinal center B cells compared to naive cells. FIG. 6B shows density plots of the expression frequency of predicted mRNA targets of miRNAs expressed highly in germinal center B cells compared to plasma cells. FIG. 6C shows density plots of the expression frequency of predicted mRNA targets of miRNAs expressed highly in the germinal center B cells compared to memory B cells.

FIG. 7 shows that differentially expressed transcription factors are frequently microRNA targets. In FIG. 7A, the left panel indicates the proportion of transcription factors that are differentially expressed in the naive to germinal center B-cell transition that are also predicted targets of differentially expressed miRNAs. The right panel indicates the proportion of transcription factors that are not differentially expressed and also are predicted targets of differentially expressed miRNA in that stage-transition. The p-value indicates the results of a chi-squared test for the enrichment of predicted miRNA targets among the differentially expressed transcription factors. FIG. 7B shows a similar analysis of the germinal center to plasma cell transition. FIG. 7C shows a similar analysis of the germinal center to memory cell transition.

FIG. 8 shows that Mybl transcript levels decrease with miR-223 overexpression. FIG. 8A shows base-pairing of the 3′UTR of the MYBL1 gene with nucleotides 2-8 of miR-223. This 7-mer is highly conserved across a number of species and serves as a potential binding site for miR-223. FIG. 8B shows the effects of over-expression of miR-223 in germinal center lymphoma-derived BJAB cells in 3 separate experiments.

FIG. 9 shows the specificity of real-time PCR probes for members of the miR-30 family.

FIG. 10 shows the results of leave one out cross validation applied to the predictors for Burkitt lymphoma, chronic lymphocytic leukemia, activated B-cell diffuse large B-cell lymphoma, and germinal center B-cell DLBCL.

FIG. 11 shows differentially expressed miRNAs that distinguish activated B cell-like diffuse large B cell lymphoma (DLBCL), germinal center-like DLBCL (GCB DLBCL), Burkitt lymphoma, chronic lymphocytic leukemia, follicular lymphoma, and Hodgkin's lymphoma. Predictor miRNAs from each pair-wise comparison that distinguish each entity are shown in the boxes.

DETAILED DESCRIPTION

All patent and non-patent literature references that are cited herein are incorporated herein by reference in their entirety.

In a general sense, the disclosure relates to nucleic acid sequences, such as microRNAs (miRNA), as well as to the identification and analysis of microRNA expression levels and/or patterns in B cells. Through concomitant microRNA and mRNA profiling, the inventors have identified regulatory roles for microRNAs at each stage in mature B cell differentiation. This provides methods identifying microRNA-mediated regulation of oncogenes and key transcription factors in B cell differentiation. This work establishes the landscape of normal microRNA expression in mature B cells and its role in regulating normal B cell differentiation. Further, our work demonstrates that in contrast to the described down-regulation in other malignancies, stage-specific microRNAs are retained in B cell malignancies. The lineage of common B cell malignancies can be predicted based upon miRNA profiles of normal B cells, pointing to a role for microRNAs in the maintenance of mature B cell phenotypes in normal and malignant B cells.

In an aspect, the disclosure relates to an isolated nucleic acid molecule comprising: (a) a nucleotide sequence as shown in Table 32; (b) a nucleotide sequence which is the complement of (a), (c) a nucleotide sequence comprising a sequence identity of at least 80%, (e.g., 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or at least 99%), to a sequence of (a) or (b) and/or (d) a nucleotide sequence which hybridizes under stringent conditions to a sequence of (a), (b) and/or (c). In some embodiments, the identity of sequence (c) to a sequence of (a) or (b) is at least 90%. In other embodiments, the identity of sequence (c) to a sequence of (a) or (b) at least 95%. The percent identity can be calculated by any routine method used by one of skill in the art such as, for example, the methods described herein.

In embodiments, the isolated nucleic acid molecule relates to a miRNA molecule and analogs thereof, a miRNA precursor molecule, or a primary miRNA molecule, as well as to DNA molecules encoding miRNA, miRNA precursor, or primary miRNA molecules. Accordingly, in such embodiments, the isolated nucleic acid molecule can function as a miRNA molecule under suitable conditions. Suitable conditions include, but are not limited to, various buffer systems that approximate physiologically relevant ionic concentrations and pHs, as well as physiological conditions.

In some embodiments, the nucleic acid molecule comprises a sequence that hybridizes to a nucleotide sequence as shown in Table 32, a complementary sequence thereof or a nucleic acid molecule having at least 80% sequence identity under stringent hybridization conditions. The basic parameters affecting the choice of hybridization conditions and guidance for devising suitable conditions are set forth by Sambrook, et al. (See, 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.; and Current Protocols in Molecular Biology, 1995, Ausubel et al., eds., John Wiley & Sons, Inc.), and can be readily determined by those of ordinary skill in the art based on, for example, the length and/or base composition of the DNA. Generally, stringent salt concentration will ordinarily be less than about 750 mM NaCl and 75 mM trisodium citrate, or less than about 500 mM NaCl and 50 mM trisodium citrate, or even less than about 250 mM NaCl and 25 mM trisodium citrate. High stringency hybridization conditions can be obtained by adding an amount of organic solvent (e.g., at least about 35% to about 50% formamide). Stringent temperature conditions will ordinarily include temperatures of at least about 30° C., (e.g., at least about 37° C., 42° C., 45° C., 50° C., or 55° C.). Varying additional parameters, such as hybridization time, the concentration of detergent (e.g., 0.1-1.0% sodium dodecyl sulfate (SDS)), and the inclusion or exclusion of carrier DNA (e.g., about 100-200 μg/ml denatured salmon sperm DNA (ssDNA)), are well known to those skilled in the art. Stringent hybridization conditions are known in the art and include non-limiting examples such as, washing for 1 hr in 300 mM NaCl, 30 mM trisodium citrate and 0.1% SDS at 45-50° C.; washing for 1 h in 300 mM NaCl, 30 mM trisodium citrate and 0.1% SDS at 45-50° C.; in 500 mM NaCl, 50 mM trisodium citrate, 1% SDS, 35% formamide, and 100 μg/ml denatured salmon sperm DNA (ssDNA) at 37° C.; or in 250 mM NaCl, 25 mM trisodium citrate, 1% SDS, 50% formamide, and 200 μg/ml ssDNA at 42° C. Useful variations on these conditions will be readily apparent to those skilled in the art.

The isolated nucleic acid molecules provided herein suitably have a length of from about 18 to about 100 nucleotides. In embodiments wherein the isolated nucleic acid molecules are miRNAs, the lengths of the miRNAs are suitably in an expected range for the particular type of miRNA molecule. For example, mature miRNAs are typically from about 15 to about 28 nucleotides in length, and suitably have a length of about 19 to about 24 nucleotides (e.g., 19, 20, 21, 22, 23, or 24 nucleotides). Precursor miRNAs typically comprise the mature miRNA sequence and contain a stem-loop structure, suitably of length of about 50 to about 90 nucleotides (e.g., 50, 55, 60, 65, 70, 75, 80, 85, or 90 nucleotides). Primary miRNAs (e.g., a primary transcript comprising a precursor miRNA) can suitably have a length of greater than 100 nucleotides.

The nucleic acid molecules can be provided in either a single-stranded or double-stranded form. Typically, a miRNA as such is identified as a single-stranded molecule, while the precursor miRNA is typically at least partially self-complementary and capable of forming double-stranded portions, e.g. stem- and loop-structures. DNA molecules encoding the miRNA and miRNA precursor molecules (e.g., expression vectors, cloning vectors, and the like) are typically double-stranded. The individual nucleic acids that comprise the isolated nucleic acid molecules can be selected from RNA, DNA, or nucleic acid analog molecules, such as chemically modified sugar (e.g., 2′-modified (2′-F, 2′-OMe, etc.) or backbone (e.g., phosphorothioates), or cap (e.g., 5′- and/or 3′-abasic groups) moieties of ribonucleotides or deoxyribonucleotides. Other nucleic acid analogs, such as peptide nucleic acids (PNA) or locked nucleic acids (LNA), are also suitable in various embodiments described herein. In some embodiments the nucleic acid molecules can comprise any combination of nucleic acid analog(s).

While many of the nucleic acid molecules in the Tables are identified as RNA sequences, e.g., miRNAs, the disclosure of those sequences should be understood to encompass the corresponding DNA (e.g., cDNA) sequences, wherein the uracil (U) nucleotides of the disclosed RNAs are substituted by thymidine (T) nucleotides in the corresponding DNA. One of skill in the art is able to generate such DNA sequences (e.g., cDNA) through routine microbiological techniques known in the art such as, for example, reverse transcription using methods that incorporate the reverse transcriptase enzyme.

In another aspect, the disclosure provides a recombinant expression vector comprising a recombinant nucleic acid sequence operatively linked to an expression control sequence, wherein expression of the recombinant nucleic acid sequence provides a miRNA sequence, a precursor miRNA sequence, or a primary miRNA sequence as described herein. The resulting sequence (e.g., primary or precursor miRNAs) can optionally be further processed to provide the miRNA sequence. In embodiments, the recombinant expression vector comprises at least one sequence in Table 32. Any suitable expression vector can be used such as, for example, a DNA vector (e.g., viral vector, plasmid, etc.). In some embodiments the expression vector is selected for expression in a eukaryotic cell such as, for example, a mammalian cell. One of skill in the art will be able to select an appropriate vector based on the particular application and/or expression system to be employed.

Thus, embodiments provide nucleic acid constructs in the form of plasmids, vectors, transcription or expression cassettes which comprise at least one nucleotide sequence encoding a miRNA described herein, or fragments thereof, and a suitable promoter region. Suitable vectors can be chosen or constructed, which contain appropriate regulatory sequences, such as promoter sequences, terminator sequences, polyadenylation sequences, enhancer sequences, marker genes and other sequences as desired. Vectors can be plasmids, phage (e.g. phage, or phagemid) or viral (e.g. lentivirus, adenovirus, AAV) or any other appropriate vector. For further details see, for example, Molecular Cloning: a Laboratory Manual: 2nd edition, Sambrook et al., 1989, Cold Spring Harbor Laboratory Press.

Relatedness of Nucleic Acid Molecules/Sequences

The term “identity” refers to a relationship between the sequences of two or more two or more nucleic acid molecules, as determined by comparing the sequences. In the art, “identity” also means the degree of sequence relatedness between amino acid or nucleic acid molecule sequences, as the case may be, as determined by the match between strings of nucleotide or amino acid sequences. “Identity” measures the percent of identical matches between two or more sequences with gap alignments addressed by a particular mathematical model or computer programs (i.e., “algorithms”).

Identity of related nucleic acid molecules can be readily calculated by known methods, including but not limited to those described in Computational Molecular Biology, Lesk, A. M., ed., Oxford University Press, New York, 1988; Biocomputing: Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York, 19933; Computer Analysis of Sequence Data, Part 1, Griffin, A. M., and Griffin, H. G., eds., Humana Press, New Jersey, 1994; Sequence Analysis in Molecular Biology, von Heinje, G., Academic Press, 1987; and Sequence Analysis Primer, Gribskov, M. and Devereux, J., eds., M. Stockton Press, New York, 1991; and Carillo, H., and Lipman, D., SIAM J. Applied Math., 48:1073 (1988).

Non-limiting methods for determining identity are designed to give the largest match between the sequences tested. Methods to determine identity are codified in publicly available computer programs. Preferred computer program methods to determine identity between two sequences include, but are not limited to, the GCG program package, including GAP (Devereux, et al., Nucleic Acids Research 12:387 [1984]; Genetics Computer Group, University of Wisconsin, Madison, Wis.), BLASTN, and FASTA (Atschul et al., J. Molec. Biol. 215:403-410 [1990]). The BLAST X program is publicly available from the National Center for Biotechnology Information (NCBI) and other sources (BLAST Manual, Altschul] et al., NCB NLM NIH Bethesda, Md. 20894; Altschul et al., J. Mol. Biol. 215:403-410 [1990]). The well known Smith Waterman algorithm may also be used to determine identity.

Exemplary parameters for nucleic acid molecule sequence comparison include the following:

Algorithm: Needleman and Wunsch, J. Mol Biol. 48:443-453 (1970)

Comparison matrix: matches=+10, mismatch=0

Gap Penalty: 50

Gap Length Penalty: 3

The GAP program is also useful with the above parameters. The aforementioned parameters are the default parameters for nucleic acid molecule comparisons.

Other exemplary algorithms, gap opening penalties, gap extension penalties, comparison matrices, thresholds of similarity, etc. can be used by those of skill in the art, including those set forth in the Program Manual, Wisconsin Package, Version 9, September 1997. The particular choices to be made will depend on the specific comparison to be made, such as DNA to DNA or RNA to DNA; and additionally, whether the comparison is between given pairs of sequences (in which case GAP or BestFit are generally preferred) or between one sequence and a large database of sequences (in which case FASTA or BLASTA are preferred).

In an aspect, the disclosure provides a vector comprising the isolated polynucleotide as described herein such as, for example one or more of SEQ ID NOs 773-1046 or 1450-1542. In embodiments, the vector can be any type of vector that finds use as a vehicle to transfer foreign genetic material into a cell. Non-limiting examples of vectors include plasmids, viral vectors (e.g., derived from lentivirus, adenovirus, adeno-associated virus (AAV), retrovirus, etc.), bacteriophage, cosmids, and artificial chromosomes. In embodiments, the vector can be an expression (or expression constructs) for driving expression of the polynucleotide in a target cell. Vectors and methods for inserting them into a target cell are known in the art [See, e.g., Sambrook et al., 1989].

In an aspect, the disclosure provides recombinant cells that comprise the vectors and/or polynucleotides described herein. The cells can be any cell suitable as a host for recombinant nucleic acid molecules, and selected based on well known techniques. Techniques for generating and maintaining recombinant cells are known in the art, such as those described in Sambrook et al., 1989.

The term “B cell malignancy,” as used herein, refers to a malignancy derived from any stage of B cell, including, but not limited to, naïve cells, germinal center cells, memory B cells, and plasma cells. Examples of B cell malignancies include, but are not limited to, mantle cell lymphoma, follicular lymphoma, Hodgkin's lymphoma, Burkitt lymphoma, germinal center B-cell like diffuse large B cell lymphoma (DLBCL), chronic lymphocytic leukemia, small lymphocytic lymphoma, lymphoplasmacytic lymphoma, multiple myeloma, and activated B-cell like DLBCL.

In an aspect, the disclosure provides a method of distinguishing B cell malignancies on the basis of the B-cell origin. In certain embodiments, methods of diagnosing B cell malignancies on the basis of the B-cell origin are provided. In certain such embodiments, a B cell malignancy is determined to be derived from a particular B-cell stage. The B-cell origin of a B cell malignancy may be determined, in certain embodiments, by detecting one or more microRNAs that can be used to distinguish B-cell stages. Certain exemplary B-cell stages include, but are not limited to, naïve cells, germinal center cells, memory B cells, and plasma cells. Certain exemplary microRNAs that can be used to distinguish B-cell stages are shown in Table 4. In various embodiments, the method comprises detecting at least one, at least two, at least five, at least 10, at least 20, at least 30, at least 50, at least 75, or at least 100 microRNAs.

In certain embodiments, a panel of microRNAs is selected that will allow determination of the B cell stage from which a B cell malignancy is derived. For example, in certain embodiments, two or more microRNAs from Table 4 are selected such that detection of the levels of those microRNAs in a B cell malignancy will indicate whether the B cell malignancy is derived from naïve, germinal center, plasma, or memory B cells. In various embodiments, the panel of microRNAs comprises at least one, at least two, at least five, at least 10, at least 20, at least 30, at least 50, at least 75, or at least 100 microRNAs from Table 4. One skilled in the art can select a suitable panel of microRNAs, including one or more microRNAs from Table 4, according to the intended use of the panel.

As described throughout the disclosure, the methods herein can include detecting one or a plurality of miRNAs. When the term “at least” is used in association with a number (e.g., “at least 20”) that term will be understood to include 20 as well as optionally any integer after 20 and up to and including the total number of microRNAs disclosed herein.

In some embodiments, a B cell malignancy derived from naïve cells is mantle cell lymphoma. In other embodiments, a B cell malignancy derived from germinal center cells includes, but is not limited to, follicular lymphoma, Hodgkin's lymphoma, Burkitt lymphoma, or germinal center B-cell like diffuse large B cell lymphoma (DLBCL). In other embodiments, a B cell malignancy derived from memory B cells includes, but is not limited to, chronic lymphocytic leukemia or small lymphocytic lymphoma. In some embodiments, a B cell malignancy derived from plasma cells includes, but is not limited to, multiple myeloma or activated B-cell DLBCL.

Certain B cell malignancies can be difficult to distinguish using current methodologies. In extreme cases, almost any B cell malignancy can be confused with another. As illustrative examples, Burkitt lymphoma and DLBCLs are often confused. Similarly, mantle cell lymphoma and small lymphocytic lymphoma can also be confused. Burkitt lymphoma and germinal center DLBCL are both derived from germinal center cells, while activated B-cell DLBCL is derived from plasma cells. Thus, if a B cell malignancy appears to be Burkitt lymphoma or a DLBCL, in certain embodiments, microRNA analysis can be used to narrow down the B cell malignancy to either a germinal center cell-derived B cell malignancy or a plasma cell-derived B cell malignancy. If the B cell malignancy is plasma-cell derived, then it may be activated B-cell DLBCL.

Thus, in certain embodiments, when the identity of a particular B cell malignancy has been narrowed down to two or more possible B cell malignancies, and at least two of those B cell malignancies are derived from different B cell stages, microRNAs that distinguish certain B cell stages can be used to further narrow down the identity of the B cell malignancy. In certain embodiments, microRNAs that distinguish certain B cell stages can be used to identify the B cell malignancy. One or more such microRNAs can be selected, in certain embodiments, from the microRNAs in Table 4. One skilled in the art can select a suitable set of microRNAs, including at least one microRNA from Table 4, for distinguishing particular B cell stages.

In an aspect, the disclosure provides a method of identifying a B cell malignancy comprising detecting one or a plurality of microRNAs. In certain embodiments, the method can provide a diagnosis of a B cell malignancy. In certain embodiments, one or more microRNAs that are characteristic of a particular B cell malignancy are used to identify the B cell malignancy. In certain embodiments, the identity of the B cell malignancy is first narrowed down to a list of two or more particular B cell malignancies using, for example, tumor morphology and/or immunohistochemistry and/or microRNA detection, e.g., to determine the B cell stage from which the tumor is derived. Certain exemplary microRNAs that can be used to identify B cell malignancies are shown in the Tables (e.g., Tables 7-35).

In certain embodiments, methods of identifying B cell malignancies comprise detecting one or more microRNAs from one or more of Tables 7 to 15, and Appendix B, Tables 16 to 30. That is, in certain embodiments, a panel of microRNAs is selected that will identify a B cell malignancy as being one of a particular selection of B cell malignancies. As a non-limiting example, a panel of microRNAs can be designed to identify a B cell malignancy as one of Burkitt lymphoma, ABC DLBCL, or GCB DLBCL. In certain such embodiments, the panel of microRNAs comprises at least one microRNA from Table 10, column “BL miRNA list” and/or Table 14, column “BL High”; at least one microRNA from Table 11 and/or Table 14, column “ABC High”; and at least one microRNA from Table 10, column “GCB miRNA list” and/or Table 14, column “GCB High”.

When other methods indicate a particular identity for a B cell malignancy, in certain embodiments, microRNAs can be used to confirm that identification. Thus, for example, if a B cell malignancy is believed to be a Burkitt lymphoma, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 10, column “BL miRNA list” and/or Table 14, column “BL High”. Similarly, if a B cell malignancy is believed to be ABC DLBCL, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 11 and/or Table 14, column “ABC High”. If a B cell malignancy is believed to be GCB DLBCL, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 10, column “GCB miRNA list” and/or Table 14, column “GCB High”. If a B cell malignancy is believed to be chronic lymphocytic leukemia, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 12 and/or Table 15, column “CLL High”. If a B cell malignancy is believed to be Hodgkin's lymphoma, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 13 and/or Table 15, column “HL High”. If a B cell malignancy is believed to be follicular lymphoma, that identification can be confirmed by determining the expression level of one or more microRNAs listed in Table 10, column “FL miRNA list” and/or Table 15, column “FL High”.

In certain embodiments, when the identity of a B cell malignancy has been narrowed down to two B cell malignancies selected from Burkitt lymphoma, GCB DLBCL, ABC DLBCL, chronic lymphocytic leukemia, follicular lymphoma, and Hodgkin's lymphoma, the identity of the B cell malignancy can be determined by detecting one or more microRNAs from Tables 16 to 30.

As discussed in the Examples, the miRNAs described herein as differentially expressed in a B cell malignancy have been identified with high confidence, and thus, identification of one miRNA is adequate to perform the methods of identification and diagnosis disclosed herein. Accordingly, in various embodiments, the methods can comprise detecting at least one, at least two, at least five, at least 10, at least 20, at least 30, or at least 50 microRNAs in order to narrow down the identity of, or identify, a B cell malignancy.

As noted above, the treatment regimens and prognoses for the various B cell malignancies can differ significantly. Thus, determining the correct identity and/or origin of a B cell malignancy can be important for selecting an effective therapy and/or setting appropriate patient expectations.

B cell malignancy samples may be obtained and prepared using methods known in the art. One skilled in the art can select an appropriate method of obtaining a B cell malignancy sample according to various parameters, such as the age, size, medical history, and/or identity of the patient. One skilled in the art can select an appropriate method of preparing a B cell malignancy sample for analysis according to the B cell malignancy sample source, size, quality, and/or intended use. For example, in certain embodiments, a B cell malignancy sample is prepared in a manner that preserves microRNAs in the sample as much as practicable under the circumstances.

MicroRNAs can be detected using any method known in the art. Exemplary methods of detecting microRNAs include, but are not limited to, hybridization-based methods and amplification-based methods. Certain exemplary detection methods include, but are not limited to, arrays (including microarrays and bead-based arrays), in situ hybridization, Northern blotting, TaqMan probes, RT-PCR, real-time PCR, and direct sequencing. One skilled in the art can select a suitable detection method according to the sample source, size, quality, and/or particular application.

In certain embodiments, real-time PCR is employed to determine the expression level of a microRNA. In some embodiments a miRNA is considered present in a subpopulation if the cycling time (CT) is less than 36 in all three biological replicates, and a CT greater than 36 is undetected.

In certain embodiments, the expression level of a microRNA in a sample is determined relative to a control sample. A control sample may be selected, in various embodiments, because it is expected to have either high or low expression of the microRNA.

In certain embodiments, the expression level of a microRNA may be normalized to the expression level of a polynucleotide that is expected to be expressed at similar levels in several different cell types and/or at constant levels in the cell type being analyzed.

In certain embodiments, an identified miRNA from Tables 7-35 is used to distinguish one of the six exemplified B cell malignancies from the other malignanicies. A “high” and a “low” in Tables 10 to 13 refer to at least a 2-fold difference in the expression of the identified miRNA when one lymphoma is compared to other lymphomas and benign lymph nodes.

In embodiments, mRNA levels can be profiled by using a microarray. In some embodiments, array elements with median signal intensities of less than 7 log 2 units across samples are removed from analysis. In embodiments, a gene is considered for further analysis if it is on-average 2-fold or higher differentially expressed in a binary comparison of B cell subsets and expressed in at least one of the two B cell subsets being compared.

In an embodiment, the level of at least one miRNA is measured by reverse transcribing RNA from a test sample obtained from a subject to provide a set of target oligodeoxynucleotides, hybridizing the target oligodeoxynucleotides to one or more miRNA-specific probe oligonucleotides (e.g., a microarray that comprises miRNA-specific probe oligonucleotides) to provide a hybridization profile for the test sample, and comparing the test sample hybridization profile to a hybridization profile generated from a control sample. An alteration in the signal of at least one miRNA in the test sample relative to the control sample is indicative of the subject either having, or being at risk for developing, a B-cell malignancy. In an embodiment, the signal of at least one miRNA is upregulated, relative to the signal generated from the control sample. In another embodiment, the signal of at least one miRNA is down-regulated, relative to the signal generated from the control sample. In some embodiments, the microarray comprises miRNA-specific probe oligonucleotides for a substantial portion of all known human miRNAs. In a further embodiment, the microarray comprises miRNA-specific probe oligonucleotides for one or more miRNAs selected from the group consisting of SEQ ID NOs: 763-1350, or 1565 and any combination thereof.

The microarray can be prepared from gene-specific oligonucleotide probes generated from known miRNA sequences. The array may contain two different oligonucleotide probes for each miRNA, one containing the active, mature sequence and the other being specific for the precursor of the miRNA. The array may also contain controls, such as one or more mouse sequences differing from human orthologs by only a few bases, which can serve as controls for hybridization stringency conditions. tRNAs and other RNAs (e.g., rRNAs, mRNAs) from both species may also be printed on the microchip, providing an internal, relatively stable, positive control for specific hybridization. One or more appropriate controls for non-specific hybridization may also be included on the microchip. For this purpose, sequences are selected based upon the absence of any homology with any known miRNAs.

The microarray may be fabricated using techniques known in the art. For example, probe oligonucleotides of an appropriate length, e.g., 40 nucleotides, are 5′-amine modified at position C6 and printed using commercially available microarray systems. Labeled cDNA corresponding to the target RNA sequence(s) is prepared by reverse transcribing the target RNA with labeled primer. Following first strand synthesis, the RNA/DNA hybrids are denatured to degrade the RNA templates. The labeled target cDNAs thus prepared are then hybridized to the microarray chip under typical hybridizing conditions. At positions on the array where the immobilized probe DNA recognizes a complementary target cDNA in the sample, hybridization occurs. The labeled target cDNA marks the exact position on the array where binding occurs, allowing automatic detection and quantification. The output consists of a list of hybridization events, indicating the relative abundance of specific cDNA sequences, and therefore the relative abundance of the corresponding complementary miRNAs, in the patient sample.

In an aspect, the disclosure relates to kits. Such kits can be used in methods of identifying a miRNA or mRNA described herein; an expression level or expression pattern of one or more miRNA(s) or mRNA(s) described herein; and/or identifying a B-cell malignancy. In some embodiments the kit can provide a diagnosis of a B-cell type and or a B-cell malignancy. In some embodiments the kit can differentiate one B-cell malignancy from other B-cell malignancies (e.g., ABC-DLBCL from GBC-DLBCL), and can provide information useful to a medical professional regarding a preferred course of therapeutic treatment. Suitably, a kit can comprise an isolated nucleic acid molecule or a plurality of isolated nucleic acid molecules as described herein (e.g., a sequence complementary to any of the miRNAs disclosed in the Tables). In embodiments, the isolated nucleic acid molecule can comprise a sequence of one or more RT-PCR target sequences, primers directed thereto, or a sequence complementary thereto. The kit can also include adapter nucleic acid molecules (e.g., universal adapter molecules for attachment to expressed miRNAs/mRNAs for reverse transcription and amplification); appropriate buffer systems and reagents, detectable labels, an energy source (e.g., ATP), and other agents and components that can be used in performing analysis of miRNA expression (e.g., in RT-PCR, deep sequencing, or microarray-based methods). Kits also include instructions for use.

It will be understood that any numerical value recited herein includes all values from the lower value to the upper value. For example, if a concentration range is stated as 1% to 50%, it is intended that values such as 2% to 40%, 10% to 30%, or 1% to 3%, etc., are expressly enumerated in this specification. These are only examples of what is specifically intended, and all possible combinations of numerical values between the lowest value and the highest value enumerated are to be considered to be expressly stated in this application.

In an aspect, the disclosure provides a DNA library comprising one or more miRNA sequences from Tables 4-5, or 6-33. In a related aspect, the disclosure provides a method for generating such a DNA library. In an embodiment the library comprises a cDNA library that includes sequences derived from a sample of the miRNAs or, in addition or alternatively, the mRNA purified from a particular source such as, for example, a collection of cells, a particular tissue, or an entire organism. In embodiments, the source of the cDNA library is a B cell, such as a B cell in any stage (e.g., naïve, germinal center, memory, activated, or plasma, etc.) or a B cell malignancy (e.g., mantle cell lymphoma, follicular lymphoma, Hodgkin's lymphoma, Burkitt lymphoma, germinal center B-cell like diffuse large B cell lymphoma (DLBCL), chronic lymphocytic leukemia, small lymphocytic lymphoma, lymphoplasmacytic lymphoma, multiple myeloma, and activated B-cell like DLBCL). Typically, the isolated miRNA (or mRNA) is converted to a DNA template by reverse transcription, and comprises the cDNA version of the expressed RNA (e.g., miRNA or mRNA). Thus, a library can represent the cDNA version of the active “transcriptome” in a particular source under the physiological, developmental, or environmental conditions that existed when the miRNA/mRNA was purified.

In an embodiment, the library comprises a miRNA sequence described in Tables 4-5; 7-33. In embodiments, the library comprises at least one of SEQ ID NOs 763-1350 or 1565, and any combination thereof. In an embodiment, the library comprises a collection of miRNA sequences comprising SEQ ID NOs 763-1350 or 1565. In embodiments the library can be used to identify and/or differentiate a B-cell malignancy from other B-cell malignancies. In such embodiments, the library comprises at least one miRNA sequence selected from those listed in any of Tables 4 or 7-35.

As used herein, a “library” is a collection of DNA sequences that is stored and propagated in a population of microorganisms through standard molecular cloning processes. A DNA library can be of any type such as, for example, a cDNA library (formed from reverse-transcribed RNA) or a genomic library (formed from genomic DNA). The DNA library can be used in any routine application or technique known in the art (e.g., gene discovery; cloning of full-length cDNAs to identify/study gene function; miRNA/mRNA expression in different cells or tissues; splice variants in different cells or tissues) and, in some embodiments, can depend on the source of the original DNA fragments. In embodiments, the library can be used to isolate, characterize, and/or quantify the actively expressed miRNA is a population of cells such as, for example, B-cells or B-cell malignancies. In some embodiments, the library can be used to study miRNA-protein interactions or miRNA-based regulation of protein expression or activity.

Any known method of library preparation can be used to make the library described herein, including the methods described in the detailed description and non-limiting Examples. Further general techniques can be based on the methods and techniques known in the art, (see, e.g., RNA Methodologies: A Laboratory Guide for Isolation and Characterization (R. E. Farrell, Academic Press, 1998); cDNA Library Protocols (Cowell & Austin, eds., Humana Press; Functional Genomics (Hunt & Livesey, eds., 2000); and the Annual Review of Genomics and Human Genetics (E. Lander, ed., yearly publications by Annual Reviews). Suitably, the nucleotide sequences of interest in a library are preserved as inserts in a plasmid or the genome of a bacteriophage that has been used to infect bacterial cells. There are differences in the cloning vectors and techniques used in library preparation, but in general each DNA fragment is uniquely inserted into a cloning vector and the pool of recombinant DNA molecules is then transferred into a population of bacteria or yeast such that each organism contains on average one construct (vector+insert). The DNA molecules are copied and propagated along with the population of organisms in culture (thus, effectively, “cloned”). Accordingly, in some embodiments, the term “library” can refer to a population of organisms, each of which carries a DNA molecule inserted into a cloning vector, or alternatively to the collection of all of the cloned vector molecules.

An “increased level” of expression, as used herein, refers to a level of expression that is at least 2-fold greater than the level of expression in a control cell type or tissue. In various embodiments, the level of expression is at least 2.5-fold, at least 3-fold, at least 5-fold, or at least 10-fold, greater than the level of expression in a control cell. Exemplary control cells and tissues include, but are not limited to, normal cells, benign lymph nodes, and other B cell malignancies. In certain embodiments, benign lymph nodes are used as a control tissue. Such benign lymph node tissue contains a variety of cell types.

A “decreased level” of expression, as used herein, refers to a level of expression that is less than 50% of the level of expression in a control cell.

The term “differentially expressed” or “differential expression” relates to a difference in the observed or detected level of expression of a biomolecule such as, for example, nucleic acids (e.g., a polynucleotide, mRNA, miRNA, etc.) or amino acid sequence (e.g., protein, polypeptide, etc.) in a test sample relative to the observed or detected level of expression of the same biomolecule in a control sample or other reference (e.g., a previously established reference level). The difference in expression can be either an increase or a decrease in the expression of the biomolecule in the test sample relative to the control sample.

The Examples that follow provide further illustration of certain aspects and embodiments described in the foregoing description. These illustrative Examples should not be interpreted as limiting the scope of the appended claims.

EXAMPLES Example 1 Materials and Methods

Patient Sample Processing

B cell populations were obtained from young patients undergoing routine tonsillectomy using a protocol approved by the Clinical Center at the National Institutes of Health. Patient tonsils were disaggregated and separated by Ficoll. The mononuclear cell layer was harvested, washed in PBS, and resuspended in ACK lysing buffer to remove small numbers of red blood cells. After a wash and resuspension with 10 ml of PBS with 10% Bovine Serum Albumin, cells were counted and 200 million were stained with fluorochrome-tagged monoclonal antibodies to CDI9, IgD, CD38 and CD27. The specific monoclonal antibodies employed were anti-CDI9-PE-Cy5.5, anti-IgD-FITC, anti-CD27-PE, and anti-CD38-APC, all from BD Biosciences and BD Pharmingen (San Jose Calif.). Cells were sorted using the MoFIo Cell sorter (Dako Cytomation, Colorado Springs, Colo.) into naive B cells (CDI9+IgD+CD2TCD38+), germinal center B cells (CDI9+IgD-CD38++), memory B cells (CDI9+IgD-CD27+CD38dim) and plasma cells (CDI9dimIgD-CD27++CD38+++). Three replicates of each B cell subset were obtained from separate patients. The sample purity was verified by FACS and found to be over 90% in all cases.

Tumor specimens were obtained from patients who were examined under a protocol approved by the Duke University Medical Center Institutional Review Board. The pathologic diagnosis of the samples was verified prior to analysis. Samples from patients with diffuse large B cell lymphoma were further subclassified as described previously. See Hans et al. (2004) Blood 103: 275-282. Chronic lymphocytic leukemia samples were processed and purified as described previously. See Volkheimer et al. (2007) Blood 109: 1559-1567. Total RNA was extracted using the phenol-chloroform method to preserve miRNAs, using Ambion reagents.

microRNA Profiling Using Multiplexed Real-time PCR

MiRNA expression profiling was conducted using the Applied Biosystems 384-well multiplexed real-time PCR assay using 400 ng of total RNA. Eight reactions, each containing 50 ng of RNA and a multiplex looped primer pool with endogenous small nucleolar (sno)-RNA controls, were used to reverse-transcribe the miRNAs in parallel fashion. Each completed reaction was loaded onto the 384-well plate per manufacturer's instructions, and real-time PCR was run on the ABI 7900HT Prism. For each 384-well plate, we used the automatically determined cycle-threshold (CT) using the SDS 2.2.1 software (Applied Biosystems). Consistent with manufacturer recommendations, we considered CT greater than 36 as undetected. A miRNA was considered to be present in a subpopulation if the CT was less than 36 in all three biological replicates. The probes deemed to be present were normalized to the average expression of a sno-RNA control. The expression values were calculated as 2^(−ΔCT), then median centered to 500 and log 2-transformed.

Gene Expression (mRNA) Profiling Using Microarrays

Gene expression profiling and normalization were performed using methods identical to those we have described previously. See Dave et al. (2004) N. Engl. J. Med. 351: 2159-2169. Array elements with median signal intensities of less than 7 log 2 units across the samples were removed from analysis, in order to exclude poorly measured genes and genes not appreciably expressed in the samples. Genes that were on-average 2-fold or higher differentially expressed in a binary comparison of B cell subsets, and appreciably expressed in at least one of the 2 B cell subsets being compared, were selected for further analysis as described below. The data have been deposited in the publicly available Gene Expression Omnibus database (GSE12366).

MiRNA Profiling Using Microarray

MiRNA expression profiling from human B cell malignancies was conducted using up to 1 μg of total RNA from sample and reference (normal lymph node), which were labeled with Cy3 or Cy5 fluorescent dyes, using the miRNA/LNA labeling kit (Exiqon, Denmark). The fluorescently labeled samples were combined and hybridized to a miRNA microarray (v. 10.0, Exiqon, Denmark), in a nitrogen atmosphere. The micro array slides were scanned with GenePix 4100 Scanner. The quantified signals were normalized using the global Lowess algorithm, using Genespring (Agilent) software. The intensity values for multiple spots were averaged and the normalized values were log 2-transformed. Missing values were replaced with the lowest value for analysis.

MiRNA Target Prediction

Annotated genes on the U133plus 2.0 array were matched to the miRNA target list downloaded from TargetScan (www.targetscan.org). For the purpose of this study, a target gene was defined by the presence of a seed sequence match (nucleotides 2-8) and conservation of the seed sequence and 3′UTR in humans, dog, rat, mouse and chicken. Additional conservation was examined in miRNA target genes selected for experimental validation. The distribution of the mRNA expression for these genes was plotted as a density plot using the Splus statistical software (Insightful Corporation). The difference in distribution between the B cell subsets was calculated using a two-sample, 1-sided Kolmogorov-Smirnov test to examine the hypothesis that being a miRNA target conferred repression in the appropriate population (consistent with the known biology of miRNA effects).

The 3′UTRs of LM02, MYBL1 and PRDM1 were aligned using Blastz alignment of Human, Chimp, Mouse, Rat, Dog, Chicken, Frog (Xenopus) and Zebrafish, and were displayed using the UCSC genome browser. The conservation of miR-223 seed sequence and the 3′UTRs of LM02 and MYBL1, as well as that of the miR-30 family and miR-9 on PRDM1, were thus verified.

Western Blot

RIPA Lysis buffer (1× phosphate-buffered saline [PBS], 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 mM phenylmethylsulfonyl fluoride, 1 μg/mL aprotinin, and 100 mM sodium orthovanadate) was added to 750,000 cells and incubated on ice for 30 minutes. The mixture was spun down and the supernatant was transferred to a new tube as the whole cell extract. A total of 20 μg of cell lysate was separated on a 4-18% Tris-Bis NuPAGE gel (Invitrogen) and transferred using the iBlot transfer device (Invitrogen) program 3 for 7 minutes (LM02 detection) or program 2 for 6 minutes (PRDM1). The blots were probed using 1:200 mouse-anti-LM02 (Santa Cruz Biotechnologies SC-65736), 1:750 mouse-anti-Blimp-1 (Santa Cruz Biotechnologies SC-66015) or 1:5000 goat-anti-B-actin (Santa Cruz Biotechnologies SC-47778) for 1 hour at room temperature. The antibodies were detected using 1:10,000 goat-anti-mouse horseradish peroxidase conjugated antibodies (Santa Cruz Biotechnologies). Western Blotting Luminol Reagent (Santa Cruz Biotechnologies) was used to visualize the bands corresponding to each antibody.

Single miRNA/mRNA Expression Using Real-time Polymerase Chain Reaction (RT-PCR)

With 10 ng of RNA per reaction, miRNAs of interest were reverse-transcribed with ABI individual stem-loop primers designed to detect only mature miRNA, and measured by Taqman real-time PCR normalized to the small nucleolar RNA, RNU48. In order to assess mRNA expression using RT-PCR, 1 μg of RNA was reverse-transcribed with the ABI High Capacity cDNA Reverse Transcription kit. Gene expression was measured with exon-spanning Taqman probes, and normalized to beta-2 micro globulin expression.

Cell Culture

BJAB and H929 were cultured in RPMI (Gibco) supplemented with 10% fetal bovine serum, and U266 was cultured in RPMI supplemented with 15% fetal bovine serum. 293T cells were grown in DMEM media (Gibco) with 10% FBS. All cell lines were grown in 37° C. humidified cell culture incubators with CO₂ maintained at 5%.

MiRNA Functional Analysis

MicroRNA Transfection

miRNAs of interest were over-expressed in cell lines of interest by transfecting the appropriate miRNA precursors (Ambion) at 100 nanomoles using Amaxa's Nucleofector system. In particular, BJAB was transfected with Nucleofector solution T, program T-016, U266 with Nucleofector C, program X-005, and H929 with Nucleofector V, program T-001. 1.5 million cells were used per transfection and mixed with appropriate miRNA precursors (Ambion) for a concentration of 100 nM.

Statistical Analysis

Identifying Differentially Expressed miRNA and mRNA

MiRNAs were considered to be differentially expressed if the mean signal was changed at least 2-fold and a false discovery rate (q) was less than 5% using Significance Analysis of Microarrays (SAM) with 1000 permutations. See Tusher et al. Proc Natl Acad Sci USA. 2001; 98:5116-5121.

Differentially expressed genes (mRNA) in Naive versus Germinal Center, Germinal Center versus Plasma Cells, and Germinal Center versus Memory Cells comparisons were identified using SAM. Genes that were 2-fold differentially expressed at a false discovery rate (q) less than 1% with 1000 permutations were identified as significantly differentially expressed.

Transcription Factors and miRNA Target Genes

Transcription factors were identified based on the gene ontology (GO search term “transcription factor”) and matched to the probes of the Affymetrix U133plus 2.0 microarray. Of the total of 938 transcription factor genes thus identified, we selected 364 genes that were differentially expressed in at least one of the B cell stage transitions. We evaluated the breakdown of the differentially expressed transcription factors among miRNA targets versus non targets. The p-values were computed using a chi-square test separately in each B cell stage-transition.

B Cell Malignancy Sample Classification

The top 50 most differentially expressed miRNAs (P<0.01) in each pair-wise B cell malignancy type comparison were chosen as the initial predictor. Singular value decomposition was applied to reduce the list to 20 most informative miRNAs in each pair-wise comparison. See West et al. Proc Natl Acad Sci USA. 2001; 98:11462-11467. A Bayesian logistic regression was performed in Matlab (Mathworks) using the 20-predictor miRNAs for each pair-wise comparison. Each sample was tested using the microRNA-based predictor in a leave-one-out fashion to determine the accuracy of each prediction. For a sample to be classified as a particular B cell malignancy (or normal) type, it had to be predicted as such in every pair-wise comparison.

Normal B Cell Stage Classification of B Cell Malignancies

We constructed a Bayesian predictor to distinguish normal naive from germinal center B cells based on the 32 miRNAs depicted in FIG. 1D. We then applied the predictor without optimization to the microarray data generated for GCB DLCBL, Burkitt lymphoma and chronic lymphocytic leukemia to render a Bayesian prediction of lineage; i.e. naive versus germinal center B cell.

Western Blot Quantitative Analysis

Western blot scans were quantified using NIH ImageJ software. For each experiment, the ratios of protein of interest (LM02, PRDM1) to Actin were determined and mean centered to 100 across the experiment. The average and standard deviation of these values across the three experiments were calculated and displayed relative to the scrambled control expression.

Luciferase Indicator Assay Quantitative Analysis

Firefly luciferase reporter constructs were created in the pL/SV40/GL3 vector for the LM02 3′UTR and the LM02 3′UTR with the predicted miR-223 binding site mutated, as described below. Mature microRNA expression of a pL/CMV/eGFP vector coding for pri-miR-223 from the 3′UTR of EGFP of the vector was confirmed by Taqman-real time PCR in transfected 293T cells. gl3 activity was normalized in dual luciferase assays to pL/SV40/RLuc, with which it was cotransfected. The PRDMI 3′UTR was also cloned into the pL/SV40/GL3 vector. microRNA expression vectors and their respective seed sequence mutants were created for miR-9-2, miR-30b, and miR-30d.

LM02

The LM02 3′UTR was PCR-amplified from BJAB cDNA using primers 1 and 2 (SEQ ID NOs: 1 and 2, respectively) and ligated into the XhoI and XbaI sites of the previously described lentiviral vector pL/SV40/GL3, which expresses firefly luciferase. See Tusher et al. Proc Natl Acad Sci USA. 2001; 98:5116-5121. As a control, an LM02 3′UTR mutant was created using mutant PCR primers 3 and 4 and then outer primers 1 and 2. The resulting fragment was also placed into the XhoI and XbaI sites of pL/SV40/GL3. In this LM02 3′UTR mutant, the seed match predicted to bind to nucleotides 2-8 of miR-223 is converted from 5′AACUGAC 3′ to 5′AACAGUC 3′. To create a miR-223 expression vector, a ˜350 nucleotide-long fragment of pri-miR-223, encompassing the pre-miRNA stem loop in its middle, was PCR-amplified from genomic BJAB DNA with primers 6 and 7 (SEQ ID NOs. 6 and 7) and ligated into the XhoI and XbaI sites of the pL/CMV/eGFP vector. This pL/CMV/eGFP vector was generated by ligating a fragment containing the CMV promoter and the EGFP ORF into the BamHI and XhoI sites of the previously described lentiviral backbone pL. See Tusher et al. Proc Natl Acad Sci USA. 2001; 98:5116-5121. The expression of miR-223 from the 3′UTR of EGFP in the resulting vector was confirmed by Taqman real time PCR in transfected 293T cells.

For luciferase indicator assays, 293T cells plated in 24 well plates were transfected using FUGENE6 as follows:

TABLE 1 Luciferase indicator assay compositions 2.5 ng pL/SV40/GL3 2.5 ng pL/SV40/GL3/ 2.5 ng pL/SV40/GL3/ 2.5 ng pL/SV40/RLuc LMO2 UTR LMO2 seed mut 0.4 μg pL/CMV/ 2.5 ng pL/SV40/RLuc 2.5 ng pL/SV40/RLuc eGFP/miR-223 0.4 μg pL/CMV/ 0.4 μg pL/CMV/eGFP/ 2.5 ng pL/SV40/GL3 eGFP/miR-223 miR-223 2.5 ng pL/SV40/RLuc 2.5 ng pL/SV40/ 2.5 ng pL/SV40/GL3/ 0.4 μg pL/CMV/eGFP GL3/LMO2 UTR LMO2 seed mut 2.5 ng pL/SV40/RLuc 2.5 ng pL/SV40/RLuc 0.4 μg pL/CMV/eGFP 0.4 μg pL/CMV/eGFP

Reporter expression was evaluated by dual luciferase assays (Promega) 48 hours post-transfection. Firefly Luciferase (GL3) to internal control Renilla Luciferase (RLuc) ratios from 293T cells transfected with pL/CMV/eGFP/miR-223 were divided by those obtained from 293T transfected with the pL/CMV/eGFP vector control. The average and standard deviation were taken across five experiments for the pL/SV40/gl3 empty, LM02, and LM02 mutant vectors.

Firefly Luciferase (GL3) activity readings of the PRDM1 3′UTR construct were divided by internal control Renilla Luciferase (RLuc) activity readings. The average and standard deviation of these ratios across three experiments were calculated and scaled relative to the empty vector (pL/CMV/eGFP) transfection.

TABLE 2 LM02 primer sequences Primer SEQ ID description Sequence (5′→3′) 1543 LMO2 3′UTR, FW ATATCTCGAGGCCCGAG TCCCCGGGCATCTTTGG 1544 LMO2 3′UTR, REV ATATATCTAGACTACAC ACGACAAATACTTTG 1545 LMO2 3′UTR seed CAGCCCATCCATAGTAA mutant, FW CAGTCATGATTAGCAGA AGAAAGG 1546 LMO2 3′UTR seed CCTTTCTTCTGCTAATC mutant, REV ATGACTGTTACTATGGA TGGGCTG 1547 pri-mir-223, FW ATATCTCGAGGGTCACA TCTCCCAGGAAGATC 1548 pri-mir-223, REV ATATATCTAGAAGCACT CTCATGGTGTGTGTAG

PRDM1

The PRDM1 3′UTR was PCR-amplified from BJAB genomic DNA in two reactions using primer pairs 7 and 8 in one reaction, and 9 and 10 in another (SEQ ID NOs: 7 to 10, respectively). The two fragments were then ligated together into the XhoI and NotI sites of pL/SV40/GL3 to generate the entire PRDM1 3′UTR. microRNA expression vectors were created as described above for mir-9-2, mir-30b, and mir-30d with the primers listed below. Again, over-expression from the 3′UTR of EGFP in the resulting vector was confirmed by Taqman real-time PCR in transfected 293T cells. For the PRDM1 luciferase assays, we used the sequences listed below to PCR-mutate the seed sequence of the microRNA expression vectors rather than the PRDM1 3′UTR, which had numerous seed sequence binding sites.

TABLE 3 PRDM1 primer sequences Primer SEQ ID: description sequence 1549 PRDM1 3′UTR AGAGACTCGAGGATTTTCAGA piece 1, FW AAACACTTATTT 1550 PRDM1 3′UTR TTGCTTCTCTAGAGGAGAAAC piece 1, REV 1551 PRDM1 3′UTR GTTTCTCCTCTAGAGAAGCAA piece 2, FW 1552 PRDM1 3′UTR AGAGAGCGGCCGCAGGGGAGA piece 2, REV GACAAATTGCATTG 1553 pri-mir-9-2, FW AGAGACTCGAGATAAAAGGAG GAATCTTAAG 1554 pri-mir-9-2, REV AGAGAGCGGCCGCGAAAAAAA CAAAACAAAAACAA 1555 pri-mir-30b, FW AGAGAGCGGCCGCCCGATTGA GTCTTGCCTCAT 1556 pri-mir-30b, REV AGAGAGAATTCAATGGTCTCA CATTTCCAAC 1557 pri-mir-30d, FW AGAGAGCGGCCGCATGTCACA GCTATTGTTCAG 1558 pri-mir-30d, REV AGAGAGAATTCGCAGTAAAAG AATGCAGCTA 1559 pri-mir-9-2 GGAAGCGAGTTGTTATCTATG seed mutant, FW CTTATCTAGCTGTATGAGT 1560 pri-mir-9-2 ACTCATACAGCTAGATAAGCA seed mutant, REV TAGATAACAACTCGCTTCC 1561 pri-mir-30b ACCAAGTTTCAGTTCATGTTA seed mutant, FW AGATCCTACACTCAGCTGT 1562 pri-mir-30b ACAGCTGAGTGTAGGATCTTA seed mutant, REV ACATGAACTGAAACTTGGT 1563 pri-mir-30d CAGAAAGTCTGTTGTTGTTAA seed mutant, FW GATCCCCGACTGGAAGCTG 1564 pri-mir-30d CAGCTTCCAGTCGGGGATCTT seed mutant, REV AACAACAACAGACTTTCTG

Luciferase assays were carried out in a manner similar to those described for LM02.

IgVH Mutation Status of Chronic Lymphocytic Leukemia Samples

IgVH mutation status was determined as described in Volkheimer et al. (Blood. 2007; 109:1559-1567) using genomic DNA. In brief, genomic DNA was isolated from purified CLL cells and isolated using the GenElute Mammalian DNA extraction Kit from Sigma (St. Louis, Mo.) according to the manufacturer's instructions. DNA was amplified using nested PCR primers. PCR products were electrophoresed, purified, and sequenced using an automated DNA sequencer (Applied Biosystems, Foster City, Calif.) with the BigDye Terminator kit (Perkin Elmer, Boston, Mass.). Forward and reverse sequences were aligned into a single resolved sequence using Sequencher 4.1 software (Gene Codes Corporation, Ann Arbor, Mich.), and then aligned with germline sequences derived from DNA Plot on the V BASE directory website (http://vbase.mrc-cpe.cam.ac.uk/). The percent sequence identity was calculated by dividing the number of mutations from FR1 to FR3 by the total number of nucleotides in this region. Samples were considered somatically mutated if they had greater than 2% mutations in this region.

Example 2 Mature B Cell Stages Display Characteristic Patterns of MicroRNA Expression

Mature B cell subsets can be defined by the expression of surface CD19, IgD, CD38, and CD27, and were obtained by fluorescence activated cell sorting of tonsils from young individuals undergoing routine tonsillectomy. See FIGS. 1B and 1C. Cells were previously gated on CD19 positive cells. Naive and memory B cells were distinguished from germinal center and plasma cells based on surface CD38 and IgD expression.

To determine whether mature B cell subsets had unique patterns of microRNA (miRNA) expression, we used a 384-well multiplexed real time polymerase chain reaction (RT-PCR) assay (Applied Biosystems) that allowed measurement of all 365 miRNAs in miRBase 9.2. See Chen et al. Nucleic Acids Res. 2005; 33:e179; and He et al. Nature. 2007; 447:1130-1134. We detected a total of 113 unique miRNAs in the B cell populations. See Table 4. This detection frequency compares favorably to the identification of 71 unique miRNAs (45 miRNAs with more than one clone) through the examination of 3101 sequences cloned from unselected CD19-positive mature B cells. See Landgraf et al. Cell. 2007; 129:1401-1414. We identified differentially expressed miRNAs in mature B cell subsets using a false discovery rate of less than 5%. See FIGS. 1D, 1F, and 1H. The complete list of assayed miRNAs found to be expressed in the B cell populations is shown in Tables 4 and 5.

In Table 4, normalized expression values for B-cell subsets are shown, along with significance analysis of microarrays q values. Empty microRNA expression cells indicate below-threshold values, defined as RT-QPCR Ct values greater than 36 or undetected. SAM q values greater than 5 were considered non-significant and not displayed.

TABLE 4 MicroRNAs detected in at least one B-cell subset qNaive qGerminal qGerminal Germinal vs Center Center Naive Center Plasma Cell Memory Germinal vs vs average average average average Center Plasma Cell Memory hsa-let-7a 11.7 9.2 11.2 1.4 hsa-let-7b 10.3 9.0 7.7 11.3 0.0 hsa-let-7c 7.3 7.2 hsa-let-7d 9.0 9.0 10.0 hsa-let-7f 10.3 7.6 8.4 10.2 0.0 hsa-let-7g 13.1 10.3 10.5 14.0 0.0 0.0 hsa-miR-100 7.4 hsa-miR-101 8.4 10.0 hsa-miR-103 9.7 11.4 9.8 10.8 0.0 0.0 hsa-miR-106b 11.7 12.5 11.6 12.7 hsa-miR-125a 6.7 8.3 hsa-miR-125b 6.3 7.3 hsa-miR-130b 7.8 9.8 8.6 10.2 3.6 4.5 hsa-miR-132 7.5 8.9 hsa-miR-133b 7.7 7.7 7.2 7.3 hsa-miR-140 10.8 12.0 11.1 12.0 4.7 hsa-miR-141 7.0 6.2 hsa-miR-142-3p 16.9 17.0 15.3 18.0 1.1 hsa-miR-142-5p 11.7 11.0 9.8 13.4 2.1 hsa-miR-146a 10.1 14.0 14.0 14.6 0.0 hsa-miR-146b 9.2 9.2 8.1 10.5 2.1 hsa-miR-148a 6.7 9.4 11.9 9.0 0.0 hsa-miR-148b 6.4 8.5 hsa-miR-151 8.2 9.6 6.6 9.0 1.5 0.0 hsa-miR-152 6.4 9.7 6.6 hsa-miR-155 14.2 14.6 15.0 15.6 hsa-miR-15a 10.2 10.1 7.8 10.8 2.0 hsa-miR-15b 11.2 14.0 12.6 12.9 0.0 2.8 hsa-miR-16 16.7 17.3 17.1 17.1 hsa-miR-17-3p 9.1 hsa-miR-17-5p 8.8 11.5 8.9 9.4 0.0 0.0 0.0 hsa-miR-181b 9.0 11.7 10.8 9.3 0.0 0.0 hsa-miR-181d 8.2 10.6 8.5 9.0 0.0 1.1 hsa-miR-182 8.7 8.7 hsa-miR-186 8.8 9.2 8.7 9.7 hsa-miR-18a 5.7 8.9 6.8 7.4 0.0 0.0 hsa-miR-191 11.9 12.7 12.4 13.3 hsa-miR-192 9.1 9.0 8.8 10.1 hsa-miR-193b 6.6 hsa-miR-194 6.8 7.4 4.9 9.5 2.0 4.7 hsa-miR-195 10.3 8.7 8.8 9.2 hsa-miR-197 9.7 10.5 8.7 11.0 0.0 hsa-miR-199a* 7.0 hsa-miR-19a 9.7 12.8 11.9 11.1 0.0 hsa-miR-19b 14.0 15.6 14.9 15.0 0.8 hsa-miR-200a 6.5 6.8 hsa-miR-200b 7.5 hsa-miR-200c 9.0 9.6 9.7 hsa-miR-203 7.9 7.6 hsa-miR-20a 12.5 14.9 12.2 13.8 0.0 0.0 hsa-miR-20b 8.4 11.0 8.0 8.5 0.0 1.1 0.0 hsa-miR-21 12.6 13.0 11.2 15.1 2.8 2.1 hsa-miR-210 9.2 11.1 10.7 10.2 0.8 hsa-miR-214 7.6 hsa-miR-22 8.3 7.4 hsa-miR-221 6.9 hsa-miR-222 11.4 11.6 7.8 12.7 0.0 4.7 hsa-miR-223 13.7 10.4 9.6 14.6 0.0 0.0 hsa-miR-23a 8.7 hsa-miR-23b 6.2 hsa-miR-24 11.7 11.8 12.8 13.4 2.1 hsa-miR-25 9.7 10.8 8.8 11.2 2.8 hsa-miR-26a 14.7 13.6 14.2 16.3 0.0 hsa-miR-26b 12.6 12.1 12.0 14.1 3.4 hsa-miR-27a 6.5 11.1 0.0 hsa-miR-27b 7.2 hsa-miR-28 9.4 13.3 8.4 10.3 0.0 0.0 0.0 hsa-miR-296 6.9 8.1 6.6 7.9 0.0 2.0 hsa-miR-29a 13.4 11.7 13.5 15.0 0.0 hsa-miR-29c 11.2 8.7 12.3 13.3 1.5 2.6 0.0 hsa-miR-301 6.0 9.6 7.7 7.9 0.0 0.0 hsa-miR-30a-3p 8.2 hsa-miR-30a-5p 11.9 12.6 11.3 13.0 2.0 hsa-miR-30b 11.7 12.6 11.2 13.0 2.8 hsa-miR-30c 13.0 13.9 12.7 14.3 4.5 hsa-miR-30d 10.8 11.9 10.1 12.1 3.8 0.0 hsa-miR-30e-3p 8.3 9.0 6.8 9.9 0.0 hsa-miR-30e-5p 12.5 8.1 10.2 14.8 0.0 hsa-miR-31 9.0 hsa-miR-32 8.4 7.0 10.5 hsa-miR-320 10.1 8.2 10.3 10.5 1.5 2.6 0.0 hsa-miR-324-3p 8.8 9.9 9.0 9.5 hsa-miR-324-5p 8.0 7.8 hsa-miR-328 8.1 8.6 7.4 8.7 2.8 hsa-miR-331 9.4 12.6 12.0 10.8 0.0 2.6 hsa-miR-335 6.3 6.9 hsa-miR-339 7.3 5.7 8.9 hsa-miR-342 12.7 12.5 10.6 13.1 0.0 hsa-miR-345 6.8 7.1 7.8 8.6 3.4 hsa-miR-361 8.3 hsa-miR-365 6.0 7.8 8.3 8.4 0.0 hsa-miR-374 8.0 8.9 10.4 9.8 hsa-miR-423 8.0 9.7 7.6 8.7 0.0 0.0 hsa-miR-425 6.9 hsa-miR-425-5p 8.7 11.6 9.7 10.2 0.0 0.0 hsa-miR-484 11.5 12.3 12.9 12.0 hsa-miR-486 7.0 8.8 9.9 9.6 3.8 hsa-miR-532 7.0 7.8 hsa-miR-545 5.5 6.3 hsa-miR-572 7.7 6.8 hsa-miR-629 6.7 7.3 7.2 9.0 1.4 hsa-miR-646 6.0 7.3 hsa-miR-650 8.8 11.4 8.0 hsa-miR-659 7.6 6.0 6.8 hsa-miR-660 9.5 8.6 10.1 hsa-miR-7 6.1 5.8 hsa-miR-9 7.8 6.8 6.2 2.8 hsa-miR-9* 6.4 6.5 hsa-miR-92 14.5 15.8 14.2 15.5 3.6 0.0 hsa-miR-93 11.5 14.6 10.5 12.3 0.0 0.0 0.0 hsa-miR-98 6.3 5.0 5.0 7.8 2.1 hsa-miR-99a 7.3 hsa-miR-99h 6.8

TABLE 5 miRNAs measured using the multiplex RT-PCR assay, but not consistently detected in any B-cell population hsa-let-7e hsa-miR-383 hsa-miR-376a hsa-miR-566 hsa-miR-I0a hsa-miR-198 hsa-miR-376b hsa-miR-551b hsa-miR-I0b hsa-miR-224 hsa-miR-380-5p hsa-miR-569 hsa-miR-34a hsa-miR-299-5p hsa-miR-410 hsa-miR-570 hsa-miR-34b hsa-miR-409-5p hsa-miR-412 hsa-miR-548a hsa-miR-34c hsa-miR-432 hsa-miR-432 hsa-miR-586 hsa-miR-107 hsa-miR-433 hsa-miR-512-5p hsa-miR-587 hsa-miR-181c hsa-miR-485-5p hsa-miR-199a hsa-miR-548b hsa-miR-215 hsa-miR-489 hsa-miR-199b hsa-miR-588 hsa-miR-218 hsa-miR-494 hsa-miR-219 hsa-miR-589 hsa-miR-372 hsa-miR-506 hsa-miR-323 hsa-miR-550 hsa-miR-375 hsa-miR-508 hsa-miR-338 hsa-miR-591 hsa-miR-378 hsa-miR-521 hsa-miR-368 hsa-miR-593 hsa-miR-137 hsa-miR-134 hsa-miR-373 hsa-miR-596 hsa-miR-200a hsa-miR-147 hsa-miR-373 hsa-miR-597 hsa-miR-I hsa-miR-149 hsa-miR-382 hsa-miR-622 hsa-miR-183 hsa-miR-153 hsa-miR-424 hsa-miR-599 hsa-miR-302a hsa-miR-187 hsa-miR-448 hsa-miR-600 hsa-miR-302c hsa-miR-190 hsa-miR-450 hsa-miR-624 hsa-miR-302d hsa-miR-193a hsa-miR-451 hsa-miR-601 hsa-miR-367 hsa-miR-196a hsa-miR-452 hsa-miR-626 hsa-miR-369-5p hsa-miR-196b hsa-miR-452 hsa-miR-548d hsa-miR-449 hsa-miR-205 hsa-miR-453 hsa-miR-639 hsa-miR-497 hsa-miR-208 hsa-miR-485-3p hsa-miR-613 hsa-miR-501 hsa-miR-213 hsa-miR-488 hsa-miR-614 hsa-miR-509 hsa-miR-220 hsa-miR-490 hsa-miR-615 hsa-miR-510 hsa-miR-325 hsa-miR-492 hsa-miR-616 hsa-miR-511 hsa-miR-326 hsa-miR-493 hsa-miR-548c hsa-miR-514 hsa-miR-337 hsa-miR-503 hsa-miR-617 hsa-miR-515-3p hsa-miR-340 hsa-miR-504 hsa-miR-642 hsa-miR-515-5p hsa-miR-380-3p hsa-miR-505 hsa-miR-618 hsa-miR-517a hsa-miR-422b hsa-miR-507 hsa-miR-644 hsa-miR-517b hsa-miR-422a hsa-miR-513 hsa-miR-647 hsa-miR-517c hsa-miR-429 hsa-miR-516-5p hsa-miR-649 hsa-miR-518a hsa-miR-491 hsa-miR-517 hsa-miR-661 hsa-miR-518b hsa-miR-496 hsa-miR-518c hsa-miR-662 hsa-miR-518c hsa-miR-500 hsa-miR-518f hsa-miR-449b hsa-miR-518d hsa-miR-502 hsa-miR-519b hsa-miR-653 hsa-miR-518e hsa-miR-105 hsa-miR-519c hsa-miR-411 hsa-miR-520a hsa-miR-122a hsa-miR-519d hsa-miR-654 hsa-miR-520b hsa-miR-124a hsa-miR-51ge hsa-miR-575 hsa-miR-520c hsa-miR-126 hsa-miR-522 hsa-miR-576 hsa-miR-520d hsa-miR-128b hsa-miR-523 hsa-miR-578 hsa-miR-520e hsa-miR-129 hsa-miR-524 hsa-miR-579 hsa-miR-520f hsa-miR-130a hsa-miR-526b hsa-miR-580 hsa-miR-520g hsa-miR-139 hsa-miR-96 hsa-miR-585 hsa-miR-520h hsa-miR-143 hsa-miR-651 hsa-miR-512- 3p hsa-miR-95 hsa-miR-145 hsa-miR-376a hsa-miR-631 hsa-miR-126 hsa-miR-182 hsa-miR-542-5p hsa-miR-363 hsa-miR-127 hsa-miR-185 hsa-miR-544 hsa-miR-487b hsa-miR-133a hsa-miR-189 hsa-miR-656 hsa-miR-645 hsa-miR-135a hsa-miR-18b hsa-miR-549 hsa-miR-556 hsa-miR-135b hsa-miR-202 hsa-miR-657 hsa-miR-558 hsa-miR-184 hsa-miR-202 hsa-miR-658 hsa-miR-627 hsa-miR-204 hsa-miR-299-3p hsa-miR-652 hsa-miR-630 hsa-miR-206 hsa-miR-302a hsa-miR-551a hsa-miR-603 hsa-miR-211 hsa-miR-302b hsa-miR-552 hsa-miR-606 hsa-miR-216 hsa-miR-302b hsa-miR-553 hsa-miR-607 hsa-miR-217 hsa-miR-302c hsa-miR-554 hsa-miR-608 hsa-miR-330 hsa-miR-329 hsa-miR-555 hsa-miR-609 hsa-miR-371 hsa-miR-33 hsa-miR-562 hsa-miR-633 hsa-miR-379 hsa-miR-362 hsa-miR-563 hsa-miR-565* hsa-miR-381 hsa-miR-369-3p hsa-miR-564 hsa-miR-594* miRNAs marked with * were not used in analyses because they have been reclassified as non-miRNAs.

The B cell subsets were profiled for gene expression at the whole genome level, as described previously. See Dave et al. N Engl J Med. 2004; 351:2159-2169. At each stage, we identified differentially expressed genes as those genes with a mean two-fold difference in expression and a false-discovery rate of less than 1%. See FIGS. 1E, 1G, and 1I. Genes that we found to be differentially expressed in each stage-transition were consistent with previous studies that examined gene expression in B cell subsets using microarrays with fewer probes, an overlap that was found to be highly statistically significant (P<0.001, chi-squared test). See, e.g., Klein et al. Proc Natl Acad Sci USA. 2003; 100:2639-2644; and Shaffer et al. Immunity. 2001; 15: 375-385.

In the naïve→germinal center (GC) B cell transition, we identified 32 miRNAs that were differentially expressed. Interestingly, all but 4 miRNAs were found to be expressed more highly in GC cells than in naive B cells. See FIG. 1D. We confirmed the mRNA expression patterns of several genes that are known to be differentially expressed in the transition including BCL6, MME, MYBL1, as well as LM02. See FIG. 1E. LM02 was found to be expressed more highly in germinal center B cells compared to both naive B cells and memory B cells. See FIGS. 1E and 1I. In the GC→plasma cell transition, we found 33 miRNAs that were differentially expressed. Once again, we noted a striking asymmetry, with all but 2 miRNAs found to be expressed highly in GC cells, but down-regulated in plasma cells. See FIG. 1F. We also confirmed that the plasma cell-specific genes, PRDMI (FIG. 1G), XBPI and IRF4 were highly differentially expressed in our experiments. In the GC→memory B cell transition, there was a preponderance of the 27 significant miRNAs expressed at higher levels in memory cells. See FIG. 1H. Five miRNAs were expressed highly in GC cells compared to all the other B cell types. These included 3 members of the miR-17˜92 cluster (miR-17-5p, miR-20b, miR-93), as well as miR-28 and miR-181b.

The expression pattern of all the miRNAs that were measurable in at least one of the B cell subsets is summarized in FIG. 5. Notably, there were no differences in the expression of genes involved in miRNA processing, including DICER1, DROSHA, XP05 (exportin5), EIF2C2 (ag02) and DGCR8, among the B cell subsets. See FIG. 1J.

Separately, we examined the expression of predicted target genes of differentially expressed microRNAs. We also found that predicted mRNA target genes of microRNAs expressed highly in GC cells were expressed at lower levels in GC cells compared to other stages. See FIG. 6 and Appendix A. FIG. 6A shows density plots of the expression frequency of predicted mRNA targets of microRNAs expressed highly in germinal center B cells compared to naive cells. mRNAs from FIG. 1E that were also predicted targets of the miRNAs (N=830) were plotted for both naive cells and germinal center B cells. The depicted p-value was calculated using a 1-sided Kolmogorov-Smirnov test. FIG. 6B shows density plots of the expression frequency of predicted mRNA targets of miRNAs expressed highly in germinal center B cells compared to plasma cells. mRNAs from FIG. 1G that were also predicted targets of the miRNAs (N=1098) were plotted for both plasma cells and germinal center B cells. The depicted p-value was calculated using a 1-sided Kolmogorov-Smirnov test. FIG. 6C shows density plots of the expression frequency of predicted mRNA targets of miRNAs expressed highly in the germinal center B cells compared to memory B cells. mRNAs from FIG. 1I that were also predicted targets of the miRNAs (N=269) were plotted for both naive cells and germinal center B cells. The depicted p-value was calculated using a 1-sided Kolmogorov-Smirnov test.

In the naïve to germinal center transition (see FIG. 6A), genes with at least a two-fold change in expression were analyzed by SAM using a false discovery rate of less than 1% (Larsson et. al, BMC Bioinformatics. 2005; 6:129), depicted in FIG. 1E. From that list of significantly differentially expressed genes, we determined those that were predicted targets of miRNAs (defined as genes with 3′UTR sequence complementarity to microRNA nucleotides 2-7) that were expressed more highly in germinal center cells. The gene expression distribution of those mRNA targets was graphed for naïve B Cells (blue curve) and germinal center B cells (orange curve). Thus, in FIG. 6A, we show genes differentially expressed between naïve and germinal center B cells that are also predicted targets of miRNA expressed more highly in germinal center B cells. We observe that the expression of these microRNA target genes is lower in germinal center B cells compared to naïve B cells.

A similar analysis was carried out for the transitions from germinal center to plasma cell (FIG. 6B) and germinal center to memory cell (FIG. 6C). In all three cases examined, the distribution of germinal center miRNA target gene expression is statistically significantly lower (leftward shift of orange curve), which suggests a possible gene regulatory role for the miRNAs that are more highly expressed in germinal center cells. We note that the observed lower expression of the miRNA target genes could, however, also be caused by other factors such as downstream effects of particular transcription factors. The complete set of genes plotted in FIG. 6 is listed in Appendix A.

Finally, we found that a higher proportion of differentially expressed transcription factors are predicted microRNA targets. See FIG. 7. Table 6 shows differentially expressed transcription factors, with the average level of expression for each in naïve, germinal center, plasma, and memory cells. Transcription factors for which the significance analysis showed a q value of 0 are indicated.

TABLE 6 Differentially-expressed transcription factors Naive GC Germinal Plasma vs GC vs Naive Center Cell Memory GC: q vs PC: q Mem: q ID NAME average average average average value value value 1 AHR 8.9 10.33 8.36 10.38 0 0 2 APBB2 6.86 7.87 7.35 6.39 0 0 3 ARID1A 12.3 12.22 11.11 12.17 0 4 ARID3A 8.03 6.9 9.81 8.76 0 0 0 5 ARNTL 9.47 8.4 8.23 9.7 0 0 6 ATF7 7.83 8.97 8.23 8.44 0 7 BACH1 10.68 9.97 11.76 10.59 0 8 BHLHB3 11.11 8.05 13.26 13.26 0 0 0 9 BPTF 12.23 12.46 11.34 11.86 0 10 BTG1 15.88 14.95 13.94 15.28 0 11 CASP8AP2 10.17 10.55 9.44 10.22 0 12 CBL 11.07 11.69 10.26 11.04 0 13 CBX4 12.23 12.36 13.69 12.68 0 14 CCNE1 7.86 9.18 8.87 7.66 0 0 15 CDH1 5.85 3.85 10.26 4.91 0 16 CITED2 9.11 9.88 12.56 9.22 0 17 CLOCK 9.85 7.68 9.91 9.62 0 0 0 18 CREB5 4.91 5.46 7.24 6.95 0 19 CREBL1 7.53 6.97 8.06 8.09 0 20 CREBL2 10.18 9.95 11.1 10.79 0 21 CSDA 12.12 8.59 10.1 8.98 0 0 22 DEK 12.73 14.09 10.29 13.15 0 0 23 DLX2 6.08 4.66 7.04 7.08 0 0 24 DR1 11.83 11.97 10.65 12.1 0 25 DTX1 10.98 11.6 10.55 9.62 0 0 26 DYRK1B 6.32 5.92 7.61 4.96 0 27 E2F1 7.01 8.37 7.95 7.21 0 0 28 EGR1 11.92 13.24 13.77 12.75 0 29 EGR2 10.21 10.43 8.07 10.4 0 30 EGR3 11.59 9.35 8.24 10.62 0 0 0 31 ELF1 12.39 12.7 11.34 12.55 0 32 ELL 7.12 7.83 9.17 7.59 0 33 ELL2 9.25 8.23 13.6 9.27 0 34 EPAS1 7.1 7.02 8.39 7.5 0 35 ETS1 14.25 14.4 12.62 14.17 0 36 ETS2 6.37 7.5 5.66 4.9 0 0 0 37 ETV1 8.19 6.9 7.38 7.06 0 38 ETV4 5.99 5.42 7.15 6.09 0 39 ETV6 10.36 7.14 8.89 10.43 0 0 0 40 FHL2 4.82 7.77 6.82 5.65 0 0 41 FLNA 9.95 9.2 8.57 11.03 0 42 FOS 12.35 11.25 13.34 11.23 0 0 43 FOSB 10.13 7.21 11.05 10.79 0 0 0 44 FOXC1 6.81 5.84 7.39 6.59 0 45 FOXF2 7.05 4.83 6.37 5.84 0 46 FOXJ2 10.01 8.38 9.97 9.85 0 0 0 47 FOXK2 8.94 8.4 9.63 8.71 0 48 GATA3 8.05 7.76 8.51 9.6 0 49 GATA6 7.08 5.41 7.59 6.26 0 0 50 GCN5L2 10.18 8.97 8.9 10.36 0 0 51 GLI2 6.93 7.26 7.52 6.09 0 52 GPX3 6.72 5.92 7.61 5.58 0 53 HCLS1 13.94 14.42 13.12 13.92 0 54 HIPK2 9.36 8.66 11.04 10.85 0 0 55 HMGA1 11.26 12.47 10.36 10.86 0 0 0 56 HMGB1 15.47 16.36 14.98 14.97 0 0 57 HMGB2 12.96 15.78 12.73 13.36 0 0 0 58 HOXA1 5.36 7.7 7.23 7.64 0 59 HOXA5 7.03 8.32 8.36 7.54 0 60 HOXB4 8.2 7.58 9.27 8.01 0 61 HOXB9 7.4 6.2 8.41 6.87 0 62 HOXC11 6.6 6.4 7.88 6.21 0 63 HOXC8 7.05 5.48 6.88 6.71 0 64 ID4 6.49 5.93 7.79 6.41 0 65 ILF3 11.26 11.94 10.71 10.99 0 66 IRAK1 12.19 11.48 12.8 11.96 0 67 IRF4 11.16 9.28 13.66 10.51 0 0 0 68 ISL1 6.98 5.91 7.6 6.11 0 69 JAZF1 11.93 10.65 7.49 11.31 0 0 70 JMJD1C 12.34 12.34 11.11 12.56 0 71 JUN 12.14 9.34 12.7 12.16 0 0 0 72 JUNB 11.62 9.72 10.84 11.37 0 0 73 KLF11 8.08 5.94 6.88 8.39 0 0 74 KLF2 12.61 9.1 11.7 12.61 0 0 0 75 KLF4 10.04 7.57 9.09 7.49 0 0 76 KLF5 7.08 5.26 6.14 5.07 0 77 KLF6 12.06 11.33 9.24 12.40 0 0 78 KLF7 9.36 8.35 8.88 9.8 0 79 KLF9 9.47 7.34 6.64 9.27 0 0 80 LITAF 12.52 10.18 11.82 12.49 0 0 0 81 LMO1 6.86 4.75 7.16 6.88 0 82 MAF 8.05 9.95 8.25 10.83 0 0 83 MAFB 6.58 7.3 8.56 7.29 0 84 MAML3 8.05 10.85 9.07 7.04 0 0 0 85 MDFIC 12.06 13.67 13.6 13.08 0 86 MEIS2 7.45 7.15 7.56 5.29 0 87 MEN1 10.79 11.33 10.49 10.23 0 88 MITF 7.51 8.05 8.01 6.41 0 89 MTF1 10.08 9.92 8.86 10.5 0 90 MXD1 9.07 7.59 9.62 8.9 0 0 0 91 MXI1 10.63 7.85 11.1 9.42 0 0 0 92 MYB 6.97 8.62 5.61 7.99 0 0 93 MYBL1 9.68 14.13 10.02 9.72 0 0 0 94 MYBL2 9.07 12.41 9.12 8.52 0 0 0 95 NAT14 6.62 7.66 7.33 7.63 0 96 NF1 9.23 10.46 11.21 9.88 0 97 NFAT5 11.71 12.09 10.72 11.77 0 98 NFATC4 6.36 7.92 8.96 5.71 0 0 99 NFIX 8.09 7.43 8.67 7.37 0 100 NFKB1 11.91 11.9 10.7 11.55 0 101 NFYC 10.2 10.27 9.03 10.03 0 102 NR3C2 8.85 5.58 4.91 8.41 0 0 103 NR6A1 9.1 6.03 6.42 7.62 0 0 104 NRIP1 11.79 10.3 10.33 11.20 0 105 PAX3 7.01 5.55 5.01 5.96 0 106 PHF1 11.85 10.69 12.26 11.45 0 0 107 POU3F1 6.08 7.52 6.86 7.52 0 108 POU4F1 5.62 8.85 8.46 7.53 0 0 109 POU4F2 7.09 5.72 7.21 5.1 0 0 110 PPARD 11.23 9.98 10.29 10.69 0 111 PPARG 7.79 7.22 6.74 5.47 0 112 PPARGC1B 6.89 6.09 6.51 7.91 0 113 PRDM1 8.49 9.15 14.1 9.33 0 114 PRDM4 10.48 9.81 9.76 10.83 0 115 PROX1 7.18 6.38 7.89 5.54 0 116 RAN 13.46 14.57 12.39 13.78 0 0 117 RSF1 10.05 9.1 9.56 10.18 0 118 RUNX1T1 7.37 5.95 6.63 6.34 0 119 RUNX2 8.75 7.91 10.22 9.75 0 0 120 RUNX3 11.8 11.13 10.26 12.47 0 121 RXRA 9.07 7.15 8.81 8.32 0 0 0 122 SAP30 8.22 9.91 9.28 8.33 0 0 123 SCMH1 8.48 9.69 9.65 8.62 0 0 124 SCML1 10.32 8.48 7.81 7.91 0 125 SCML2 10.33 8.76 9.27 8.96 0 126 SF1 11.72 11.44 10.36 11.37 0 127 SIAH2 10.35 12.34 10.57 9.90 0 0 0 128 SLC2A4RG 8.25 8.98 7.4 8.91 0 129 SMAD1 5.91 8.1 6.34 7.33 0 0 130 SMAD2 10.45 11.57 10.8 10.98 0 131 SMAD3 10.72 9.23 7.74 10.54 0 0 0 132 SMARCA2 11.14 10.12 10.79 11.19 0 0 133 SOLH 8.78 7.88 8.7 9.03 0 134 SOX4 8.99 9.14 9.17 10.2 0 135 SOX5 9.3 10.47 7.33 9.08 0 0 0 136 SOX9 6.72 8.42 8.18 7.03 0 0 137 SP4 11.26 10.14 9.58 11.75 0 0 138 SRCAP 8.58 8.06 6.96 8.38 0 139 SREBF1 8.23 8.36 6.56 5.89 0 0 140 STAT5B 10.35 10.95 9.73 10.7 0 141 SUFU 7.12 6.03 7.84 7.62 0 0 142 SUPT16H 11.12 11.35 9.6 10.71 0 143 SUPT3H 7.77 6.3 8.05 8.35 0 0 0 144 TARDBP 12.31 12.72 11.49 11.91 0 145 TBP 10.55 10.14 9.09 10.38 0 146 TBX3 5.67 6.05 7.89 5.53 0 147 TCEA1 13.31 15 14.05 13.6 0 0 148 TCERG1 12.29 12.5 11.46 12.04 0 149 TCF7 10.21 10.82 9.97 12.61 0 150 TFAP2A 6.7 5.54 8.26 6.88 0 151 TFAP4 7.28 5.29 5.42 5.13 0 152 TFDP1 10.95 12.9 10.49 11.36 0 0 0 153 TFEB 11.56 11.15 9.49 11.77 0 154 THRA 7.41 7.26 8.48 7.05 0 155 THRB 7.45 7.51 6.11 6.29 0 0 156 TLE1 9.19 7.74 9.63 9.13 0 0 0 157 TMF1 10.76 9.68 10.71 10.42 0 158 TSC22D3 13.22 11.26 12.67 13.4 0 0 0 159 UHRF1 9.23 12.22 8.72 8.96 0 0 0 160 VEZF1 10.98 11.45 9.94 10.81 0 161 XBP1 10.1 10.74 15.84 10.65 0 162 YBX1 14.79 15.31 14.2 14.53 0 163 YWHAH 8.94 10.82 9.09 9.36 0 0 0 164 YWHAZ 13.38 13.62 12.61 13.62 0 165 ZFP36L1 14.07 12.89 10.09 13.87 0 0 166 ZHX3 8.29 7.76 7.47 6.66 0 167 ZNF207 12.29 13.51 12.69 12.54 0 168 ZNF217 11.68 10.77 9.73 11.61 0 169 ZNF219 6.13 6.11 8.42 6.48 0 170 ZNF238 13.05 11.27 10.08 12.54 0 0 0 171 ZNF3 8.86 7.27 8.75 8.89 0 0 0 172 ZNF367 7.97 10.99 8.04 8.22 0 0 0 173 ZNF398 10.39 9.28 10.47 10.25 0 0

Example 3 MiR-223 Regulates LM02 in the Naive˜Germinal Center and Germinal Center˜Memory Cell Transitions

MiR-223 has previously been described as being important in the commitment to myeloid lineage. See Chen et al. Science. 2004; 303:83-86; Johnnidis et al. Nature. 2008; 451:1125-1129. We found miR-223 to be expressed at nearly 8-fold higher levels in both naive and memory cells compared to GC cells. This miRNA has a highly conserved sequence complementarity to the 3′UTR of 2 transcription factors that are expressed highly during GC cell differentiation: LM02 (FIG. 2A) and MYBL1 (FIG. 8A). Higher expression of miR-223 in the naive B cell stage could inhibit the untimely expression of these transcription factors until the cell is ready to undergo the germinal center reaction.

We evaluated the effects of miR-223 expression on its predicted target gene, LM02, by transfecting precursors of miR-223 into a cell line derived from GC cell lymphoma cells (BlAB). Over-expression of miR-223 resulted in a consistent down-regulation of LM02 at the transcript level compared to a transfection with a scrambled control with no sequence complementarity to the human genome. See FIG. 2B. In that figure, the blue bars depict expression of LM02 24 hours after transfection with a scrambled control that does not possess complementarity to the human genome. The orange bars depict the expression of LM02 24 hours after transfection with a precursor for miR-223. The expression of LM02 was consistently lower in the cells treated with the miR-223 precursor, and the results were statistically significant (P<0.05 in all cases, student's t-test). There was no effect on the expression of a non-target control, beta-2 micro globulin in these experiments (data not shown). Over-expression of miR-223 also resulted in a consistent down-regulation of LM02 at the protein level compared to a transfection with a scrambled control with no sequence complementarity to the human genome. See FIG. 2C. We quantified the results of 3 separate experiments examining LM02 protein expression and found consistent down-regulation of LM02 in cells treated with miR-223 compared to cells transfected with scrambled controls. See FIG. 2D. Those results that were statistically significant (P<0.05, student's t-test). The extent of down-regulation of LM02 mRNA and protein by miR-223 was comparable, suggesting that miR-223 regulation of LM02 occurs predominantly at the mRNA level. Similarly, over-expression of miR-223 resulted in a down-regulation of MYBL1 transcripts. See FIG. 8B. In that figure, the blue bars depict expression of MYBL1 mRNA 24 hours after transfection with a scrambled control that does not possess complementarity to the human genome. The orange bars depict the expression of Mybl1 24 hours after transfection with a precursor for miR-223. The expression of LM02 was consistently lower in the cells treated with the miR-223 precursor (P<0.05 in all cases).

As additional validation, we investigated whether the miR-223 had a direct effect on LM02 by cloning the 3′UTR sequence of LM02 3′ to the firefly luciferase ORF (Flue). See Gottwein et al. Nature. 2007; 450:1096-1099. The resulting constructs and the unmodified vector were co-transfected into 293T cells along with a Renilla luciferase internal control and pL-CMV-eGFP constructs expressing either no miRNA or miR-223. Flue expression from constructs bearing LM02 3′ UTR sequences were differentially down-regulated by miR-223 compared to those with mutated seed sequences; the seed sequence mutant construct had consistently diminished miR-223 repression compared to the wild-type construct in 5 separate experiments. See FIG. 2E. Those results were statistically significant (P<0.05, student's t-test). These observations provide evidence for an inhibitory role for miR-223 in regulating the transcription factor LM02.

Activation of LM02 has been associated with the development of leukemia in patients undergoing gene therapy. Hacein-Bey-Abina et al. Science. 2003; 302:415-419. On the other hand, higher expression of PRDM1 alone is sufficient to induce plasma cell-differentiation. Turner et al. Cell. 1994; 77:297-306. Inappropriate expression of such genes must be effectively turned off for a cell to maintain its state. This mode of regulation is reflected in the effects of miR-223, miR-9 and miR-30, which turn off the inappropriate expression of LM02 and PRDMI and might promote state maintenance and inhibition of lymphomagenesis.

On the other hand, our data also identify a number of instances in which miRNAs are co-expressed with their predicted targets. It is possible that such interactions within the cell help to stabilize a defined expression level by dampening fluctuations. For example, in GC cells, we found that miR-181b was strongly co-expressed with its predicted target, BCL6. Such interactions could also be important in B cell stage maintenance and curbing the oncogenic potential of genes involved in B cell differentiation. See Cattoretti et al. Cancer Cell. 2005; 7:445-455; Dorsett et al. Immunity. 2008; 28:630-638.

Example 4 MiR-9 and the miR-30 Family Regulate PRDM1 (Blimp-1) in the Germinal Center →Plasma Cell Transition

In the GC→plasma cell transition, we observed that several members of the miR-30 family were expressed at 2-fold or higher levels in GC cells. See FIG. 1F. The transcription factor PRDMI is an essential regulator of plasma cell differentiation. Martins et al. Annu Rev Immunol. 2008; 26:133-169. The miR-30 family comprises 5 members (miR-30a, 30b, 30c, 30d and 30e), of which 4 (all except 30e) were found to be expressed at higher levels in GC cells compared to plasma cells. Control transfection experiments documented good specificity of the RT-PCR probes for individual members of the miR-30 family with no discernible cross-hybridization. See FIG. 9. Three separate transfection experiments using high concentrations of miR-30b precursors are shown in the left panel with measurement of miR-30b and miR-30d. Similar experiments were performed with precursors for miR-30d (right panel).

The 3′UTR of PRDM1 contains 3 highly conserved binding sites complementary to the seed sequence of members of the miR-30 family, as well as 3 binding sites for the seed sequence of miR-9, 2 of which are highly conserved across multiple species. See FIG. 3A. The 3′UTR region of PRDM1 complementary to miR-30 is shown in red. The 3 sites are complementary to nucleotides 2-8 (UTR position 408), nucleotides 1-8 (UTR position 2370) and nucleotides 2-8 (UTR position 2383) on the miRNA, respectively. The 3′UTR region of PRDM1 complementary to miR-9 is shown in green. The 3 sites are complementary to nucleotides 1-7 (UTR position 1459), nucleotides 2-8 (UTR position 2108) and nucleotides 2-8 (UTR position 2323) on the miRNA respectively. These sites are highly conserved across a number of species, with the exception of one miR-9 site (UTR position 1459) that is only present in humans.

To evaluate the effects of the miR-30 family and miR-9 on PRDM1 expression in plasma cells, we introduced precursors of miR-9, miR-30b and miR-30d into the U266 multiple myeloma (plasma cell) cell line. Overexpression of miR-30 family members miR-30b and miR-30d, as well as miR-9, had no effect on PRDM1 at the mRNA level. See FIG. 3B. In that figure, the blue bars depict expression of PRDM1 24 hours after transfection with a scrambled control with no complementarity to the human genome. The magenta bars depict the expression of PRDM1 24 hours after transfection with a hairpin precursor for miR-30b, while the red bars depict the expression of PRDM1 24 hours after transfection with a hairpin precursor for miR-30d. The green bars depict the expression of PRDM1 24 hours after transfection with a hairpin precursor for miR-9. By contrast, there was a consistent down-regulation of PRDM1 at the protein level. See FIGS. 3C and 3D. Those results were statistically significant in each case (P<0.05, student's t-test), except for the transfections with the precursor to miR-9 (P=0.08, student's t-test). Overexpression of each of those microRNAs had an average knockdown effect of around 40%. These exclusively post-transcriptional effects of miR-9 and miR-30 on PRDMI expression are consistent with one mechanism of miRNA regulation that has been described previously in other systems. See, e.g., O'Donnell et al. Nature. 2005; 435:839-843; Gottwein et al. Nature. 2007; 450:1096-1099; Selbach et al. Nature. 2008; 455:58-63; and Baek et al. Nature. 2008; 455:64-71. There was no effect on the expression of a non-target control (Actin).

Additionally, luciferase reporter activity of the PRDM1 3′UTR construct was decreased by overexpression of miR-9, miR-30b, and miR-30d, but not their respective seed sequence mutants. See FIG. 3E, which shows the average of three experiments. The down-regulation of the luciferase reporter signal and its restoration in the mutant constructs was found to be statistically significant in each of the 3 microRNAs: miR-9, miR-30b and miR-30d (P<0.05, student's t-test). The luciferase reporter activity level was rescued to the activity level of the empty vector control when the seed sequence of the microRNAs was mutated.

The combined effect of 5 different microRNA species (miR-30a, miR-30b, miR-30c, miR-30d and miR-9) is likely to be more potent than that of a single microRNA. The role of mutual repression of BCL6 and PRDMI in the germinal center to plasma cell differentiation as been described previously. See Martins et al. Immunol. 2008; 26:133-169. Our data suggest that microRNAs may bolster the effects of BCL6 in the inhibition of PRDM1.

Our data show that members of the miR-17˜92 family are consistently expressed in GC cells and may play a role in mature B cell differentiation. Interestingly, the miR-17˜92 family has been implicated in early B cell differentiation and mice lacking the loci that encode these miRNAs have arrested early B cell development. See Ventura et al. Cell. 2008; 132:875-886. The expression patterns of the miR-17˜92 family suggest that the regulatory motifs embedded in the interaction of this miRNA family and its targets might have an additional function in regulating mature B cell differentiation.

A striking observation in this study is the high degree of asymmetry observed in relative expression of miRNAs in GC cells compared to naive and plasma cells. At least 2 hypotheses could account for these findings. First, miRNA expression may promote a highly regulated state that enables GC cells to interact with T cells and antigen presenting cells, and to leave the GC cells poised for differentiation into memory or plasma cells. Second, miRNAs expressed highly in naive and plasma cells may be underrepresented in current miRNA libraries. Such libraries are often constructed from lymph nodes, which are typically enriched in GC cells. High throughput sequencing of sorted populations of B cells could reveal novel miRNAs that are highly expressed in those populations. Interestingly, a larger number of miRNAs were highly expressed in memory cells compared to GC cells. This observation might stem from the fact that memory cells are known to be heterogeneous (Sanz et al. Semin Immunol. 2008; 20:67-82) and standard methods used to select memory cells may capture a diverse group of memory subpopulations.

Example 5 MiRNAs and B Cell Malignancies

To examine the expression of B cell stage-specific microRNAs in B cell malignancies, we undertook miRNA profiling of 75 tissue samples derived from normal lymph nodes (N=5) as well as patients with B cell malignancies including the molecular subsets of diffuse large B cell lymphoma (DLBCL; see Rosenwald et al. N Engl J Med. 2002; 346:1937-1947), germinal center B cell-like (GCB) DLBCL (N=20) and activated B cell-like (ABC) DLBCL (N=20), as well as cases of IgV mutated and unmutated chronic lymphocytic leukemia (N=20) and Burkitt lymphoma (N=10).

We constructed a Bayesian predictor from miRNAs that distinguished normal memory B cells from GC cells. See FIG. 1H. We tested the predictor in the B cell malignancies derived from germinal center B cells (Burkitt lymphoma and GCB DLBCL) along with chronic lymphocytic leukemia, which is thought to arise from memory B cells. See Klein et al. J Exp Med. 2001; 194:1625-1638. Using leave one out cross-validation, we found that the predictor constructed from miRNAs expressed in normal B cells was able to correctly identify the B cell specific stage of the B cell malignancy type in over 95% of the cases. See FIG. 4A.

An interesting aspect regarding the role of miRNAs in malignancies is their reported down-regulation in a number of malignancies compared to normal cells from the same lineage. See Lu et al. Nature. 2005; 435:834-838. To further examine this effect in B cell malignancies, we examined the expression of 113 miRNAs that we had identified in normal B cells. See Table 4, above. Of the 113 miRNAs, 103 were detected using the microarrays that we used to profile B cell malignancies and normal lymph nodes. We applied a 2-sided student's t-test to evaluate the relative expression of those 103 miRNAs in B cell malignancies (N=60) and normal lymph nodes (N=5). 34 miRNAs were differentially expressed (P<0.05) at higher levels in malignant cells and 9 miRNAs were expressed more highly in normal cells. 60 miRNAs were not differentially expressed. See FIG. 4B.

As additional validation, we examined miRNA cloning frequencies for sequences cloned from normal and malignant B cells. See Landgraf et al. Cell. 2007; 129:1401-1414. MiRNAs for which a sequence was identified in at least 2 of the 3 available normal B cell samples were used in the analysis. We applied a 2-sided student's t-test (P<0.05) to compare the differential cloning frequency of the miRNAs between normal B cells (N=3) and a variety of mature B cell malignancy patient samples and cell lines (N=42). In all, we found 56 miRNAs that were consistently expressed in normal B cells. We found 13 of those 56 miRNAs were differentially expressed (P<0.05) between normal and malignant B cells, of which 12 miRNAs were expressed more highly in malignant cells and 1 miRNA was expressed more highly in normal cells. See FIG. 4C. In order to avoid effects from tumor-infiltrating non-malignant cells, we repeated the analysis with 20 chronic lymphocytic leukemia samples in the malignant group. The results were similar to those obtained with the larger set of malignancies (data not shown).

These results demonstrate that miRNAs are not down-regulated in B cell malignancies compared to normal B cells and that normal B cell stage-specific miRNAs are maintained in B cell malignancies.

MicroRNA profiling also revealed that each B cell malignancy type had a distinctive pattern of miRNA expression. See FIG. 4D. In order to evaluate the ability of miRNA profiles to distinguish different B cell malignancy types, we constructed Bayesian predictors from the most highly differentially expressed miRNAs for each pair-wise comparison. See Tables 7, 8, and 9.

TABLE 7 Predictor microRNAs that distinguish germinal center B-cell (GCB) DLBCL from Burkitt Lymphoma, activated B-cell (ABC) DLBCL, and chronic lymphocytic leukemia GCBvsBL GCBvsABC GCBvsCLL hsa-miR-146a hsa-miR-142-3p hsa-miR-126 hsa-miR-154 hsa-miR-16 hsa-miR-130a hsa-miR-155 hsa-miR-184 hsa-miR-I0b hsa-miR-184 hsa-miR-191 hsa-miR-154 hsa-miR-29b hsa-miR-19a hsa-miR-193b hsa-miR-29c hsa-miR-19b hsa-miR-199a-3p hsa-miR-363 hsa-miR-299-5p hsa-miR-365 hsa-miR-503 hsa-miR-32 hsa-miR-99b hsa-miR-519c-5p hsa-miR-30e* hsa-miR-143 hsa-miR-301a hsa-miR-151-5p hsa-miR-585 hsa-miR-152 hsa-miR-583 hsa-miR-193a-5p hsa-miR-30b* mghv-miR-MI-7-5p hsa-miR-886-5p hsa-miR-590-5p hsa-miR-142-5p hsa-miR-I00 hsa-miR-149* hsa-miR-106b hsa-miR-768-5p hsa-miR-300 hsa-miR-30e hsa-miR-145 hsa-miR-625* hsa-miR-140-3p hsa-miR-943 kshv-miR-K12-3 hsa-miR-20a hsa-miR-371-5p hsa-miR-28-5p hsa-miR-526b* hsa-miR-675 hsa-miR-25* hsa-miR-28-5p hsa-miR-150 ebv-miR-BHRFI-2 hsa-miR-30c hsa-miR-181a BL = Burkitt lymphoma, ABC = activated B-cell DLBCL, CLL = chronic lymphocytic lymphoma

TABLE 8 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from Burkitt Lymphoma and chronic lymphocytic leukemia ABCvsBL ABCvsCLL hsa-miR-182 hsa-miR-193b hsa-miR-377 hsa-miR-99b hsa-miR-660 hsa-miR-551a hsa-miR-595 mghv-miR-MI-7-3p ebv-miR-BARTI0 hsa-miR-585 hsa-miR-532-5p hsa-miR-617 hsa-miR-200c* hsa-miR-629* hsa-miR-362-3p hsa-miR-575 hsa-miR-455-3p kshv-miR-K12-6-5p hsa-miR-128 hsa-miR-193a-5p hsa-miR-21* hsa-miR-30e hsa-miR-589 hsa-miR-296-3p hsa-miR-135a* hsa-miR-518b hsa-miR-532-3p hsa-miR-492 hsa-miR-548d-5p hsa-miR-220c hsa-miR-652 hsa-miR-326 hsa-miR-150* hsa-miR-671-5p hsa-miR-330-5p hsa-miR-340* hsa-miR-339-3p hsa-miR-150 hsa-miR-502-3p hsa-miR-193b* BL = Burkitt lymphoma, CLL = chronic lymphocytic lymphoma.

TABLE 9 Predictor microRNAs that distinguish Burkitt lymphoma from chronic lymphocytic leukemia BLvsCLL hsa-miR-130b hsa-miR-154 hsa-miR-155 hsa-miR-29b hsa-miR-29c hsa-miR-637 hsa-miR-658 hsa-miR-193a-5p hsa-miR-886-5p hsa-miR-768-5p hsa-miR-I0I hsa-miR-933 hsa-miR-371-5p hsa-miR-675 hsa-miR-150 hsa-miR-874 hsa-miR-181a hsa-miR-30c ebv-miR-BHRFI-2 hsa-miR-628-3p CLL = chronic lymphocytic lymphoma

We tested the performance of the predictor using leave-one-out cross-validation applied to the predictors for Burkitt lymphoma, chronic lymphocytic leukemia, activated B-cell diffuse large B-cell lymphoma, and germinal center B-cell DLBCL. For a sample prediction to be correct, it had to be classified correctly in each pair-wise comparison with all remaining entities. We found it to be over 90% accurate in the identification of each entity. See FIG. 10.

We next expanded the analysis to include follicular lymphoma and Hodgkin's lymphoma. We included the samples from the earlier study and we undertook miRNA profiling of the following additional samples: normal lymph nodes (N=5) and patients with germinal center B cell-like (GCB) DLBCL (N=10), activated B cell-like (ABC) DLBCL (N=10), chronic lymphocytic leukemia (N=10), Burkitt lymphoma (N=10), follicular lymphoma (N=10), and Hodgkin's lymphoma (N=9). As before, microRNA profiling revealed that each B cell malignancy type had a distinctive pattern of miRNA expression. See FIG. 11.

From that data, we identified microRNAs that can be used to distinguish each of the six B cell malignancies analyzed from the other five. Lists of those microRNAs, and whether they are expressed in high levels or low levels relative to the other 5 B cell malignancies, are shown in Tables 10 through 13. In certain embodiments, each of those microRNAs could be used to distinguish one of the six B cell malignancies from the other five. High and low in the table refer to at least a 2 fold difference when compared to other lymphomas and benign lymph nodes.

TABLE 10 Predictor microRNAs that distinguish Burkitt lymphoma, germinal center B-cell (GCB) DLBCL, and follicular lymphoma from all other B cell malignancies in the study BL vs GCB vs FL vs BL miRNA list others GCB miRNA list others FL miRNA list others hsa-miR-106a High hsa-miR-93/mmu-miR- High hsa-miR-96/mmu-miR- High hsa-miR-17/mmu- High 93/rno-miR-93 96/rno-miR-96 miR-17/rno-miR-17- hsa-miR-886-3p High hsa-miR-138/mmu-miR- High 5p/rno-miR-17 hsa-miR-365/mmu-miR- High 138/rno-miR-138 hsa-miR-628-3p High 365/rno-miR-365 hsa-miR-342-5p/mmu- High hsa-miR-193a-5p High hsa-miR-378/mmu-miR- High miR-342-5p/rno-miR-342- hsa-miR-371-5p High 378/rno-miR-378 5p hsa-miR-20a/mmu- High hsa-miR-320/mmu-miR- High hsa-miR-337-3p High miR-20a/rno-miR-20a 320/rno-miR-320 hsa-miR-301a/mmu-miR- High hsa-miR-23a/mmu- Low hsa-miR-103/mmu-miR- High 301a/rno-miR-301a miR-23a/rno-miR-23a 103/rno-miR-103 hsa-miR-922 High hsa-miR-27a/mmu- Low hsa-miR-637 High hsa-miR-744/mmu-miR- High miR-27a/rno-miR-27a hsa-miR-148a/mmu- High 744 hsa-miR-34b/mmu- Low miR-148a hsa-miR-221* High miR-34b-3p hsa-miR-199a-3p/hsa- High hsa-miR-215 High hsa-miR-21/mmu- Low miR-199b-3p/mmu-miR- hsa-miR-197/mmu-miR- High miR-21/rno-miR-21 199a-3p/mmu-miR- 197 hsa-miR-29a/mmu- Low 199b/rno-miR-199a-3p hsa-miR-92b/mmu-miR- High miR-29a/rno-miR-29a hsa-miR-126*/mmu- High 92b/rno-miR-92b hsa-let-7b/mmu-let- Low miR-126-5p/rno-miR- hsa-miR-218-2*/mmu- High 7b/rno-let-7b 126* miR-218-2*/rno-miR- hsa-let-7f/mmu-let- Low kshv-miR-K12-6-3p High 218* 7f/rno-let-7f hsa-miR-125a-5p/mmu- High hsa-miR-636 High hsa-miR-29b/mmu- Low miR-125a-5p/rno-miR- hsa-miR-600 High miR-29b/rno-miR- 125a-5p kshv-miR-K12-7 High 29b hsa-miR-551b/mmu- Low hsa-miR-194/mmu-miR- High hsa-miR-549 Low miR-551b/rno-miR-551b 194/rno-miR-194 hsa-miR-374a Low hsa-miR-923 Low hsa-miR-524-5p High hsa-miR-513a-5p Low hsa-miR-22*/mmu-miR- High hsa-miR-148a/mmu- Low 22*/rno-miR-22* miR-148a hsa-miR-34c-5p/mmu- High hsa-miR-223/mmu- Low miR-34c/rno-miR-34c miR-223/rno-miR-223 hsa-miR-151-3p High hsa-miR-138- Low hsa-miR-425/mmu-miR- High 1*/mmu-miR- 425/rno-miR-425 138*/rno-miR-138* ebv-miR-BART16 High hsa-miR-342- Low hsa-miR-20b* High 3p/mmu-miR-342- hsa-miR-574-3p/mmu- High 3p/rno-miR-342-3p miR-574-3p hsa-miR-146b- Low hsa-miR-155* High 5p/mmu-miR- hsa-miR-374b* High 146b/rno-miR-146b hsa-miR-497/mmu-miR- High hsa-miR-195/mmu- Low 497/rno-miR-497 miR-195/rno-miR-195 hsa-miR-708/mmu-miR- High hsa-miR-103/mmu- Low 708/rno-miR-708 miR-103/rno-miR-103 hsa-miR-92a/mmu-miR- High hsa-miR-888* Low 92a/rno-miR-92a hsa-miR-363/mmu- Low hsa-miR-361-3p High miR-363/rno-miR-363 hsa-miR-513a-3p High hsa-miR-140- Low hsa-miR-934 High 3p/mmu-miR- hsa-miR-363*/rno-miR- High 140*/rno-miR-140* 363* hsa-miR-191/mmu- Low mghv-miR-M1-3 High miR-191/rno-miR-191 hsa-miR-129* High hsa-miR-768-5p Low hsa-miR-148b/mmu-miR- High hsa-miR-222/mmu- Low 148b/rno-miR-148b-3p miR-222/rno-miR-222 hsa-miR-493 High hsa-miR-668/mmu- Low hsa-miR-151-5p/mmu- High miR-668 miR-151-5p/rno-miR-151 hsa-miR-221/mmu- Low hsa-miR-146b-3p High miR-221/rno-miR-221 hsa-miR-886-5p High hsa-miR-24-1*/mmu- Low hsa-miR-331-3p/mmu- High miR-24-1*/rno-miR- miR-331-3p/rno-miR-331 24-1* hsa-miR-574-5p/mmu- High hsa-miR-29c/mmu- Low miR-574-5p miR-29c/rno-miR-29c hsa-miR-424 High hsa-miR-146a/mmu- Low hsa-miR-152/mmu-miR- High miR-146a/rno-miR- 152/rno-miR-152 146a hsa-miR-302a/mmu-miR- High hsa-miR-154/mmu- Low 302a miR-154/rno-miR-154 hsa-miR-181a/mmu-miR- High hsa-miR-215 Low 181a/rno-miR-181a hsa-miR-487b/mmu- Low hsa-miR-509-5p High miR-487b/rno-miR- hsa-let-7d/mmu-let- High 487b 7d/rno-let-7d hsa-miR-155 Low hsa-miR-18b High hsa-miR-620 High hsa-miR-18a/mmu-miR- High 18a/rno-miR-18a hsa-miR-298 High hsa-miR-98/mmu-miR- High 98/rno-miR-98 hsa-miR-576-3p High hsa-miR-374b/mmu-miR- High 374/rno-miR-374 hsa-miR-32* High hsa-miR-302d* High ebv-miR-BART17-5p High hsa-miR-620 High hsa-miR-665 High hsa-miR-185/mmu-miR- High 185/rno-miR-185 hsa-miR-34b/mmu-miR- High 34b-3p hsa-let-7e/mmu-let- High 7e/rno-let-7e

TABLE 11 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from all other B cell malignancies in the study ABC vs ABC miRNA list others hsa-miR-126/mmu-miR- High 126-3p/rno-miR-126 hsa-miR-125b/mmu-miR- High 125b-5p/rno-miR-125b-5p hsa-miR-145/mmu-miR- High 145/rno-miR-145 hsa-miR-22/mmu-miR- High 22/rno-miR-22 hsa-miR-21/mmu-miR- High 21/rno-miR-21 hsa-miR-199a-3p/hsa-miR- High 199b-3p/mmu-miR-199a- 3p/mmu-miR-199b/rno- miR-199a-3p hsa-miR-24/mmu-miR- High 24/rno-miR-24 hsa-miR-143/mmu-miR- High 143/rno-miR-143 hsa-miR-23b/mmu-miR- High 23b/rno-miR-23b hsa-miR-23a/mmu-miR- High 23a/rno-miR-23a hsa-miR-142-3p/mmu-miR- High 142-3p/rno-miR-142-3p hsa-let-7a/mmu-let-7a/rno- High let-7a hsa-miR-146b-5p/mmu- High miR-146b/rno-miR-146b hsa-miR-27a/mmu-miR- High 27a/rno-miR-27a hsa-miR-30a/mmu-miR- High 30a/rno-miR-30a hsa-miR-27b/mmu-miR- High 27b/rno-miR-27b hsa-let-7c/mmu-let-7c/rno- High let-7c hsa-miR-921 Low ebv-miR-BHRF1-2 Low hsa-miR-199a-5p/mmu- Low miR-199a-5p/rno-miR- 199a-5p hsa-miR-768-5p Low hsa-miR-491-3p Low hsa-miR-185/mmu-miR- Low 185/rno-miR-185 ebv-miR-BART17-5p Low hsa-miR-32* Low hsa-miR-335/mmu-miR- Low 335-5p/rno-miR-335 hsa-miR-149* Low hsa-miR-576-3p Low hsa-miR-214/mmu-miR- Low 214/rno-miR-214 hsa-miR-184/mmu-miR- Low 184/rno-miR-184 hsa-miR-520d-5p Low hsa-miR-518c* Low hsa-miR-801/mmu-miR-801 Low hsa-miR-298 Low hsa-miR-634 Low hsa-miR-583 Low hsa-miR-187* Low hsa-miR-30d/mmu-miR- Low 30d/rno-miR-30d hsa-miR-129-5p/mmu-miR- Low 129-5p/rno-miR-129 hsa-miR-300 Low hsa-miR-620 Low hsa-miR- Low 130b*/mmu-miR- 130b* hsa-miR-20b/mmu- Low miR-20b/rno-miR- 20b-5p kshv-miR-K12-3 Low hsa-miR-28-3p/rno- Low miR-28* hsa-miR-557 Low hsa-miR-150/mmu- Low miR-150/rno-miR- 150 hsa-miR-98/mmu- Low miR-98/rno-miR-98 hsa-miR-486- Low 5p/mmu-miR-486 hsa-miR-518a- Low 5p/hsa-miR-527 hsa-miR-302d* Low hsa-miR-516a-5p Low hsa-miR-148b/mmu- Low miR-148b/rno-miR- 148b-3p hsa-miR-25* Low hsa-miR-374b/mmu- Low miR-374/rno-miR- 374 hsa-miR-638 Low hsa-miR-302a/mmu- Low miR-302a hsa-miR-99b*/mmu- Low miR-99b*/rno-miR- 99b* hsa-miR-29c*/mmu- Low miR-29c*/rno-miR- 29c* hsa-miR-138/mmu- Low miR-138/rno-miR- 138 hsa-miR-766 Low hsa-miR-488 Low hsa-miR-498 Low hsa-miR-339- Low 5p/mmu-miR-339- 5p/rno-miR-339-5p hsa-miR-193b* Low hsa-miR-299- Low 5p/mmu-miR- 299*/rno-miR-299 ebv-miR-BART8* Low hsa-miR-107/mmu- Low miR-107/rno-miR- 107 hsa-miR-519e* Low hsa-miR-146b-3p Low hsa-miR-552 Low hsa-miR-509-5p Low hsa-miR-574- Low 5p/mmu-miR-574- 5p hsa-miR-524-5p Low mghv-miR-M1-7-5p Low hsa-miR-659 Low hcmv-miR-UL148D Low hsa-miR-92a/mmu- Low miR-92a/rno-miR- 92a hsa-miR- Low 30e*/mmu-miR- 30e*/rno-miR- 30e* hsa-miR- Low 183*/mmu-miR- 183* hsa-miR-144* Low hsa-miR-574- Low 3p/mmu-miR-574- 3p hsa-miR-889 Low hsa-miR-525-5p Low kshv-miR-K12-8 Low hsa-miR-32/mmu- Low miR-32/rno-miR- 32 hsa-miR-938 Low hsa-miR-198 Low hsa-miR- Low 186/mmu-miR- 186/rno-miR-186 hsa-miR- Low 18a/mmu-miR- 18a/rno-miR-18a hsa-miR-516b Low hsa-miR-625* Low hsa-miR-551b* Low hsa-miR-885-5p Low hsa-miR-891a Low hsa-miR- Low 340/mmu-miR- 340-5p/rno-miR- 340-5p hsa-let-7d/mmu- Low let-7d/rno-let-7d hsa-miR-151- Low 5p/mmu-miR-151- 5p/rno-miR-151 hsa-miR-18b Low ebv-miR-BHRF1-1 Low hsa-miR-510 Low hsa-miR-625 Low mghv-miR-M1-8 Low ebv-miR-BART19- Low 3p hsa-miR-147 Low hsa-miR-28- Low 5p/mmu-miR- 28/rno-miR-28 ebv-miR-BART13 Low hsa-miR-25/mmu- Low miR-25/rno-miR- 25 hsa-miR-519d Low hsa-miR-361- Low 5p/mmu-miR- 361/rno-miR-361 hsa-miR-331- Low 3p/mmu-miR-331- 3p/rno-miR-331 hsa-miR-423- Low 3p/mmu-miR-423- 3p/rno-miR-423 hsa-miR-93/mmu- Low miR-93/rno-miR- 93

TABLE 12 Predictor microRNAs that distinguish chronic lymphocytic leukemia from all other B cell malignancies in the study CLL vs CLL miRNA list others hsa-miR- High 30e*/mmu-miR- 30e*/rno-miR-30e* hsa-miR-32/mmu- High miR-32/rno-miR-32 hsa-let-7g/mmu- High let-7g hsa-miR-186/mmu- High miR-186/rno-miR- 186 hsa-miR-140- High 5p/mmu-miR- 140/rno-miR-140 hsa-miR- High 196a*/mmu-miR- 196a*/rno-miR- 196a* hsa-miR- High 487b/mmu-miR- 487b/rno-miR-487b hsa-miR-150/mmu- High miR-150/rno-miR- 150 hsa-miR-147 High hsa-miR-486- High 5p/mmu-miR-486 hsa-miR-144* High hsa-miR-154/mmu- High miR-154/rno-miR- 154 hsa-miR-28- High 5p/mmu-miR- 28/rno-miR-28 hsa-miR-299- High 5p/mmu-miR- 299*/rno-miR-299 hsa-miR-33a/mmu- High miR-33/rno-miR-33 hsa-miR-363/mmu- High miR-363/rno-miR- 363 hsa-miR-891a High hsa-miR-768-5p High hsa-miR-361- High 5p/mmu-miR- 361/rno-miR-361 hsa-miR-519d High hsa-miR-335/mmu- High miR-335-5p/rno- miR-335 hsa-miR-668/mmu- High miR-668 hsa-let-7f/mmu-let- High 7f/rno-let-7f hsa-miR-24- High 1*/mmu-miR-24- 1*/rno-miR-24-1* hsa-miR-223/mmu- High miR-223/rno-miR- 223 hsa-miR-140- High 3p/mmu-miR- 140*/rno-miR-140* hsa-miR-144/mmu- High miR-144/rno-miR- 144 hsa-miR-638 High hsa-miR-30d/mmu- High miR-30d/rno-miR- 30d hsa-miR-423- High 3p/mmu-miR-423- 3p/rno-miR-423 hsa-miR-155 High hsa-miR-101/mmu- High miR-101a/rno-miR- 101a hsa-miR-20b/mmu- High miR-20b/rno-miR- 20b-5p hsa-miR-374a High hsa-miR-25/mmu- High miR-25/rno-miR-25 hsa-miR-199a- High 5p/mmu-miR-199a- 5p/rno-miR-199a- 5p hsa-miR-649 High hsa-miR-191/mmu- High miR-191/rno-miR- 191 hsa-miR-30e/mmu- High miR-30e/rno-miR- 30e hsa-miR-107/mmu- High miR-107/rno-miR- 107 hsa-miR-93/mmu- High miR-93/rno-miR-93 hsa-miR-29c/mmu- High miR-29c/rno-miR- 29c hsa-miR-541* High hsa-miR-888* High hsa-miR-549 High hsa-miR-19a/mmu- High miR-19a/rno-miR- 19a hsa-miR-342- High 3p/mmu-miR-342- 3p/rno-miR-342-3p hsa-miR-142- High 5p/mmu-miR-142- 5p/rno-miR-142-5p hsa-miR-801/mmu- High miR-801 hsa-let-7i/mmu-let- High 7i/rno-let-7i hsa-miR-26a/mmu- High miR-26a/rno-miR- 26a hsa-miR-15a/mmu- High miR-15a hsa-miR-195/mmu- High miR-195/rno-miR- 195 hsa-miR- High 106b/mmu-miR- 106b/rno-miR-106b hsa-miR-26b/mmu- High miR-26b/rno-miR- 26b hsa-miR-15b/mmu- High miR-15b/rno-miR- 15b hsa-miR-222/mmu- High miR-222/rno-miR- 222 hsa-miR-185/mmu- High miR-185/rno-miR- 185 hsa-miR-550 High hsa-let-7e/mmu- Low let-7e/rno-let-7e hsa-miR-24/mmu- Low miR-24/rno-miR-24 hsa-miR-30c- Low 2*/mmu-miR-30c- 2*/rno-miR-30c-2* hsa-miR-765 Low mghv-miR-M1-4 Low hsa-miR-933 Low hsa-miR-620 Low hsa-miR-30b* Low hsa-miR-658 Low hsa-miR-10a/mmu- Low miR-10a/rno-miR- 10a-5p hsa-miR-665 Low hsa-miR-185* Low hsa-miR-503 Low hsa-miR-126*/mmu-miR- Low 126-5p/rno-miR-126* hsa-miR-10b/mmu-miR- Low 10b/rno-miR-10b hsa-miR-628-3p Low hsa-miR-422a Low hsa-miR-193a-5p Low hsa-miR-143/mmu-miR- Low 143/rno-miR-143 hsa-miR-371-5p Low hsa-miR-100/mmu-miR- Low 100/rno-miR-100 hsa-miR-365/mmu-miR- Low 365/rno-miR-365 hsa-miR-145/mmu-miR- Low 145/rno-miR-145 kshv-miR-K12-6-3p Low ebv-miR-BART6-3p Low hsa-miR-220c Low hsa-miR-519c-5p/hsa-miR- Low 519b-5p/hsa-miR-523*/hsa- miR-518e*/hsa-miR- 522*/hsa-miR-519a* hsa-miR-130a/mmu-miR- Low 130a/rno-miR-130a hsa-miR-424 Low hsa-miR-483-5p Low hsa-miR-193b Low hsa-miR-637 Low hsa-miR-920 Low hsa-miR-488 Low ebv-miR-BHRF1-2 Low hsa-miR-526b Low hsa-miR-126/mmu-miR-126- Low 3p/rno-miR-126 hsa-miR-943 Low hsa-miR-199a-3p/hsa-miR- Low 199b-3p/mmu-miR-199a- 3p/mmu-miR-199b/rno-miR- 199a-3p mghv-miR-M1-3 Low hsa-miR-934 Low hsa-miR-886-5p Low hsa-miR-200b*/mmu-miR- Low 200b* hsa-miR-485-3p/mmu-miR- Low 485* hsa-miR-181a/mmu-miR- Low 181a/rno-miR-181a hsa-miR-125b/mmu-miR- Low 125b-5p/rno-miR-125b-5p

TABLE 13 Predictor microRNAs that distinguish Hodgkin's lympoma from all other B cell malignancies in the study HL vs HL miRNA list others hsa-miR-338- High 5p/mmu-miR-338- 5p/rno-miR-338* hsa-miR-433/mmu- High miR-433/rno-miR- 433 hsa-miR-552 High hsa-miR-202 High hsa-miR-299-3p High hsa-miR-509-3-5p High hsa-miR-490-5p High hsa-miR-508-5p High hsa-miR-181a-2* High hsa-miR-663 High hsa-miR-326/mmu- High miR-326/rno-miR- 326 hsa-miR-542- High 3p/mmu-miR-542- 3p/rno-miR-542-3p hsa-miR-492 High hsa-miR-584 High hsa-miR-654-5p High ebv-miR-BART20-3p High hsa-miR-542- High 5p/mmu-miR-542- 5p/rno-miR-542-5p ebv-miR-BART9* High hsa-miR-124/mmu- High miR-124/rno-miR- 124 hsa-miR-551a High hsa-miR-208a/mmu- High miR-208a/rno-miR- 208 hsa-miR-220b High hsa-miR-615- High 3p/mmu-miR-615-3p hsa-miR- High 135a*/mmu-miR- 135a* hiv1-miR-H1 High hsa-miR-124*/mmu- High miR-124*/rno-miR- 124* hsa-miR-502-5p High hsa-miR-92b* High hsa-miR-518a-3p High hsa-miR-377* High hsa-miR-125a- High 3p/mmu-miR-125a- 3p/rno-miR-125a-3p hsa-miR-30c- High 1*/mmu-miR-30c- 1*/rno-miR-30c-1* hsa-miR-650 High hsa-miR-629 High hsa-miR-296- High 3p/mmu-miR-296- 3p/rno-miR-296 hsa-miR-425*/mmu- High miR-425* hsa-miR-514 High hsa-miR-519e High hsa-miR-938 High hsa-miR-340*/mmu- High miR-340-3p/rno- miR-340-3p hsa-miR-657 High hsa-miR-9*/mmu- High miR-9*/rno-miR-9* ebv-miR-BART7* High hsa-miR-612 High hsa-miR-640 High hsa-miR-623 High hsa-miR-99b*/mmu- High miR-99b*/rno-miR- 99b* hsa-miR-645 High hsa-miR-484/mmu- High miR-484/rno-miR- 484 hsa-miR-376a* High hsa-miR-345 High hsa-miR-586 High hsa-miR-622 High hsa-miR-206/mmu- High miR-206/rno-miR- 206 hcmv-miR-US25-1* High hsa-miR-302c* High hsa-miR- High 106b*/mmu-miR- 106b*/rno-miR- 106b* hsa-miR-500 High hsa-miR-890 High hsa-miR-10a*/mmu- High miR-10a*/rno-miR- 10a-3p kshv-miR-K12-1 High hsa-miR-629* High hsa-miR-193b* High ebv-miR-BHRF1-3 High hsa-miR-183/mmu- High miR-183/rno-miR- 183 hsa-let-7b*/mmu- High let-7b*/rno-let-7b* hsa-miR-409- High 5p/mmu-miR-409- 5p/rno-miR-409-5p hsa-miR-585 High hsa-miR-526b* High hsa-miR-337-3p High hsa-miR-212/mmu- High miR-212/rno-miR- 212 hsa-miR-548b-3p High hcmv-miR-UL112 High hsa-miR-601 High hsa-let-7d*/mmu- High let-7d*/rno-let-7d* hsa-miR-181b/mmu- High miR-181b/rno-miR- 181b hsa-miR-195* High kshv-miR-K12-5 High hsa-miR-500* High hsa-miR-24- High 2*/mmu-miR-24- 2*/rno-miR-24-2* hsa-miR-382/mmu- High miR-382/rno-miR- 382 ebv-miR-BART8* High hsa-miR-125b- High 2*/rno-miR-125b* hsa-miR-194* High hsa-miR-297/mmu- High miR-297a hsa-miR-610 High hsa-miR-575 High hsa-miR-21* High hsa-miR-936 High kshv-miR-K12-6-5p High hsa-miR-553 High hsa-miR-652/mmu- High miR-652/rno-miR- 652 hsa-miR-877/mmu- High miR-877/rno-miR- 877 hsa-miR-526a/hsa- High miR-520c-5p/hsa- miR-518d-5p hsa-miR-122* High hsa-miR-576-5p High mghv-miR-M1-6 High hsa-miR-551b* High hsa-miR-125b- High 1*/mmu-miR-125b- 3p/rno-miR-125b- 3p hsa-miR-137/mmu- High miR-137/rno-miR- 137 ebv-miR-BART18-3p High hsa-miR-452 High hsa-miR-23a*/rno- High miR-23a* hsa-miR-617 High hsa-miR-550* High hsa-miR-557 High hsa-miR-331- High 5p/mmu-miR-331- 5p hsa-miR-296- High 5p/mmu-miR-296- 5p/rno-miR-296* mghv-miR-M1-2 High ebv-miR-BART6-3p High hsa-miR-518b High hsa-miR-99b/mmu- High miR-99b/rno-miR- 99b hsa-miR-525-5p High hsa-miR-589 High hsa-miR-7-2* High hsa-miR-490- High 3p/mmu-miR-490 hsa-miR- High 150*/mmu-miR- 150* hsa-miR-17*/rno- High miR-17-3p hsa-miR-509-3p High ebv-miR-BHRF1-1 High hsa-miR- High 183*/mmu-miR- 183* hsa-miR-635 High hsa-miR- High 130b/mmu-miR- 130b/rno-miR-130b mghv-miR-M1-8 High hsa-miR-887 High hsa-miR-210/mmu- High miR-210/rno-miR- 210 hsa-miR-766 High hsa-miR-671- High 5p/mmu-miR-671- 5p hsa-miR-659 High hsa-miR-330- High 5p/mmu-miR- 330/rno-miR-330 hsa-miR-323- High 3p/mmu-miR-323- 3p/rno-miR-323 ebv-miR-BART13 High ebv-miR-BART5 High hsa-miR-602 High hcmv-miR-UL148D High hsa-miR-373* High hsa-miR-526b High hsa-miR-328/mmu- High miR-328/rno-miR- 328 hsa-miR-874/mmu- High miR-874/rno-miR- 874 ebv-miR-BART19-3p High hsa-miR-595 High hsa-miR-889 High mghv-miR-M1-7-5p High hsa-miR-483-5p High hsa-miR- High 487b/mmu-miR- 487b/rno-miR-487b hsa-miR-675 High hsa-miR-220c High mghv-miR-M1-7-3p High hsa-miR-485- High 3p/mmu-miR-485* hsa-miR-198 High hsa-miR-483-3p High hcmv-miR-UL70-3p High hsa-miR-149/mmu- High miR-149 hsa-miR-516a-5p High hsa-miR- High 145*/mmu-miR- 145* hsa-miR-656 High hsa-miR-502-3p High hsa-miR-29c*/mmu-miR- High 29c*/rno-miR-29c* hsa-miR-937 High hsa-miR-515-5p High hsa-miR-153/mmu-miR- High 153/rno-miR-153 hsa-miR-519e* High hsa-miR-128/mmu-miR- High 128/rno-miR-128 hsa-miR-516b High hsa-miR-532-5p/mmu-miR- High 532-5p/rno-miR-532-5p kshv-miR-K12-8 High hsa-miR-455-3p High hsa-miR-27a*/mmu-miR- High 27a*/rno-miR-27a* hsa-miR-510 High hsa-miR-505/rno-miR-505 High hsa-miR-187* High hsa-miR-498 High hsa-miR-625 High hsa-miR-129-5p/mmu-miR- High 129-5p/rno-miR-129 ebv-miR-BHRF1-2 High hsa-miR-143* High kshv-miR-K12-3 High hsa-miR-660 High hsa-miR-25* High hsa-miR-29a*/mmu-miR- High 29a*/rno-miR-29a* hsa-miR-422a High hsa-miR-518a-5p/hsa-miR- High 527 hsa-miR-519c-5p/hsa-miR- High 519b-5p/hsa-miR- 523*/hsa-miR-518e*/hsa- miR-522*/hsa-miR-519a* hsa-miR-28-3p/rno-miR-28* High hsa-miR-300 High hsa-miR-130a/mmu-miR- High 130a/rno-miR-130a hsa-miR-583 High hsa-miR-149* High hsa-miR-184/mmu-miR- High 184/rno-miR-184 hsa-miR-625* High hsa-miR-99a/mmu-miR- High 99a/rno-miR-99a hsa-miR-199b-5p High hsa-miR-513a-5p High hsa-miR-494/mmu-miR- High 494/rno-miR-494 mghv-miR-M1-4 High hsa-miR-634 High hsa-miR-923 High hsa-miR-503 High ebv-miR-BART2-3p High hsa-miR-520d-5p High hsa-miR-30b* High hsa-miR-30c-2*/mmu-miR- High 30c-2*/rno-miR-30c-2* hsa-miR-658 High hsa-miR-921 High hsa-miR-423-5p/mmu-miR- High 423-5p hsa-miR-933 High hsa-miR-23b/mmu-miR- Low 23b/rno-miR-23b hsa-miR-27b/mmu-miR- Low 27b/rno-miR-27b hsa-miR-550 Low hsa-let-7a/mmu-let-7a/rno- Low let-7a hsa-miR-24/mmu-miR- Low 24/rno-miR-24 hsa-miR-451/mmu-miR- Low 451/rno-miR-451 hsa-miR-30a/mmu-miR- Low 30a/rno-miR-30a hsa-miR-20b/mmu-miR- Low 20b/rno-miR-20b-5p hsa-miR-26a/mmu-miR- Low 26a/rno-miR-26a hsa-miR-26b/mmu-miR- Low 26b/rno-miR-26b hsa-miR-101/mmu-miR- Low 101a/rno-miR-101a hsa-miR-106b/mmu-miR- Low 106b/rno-miR-106b hsa-miR-16/mmu-miR- Low 16/rno-miR-16 hsa-miR-29b/mmu-miR- Low 29b/rno-miR-29b hsa-miR-768-3p Low hsa-miR-30e/mmu-miR- Low 30e/rno-miR-30e hsa-miR-106a Low hsa-miR-142-5p/mmu-miR- Low 142-5p/rno-miR-142-5p hsa-miR-144/mmu-miR- Low 144/rno-miR-144 hsa-miR-17/mmu-miR- Low 17/rno-miR-17-5p/rno-miR- 17 hsa-miR-15b/mmu-miR- Low 15b/rno-miR-15b hsa-miR-30c/mmu-miR- Low 30c/rno-miR-30c hsa-miR-142-3p/mmu-miR- Low 142-3p/rno-miR-142-3p hsa-miR-20a/mmu-miR- Low 20a/rno-miR-20a hsa-miR-30b/mmu-miR- Low 30b/rno-miR-30b-5p hsa-miR-19a/mmu-miR- Low 19a/rno-miR-19a hsa-miR-19b/mmu-miR- Low 19b/rno-miR-19b

From the data in Tables 10 through 13, we identified subsets of microRNAs that are sufficient to distinguish each of the six B cell malignancies from the other five. We selected only microRNAs that are expressed more highly in the selected B cell malignancy. Those microRNAs are listed in Tables 14 and 15. In certain embodiments, each of the microRNAs listed in Tables 14 and 15 can be used to distinguish one B cell malignancy from the other five.

TABLE 14 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL, germinal center B-cell like (GCB) DLBCL, and Burkitt lymphoma ABC High GCB High BL High hsa-miR-22/mmu-miR-22/ hsa-miR-93/mmu- hsa-miR-628- rno-miR-22 miR-93/rno-miR-93 3p hsa-miR-21/mmu-miR-21/ hsa-miR-103/mmu- rno-miR-21 miR-103/rno-miR-103 hsa-miR-24/mmu-miR-24/ hsa-miR-320/mmu-miR- rno-miR-24 320/rno-miR-320 hsa-miR-23b/mmu-miR- hsa-miR-125a-5p/mmu- 23b/rno-miR-23b miR-125a-5p/rno-miR- 125a-5p hsa-miR-23a/mmu- miR-23a/rno-miR-23a hsa-let-7a/mmu-let-7a/ rno-let-7a hsa-let-7c/mmu-let-7c/ rno-let-7c

TABLE 15 Predictor microRNAs that distinguish chromic lymphocytic leukemia, follicular lymphoma, and Hodgkin's lymphoma CLL High FL High HL High hsa-miR-32/mmu-miR-32/rno- hsa-miR-152/mmu-miR- hsa-miR-498 miR-32 152/rno-miR-152 hsa-miR-525-5p hsa-miR-150/mmu-miR-150/rno- hsa-miR-885-5p hsa-miR-551b* miR-150 hsv1-miR-H1 hsa-miR-340*/mmu-miR-340- hsa-miR-140-5p/mmu-miR- hsa-miR-548d-5p 3p/rno-miR-340-3p 140/rno-miR-140 hsa-miR-488 hsa-miR-494/mmu-miR-494/rno- hsa-let-7g/mmu-let-7g ebv-miR-BART16 miR-494 hsa-miR-154/mmu-miR-154/rno- hsa-miR-22*/mmu-miR- hsa-miR-183*/mmu-miR-183* miR-154 22*/rno-miR-22* hsa-miR-659 hsa-miR-486-5p/mmu-miR-486 hsa-miR-513a-3p hsa-miR-193b* hsa-miR-101/mmu-miR- hsa-miR-708/mmu-miR- hsa-miR-766 101a/rno-miR-101a 708/rno-miR-708 hsa-miR-516a-5p hsa-miR-30e/mmu-miR-30e/rno- hsa-miR-425/mmu-miR- hsa-miR-125b-1*/mmu-miR- miR-30e 425/rno-miR-425 125b-3p/rno-miR-125b-3p hsa-miR-768-5p hsa-miR-337-3p ebv-miR-BART6-3p hsa-miR-363/mmu-miR-363/rno- ebv-miR-BART17-5p ebv-miR-BART8* miR-363 hsa-miR-221* hsa-miR-509-3-5p hsa-miR-668/mmu-miR-668 hsa-miR-92b/mmu-miR- hsa-miR-602 hsa-miR-147 92b/rno-miR-92b ebv-miR-BHRF1-1 hsa-miR-196a*/mmu-miR- hsa-miR-197/mmu-miR-197 mghv-miR-M1-2 196a*/rno-miR-196a* hsa-miR-32* hsa-miR-145*/mmu-miR-145* hsa-miR-142-5p/mmu-miR-142- hsa-miR-342-5p/mmu-miR- hsa-miR-296-5p/mmu-miR-296- 5p/rno-miR-142-5p 342-5p/rno-miR-342-5p 5p/rno-miR-296* hsa-miR-199a-5p/mmu-miR- hsa-miR-524-5p hsa-miR-17*/rno-miR-17-3p 199a-5p/rno-miR-199a-5p hsa-miR-34c-5p/mmu-miR- hsa-miR-452 hsa-miR-24-1*/mmu-miR-24- 34c/rno-miR-34c hsa-miR-326/mmu-miR-326/rno- 1*/rno-miR-24-1* hsa-let-7e/mmu-let-7e/rno-let- miR-326 hsa-miR-891a 7e hsa-miR-652/mmu-miR-652/rno- hsa-miR-550 hsa-miR-151-3p miR-652 hsa-miR-801/mmu-miR-801 hsa-miR-744/mmu-miR-744 hsa-miR-623 hsa-miR-549 hsa-miR-574-3p/mmu-miR- hsa-miR-194* hsa-miR-888* 574-3p hsa-miR-125a-3p/mmu-miR- hsa-miR-600 125a-3p/rno-miR-125a-3p hsa-miR-20b* hsa-miR-10a*/mmu-miR- hsa-miR-194/mmu-miR- 10a*/rno-miR-10a-3p 194/rno-miR-194 hsa-miR-519e hsa-miR-363*/rno-miR-363* hsa-miR-502-5p hsa-miR-155* hsa-miR-124*/mmu-miR- hsa-miR-34b/mmu-miR-34b-3p 124*/rno-miR-124* hsa-miR-922 hsa-miR-345 hsa-miR-497/mmu-miR- hsa-miR-584 497/rno-miR-497 hsa-miR-650 hsa-miR-493 hsa-miR-202 hsa-miR-138/mmu-miR- hsa-miR-548b-3p 138/rno-miR-138 hsa-miR-492 hsa-miR-215 hsa-miR-135a*/mmu-miR-135a* hsa-miR-302a/mmu-miR-302a ebv-miR-BART20-3p hsa-miR-96/mmu-miR-96/rno- hsa-miR-586 miR-96 hsa-miR-338-5p/mmu-miR-338- hsa-miR-218-2*/mmu-miR- 5p/rno-miR-338* 218-2*/rno-miR-218* hsa-miR-92b* kshv-miR-K12-7 hiv1-miR-H1 hsa-miR-301a/mmu-miR- hsa-miR-508-5p 301a/rno-miR-301a hsa-miR-542-5p/mmu-miR-542- 5p/rno-miR-542-5p hsa-miR-490-5p hsa-miR-663 hsa-miR-433/mmu-miR-433/rno- miR-433

Finally, we identified sets of microRNAs that can distinguish between each pair of B cell malignancies in the study. Lists of those microRNAs are shown in Appendix B, Tables 16 to 30. In certain embodiments, each of the listed microRNAs is sufficient to distinguish between the two B cell malignancies listed in the table description.

The consistent expression of a number of miRNAs in a diverse set of B cell malignances suggests a role for miRNAs in the maintenance of tumor phenotype. Assays for stage-specific B cell markers such as BCL6, a marker for GC cells, are essential in the clinical diagnosis of B cell malignancies. Our data suggest that stage-specific biology in B cell malignancies is retained at the miRNA level. Recent work has demonstrated the utility of gene expression profiling in reliably distinguishing closely related B cell malignancies. See Hummel et al. N Engl J Med. 2006; 354:2419-2430; Dave et al. N Engl J Med. 2006; 354:2431-2442. However, clinical translation of gene expression profiling has proved to be difficult because of the need for freshly frozen tissue. Since intact miRNAs can be isolated from tissues preserved using standard methods (see, e.g., Doleshal et al. J Mol Diagn. 2008; 10:203-211; Xi et al. Rna. 2007; 13:1668-1674), diagnostic methods based upon miRNA profiles could be fairly easy to translate to clinical use.

Interestingly, in contrast to a previous study (Lu et al. Nature 2005; 435:834-838), we did not note a decrease in the expression of the total number or overall expression levels of miRNAs in B cell malignancies compared to normal lymph nodes. Although B cell malignancies maintain the expression of a number of stage-specific miRNAs, their miRNA expression patterns are clearly deranged compared to normal lymph nodes. The consequences of altered miRNA expression in B cell tumors would be important to explore in future studies.

In conclusion, our study demonstrates that mature B cell subsets have distinct patterns of microRNA expression, suggesting a role for miRNAs in B cell differentiation. We provide experimental evidence that transcription factors such as LM02 and PRDMI are direct targets of differentially expressed miRNAs. B cell malignancies demonstrate a distinct pattern of miRNA expression that could be useful in distinguishing morphologically identical subtypes of these tumors. The conserved expression of stage-specific microRNAs in normal and malignant B cells suggests a role for microRNAs in the maintenance of the mature B cell phenotype.

Example 6 Differential Expression of miRNAs in ABC DLBCL Vs. GBC DLBCL Malignancies

As discussed above, microRNAs have shown promise as biomarkers in a number of malignancies. Diffuse large B cell lymphoma (DLBCL) is the most common form of lymphoma and is known to comprise at least 2 molecularly distinct subgroups with different responses to standard therapy. These two distinct subgroups are typically identified as ABC DLBCL and GC (or GCB) DLBCL.

However, the current methods used to distinguish GCB from non GCB DLBCL are limited fashion and can yield inconsistent results. While gene expression profiling remains the gold standard for distinguishing these 2 molecular subgroups it is not routinely performed in clinical laboratories. In an effort to expand and improve the existing analytical options we sought to develop microRNA-based assays. We created RNA libraries from 31 different samples and performed deep sequencing analysis to identify the present miRNAs.

Small RNA Library Creation and Deep Sequencing

Total RNA was extracted from the 31 samples using the phenol-chloroform method to preserve microRNAs, using Ambion reagents. Total RNA (typically 5 μg) from each sample was run on denaturing polyacrylamide-urea gels. The ˜17-25 nucleotide RNAs were excised from the gel, ligated to sequencing adaptors on both ends and reverse transcribed. The resulting cDNA library was PCR-amplified for 15 cycles and gel purified on 6% acrylamide gel. The gel-purified amplicon quality and quantity were analyzed on a 6% acrylamide gel relative to oligonucleotides of known concentration and size. 120 μl of 1-4 pM library were loaded on to the Illumina cluster station, where DNA molecules were attached to high-density universal adaptors in the flow cells and amplified. The DNA clusters generated via this process were sequenced with sequencing-by-synthesis technology, where successive high-resolution images of the four-color fluorescence excitation dependent on the base incorporated during each cycle were captured. Sequencing reads were generated for each of the 31 samples and base calls were rendered using Illumina software. All the primary sequencing data and gene expression data is publicly available through the GEO archive through accession GSE22898.

The small RNA libraries from the 31 samples which were subjected to massively parallel, high-throughput sequencing using the Illumina platform generated a total of 328 million separate reads. Our approach to analyzing the sequences and discovering microRNAs broadly follows a previously described method (see, Zheng, Q., et al. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis, Nucleic acids Res. 2008; 36 (Web Server issue: W358-363). All bioinformatics analyses were performed using a cluster of 1024 Linux computer nodes. Preprocessing was carried out using locally written Shell and Perl scripts.

From the raw sequences generated by high-throughput sequencing, the 3′- and 5′-adaptor sequences were trimmed. Low quality sequences were identified as those sequencing reads that contained stretches of consecutive identical bases or uncalled nucleotides (N) in the first 12 bases and sequencing reads shorter than 17 nucleotides. To minimize redundancy, reads were initially curtailed to the first 22 nucleotides and identical sequences were represented with a single fasta entry for analysis. Each unique sequence was mapped to the reference genome (Ensembl, build 50) and reads were filtered such that only perfect alignments (full length, 100% identity) were retained. Reads that aligned to more than five positions in the genome and reads that overlapped with the UCSC RNA genes were identified and excluded from microRNA analysis.

Identification and Analysis of the Captured miRNA Sequences

Sequences that occurred 20 or more times in at least one sample were consolidated and annotated for the 31 samples. Genomic loci that overlapped with microRNAs described in miRBase (version 13) were identified as known microRNAs (see Table 31). The remaining genomic loci were identified as encoding candidate novel microRNAs (see Table 32).

The vast majority (96%) of the candidate novel microRNAs were found in more than one sample, with only a small minority of microRNAs were expressed exclusively in a specific B cell subset or malignancy. Many of the microRNAs that we identified in normal and malignant B cells were expressed at ten-fold or higher levels in these non B cell cases. These findings suggest that the microRNAs we have identified are broadly expressed and may have roles in a number of diverse tissue types.

miRNA Profiling Using Real-time PCR

miRNA expression profiling was conducted using the Applied Biosystems 384-well multiplexed real-time PCR assay using 400 ng of total RNA. Eight reactions, each containing 50 ng of RNA and a multiplex looped primer pool with endogenous small nucleolar (sno)-RNA controls, were used to reverse-transcribe the miRNAs in parallel fashion (see Tables 33 and 34 for primers). The completed reactions were loaded onto the 384-well plate per manufacturer's instructions, and real-time PCR was run on the ABI 7900HT Prism instrument. For each 384-well plate, we used the automatically determined cycle-threshold (C_(T)) using the SDS 2.2.1 software (Applied Biosystems). Consistent with manufacturer recommendations, a C_(T) greater than 35 was treated as undetected. The probes deemed to be present were normalized to the average expression of a sno-RNA control. The expression values were calculated as 2^(−ΔCT), then median centered to 500 and log 2-transformed.

For further validation of the deep sequencing results, we selected candidate novel microRNAs (see Table 34) that were detectably measured in at the sequencing data from least one of four diffuse large B cell lymphoma (DLBCL) cases. Using stem-loop reverse transcription (Ashburner, M., et al., Nat Genet. (2000); 25(1):25-29) for quantitative PCR, we tested the expression of the candidate microRNAs in 101 primary tumors from patients with DLBCL and found that about 92% were detectably measured by real-time PCR in at least 10% of these cases, suggesting that real-time PCR reproducibly identifies microRNAs that are expressed in lymphomas. We also used real-time PCR to measure the expression of known microRNAs (see Table 33) in the same 101 samples and found that over 90% of these were also detected in at least 10% of the cases using real-time PCR. We found that six of the seven RT-PCR constructs that targeted RNA hairpins that had low probability of being a microRNA resulted in no detectable signal. These results suggest that our assays have high specificity for microRNAs and that the computational predictions based on our sequencing data correctly identified microRNAs.

Differentiating ABC DLBCL Vs. GCB DLBCL Malignancies

Gene expression profiling of patients with DLBCL has demonstrated that the tumors comprise at least two distinct diseases with different response rates to standard chemotherapy regimens (Chen, C., et al., Nucleic Acids Res. (2005); 33(20):e179). We hypothesized that microRNAs might be used to make this clinically important distinction for which gene expression profiling remains the gold standard. We performed gene expression profiling on 101 DLBCL cases and further subdivided these cases into the molecular subgroups.

Tumor samples from 101 patients with diffuse large B cell lymphoma were obtained at the time of diagnosis and freshly frozen. These cases were profiled using Affymetrix Gene 1.0 ST arrays. The molecular subgroups were distinguished using a Bayesian approach described previously (Ambros, V., et al., RNA (2003);9(3):277-279).

We found that 25 microRNAs with the highest t-statistic were equally efficacious as the gene expression profiling in differentiating the two groups of DLBCL with over 95% overlap between the classifications rendered by the two methods, using leave out one cross-validation (see Table 35). Interestingly, a subset of these 25 predictor microRNAs was candidate novel microRNAs, suggesting a biological and clinical relevance for these candidate novel microRNAs in DLBCL tumors.

Our work provides an exhaustive identification of the microRNAs in normal and malignant B cells; that is a prerequisite to the delineation of their role. Further, we have developed a comprehensive framework that spans the identification of microRNAs from deep sequencing data to measuring their expression using real-time PCR and validating their expression in primary human tumors.

It is also conceivable that some of the low-abundance microRNAs that we have identified in our study may be expressed at higher levels in other development stages or in other cell types. This notion is confirmed by our examination of the novel microRNAs in non B cell data. For instance, a number of the microRNAs that we discovered were also present at 10-fold or higher levels in cell lines derived from breast cancer and cervical cancer, suggesting that the microRNAs that we have discovered in B cells have broad biological significance.

Deep Sequencing Reveals a Novel miRNA Cluster that Regulates the TGF-β Pathway

Although microRNAs appear to be distributed throughout the genome, a number of microRNAs have been found in clusters such as miR-17-92 that are transcribed from a single primary transcript and cleaved into the individual microRNAs by the enzyme DROSHA. We found 2 separate clusters of candidate novel microRNAs on chromosome 9 and chromosome 14 (within the IgH locus), respectively. The first cluster was previously annotated as a hypothetical gene LOC100130622, and subsequently discarded from Refseq when no associated protein was identified. Our data demonstrate that this cluster (miR-2355), conserved only in primates, encodes 6 separate microRNAs: has-miR-2355a-1, has-miR-2356-1, has-miR-2355a-2, has-miR-2356-2, hsa-miR2355a—3, and hsa-miR-2355b (see Table 32 for sequence).

In order to evaluate whether the microRNAs encoded in these clusters originate from the same primary transcript, we took KMS12 multiple myeloma cells which express these microRNAs and used siRNA to knock-down the expression of the microRNA processing enzyme Drosha. This enzyme acts at the first step of microRNA processing by cleaving microRNA precursors from the primary transcript. We found that decreased Drosha expression was associated with increased accumulation of primary transcripts of both the miR-17-92 cluster as well as the novel miR-2355 cluster. MicroRNAs from miR-2355 cluster were found to be expressed more highly in normal germinal center (GC) B cells compared to memory cells.

The microRNAs of this cluster all share the same seed sequence, suggesting that they target the same genes. Among the computationally predicted targets of this microRNA cluster, we identified SMAD2 and SMAD3 which are well known mediators of the TGF-beta signaling pathway. We noted that gene expression of both SMAD2 and SMAD3 in our set of 101 DLBCLs were inversely correlated with this cluster (P<0.001, correlation test). Gene set enrichment analysis revealed that expression of the TGF-beta pathway in DLBCL samples varied inversely with the expression of the microRNA cluster, with a higher expression of the microRNA associated with a lower expression of the pathway (P<10⁻⁶), which has been noted as a factor in the biology of these tumors.

TABLE 31 miRNAs identified by deep sequencing analysis. miRBase SEQ Mature Putative miRBase Mature/Minor miRBase SEQ ID Sequence Mature/Minor miRBase Mature/Minor Accession Mature/Minor ID NO. Captured miRNA ID ID ID Number Sequence NO.   1 CUGCGCAAGCUA hsa-let-7i* hsa-let-7i hsa-let-7i* MIMAT0004585 CUGCGCAAGCUA 393 CUGCCUUGCU CUGCCUUGCU   2 CCACGGAUGUUU hsa-mir-105-1* hsa-mir-105-1 hsa-miR-105* MIMAT0004516 ACGGAUGUUUGA 394 GAGCAUGUGC GCAUGUGCUA   3 CCACGGAUGUUU hsa-mir-105-2* hsa-mir-105-2 hsa-miR-105* MIMAT0004516 ACGGAUGUUUGA 395 GAGCAUGUGC GCAUGUGCUA   4 UACUGCAAUGUA hsa-mir-106a*  hsa-mir-106a hsa-miR-106a* MIMAT0004517 CUGCAAUGUAAG 396 AGCACUUCUU CACUUCUUAC   5 CAUUAUUACUUU hsa-mir-126* hsa-mir-126 hsa-miR-126* MIMAT0000444 CAUUAUUACUUU 397 UGGUACGCG UGGUACGCG   6 AAGCCCUUACCC hsa-mir-129* hsa-mir-129-1 hsa-miR-129* MIMAT0004548 AAGCCCUUACCC 398 CAAAAAGUAU CAAAAAGUAU   7 AAGCCCUUACCC hsa-mir-129-2* hsa-mir-129-2 hsa-miR-129-3p MIMAT0004605 AAGCCCUUACCC 399 CAAAAAGCAU CAAAAAGCAU   8 UCUACAGUGCAC hsa-mir-139-5p hsa-mir-139 hsa-miR-139-5p MIMAT0000250 UCUACAGUGCAC 400 GUGUCUCCAG GUGUCUCCAG   9 CUGGUACAGGCC hsa-mir-150* hsa-mir-150 hsa-miR-150* MIMAT0004610 CUGGUACAGGCC 401 UGGGGGACAG UGGGGGACAG  10 ACUGCAGUGAAG hsa-mir-17* hsa-mir-17 hsa-miR-17* MIMAT0000071 ACUGCAGUGAAG 402 GCACUUGUAG GCACUUGUAG  11 UGAAUUACCGAA hsa-mir-183* hsa-mir-183 hsa-miR-183* MIMAT0004560 GUGAAUUACCGA 403 GGGCCAUAA AGGGCCAUAA  12 AGGGGCUGGCUU hsa-mir-185* hsa-mir-185 hsa-miR-185* MIMAT0004611 AGGGGCUGGCUU 404 UCCUCUGGUC UCCUCUGGUC  13 ACUGCCCUAAGU hsa-mir-18a* hsa-mir-18a hsa-miR-18a* MIMAT0002891 ACUGCCCUAAGU 405 GCUCCUUCUGG GCUCCUUCUGG  14 AACUGGCCUACA hsa-mir-193a-3p hsa-mir-193a hsa-miR-193a-3p MIMAT0000459 AACUGGCCUACA 406 AAGUCCCAGU AAGUCCCAGU  15 CGGGGUUUUGAG hsa-mir-193b* hsa-mir-193b hsa-miR-193b* MIMAT0004767 CGGGGUUUUGAG 407 GGCGAGAUGA GGCGAGAUGA  16 CCCAGUGUUCAG hsa-mir-199a-2* hsa-mir-199a-2 hsa-miR-199a-5p MIMAT0000231 CCCAGUGUUCAG 408 ACUACCUGUUC ACUACCUGUUC  17 UAGUUUUGCAUA hsa-mir-19a* hsa-mir-19a hsa-miR-19a* MIMAT0004490 AGUUUUGCAUAG 409 GUUGCACUAC UUGCACUACA  18 AGUUUUGCAGGU hsa-mir-19b-1* hsa-mir-19b-1 hsa-miR-19b-1* MIMAT0004491 AGUUUUGCAGGU 410 UUGCAUCCAGC UUGCAUCCAGC  19 ACUGUAGUAUGG hsa-mir-20b* hsa-mir-20b hsa-miR-20b* MIMAT0004752 ACUGUAGUAUGG 411 GCACUUCCAG GCACUUCCAG  20 ACCUGGCAUACA hsa-mir-221* hsa-mir-221 hsa-miR-221* MIMAT0004568 ACCUGGCAUACA 412 AUGUAGAUUU AUGUAGAUUU  21 GGGUUCCUGGCA hsa-mir-23b* hsa-mir-23b hsa-miR-23b* MIMAT0004587 UGGGUUCCUGGC 413 UGCUGAUUU AUGCUGAUUU  22 AGGCGGAGACUU hsa-mir-25* hsa-mir-25 hsa-miR-25* MIMAT0004498 AGGCGGAGACUU 414 GGGCAAUUG GGGCAAUUG  23 AGAGCUUAGCUG hsa-mir-27b* hsa-mir-27b hsa-miR-27b* MIMAT0004588 AGAGCUUAGCUG 415 AUUGGUGAAC AUUGGUGAAC  24 CUGGGAGGUGGA hsa-mir-30b* hsa-mir-30b hsa-miR-30b* MIMAT0004589 CUGGGAGGUGGA 416 UGUUUACUUC UGUUUACUUC  25 CUGGGAGAGGGU hsa-mir-30c-1* hsa-mir-30c-1 hsa-miR-30c-1* MIMAT0004674 CUGGGAGAGGGU 417 UGUUUACUCC UGUUUACUCC  26 CUGGGAGAAGGC hsa-mir-30c-2* hsa-mir-30c-2 hsa-miR-30c-2* MIMAT0004550 CUGGGAGAAGGC 418 UGUUUACUCU UGUUUACUCU  27 CUUUCAGUCGGA hsa-mir-30e* hsa-mir-30e hsa-miR-30e* MIMAT0000693 CUUUCAGUCGGA 419 UGUUUACAGC UGUUUACAGC  28 UCCCUGUCCUCC hsa-mir-339-5p hsa-mir-339 hsa-miR-339-5p MIMAT0000764 UCCCUGUCCUCC 420 AGGAGCUCACG AGGAGCUCACG  29 UCUCACACAGAA hsa-mir-342-3p hsa-mir-342 hsa-miR-342-3p MIMAT0000753 UCUCACACAGAA 421 AUCGCACCCGU AUCGCACCCGU  30 AAUCAGCAAGUA hsa-mir-34a* hsa-mir-34a hsa-miR-34a* MIMAT0004557 CAAUCAGCAAGU 422 UACUGCCCUA AUACUGCCCU  31 UCCCCCAGGUGU hsa-mir-361-3p hsa-mir-361 hsa-miR-361-3p MIMAT0004682 UCCCCCAGGUGU 423 GAUUCUGAUUU GAUUCUGAUUU  32 AAUCCUUGGAAC hsa-mir-362-5p hsa-mir-362 hsa-miR-362-5p MIMAT0000705 AAUCCUUGGAAC 424 CUAGGUGUGAGU CUAGGUGUGAGU  33 AGGGACUUUCAG hsa-mir-365-2* hsa-mir-365-2 hsa-miR-365* MIMAT0009199 AGGGACUUUCAG 425 GGGCAGCUGU GGGCAGCUGU  34 CUUAUCAGAUUG hsa-mir-374a* hsa-mir-374a hsa-miR-374a* MIMAT0004688 CUUAUCAGAUUG 426 UAUUGUAAUU UAUUGUAAUU  35 CUUAGCAGGUUG hsa-mir-374b* hsa-mir-374b hsa-miR-374b* MIMAT0004956 CUUAGCAGGUUG 427 UAUUAUCAUU UAUUAUCAUU  36 AGGUUACCCGAG hsa-mir-409-5p hsa-mir-409 hsa-miR-409-5p MIMAT0001638 AGGUUACCCGAG 428 CAACUUUGCAU CAACUUUGCAU  37 CAAAACGUGAGG hsa-mir-424* hsa-mir-424 hsa-miR-424* MIMAT0004749 CAAAACGUGAGG 429 CGCUGCUAU CGCUGCUAU  38 UAUGUGCCUUUG hsa-mir-455-5p hsa-mir-455 hsa-miR-455-5p MIMAT0003150 UAUGUGCCUUUG 430 GACUACAUCG GACUACAUCG  39 GUCAUACACGGC hsa-mir-485-3p hsa-mir-485 hsa-miR-485-3p MIMAT0002176 GUCAUACACGGC 431 UCUCCUCUCU UCUCCUCUCU  40 UGUCUUACUCCC hsa-mir-550-1* hsa-mir-550-1 hsa-miR-550* MIMAT0003257 UGUCUUACUCCC 432 UCAGGCACAU UCAGGCACAU  41 UGUCUUACUCCC hsa-mir-550-2* hsa-mir-550-2 hsa-miR-550* MIMAT0003257 UGUCUUACUCCC 433 UCAGGCACAU UCAGGCACAU  42 GAAAUCAAGCGU hsa-mir-551b* hsa-mir-551b hsa-miR-551b* MIMAT0004794 GAAAUCAAGCGU 434 GGGUGAGACC GGGUGAGACC  43 AUUCUAAUUUCU hsa-mir-576-5p hsa-mir-576 hsa-miR-576-5p MIMAT0003241 AUUCUAAUUUCU 435 CCACGUCUUU CCACGUCUUU  44 UCAGAACAAAUG hsa-mir-589* hsa-mir-589 hsa-miR-589* MIMAT0003256 UCAGAACAAAUG 436 CCGGUUCCCAGA CCGGUUCCCAGA  45 GAGCUUAUUCAU hsa-mir-590-5p hsa-mir-590 hsa-miR-590-5p MIMAT0003258 GAGCUUAUUCAU 437 AAAAGUGCAG AAAAGUGCAG  46 GGGGGUCCCCGG hsa-mir-615-5p hsa-mir-615 hsa-miR-615-5p MIMAT0004804 GGGGGUCCCCGG 438 UGCUCGGAUC UGCUCGGAUC  47 GACUAUAGAACU hsa-mir-625* hsa-mir-625 hsa-miR-625* MIMAT0004808 GACUAUAGAACU 439 UUCCCCCUCA UUCCCCCUCA  48 UGGUGGGCCGCA hsa-mir-654-5p hsa-mir-654 hsa-miR-654-5p MIMAT0003330 UGGUGGGCCGCA 440 GAACAUGUGC GAACAUGUGC  49 AGGAAGCCCUGG hsa-mir-671-5p hsa-mir-671 hsa-miR-671-5p MIMAT0003880 AGGAAGCCCUGG 441 AGGGGCUGGAG AGGGGCUGGAG  50 AACUAGACUGUG hsa-mir-708* hsa-mir-708 hsa-miR-708* MIMAT0004927 CAACUAGACUGU 442 AGCUUCUAGA GAGCUUCUAG  51 CAACAAAUCACA hsa-mir-7-1* hsa-mir-7-1 hsa-miR-7-1* MIMAT0004553 CAACAAAUCACA 443 GUCUGCCAUA GUCUGCCAUA  52 AUAAAGCUAGAU hsa-mir-9-1* hsa-mir-9-1 hsa-miR-9* MIMAT0000442 AUAAAGCUAGAU 444 AACCGAAAGU AACCGAAAGU  53 AUAAAGCUAGAU hsa-mir-9-2* hsa-mir-9-2 hsa-miR-9* MIMAT0000442 AUAAAGCUAGAU 445 AACCGAAAGU AACCGAAAGU  54 AGGGACGGGACG hsa-mir-92b* hsa-mir-92b hsa-miR-92b* MIMAT0004792 AGGGACGGGACG 446 CGGUGCAGUG CGGUGCAGUG  55 AUAAAGCUAGAU hsa-mir-9-3* hsa-mir-9-3 hsa-miR-9* MIMAT0000442 AUAAAGCUAGAU 447 AACCGAAAGU AACCGAAAGU  56 UGAGGUAGUAGG hsa-let-7a-2 hsa-let-7a-2 hsa-let-7a MIMAT0000062 UGAGGUAGUAGG 448 UUGUAUAGUU UUGUAUAGUU  57 UGAGGUAGUAGG hsa-let-7a-3 hsa-let-7a-3 hsa-let-7a MIMAT0000062 UGAGGUAGUAGG 449 UUGUAUAGUU UUGUAUAGUU  58 UGAGGUAGUAGG hsa-let-7c hsa-let-7c hsa-let-7c MIMAT0000064 UGAGGUAGUAGG 450 UUGUAUGGUU UUGUAUGGUU  59 UGAGGUAGGAGG hsa-let-7e hsa-let-7e hsa-let-7e MIMAT0000066 UGAGGUAGGAGG 451 UUGUAUAGUU UUGUAUAGUU  60 UGAGGUAGUAGA hsa-let-7f-1 hsa-let-7f-1 hsa-let-7f MIMAT0000067 UGAGGUAGUAGA 452 UUGUAUAGUU UUGUAUAGUU  61 UGAGGUAGUAGU hsa-let-7g hsa-let-7g hsa-let-7g MIMAT0000414 UGAGGUAGUAGU 453 UUGUACAGUU UUGUACAGUU  62 UGAGGUAGUAGU hsa-let-7i hsa-let-7i hsa-let-7i MIMAT0000415 UGAGGUAGUAGU 454 UUGUGCUGUU UUGUGCUGUU  63 AACCCGUAGAUC hsa-mir-100 hsa-mir-100 hsa-miR-100 MIMAT0000098 AACCCGUAGAUC 455 CGAACUUGUG CGAACUUGUG  64 UACAGUACUGUG hsa-mir-101-1 hsa-mir-101-1 hsa-miR-101 MIMAT0000099 UACAGUACUGUG 456 AUAACUGAA AUAACUGAA  65 GUACAGUACUGU hsa-mir-101-2 hsa-mir-101-2 hsa-miR-101 MIMAT0000099 UACAGUACUGUG 457 GAUAACUGAA AUAACUGAA  66 AGCAGCAUUGUA hsa-mir-103-1 hsa-mir-103-1 hsa-miR-103 MIMAT0000101 AGCAGCAUUGUA 458 CAGGGCUAUGA CAGGGCUAUGA  67 AGCAGCAUUGUA hsa-mir-103-2 hsa-mir-103-2 hsa-miR-103 MIMAT0000101 AGCAGCAUUGUA 4589 CAGGGCUAUGA CAGGGCUAUGA  68 AAAUGCUCAGAC hsa-mir-105-1 hsa-mir-105-1 hsa-miR-105 MIMAT0000102 UCAAAUGCUCAG 460 UCCUGUGGUG ACUCCUGUGGU  69 AAAUGCUCAGAC hsa-mir-105-2 hsa-mir-105-2 hsa-miR-105 MIMAT0000102 UCAAAUGCUCAG 461 UCCUGUGGUG ACUCCUGUGGU  70 AAAAGUGCUUAC hsa-mir-106a hsa-mir-106a hsa-miR-106a MIMAT0000103 AAAAGUGCUUAC 462 AGUGCAGGUAG AGUGCAGGUAG  71 UAAAGUGCUGAC hsa-mir-106b hsa-mir-106b hsa-miR-106b MIMAT0000680 UAAAGUGCUGAC 463 AGUGCAGAU AGUGCAGAU  72 AGCAGCAUUGUA hsa-mir-107 hsa-mir-107 hsa-miR-107 MIMAT0000104 AGCAGCAUUGUA 464 CAGGGCUAUCA CAGGGCUAUCA  73 UACCCUGUAGAU hsa-mir-10a hsa-mir-10a hsa-miR-10a MIMAT0000253 UACCCUGUAGAU 465 CCGAAUUUGUG CCGAAUUUGUG  74 UACCCUGUAGAA hsa-mir-10b hsa-mir-10b hsa-miR-10b MIMAT0000254 UACCCUGUAGAA 466 CCGAAUUUGUG CCGAAUUUGUG  75 UGGAAUGUAAAG hsa-mir-1-1 hsa-mir-1-1 hsa-miR-1 MIMAT0000416 UGGAAUGUAAAG 467 AAGUAUGUAU AAGUAUGUAU  76 UGGAAUGUAAAG hsa-mir-1-2 hsa-mir-1-2 hsa-miR-1 MIMAT0000416 UGGAAUGUAAAG 468 AAGUAUGUAU AAGUAUGUAU  77 UGGAGUGUGACA hsa-mir-122 hsa-mir-122 hsa-miR-122 MIMAT0000421 UGGAGUGUGACA 469 AUGGUGUUUG AUGGUGUUUG  78 UAAGGCACGCGG hsa-mir-124-1 hsa-mir-124-1 hsa-miR-124 MIMAT0000422 UAAGGCACGCGG 470 UGAAUGCC UGAAUGCC  79 UAAGGCACGCGG hsa-mir-124-2 hsa-mir-124-2 hsa-miR-124 MIMAT0000422 UAAGGCACGCGG 471 UGAAUGCC UGAAUGCC  80 UAAGGCACGCGG hsa-mir-124-3 hsa-mir-124-3 hsa-miR-124 MIMAT0000422 UAAGGCACGCGG 472 UGAAUGCC UGAAUGCC  81 ACCCGUCCCGUU hsa-mir-1247 hsa-mir-1247 hsa-miR-1247 MIMAT0005899 ACCCGUCCCGUU 473 CGUCCCCGGA CGUCCCCGGA  82 ACGGUGCUGGAU hsa-mir-1250 hsa-mir-1250 hsa-miR-1250 MIMAT0005902 ACGGUGCUGGAU 474 GUGGCCUUU GUGGCCUUU  83 AGAAGGAAAUUG hsa-mir-1252 hsa-mir-1252 hsa-miR-1252 MIMAT0005944 AGAAGGAAAUUG 475 AAUUCAUUUA AAUUCAUUUA  84 AGCCUGGAAGCU hsa-mir-1254 hsa-mir-1254 hsa-miR-1254 MIMAT0005905 AGCCUGGAAGCU 476 GGAGCCUGCAGU GGAGCCUGCAGU  85 AGGAUGAGCAAA hsa-mir-1255a hsa-mir-1255a hsa-miR-1255a MIMAT0005906 AGGAUGAGCAAA 477 GAAAGUAGAUU GAAAGUAGAUU  86 AGGCAUUGACUU hsa-mir-1256 hsa-mir-1256 hsa-miR-1256 MIMAT0005907 AGGCAUUGACUU 478 CUCACUAGCU CUCACUAGCU  87 CGUACCGUGAGU hsa-mir-126 hsa-mir-126 hsa-miR-126 MIMAT0000445 UCGUACCGUGAG 479 AAUAAUGCG UAAUAAUGCG  88 AUGGGUGAAUUU hsa-mir-1262 hsa-mir-1262 hsa-miR-1262 MIMAT0005914 AUGGGUGAAUUU 480 GUAGAAGGAU GUAGAAGGAU  89 AUGGUACCCUGG hsa-mir-1263 hsa-mir-1263 hsa-miR-1263 MIMAT0005915 AUGGUACCCUGG 481 CAUACUGAGU CAUACUGAGU  90 CAGGAUGUGGUC hsa-mir-1265 hsa-mir-1265 hsa-miR-1265 MIMAT0005918 CAGGAUGUGGUC 482 AAGUGUUGUU AAGUGUUGUU  91 CCUCAGGGCUGU hsa-mir-1266 hsa-mir-1266 hsa-miR-1266 MIMAT0005920 CCUCAGGGCUGU 483 AGAACAGGGCU AGAACAGGGCU  92 CUGGACUGAGCC hsa-mir-1269 hsa-mir-1269 hsa-miR-1269 MIMAT0005923 CUGGACUGAGCC 484 GUGCUACUGG GUGCUACUGG  93 CUGGAGAUAUGG hsa-mir-1270 hsa-mir-1270 hsa-miR-1270 MIMAT0005924 CUGGAGAUAUGG 485 AAGAGCUGUGU AAGAGCUGUGU  94 CUUGGCACCUAG hsa-mir-1271 hsa-mir-1271 hsa-miR-1271 MIMAT0005796 CUUGGCACCUAG 486 CAAGCACUCA CAAGCACUCA  95 UCGGAUCCGUCU hsa-mir-127-3p hsa-mir-127 hsa-miR-127-3p MIMAT0000446 UCGGAUCCGUCU 487 GAGCUUGGCU GAGCUUGGCU  96 UACGUAGAUAUA hsa-mir-1277 hsa-mir-1277 hsa-miR-1277 MIMAT0005933 UACGUAGAUAUA 488 UAUGUAUUUU UAUGUAUUUU  97 UAGUACUGUGCA hsa-mir-1278 hsa-mir-1278 hsa-miR-1278 MIMAT0005936 UAGUACUGUGCA 489 UAUCAUCUAU UAUCAUCUAU  98 UCACAGUGAACC hsa-mir-128-1 hsa-mir-128-1 hsa-miR-128 MIMAT0000424 UCACAGUGAACC 490 GGUCUCUUU GGUCUCUUU  99 UCACAGUGAACC hsa-mir-128-2 hsa-mir-128-2 hsa-miR-128 MIMAT0000424 UCACAGUGAACC 491 GGUCUCUUU GGUCUCUUU 100 CUUUUUGCGGUC hsa-mir-129-1 hsa-mir-129-1 hsa-miR-129-5p MIMAT0000242 CUUUUUGCGGUC 492 UGGGCUUGC UGGGCUUGC 101 CUUUUUGCGGUC hsa-mir-129-2 hsa-mir-129-2 hsa-miR-129-5p MIMAT0000242 CUUUUUGCGGUC 493 UGGGCUUGC UGGGCUUGC 102 UGUGAGGUUGGC hsa-mir-1294 hsa-mir-1294 hsa-miR-1294 MIMAT0005884 UGUGAGGUUGGC 494 AUUGUUGUCU AUUGUUGUCU 103 UUAGGCCGCAGA hsa-mir-1295 hsa-mir-1295 hsa-miR-1295 MIMAT0005885 UUAGGCCGCAGA 495 UCUGGGUGA UCUGGGUGA 104 UUCAUUCGGCUG hsa-mir-1298 hsa-mir-1298 hsa-miR-1298 MIMAT0005800 UUCAUUCGGCUG 496 UCCAGAUGUA UCCAGAUGUA 105 UUGCAGCUGCCU hsa-mir-1301 hsa-mir-1301 hsa-miR-1301 MIMAT0005797 UUGCAGCUGCCU 497 GGGAGUGACUUC GGGAGUGACUUC 106 CGGUUUGAGGCU hsa-mir-1304 hsa-mir-1304 hsa-miR-1304 MIMAT0005892 UUUGAGGCUACA 498 ACAGUGAGAU GUGAGAUGUG 107 ACGUUGGCUCUG hsa-mir-1306 hsa-mir-1306 hsa-miR-1306 MIMAT0005950 ACGUUGGCUCUG 499 GUGGUG GUGGUG 108 ACUCGGCGUGGC hsa-mir-1307 hsa-mir-1307 hsa-miR-1307 MIMAT0005951 ACUCGGCGUGGC 500 GUCGGUCGUG GUCGGUCGUG 109 CAGUGCAAUGUU hsa-mir-130a hsa-mir-130a hsa-miR-130a MIMAT0000425 CAGUGCAAUGUU 501 AAAAGGGCAU AAAAGGGCAU 110 CAGUGCAAUGAU hsa-mir-130b hsa-mir-130b hsa-miR-130b MIMAT0000691 CAGUGCAAUGAU 502 GAAAGGGCAU GAAAGGGCAU 111 UAACAGUCUACA hsa-mir-132 hsa-mir-132 hsa-miR-132 MIMAT0000426 UAACAGUCUACA 503 GCCAUGGUCG GCCAUGGUCG 112 ACCGUGGCUUUC hsa-mir-132* hsa-mir-132 hsa-miR-132* MIMAT0004594 ACCGUGGCUUUC 504 GAUUGUUACU GAUUGUUACU 113 UGUGACUGGUUG hsa-mir-134 hsa-mir-134 hsa-miR-134 MIMAT0000447 UGUGACUGGUUG 505 ACCAGAGGGG ACCAGAGGGG 114 UAUGGCUUUUCA hsa-mir-135b hsa-mir-135b hsa-miR-135b MIMAT0000758 UAUGGCUUUUCA 506 UUCCUAUGUGA UUCCUAUGUGA 115 ACUCCAUUUGUU hsa-mir-136 hsa-mir-136 hsa-miR-136 MIMAT0000448 ACUCCAUUUGUU 507 UUGAUGAUGGA UUGAUGAUGGA 116 AGCUGGUGUUGU hsa-mir-138-1 hsa-mir-138-1 hsa-miR-138 MIMAT0000430 AGCUGGUGUUGU 508 GAAUCAGGCCG GAAUCAGGCCG 117 AGCUGGUGUUGU hsa-mir-138-2 hsa-mir-138-2 hsa-miR-138 MIMAT0000430 AGCUGGUGUUGU 509 GAAUCAGGCCG GAAUCAGGCCG 118 UGGAGACGCGGC hsa-mir-139-3p hsa-mir-139 hsa-miR-139-3p MIMAT0004552 GGAGACGCGGCC 510 CCUGUUGGAG CUGUUGGAGU 119 UACCACAGGGUA hsa-mir-140-3p hsa-mir-140 hsa-miR-140-3p MIMAT0004597 UACCACAGGGUA 511 GAACCACGG GAACCACGG 120 UAACACUGUCUG hsa-mir-141 hsa-mir-141 hsa-miR-141 MIMAT0000432 UAACACUGUCUG 512 GUAAAGAUGG GUAAAGAUGG 121 CCCAUAAAGUAG hsa-mir-142 hsa-mir-142 hsa-miR-142-5p MIMAT0000433 CAUAAAGUAGAA 513 AAAGCACU AGCACUACU 122 UGAGAUGAAGCA hsa-mir-143 hsa-mir-143 hsa-miR-143 MIMAT0000435 UGAGAUGAAGCA 514 CUGUAGCUC CUGUAGCUC 123 GGAUAUCAUCAU hsa-mir-144 hsa-mir-144 hsa-miR-144* MIMAT0004600 GGAUAUCAUCAU 515 AUACUGUAAG AUACUGUAAG 124 GUCCAGUUUUCC hsa-mir-145 hsa-mir-145 hsa-miR-145 MIMAT0000437 GUCCAGUUUUCC 516 CAGGAAUCCCU CAGGAAUCCCU 125 UGAGAACUGAAU hsa-mir-146a hsa-mir-146a hsa-miR-146a MIMAT0000449 UGAGAACUGAAU 517 UCCAUGGGUU UCCAUGGGUU 126 UGAGAACUGAAU hsa-mir-146b hsa-mir-146b hsa-miR-146b-5p MIMAT0002809 UGAGAACUGAAU 518 UCCAUAGGCU UCCAUAGGCU 127 UCAGUGCACUAC hsa-mir-148a hsa-mir-148a hsa-miR-148a MIMAT0000243 UCAGUGCACUAC 519 AGAACUUUGU AGAACUUUGU 128 UCAGUGCAUCAC hsa-mir-148b hsa-mir-148b hsa-miR-148b MIMAT0000759 UCAGUGCAUCAC 520 AGAACUUUGU AGAACUUUGU 129 UCUCCCAACCCU hsa-mir-150 hsa-mir-150 hsa-miR-150 MIMAT0000451 UCUCCCAACCCU 521 UGUACCAGUG UGUACCAGUG 130 CUAGACUGAAGC hsa-mir-151-3p hsa-mir-151 hsa-miR-151-3p MIMAT0000757 CUAGACUGAAGC 522 UCCUUGAGG UCCUUGAGG 131 UCAGUGCAUGAC hsa-mir-152 hsa-mir-152 hsa-miR-152 MIMAT0000438 UCAGUGCAUGAC 523 AGAACUUGG AGAACUUGG 132 UUAAUGCUAAUC hsa-mir-155 hsa-mir-155 hsa-miR-155 MIMAT0000646 UUAAUGCUAAUC 524 GUGAUAGGGGU GUGAUAGGGGU 133 UAGCAGCACAUA hsa-mir-15a hsa-mir-15a hsa-miR-15a MIMAT0000068 UAGCAGCACAUA 525 AUGGUUUGUG AUGGUUUGUG 134 UAGCAGCACAUC hsa-mir-15b hsa-mir-15b hsa-miR-15b MIMAT0000417 UAGCAGCACAUC 526 AUGGUUUACA AUGGUUUACA 135 UAGCAGCACGUA hsa-mir-16-1 hsa-mir-16-1 hsa-miR-16 MIMAT0000069 UAGCAGCACGUA 527 AAUAUUGGCG AAUAUUGGCG 136 UAGCAGCACGUA hsa-mir-16-2 hsa-mir-16-2 hsa-miR-16 MIMAT0000069 UAGCAGCACGUA 528 AAUAUUGGCG AAUAUUGGCG 137 CAAAGUGCUUAC hsa-mir-17 hsa-mir-17 hsa-miR-17 MIMAT0000070 CAAAGUGCUUAC 529 AGUGCAGGUAG AGUGCAGGUAG 138 AACAUUCAACGC hsa-mir-181a-1 hsa-mir-181a-1 hsa-miR-181a MIMAT0000256 AACAUUCAACGC 530 UGUCGGUGAGU UGUCGGUGAGU 139 AACAUUCAACGC hsa-mir-181a-2 hsa-mir-181a-2 hsa-miR-181a MIMAT0000256 AACAUUCAACGC 531 UGUCGGUGAGU UGUCGGUGAGU 140 AACAUUCAUUGC hsa-mir-181b-1 hsa-mir-181b-1 hsa-miR-181b MIMAT0000257 AACAUUCAUUGC 532 UGUCGGUGGGU UGUCGGUGGGU 141 AACAUUCAUUGC hsa-mir-181b-2 hsa-mir-181b-2 hsa-miR-181b MIMAT0000257 AACAUUCAUUGC 533 UGUCGGUGGGU UGUCGGUGGGU 142 AACAUUCAACCU hsa-mir-181c hsa-mir-181c hsa-miR-181c MIMAT0000258 AACAUUCAACCU 534 GUCGGUGAGU GUCGGUGAGU 143 AACAUUCAUUGU hsa-mir-181d hsa-mir-181d hsa-miR-181d MIMAT0002821 AACAUUCAUUGU 535 UGUCGGUGGGU UGUCGGUGGGU 144 UUUGGCAAUGGU hsa-mir-182 hsa-mir-182 hsa-miR-182 MIMAT0000259 UUUGGCAAUGGU 536 AGAACUCACACU AGAACUCACACU 145 UAUGGCACUGGU hsa-mir-183 hsa-mir-183 hsa-miR-183 MIMAT0000261 UAUGGCACUGGU 537 AGAAUUCACU AGAAUUCACU 146 UGGACGGAGAAC hsa-mir-184 hsa-mir-184 hsa-miR-184 MIMAT0000454 UGGACGGAGAAC 538 UGAUAAGGGU UGAUAAGGGU 147 UGGAGAGAAAGG hsa-mir-185 hsa-mir-185 hsa-miR-185 MIMAT0000455 UGGAGAGAAAGG 539 CAGUUCCUGA CAGUUCCUGA 148 CAAAGAAUUCUC hsa-mir-186 hsa-mir-186 hsa-miR-186 MIMAT0000456 CAAAGAAUUCUC 540 CUUUUGGGCU CUUUUGGGCU 149 CAUCCCUUGCAU hsa-mir-188-5p hsa-mir-188 hsa-miR-188-5p MIMAT0000457 CAUCCCUUGCAU 541 GGUGGAGGG GGUGGAGGG 150 UAAGGUGCAUCU hsa-mir-18a hsa-mir-18a hsa-miR-18a MIMAT0000072 UAAGGUGCAUCU 542 AGUGCAGAUAG AGUGCAGAUAG 151 CAACGGAAUCCC hsa-mir-191 hsa-mir-191 hsa-miR-191 MIMAT0000440 CAACGGAAUCCC 543 AAAAGCAGCUG AAAAGCAGCUG 152 CUGACCUAUGAA hsa-mir-192 hsa-mir-192 hsa-miR-192 MIMAT0000222 CUGACCUAUGAA 544 UUGACAGCC UUGACAGCC 153 UGGGUCUUUGCG hsa-mir-193a-5p hsa-mir-193a hsa-miR-193a-5p MIMAT0004614 UGGGUCUUUGCG 545 GGCGAGAUGA GGCGAGAUGA 154 AACUGGCCCUCA hsa-mir-193b hsa-mir-193b hsa-miR-193b MIMAT0002819 AACUGGCCCUCA 546 AAGUCCCGCU AAGUCCCGCU 155 UGUAACAGCAAC hsa-mir-194-1 hsa-mir-194-1 hsa-miR-194 MIMAT0000460 UGUAACAGCAAC 547 UCCAUGUGGA UCCAUGUGGA 156 UAGCAGCACAGA hsa-mir-195 hsa-mir-195 hsa-miR-195 MIMAT0000461 UAGCAGCACAGA 548 AAUAUUGGC AAUAUUGGC 157 UAGGUAGUUUCA hsa-mir-196a-1 hsa-mir-196a-1 hsa-miR-196a MIMAT0000226 UAGGUAGUUUCA 549 UGUUGUUGGG UGUUGUUGGG 158 UAGGUAGUUUCA hsa-mir-196a-2 hsa-mir-196a-2 hsa-miR-196a MIMAT0000226 UAGGUAGUUUCA 550 UGUUGUUGGG UGUUGUUGGG 159 UAGGUAGUUUCC hsa-mir-196b hsa-mir-196b hsa-miR-196b MIMAT0001080 UAGGUAGUUUCC 551 UGUUGUUGGG UGUUGUUGGG 160 UUCACCACCUUC hsa-mir-197 hsa-mir-197 hsa-miR-197 MIMAT0000227 UUCACCACCUUC 552 UCCACCCAGC UCCACCCAGC 161 ACAGUAGUCUGC hsa-mir-199a-1 hsa-mir-199a-1 hsa-miR-199a-3p MIMAT0000232 ACAGUAGUCUGC 553 ACAUUGGUUA ACAUUGGUUA 162 ACAGUAGUCUGC hsa-mir-199a-2 hsa-mir-199a-2 hsa-miR-199a-3p MIMAT0000232 ACAGUAGUCUGC 554 ACAUUGGUUA ACAUUGGUUA 163 ACAGUAGUCUGC hsa-mir-199b hsa-mir-199b hsa-miR-199b-3p MIMAT0004563 ACAGUAGUCUGC 555 ACAUUGGUUA ACAUUGGUUA 164 UGUGCAAAUCUA hsa-mir-19a hsa-mir-19a hsa-miR-19a MIMAT0000073 UGUGCAAAUCUA 556 UGCAAAACUGA UGCAAAACUGA 165 UGUGCAAAUCCA hsa-mir-19b-1 hsa-mir-19b-1 hsa-miR-19b MIMAT0000074 UGUGCAAAUCCA 557 UGCAAAACUGA UGCAAAACUGA 166 UGUGCAAAUCCA hsa-mir-19b-2 hsa-mir-19b-2 hsa-miR-19b MIMAT0000074 UGUGCAAAUCCA 558 UGCAAAACUGA UGCAAAACUGA 167 UAACACUGUCUG hsa-mir-200a hsa-mir-200a hsa-miR-200a MIMAT0000682 UAACACUGUCUG 559 GUAACGAUGU GUAACGAUGU 168 UAAUACUGCCUG hsa-mir-200b hsa-mir-200b hsa-miR-200b MIMAT0000318 UAAUACUGCCUG 560 GUAAUGAUGA GUAAUGAUGA 169 UAAUACUGCCGG hsa-mir-200c hsa-mir-200c hsa-miR-200c MIMAT0000617 UAAUACUGCCGG 561 GUAAUGAUGGA GUAAUGAUGGA 170 UUCCUAUGCAUA hsa-mir-202* hsa-mir-202 hsa-miR-202* MIMAT0002810 UUCCUAUGCAUA 562 UACUUCUUUG UACUUCUUUG 171 GUGAAAUGUUUA hsa-mir-203 hsa-mir-203 hsa-miR-203 MIMAT0000264 GUGAAAUGUUUA 563 GGACCACUAG GGACCACUAG 172 UUCCCUUUGUCA hsa-mir-204 hsa-mir-204 hsa-miR-204 MIMAT0000265 UUCCCUUUGUCA 564 UCCUAUGCCU UCCUAUGCCU 173 UCCUUCAUUCCA hsa-mir-205 hsa-mir-205 hsa-miR-205 MIMAT0000266 UCCUUCAUUCCA 565 CCGGAGUCUG CCGGAGUCUG 174 UGGAAUGUAAGG hsa-mir-206 hsa-mir-206 hsa-miR-206 MIMAT0000462 UGGAAUGUAAGG 566 AAGUGUGUGG AAGUGUGUGG 175 UAAAGUGCUUAU hsa-mir-20a hsa-mir-20a hsa-miR-20a MIMAT0000075 UAAAGUGCUUAU 567 AGUGCAGGUAG AGUGCAGGUAG 176 CAAAGUGCUCAU hsa-mir-20b hsa-mir-20b hsa-miR-20b MIMAT0001413 CAAAGUGCUCAU 568 AGUGCAGGUAG AGUGCAGGUAG 177 UAGCUUAUCAGA hsa-mir-21 hsa-mir-21 hsa-miR-21 MIMAT0000076 UAGCUUAUCAGA 569 CUGAUGUUGA CUGAUGUUGA 178 CUGUGCGUGUGA hsa-mir-210 hsa-mir-210 hsa-miR-210 MIMAT0000267 CUGUGCGUGUGA 570 CAGCGGCUGA CAGCGGCUGA 179 UAACAGUCUCCA hsa-mir-212 hsa-mir-212 hsa-miR-212 MIMAT0000269 UAACAGUCUCCA 571 GUCACGGCC GUCACGGCC 180 ACAGCAGGCACA hsa-mir-214 hsa-mir-214 hsa-miR-214 MIMAT0000271 ACAGCAGGCACA 572 GACAGGCAGU GACAGGCAGU 181 UGACCUAUGAAU hsa-mir-215 hsa-mir-215 hsa-miR-215 MIMAT0000272 AUGACCUAUGAA 573 UGACAG UUGACAGAC 182 AAAUCUCUGCAG hsa-mir-216b hsa-mir-216b hsa-miR-216b MIMAT0004959 AAAUCUCUGCAG 574 GCAAAUGUGA GCAAAUGUGA 183 AUACUGCAUCAG hsa-mir-217 hsa-mir-217 hsa-miR-217 MIMAT0000274 UACUGCAUCAGG 575 GAACUGAUUG AACUGAUUGGA 184 AGAGUUGAGUCU hsa-mir-219-1 hsa-mir-219-1 hsa-miR-219-1-3p MIMAT0004567 AGAGUUGAGUCU 576 GGACGUCCCG GGACGUCCCG 185 AAGCUGCCAGUU hsa-mir-22 hsa-mir-22 hsa-miR-22 MIMAT0000077 AAGCUGCCAGUU 577 GAAGAACUGU GAAGAACUGU 186 AGCUACAUUGUC hsa-mir-221 hsa-mir-221 hsa-miR-221 MIMAT0000278 AGCUACAUUGUC 578 UGCUGGGUUUC UGCUGGGUUUC 187 AGCUACAUCUGG hsa-mir-222 hsa-mir-222 hsa-miR-222 MIMAT0000279 AGCUACAUCUGG 579 CUACUGGGU CUACUGGGU 188 CGUGUAUUUGAC hsa-mir-223* hsa-mir-223 hsa-miR-223* MIMAT0004570 CGUGUAUUUGAC 580 AAGCUGAGUU AAGCUGAGUU 189 CAAGUCACUAGU hsa-mir-224 hsa-mir-224 hsa-miR-224 MIMAT0000281 CAAGUCACUAGU 581 GGUUCCGUU GGUUCCGUU 190 AUCACAUUGCCA hsa-mir-23a hsa-mir-23a hsa-miR-23a MIMAT0000078 AUCACAUUGCCA 582 GGGAUUUCC GGGAUUUCC 191 AUCACAUUGCCA hsa-mir-23b hsa-mir-23b hsa-miR-23b MIMAT0000418 AUCACAUUGCCA 583 GGGAUUACC GGGAUUACC 192 UGGCUCAGUUCA hsa-mir-24-1 hsa-mir-24-1 hsa-miR-24 MIMAT0000080 UGGCUCAGUUCA 584 GCAGGAACAG GCAGGAACAG 193 UGGCUCAGUUCA hsa-mir-24-2 hsa-mir-24-2 hsa-miR-24 MIMAT0000080 UGGCUCAGUUCA 585 GCAGGAACAG GCAGGAACAG 194 CAUUGCACUUGU hsa-mir-25 hsa-mir-25 hsa-miR-25 MIMAT0000081 CAUUGCACUUGU 586 CUCGGUCUGA CUCGGUCUGA 195 UUCAAGUAAUCC hsa-mir-26a-1 hsa-mir-26a-1 hsa-miR-26a MIMAT0000082 UUCAAGUAAUCC 587 AGGAUAGGCU AGGAUAGGCU 196 UUCAAGUAAUCC hsa-mir-26a-2 hsa-mir-26a-2 hsa-miR-26a MIMAT0000082 UUCAAGUAAUCC 588 AGGAUAGGCU AGGAUAGGCU 197 UUCAAGUAAUUC hsa-mir-26b hsa-mir-26b hsa-miR-26b MIMAT0000083 UUCAAGUAAUUC 589 AGGAUAGGU AGGAUAGGU 198 UUCACAGUGGCU hsa-mir-27a hsa-mir-27a hsa-miR-27a MIMAT0000084 UUCACAGUGGCU 590 AAGUUCCGC AAGUUCCGC 199 UUCACAGUGGCU hsa-mir-27b hsa-mir-27b hsa-miR-27b MIMAT0000419 UUCACAGUGGCU 591 AAGUUCUGC AAGUUCUGC 200 CACUAGAUUGUG hsa-mir-28 hsa-mir-28 hsa-miR-28-3p MIMAT0004502 CACUAGAUUGUG 592 AGCUCCUGGA AGCUCCUGGA 201 GAGGGUUGGGUG hsa-mir-296-3p hsa-mir-296 hsa-miR-296-3p MIMAT0004679 GAGGGUUGGGUG 593 GAGGCUCUCC GAGGCUCUCC 202 AUGGUUUACCGU hsa-mir-299-5p hsa-mir-299 hsa-miR-299-5p MIMAT0002890 UGGUUUACCGUC 594 CCCACAUACA CCACAUACAU 203 UAGCACCAUCUG hsa-mir-29a hsa-mir-29a hsa-miR-29a MIMAT0000086 UAGCACCAUCUG 595 AAAUCGGUUA AAAUCGGUUA 204 UAGCACCAUUUG hsa-mir-29b-1 hsa-mir-29b-1 hsa-miR-29b MIMAT0000100 UAGCACCAUUUG 596 AAAUCAGUGUU AAAUCAGUGUU 205 UAGCACCAUUUG hsa-mir-29b-2 hsa-mir-29b-2 hsa-miR-29b MIMAT0000100 UAGCACCAUUUG 597 AAAUCAGUGUU AAAUCAGUGUU 206 UAGCACCAUUUG hsa-mir-29c hsa-mir-29c hsa-miR-29c MIMAT0000681 UAGCACCAUUUG 598 AAAUCGGUUA AAAUCGGUUA 207 CAGUGCAAUGAU hsa-mir-301b hsa-mir-301b hsa-miR-301b MIMAT0004958 CAGUGCAAUGAU 599 AUUGUCAAAGC AUUGUCAAAGC 208 UGUAAACAUCCU hsa-mir-30a hsa-mir-30a hsa-miR-30a MIMAT0000087 UGUAAACAUCCU 600 CGACUGGAAG CGACUGGAAG 209 UGUAAACAUCCU hsa-mir-30b hsa-mir-30b hsa-miR-30b MIMAT0000420 UGUAAACAUCCU 601 ACACUCAGCU ACACUCAGCU 210 UGUAAACAUCCU hsa-mir-30c-1 hsa-mir-30c-1 hsa-miR-30c MIMAT0000244 UGUAAACAUCCU 602 ACACUCUCAGC ACACUCUCAGC 211 UGUAAACAUCCU hsa-mir-30c-2 hsa-mir-30c-2 hsa-miR-30c MIMAT0000244 UGUAAACAUCCU 603 ACACUCUCAGC ACACUCUCAGC 212 UGUAAACAUCCC hsa-mir-30d hsa-mir-30d hsa-miR-30d MIMAT0000245 UGUAAACAUCCC 604 CGACUGGAAG CGACUGGAAG 213 UGUAAACAUCCU hsa-mir-30e hsa-mir-30e hsa-miR-30e MIMAT0000692 UGUAAACAUCCU 605 UGACUGGAAG UGACUGGAAG 214 AGGCAAGAUGCU hsa-mir-31 hsa-mir-31 hsa-miR-31 MIMAT0000089 AGGCAAGAUGCU 606 GGCAUAGCU GGCAUAGCU 215 UAUUGCACAUUA hsa-mir-32 hsa-mir-32 hsa-miR-32 MIMAT0000090 UAUUGCACAUUA 607 CUAAGUUGCA CUAAGUUGCA 216 AAAAGCUGGGUU hsa-mir-320a hsa-mir-320a hsa-miR-320a MIMAT0000510 AAAAGCUGGGUU 608 GAGAGGGCGA GAGAGGGCGA 217 AAAAGCUGGGUU hsa-mir-320b-1 hsa-mir-320b-1 hsa-miR-320b MIMAT0005792 AAAAGCUGGGUU 609 GAGAGGGCAA GAGAGGGCAA 218 AAAAGCUGGGUU hsa-mir-320b-2 hsa-mir-320b-2 hsa-miR-320b MIMAT0005792 AAAAGCUGGGUU 610 GAGAGGGCAA GAGAGGGCAA 219 AAAAGCUGGGUU hsa-mir-320c-1 hsa-mir-320c-1 hsa-miR-320c MIMAT0005793 AAAAGCUGGGUU 611 GAGAGGGU GAGAGGGU 220 AAAAGCUGGGUU hsa-mir-320c-2 hsa-mir-320c-2 hsa-miR-320c MIMAT0005793 AAAAGCUGGGUU 612 GAGAGGGU GAGAGGGU 221 AAAAGCUGGGUU hsa-mir-320d-1 hsa-mir-320d-1 hsa-miR-320d MIMAT0006764 AAAAGCUGGGUU 613 GAGAGGA GAGAGGA 222 AAAAGCUGGGUU hsa-mir-320d-2 hsa-mir-320d-2 hsa-miR-320d MIMAT0006764 AAAAGCUGGGUU 614 GAGAGGA GAGAGGA 223 CACAUUACACGG hsa-mir-323 hsa-mir-323 hsa-miR-323-3p MIMAT0000755 CACAUUACACGG 615 UCGACCUCU UCGACCUCU 224 CGCAUCCCCUAG hsa-mir-324 hsa-mir-324 hsa-miR-324-5p MIMAT0000761 CGCAUCCCCUAG 616 GGCAUUGGUGU GGCAUUGGUGU 225 CUGGCCCUCUCU hsa-mir-328 hsa-mir-328 hsa-miR-328 MIMAT0000752 CUGGCCCUCUCU 617 GCCCUUCCGU GCCCUUCCGU 226 GCAAAGCACACG hsa-mir-330 hsa-mir-330 hsa-miR-330-3p MIMAT0000751 GCAAAGCACACG 618 GCCUGCAGAGA GCCUGCAGAGA 227 GCCCCUGGGCCU hsa-mir-331 hsa-mir-331 hsa-miR-331-3p MIMAT0000760 GCCCCUGGGCCU 619 AUCCUAGAA AUCCUAGAA 228 UCAAGAGCAAUA hsa-mir-335 hsa-mir-335 hsa-miR-335 MIMAT0000765 UCAAGAGCAAUA 620 ACGAAAAAUGU ACGAAAAAUGU 229 UCCAGCAUCAGU hsa-mir-338 hsa-mir-338 hsa-miR-338-3p MIMAT0000763 UCCAGCAUCAGU 621 GAUUUUGUUG GAUUUUGUUG 230 UGAGCGCCUCGA hsa-mir-339-3p hsa-mir-339 hsa-miR-339-3p MIMAT0004702 UGAGCGCCUCGA 622 CGACAGAGCCG CGACAGAGCCG 231 GUGCAUUGUAGU hsa-mir-33a hsa-mir-33a hsa-miR-33a MIMAT0000091 GUGCAUUGUAGU 623 UGCAUUGCA UGCAUUGCA 232 GUGCAUUGCUGU hsa-mir-33b hsa-mir-33b hsa-miR-33b MIMAT0003301 GUGCAUUGCUGU 624 UGCAUUGC UGCAUUGC 233 UUAUAAAGCAAU hsa-mir-340 hsa-mir-340 hsa-miR-340 MIMAT0004692 UUAUAAAGCAAU 625 GAGACUGAUU GAGACUGAUU 234 AGGGGUGCUAUC hsa-mir-342-5p hsa-mir-342 hsa-miR-342-5p MIMAT0004694 AGGGGUGCUAUC 626 UGUGAUUGA UGUGAUUGA 235 GCUGACUCCUAG hsa-mir-345 hsa-mir-345 hsa-miR-345 MIMAT0000772 GCUGACUCCUAG 627 UCCAGGGCUC UCCAGGGCUC 236 UGGCAGUGUCUU hsa-mir-34a hsa-mir-34a hsa-miR-34a MIMAT0000255 UGGCAGUGUCUU 628 AGCUGGUUGU AGCUGGUUGU 237 AGGCAGUGUCAU hsa-mir-34b* hsa-mir-34b hsa-miR-34b* MIMAT0000685 UAGGCAGUGUCA 629 UAGCUGAUUG UUAGCUGAUUG 238 AGGCAGUGUAGU hsa-mir-34c-5p hsa-mir-34c hsa-miR-34c-5p MIMAT0000686 AGGCAGUGUAGU 630 UAGCUGAUUGC UAGCUGAUUGC 239 UUAUCAGAAUCU hsa-mir-361-5p hsa-mir-361 hsa-miR-361-5p MIMAT0000703 UUAUCAGAAUCU 631 CCAGGGGUAC CCAGGGGUAC 240 AACACACCUAUU hsa-mir-362-3p hsa-mir-362 hsa-miR-362-3p MIMAT0004683 AACACACCUAUU 632 CAAGGAUUCA CAAGGAUUCA 241 AAUUGCACGGUA hsa-mir-363 hsa-mir-363 hsa-miR-363 MIMAT0000707 AAUUGCACGGUA 633 UCCAUCUGUA UCCAUCUGUA 242 UAAUGCCCCUAA hsa-mir-365-2 hsa-mir-365-2 hsa-miR-365 MIMAT0000710 UAAUGCCCCUAA 634 AAAUCCUUAU AAAUCCUUAU 243 AAUAAUACAUGG hsa-mir-369 hsa-mir-369 hsa-miR-369-3p MIMAT0000721 AAUAAUACAUGG 635 UUGAUCUUU UUGAUCUUU 244 GCCUGCUGGGGU hsa-mir-370 hsa-mir-370 hsa-miR-370 MIMAT0000722 GCCUGCUGGGGU 636 GGAACCUGGU GGAACCUGGU 245 ACUCAAACUGUG hsa-mir-371 hsa-mir-371 hsa-miR-371-5p MIMAT0004687 ACUCAAACUGUG 637 GGGGCACU GGGGCACU 246 UUAUAAUACAAC hsa-mir-374a hsa-mir-374a hsa-miR-374a MIMAT0000727 UUAUAAUACAAC 638 CUGAUAAGUG CUGAUAAGUG 247 AUAUAAUACAAC hsa-mir-374b hsa-mir-374b hsa-miR-374b MIMAT0004955 AUAUAAUACAAC 639 CUGCUAAGUG CUGCUAAGUG 248 UUUGUUCGUUCG hsa-mir-375 hsa-mir-375 hsa-miR-375 MIMAT0000728 UUUGUUCGUUCG 640 GCUCGCGUGA GCUCGCGUGA 249 AGAGGUUGCCCU hsa-mir-377* hsa-mir-377 hsa-miR-377* MIMAT0004689 AGAGGUUGCCCU 641 UGGUGAAUUC UGGUGAAUUC 250 ACUGGACUUGGA hsa-mir-378 hsa-mir-378 hsa-miR-378 MIMAT0000732 ACUGGACUUGGA 642 GUCAGAAGG GUCAGAAGG 251 UGGUAGACUAUG hsa-mir-379 hsa-mir-379 hsa-miR-379 MIMAT0000733 UGGUAGACUAUG 643 GAACGUAGG GAACGUAGG 252 UAUACAAGGGCA hsa-mir-381 hsa-mir-381 hsa-miR-381 MIMAT0000736 UAUACAAGGGCA 644 AGCUCUCUGU AGCUCUCUGU 253 GAAGUUGUUCGU hsa-mir-382 hsa-mir-382 hsa-miR-382 MIMAT0000737 GAAGUUGUUCGU 645 GGUGGAUUCG GGUGGAUUCG 254 AGAUCAGAAGGU hsa-mir-383 hsa-mir-383 hsa-miR-383 MIMAT0000738 AGAUCAGAAGGU 646 GAUUGUGGCU GAUUGUGGCU 255 CGAAUGUUGCUC hsa-mir-409-3p hsa-mir-409 hsa-miR-409-3p MIMAT0001639 GAAUGUUGCUCG 647 GGUGAACCCC GUGAACCCCU 256 AAUAUAACACAG hsa-mir-410 hsa-mir-410 hsa-miR-410 MIMAT0002171 AAUAUAACACAG 648 AUGGCCUGU AUGGCCUGU 257 AUAGUAGACCGU hsa-mir-411 hsa-mir-411 hsa-miR-411 MIMAT0003329 UAGUAGACCGUA 649 AUAGCGUACG UAGCGUACG 258 AUCAACAGACAU hsa-mir-421 hsa-mir-421 hsa-miR-421 MIMAT0003339 AUCAACAGACAU 650 UAAUUGGGCGC UAAUUGGGCGC 259 UGAGGGGCAGAG hsa-mir-423 hsa-mir-423 hsa-miR-423-5p MIMAT0004748 UGAGGGGCAGAG 651 AGCGAGACUUU AGCGAGACUUU 260 CAGCAGCAAUUC hsa-mir-424 hsa-mir-424 hsa-miR-424 MIMAT0001341 CAGCAGCAAUUC 652 AUGUUUUGAA AUGUUUUGAA 261 UAAUACUGUCUG hsa-mir-429 hsa-mir-429 hsa-miR-429 MIMAT0001536 UAAUACUGUCUG 653 GUAAAACCGU GUAAAACCGU 262 UCUUGGAGUAGG hsa-mir-432 hsa-mir-432 hsa-miR-432 MIMAT0002814 UCUUGGAGUAGG 654 UCAUUGGGUGG UCAUUGGGUGG 263 AUCAUGAUGGGC hsa-mir-433 hsa-mir-433 hsa-miR-433 MIMAT0001627 AUCAUGAUGGGC 655 UCCUCGGUGU UCCUCGGUGU 264 UUGCAUAUGUAG hsa-mir-448 hsa-mir-448 hsa-miR-448 MIMAT0001532 UUGCAUAUGUAG 656 GAUGUCCCAU GAUGUCCCAU 265 UGGCAGUGUAUU hsa-mir-449a hsa-mir-449a hsa-miR-449a MIMAT0001541 UGGCAGUGUAUU 657 GUUAGCUGGU GUUAGCUGGU 266 AGGCAGUGUAUU hsa-mir-449b hsa-mir-449b hsa-miR-449b MIMAT0003327 AGGCAGUGUAUU 658 GUUAGCUGGC GUUAGCUGGC 267 UUUUGCGAUGUG hsa-mir-450a-1 hsa-mir-450a-1 hsa-miR-450a MIMAT0001545 UUUUGCGAUGUG 659 UUCCUAAUAU UUCCUAAUAU 268 UUUUGCGAUGUG hsa-mir-450a-2 hsa-mir-450a-2 hsa-miR-450a MIMAT0001545 UUUUGCGAUGUG 660 UUCCUAAUAU UUCCUAAUAU 269 UUUUGCAAUAUG hsa-mir-450b-5p hsa-mir-450b hsa-miR-450b-5p MIMAT0004909 UUUUGCAAUAUG 661 UUCCUGAAUA UUCCUGAAUA 270 AACUGUUUGCAG hsa-mir-452 hsa-mir-452 hsa-miR-452 MIMAT0001635 AACUGUUUGCAG 662 AGGAAACUGA AGGAAACUGA 271 UAGUGCAAUAUU hsa-mir-454 hsa-mir-454 hsa-miR-454 MIMAT0003885 UAGUGCAAUAUU 663 GCUUAUAGGGU GCUUAUAGGGU 272 GCAGUCCAUGGG hsa-mir-455-3p hsa-mir-455 hsa-miR-455-3p MIMAT0004784 GCAGUCCAUGGG 664 CAUAUACAC CAUAUACAC 273 AAGACGGGAGGA hsa-mir-483-5p hsa-mir-483 hsa-miR-483-5p MIMAT0004761 AAGACGGGAGGA 665 AAGAAGGGAG AAGAAGGGAG 274 UCAGGCUCAGUC hsa-mir-484 hsa-mir-484 hsa-miR-484 MIMAT0002174 UCAGGCUCAGUC 666 CCCUCCCGAU CCCUCCCGAU 275 AGAGGCUGGCCG hsa-mir-485-5p hsa-mir-485 hsa-miR-485-5p MIMAT0002175 AGAGGCUGGCCG 667 UGAUGAAUUC UGAUGAAUUC 276 UCCUGUACUGAG hsa-mir-486-5p hsa-mir-486 hsa-miR-486-5p MIMAT0002177 UCCUGUACUGAG 668 CUGCCCCGAG CUGCCCCGAG 277 AAUCGUACAGGG hsa-mir-487b hsa-mir-487b hsa-miR-487b MIMAT0003180 AAUCGUACAGGG 669 UCAUCCACUU UCAUCCACUU 278 CCCAGAUAAUGG hsa-mir-488* hsa-mir-488 hsa-miR-488* MIMAT0002804 CCCAGAUAAUGG 670 CACUCUCAA CACUCUCAA 279 UUGUACAUGGUA hsa-mir-493* hsa-mir-493 hsa-miR-493* MIMAT0002813 UUGUACAUGGUA 671 GGCUUUCAUU GGCUUUCAUU 280 UGAAACAUACAC hsa-mir-494 hsa-mir-494 hsa-miR-494 MIMAT0002816 UGAAACAUACAC 672 GGGAAACCUC GGGAAACCUC 281 AAACAAACAUGG hsa-mir-495 hsa-mir-495 hsa-miR-495 MIMAT0002817 AAACAAACAUGG 673 UGCACUUCUU UGCACUUCUU 282 CAGCAGCACACU hsa-mir-497 hsa-mir-497 hsa-miR-497 MIMAT0002820 CAGCAGCACACU 674 GUGGUUUGU GUGGUUUGU 283 UUAAGACUUGCA hsa-mir-499-5p hsa-mir-499 hsa-miR-499-5p MIMAT0002870 UUAAGACUUGCA 675 GUGAUGUUU GUGAUGUUU 284 AUGCACCUGGGC hsa-mir-500* hsa-mir-500 hsa-miR-500* MIMAT0002871 AUGCACCUGGGC 676 AAGGAUUCUG AAGGAUUCUG 285 AAUGCACCCGGG hsa-mir-501-3p hsa-mir-501 hsa-miR-501-3p MIMAT0004774 AAUGCACCCGGG 677 CAAGGAUUCU CAAGGAUUCU 286 AAUGCACCUGGG hsa-mir-502-3p hsa-mir-502 hsa-miR-502-3p MIMAT0004775 AAUGCACCUGGG 678 CAAGGAUUCA CAAGGAUUCA 287 UAGCAGCGGGAA hsa-mir-503 hsa-mir-503 hsa-miR-503 MIMAT0002874 UAGCAGCGGGAA 679 CAGUUCUGCAG CAGUUCUGCAG 288 AGACCCUGGUCU hsa-mir-504 hsa-mir-504 hsa-miR-504 MIMAT0002875 AGACCCUGGUCU 680 GCACUCUAUC GCACUCUAUC 289 GGGAGCCAGGAA hsa-mir-505* hsa-mir-505 hsa-miR-505* MIMAT0004776 GGGAGCCAGGAA 681 GUAUUGAUGU GUAUUGAUGU 290 UGAUUGUAGCCU hsa-mir-508-3p hsa-mir-508 hsa-miR-508-3p MIMAT0002880 UGAUUGUAGCCU 682 UUUGGAGUAGA UUUGGAGUAGA 291 UACUGCAGACGU hsa-mir-509-3-5p hsa-mir-509-3 hsa-miR-509-3-5p MIMAT0004975 UACUGCAGACGU 683 GGCAAUCAUG GGCAAUCAUG 292 UUCACAGGGAGG hsa-mir-513a-1 hsa-mir-513a-1 hsa-miR-513a-5p MIMAT0002877 UUCACAGGGAGG 684 UGUCAU UGUCAU 293 UUCACAGGGAGG hsa-mir-513a-2 hsa-mir-513a-2 hsa-miR-513a-5p MIMAT0002877 UUCACAGGGAGG 685 UGUCAU UGUCAU 294 UUCACAAGGAGG hsa-mir-513b hsa-mir-513b hsa-miR-513b MIMAT0005788 UUCACAAGGAGG 686 UGUCAUUUAU UGUCAUUUAU 295 UUCUCAAGGAGG hsa-mir-513c hsa-mir-513c hsa-miR-513c MIMAT0005789 UUCUCAAGGAGG 687 UGUCGUUUAU UGUCGUUUAU 296 CAUGCCUUGAGU hsa-mir-532 hsa-mir-532 hsa-miR-532-5p MIMAT0002888 CAUGCCUUGAGU 688 GUAGGACCGU GUAGGACCGU 297 UGUGACAGAUUG hsa-mir-542-3p hsa-mir-542 hsa-miR-542-3p MIMAT0003389 UGUGACAGAUUG 689 AUAACUGAAA AUAACUGAAA 298 AAACAUUCGCGG hsa-mir-543 hsa-mir-543 hsa-miR-543 MIMAT0004954 AAACAUUCGCGG 690 UGCACUUCUU UGCACUUCUU 299 CAAAACUGGCAA hsa-mir-548a-1 hsa-mir-548a-1 hsa-miR-548a-3p MIMAT0003251 CAAAACUGGCAA 691 UUACUUUUGC UUACUUUUGC 300 CAAAACUGGCAA hsa-mir-548a-2 hsa-mir-548a-2 hsa-miR-548a-3p MIMAT0003251 CAAAACUGGCAA 692 UUACUUUUGC UUACUUUUGC 301 CAAAACUGGCAA hsa-mir-548a-3 hsa-mir-548a-3 hsa-miR-548a-3p MIMAT0003251 CAAAACUGGCAA 693 UUACUUUUGC UUACUUUUGC 302 CAAGAACCUCAG hsa-mir-548b-3p hsa-mir-548b hsa-miR-548b-3p MIMAT0003254 CAAGAACCUCAG 694 UUGCUUUUGU UUGCUUUUGU 303 AAAAACUGAGAC hsa-mir-548e hsa-mir-548e hsa-miR-548e MIMAT0005874 AAAAACUGAGAC 695 UACUUUUGCA UACUUUUGCA 304 AAAAGUAAUCGC hsa-mir-548h-1 hsa-mir-548h-1 hsa-miR-548h MIMAT0005928 AAAAGUAAUCGC 696 GGUUUUUGUC GGUUUUUGUC 305 AAAAGUAAUCGC hsa-mir-548h-2 hsa-mir-548h-2 hsa-miR-548h MIMAT0005928 AAAAGUAAUCGC 697 GGUUUUUGUC GGUUUUUGUC 306 AAAAGUAAUCGC hsa-mir-548h-3 hsa-mir-548h-3 hsa-miR-548h MIMAT0005928 AAAAGUAAUCGC 698 GGUUUUUGUC GGUUUUUGUC 307 AAAAGUAAUCGC hsa-mir-548h-4 hsa-mir-548h-4 hsa-miR-548h MIMAT0005928 AAAAGUAAUCGC 699 GGUUUUUGUC GGUUUUUGUC 308 AAAAGUAAUUGC hsa-mir-548j hsa-mir-548j hsa-miR-548j MIMAT0005875 AAAAGUAAUUGC 700 GGUCUUUGGU GGUCUUUGGU 309 AAAAGUACUUGC hsa-mir-548k hsa-mir-548k hsa-miR-548k MIMAT0005882 AAAAGUACUUGC 701 GGAUUUUGCU GGAUUUUGCU 310 AAAAGUAUUUGC hsa-mir-548l hsa-mir-548l hsa-miR-548l MIMAT0005889 AAAAGUAUUUGC 702 GGGUUUUGUC GGGUUUUGUC 311 CAAAAGUAAUUG hsa-mir-548n hsa-mir-548n hsa-miR-548n MIMAT0005916 CAAAAGUAAUUG 703 UGGAUUUUGU UGGAUUUUGU 312 AGUGCCUGAGGG hsa-mir-550-1 hsa-mir-550-1 hsa-miR-550 MIMAT0004800 AGUGCCUGAGGG 704 AGUAAGAGCCC AGUAAGAGCCC 313 AGUGCCUGAGGG hsa-mir-550-2 hsa-mir-550-2 hsa-miR-550 MIMAT0004800 AGUGCCUGAGGG 705 AGUAAGAGCCC AGUAAGAGCCC 314 GCGACCCAUACU hsa-mir-551b hsa-mir-551b hsa-miR-551b MIMAT0003233 GCGACCCAUACU 706 UGGUUUCAG UGGUUUCAG 315 CACGCUCAUGCA hsa-mir-574-3p hsa-mir-574 hsa-miR-574-3p MIMAT0003239 CACGCUCAUGCA 707 CACACCCACA CACACCCACA 316 AAGAUGUGGAAA hsa-mir-576-3p hsa-mir-576 hsa-miR-576-3p MIMAT0004796 AAGAUGUGGAAA 708 AAUUGGAAUC AAUUGGAAUC 317 GUAGAUAAAAUA hsa-mir-577 hsa-mir-577 hsa-miR-577 MIMAT0003242 UAGAUAAAAUAU 709 UUGGUACCUG UGGUACCUG 318 UAACUGGUUGAA hsa-mir-582-3p hsa-mir-582 hsa-miR-582-3p MIMAT0004797 UAACUGGUUGAA 710 CAACUGAACC CAACUGAACC 319 UUACAGUUGUUC hsa-mir-582-5p hsa-mir-582 hsa-miR-582-5p MIMAT0003247 UUACAGUUGUUC 711 AACCAGUUACU AACCAGUUACU 320 UUAUGGUUUGCC hsa-mir-584 hsa-mir-584 hsa-miR-584 MIMAT0003249 UUAUGGUUUGCC 712 UGGGACUGAG UGGGACUGAG 321 UGAGAACCACGU hsa-mir-589 hsa-mir-589 hsa-miR-589 MIMAT0004799 UGAGAACCACGU 713 CUGCUCUGAG CUGCUCUGAG 322 UAAUUUUAUGUA hsa-mir-590-3p hsa-mir-590 hsa-miR-590-3p MIMAT0004801 UAAUUUUAUGUA 714 UAAGCUAGU UAAGCUAGU 323 UACGUCAUCGUU hsa-mir-598 hsa-mir-598 hsa-miR-598 MIMAT0003266 UACGUCAUCGUU 715 GUCAUCGUCA GUCAUCGUCA 324 UCCGAGCCUGGG hsa-mir-615-3p hsa-mir-615 hsa-miR-615-3p MIMAT0003283 UCCGAGCCUGGG 716 UCUCCCUCUU UCUCCCUCUU 325 AAGUCAUUGGAG hsa-mir-616 hsa-mir-616 hsa-miR-616 MIMAT0004805 AGUCAUUGGAGG 717 GGUUUGAGCA GUUUGAGCAG 326 AAACUCUACUUG hsa-mir-618 hsa-mir-618 hsa-miR-618 MIMAT0003287 AAACUCUACUUG 718 UCCUUCUGAGU UCCUUCUGAGU 327 AGGGGGAAAGUU hsa-mir-625 hsa-mir-625 hsa-miR-625 MIMAT0003294 AGGGGGAAAGUU 719 CUAUAGUCC CUAUAGUCC 328 AUGCUGACAUAU hsa-mir-628-5p hsa-mir-628 hsa-miR-628-5p MIMAT0004809 AUGCUGACAUAU 720 UUACUAGAGG UUACUAGAGG 329 UGGGUUUACGUU hsa-mir-629 hsa-mir-629 hsa-miR-629 MIMAT0004810 UGGGUUUACGUU 721 GGGAGAACU GGGAGAACU 330 AAAGACAUAGGA hsa-mir-641 hsa-mir-641 hsa-miR-641 MIMAT0003311 AAAGACAUAGGA 722 UAGAGUCACCUC UAGAGUCACCUC 331 ACACUUGUAUGC hsa-mir-643 hsa-mir-643 hsa-miR-643 MIMAT0003313 ACUUGUAUGCUA 723 UAGCUCAGGU GCUCAGGUAG 332 UUUAGGAUAAGC hsa-mir-651 hsa-mir-651 hsa-miR-651 MIMAT0003321 UUUAGGAUAAGC 724 UUGACUUUUG UUGACUUUUG 333 AAUGGCGCCACU hsa-mir-652 hsa-mir-652 hsa-miR-652 MIMAT0003322 AAUGGCGCCACU 725 AGGGUUGUG AGGGUUGUG 334 UAUGUCUGCUGA hsa-mir-654-3p hsa-mir-654 hsa-miR-654-3p MIMAT0004814 UAUGUCUGCUGA 726 CCAUCACCUU CCAUCACCUU 335 UACCCAUUGCAU hsa-mir-660 hsa-mir-660 hsa-miR-660 MIMAT0003338 UACCCAUUGCAU 727 AUCGGAGUUG AUCGGAGUUG 336 UCCGGUUCUCAG hsa-mir-671-3p hsa-mir-671 hsa-miR-671-3p MIMAT0004819 UCCGGUUCUCAG 728 GGCUCCACC GGCUCCACC 337 AAGGAGCUUACA hsa-mir-708 hsa-mir-708 hsa-miR-708 MIMAT0004926 AAGGAGCUUACA 729 AUCUAGCUGGG AUCUAGCUGGG 338 UGGAAGACUAGU hsa-mir-7-1 hsa-mir-7-1 hsa-miR-7 MIMAT0000252 UGGAAGACUAGU 730 GAUUUUGUUGU GAUUUUGUUGU 339 UGGAAGACUAGU hsa-mir-7-2 hsa-mir-7-2 hsa-miR-7 MIMAT0000252 UGGAAGACUAGU 731 GAUUUUGUUGU GAUUUUGUUGU 340 UGGAAGACUAGU hsa-mir-7-3 hsa-mir-7-3 hsa-miR-7 MIMAT0000252 UGGAAGACUAGU 732 GAUUUUGUUGU GAUUUUGUUGU 341 CGGCUCUGGGUC hsa-mir-760 hsa-mir-760 hsa-miR-760 MIMAT0004957 CGGCUCUGGGUC 733 UGUGGGGA UGUGGGGA 342 UGCACCAUGGUU hsa-mir-767-5p hsa-mir-767 hsa-miR-767-5p MIMAT0003882 UGCACCAUGGUU 734 GUCUGAGCAUG GUCUGAGCAUG 343 UGAGACCUCUGG hsa-mir-769-5p hsa-mir-769 hsa-miR-769-5p MIMAT0003886 UGAGACCUCUGG 735 GUUCUGAGCU GUUCUGAGCU 344 GCAGGAACUUGU hsa-mir-873 hsa-mir-873 hsa-miR-873 MIMAT0004953 GCAGGAACUUGU 736 GAGUCUCCU GAGUCUCCU 345 CUGCCCUGGCCC hsa-mir-874 hsa-mir-874 hsa-miR-874 MIMAT0004911 CUGCCCUGGCCC 737 GAGGGACCGA GAGGGACCGA 346 GUAGAGGAGAUG hsa-mir-877 hsa-mir-877 hsa-miR-877 MIMAT0004949 GUAGAGGAGAUG 738 GCGCAGGG GCGCAGGG 347 GUGAACGGGCGC hsa-mir-887 hsa-mir-887 hsa-miR-887 MIMAT0004951 GUGAACGGGCGC 739 CAUCCCGAGG CAUCCCGAGG 348 UUAAUAUCGGAC hsa-mir-889 hsa-mir-889 hsa-miR-889 MIMAT0004921 UUAAUAUCGGAC 740 AACCAUUGU AACCAUUGU 349 UGCAACGAACCU hsa-mir-891a hsa-mir-891a hsa-miR-891a MIMAT0004902 UGCAACGAACCU 741 GAGCCACUGA GAGCCACUGA 350 CACUGUGUCCUU hsa-mir-892a hsa-mir-892a hsa-miR-892a MIMAT0004907 CACUGUGUCCUU 742 UCUGCGUAG UCUGCGUAG 351 UCUUUGGUUAUC hsa-mir-9-1 hsa-mir-9-1 hsa-miR-9 MIMAT0000441 UCUUUGGUUAUC 743 UAGCUGUAUGA UAGCUGUAUGA 352 UCUUUGGUUAUC hsa-mir-9-2 hsa-mir-9-2 hsa-miR-9 MIMAT0000441 UCUUUGGUUAUC 744 UAGCUGUAUGA UAGCUGUAUGA 353 UAUUGCACUUGU hsa-mir-92a-1 hsa-mir-92a-1 hsa-miR-92a MIMAT0000092 UAUUGCACUUGU 745 CCCGGCCUGU CCCGGCCUGU 354 UAUUGCACUUGU hsa-mir-92a-2 hsa-mir-92a-2 hsa-miR-92a MIMAT0000092 UAUUGCACUUGU 746 CCCGGCCUGU CCCGGCCUGU 355 UAUUGCACUCGU hsa-mir-92b hsa-mir-92b hsa-miR-92b MIMAT0003218 UAUUGCACUCGU 747 CCCGGCCUCC CCCGGCCUCC 356 CAAAGUGCUGUU hsa-mir-93 hsa-mir-93 hsa-miR-93 MIMAT0000093 CAAAGUGCUGUU 748 CGUGCAGGUAG CGUGCAGGUAG 357 UCUUUGGUUAUC hsa-mir-9-3 hsa-mir-9-3 hsa-miR-9 MIMAT0000441 UCUUUGGUUAUC 749 UAGCUGUAUGA UAGCUGUAUGA 358 AAGGCAGGGCCC hsa-mir-940 hsa-mir-940 hsa-miR-940 MIMAT0004983 AAGGCAGGGCCC 750 CCGCUCCCC CCGCUCCCC 359 UUCUCUGUUUUG hsa-mir-942 hsa-mir-942 hsa-miR-942 MIMAT0004985 UCUUCUCUGUUU 751 GCCAUGUGUG UGGCCAUGUG 360 AAAUUAUUGUAC hsa-mir-944 hsa-mir-944 hsa-miR-944 MIMAT0004987 AAAUUAUUGUAC 752 AUCGGAUGAG AUCGGAUGAG 361 UUCAACGGGUAU hsa-mir-95 hsa-mir-95 hsa-miR-95 MIMAT0000094 UUCAACGGGUAU 753 UUAUUGAGCA UUAUUGAGCA 362 UUUGGCACUAGC hsa-mir-96 hsa-mir-96 hsa-miR-96 MIMAT0000095 UUUGGCACUAGC 754 ACAUUUUUGCU ACAUUUUUGCU 363 UGAGGUAGUAAG hsa-mir-98 hsa-mir-98 hsa-miR-98 MIMAT0000096 UGAGGUAGUAAG 755 UUGUAUUGUU UUGUAUUGUU 364 AACCCGUAGAUC hsa-mir-99a hsa-mir-99a hsa-miR-99a MIMAT0000097 AACCCGUAGAUC 756 CGAUCUUGUG CGAUCUUGUG 365 CACCCGUAGAAC hsa-mir-99b hsa-mir-99b hsa-miR-99b MIMAT0000689 CACCCGUAGAAC 757 CGACCUUGCG CGACCUUGCG 366 AACAUAGAGGAA hsa-mir-376c hsa-mir-376c hsa-mir-376c AACAUAGAGGAA 758 AUUCCACGU AUUCCACGU 367 AUCAUAGAGGAA hsa-mir-376b hsa-mir-376b hsa-mir-376b AUCAUAGAGGAA 759 AAUCCAUGUU AAUCCAUGUU 368 UGGUGGGCCGCA hsa-mir-654 hsa-mir-654 hsa-mir-654 UGGUGGGCCGCA 760 GAACAUGUGC GAACAUGUGC 369 AUCAUAGAGGAA hsa-mir-376a-2 hsa-mir-376a-2 hsa-mir-376a-2 AUCAUAGAGGAA 761 AAUCCACGU AAUCCACGU 370 AUCAUAGAGGAA hsa-mir-376a-1 hsa-mir-376a-1 hsa-mir-376a-1 AUCAUAGAGGAA 762 AAUCCACGU AAUCCACGU 371 AAAACCGUCUAG hsa-mir-1537 UUACAGUUGU 372 AUAUACAGGGGG hsa-mir-1185-2 AGACUCUCAU 373 CCUAGAAUGGGG hsa-mir-1301* AUUGUGGG 374 AGCGAGACCUCA hsa-mir-1303 ACUCUACAAU 375 UCGACCGGACCU hsa-mir-1307* CGACCGGCUC 376 AUGUAGGGAUGG hsa-mir-135a-2 AAGCCAUGAA 377 CUCACUGAACAA hsa-mir-181b-1* UGAAUGCAA 378 CGGGUAGAGAGG hsa-mir-197* GCAGUGGGAG 379 GCUGGGAAGGCA hsa-mir-204* AAGGGACGU 380 ACCUUGGCUCUA hsa-mir-212* GACUGCUUAC 381 GCUCUGACUUUA hsa-mir-301a UUGCACUACU 382 AGGGACUUUUGG hsa-mir-365-1 GGGCAGAUGU 383 UUGGGGACAUUU hsa-mir-450a-2* UGCAUUCAU 384 AAUGUGUAGCAA hsa-mir-511-1-3p AAGACAGA 385 AAUGUGUAGCAA hsa-mir-511-2-3p AAGACAGA 386 AUCAUACAAGGA hsa-mir-539 CAAUUUCUUU 387 AAAGGUAAUUGC hsa-mir-570 AGUUUUUCCC 388 UCGCGGUUUGUG hsa-mir-579 CCAGAUGACG 389 AGAAGGCACUAU hsa-mir-605 GAGAUUUAGA 390 AGACACAUUUGG hsa-mir-642 AGAGGGAACC 391 AGGACCUUCCCU hsa-mir-659 GAACCAAGGA 392 AUAUACAGGGGG hsa-mir-1185-1 AGACUCUUAU

TABLE 32 Novel miRNAs identified by deep sequencing analysis. SEQ Mature Temporary SEQ ID Sequence Assigned ID NO. Captured miRNA ID miRBase ID NO. miRNA Precursor Sequence  763 CCAAAACUGCAGUUACUUUUG has-mir-548o-2 pending 1057 UggUgcaaaagUaaUUgcggUUUUUgcc aUUaaaagUaaUgcggCCAAAACUGCAG UUACUUUUGcaccc  764 GAGCCUGGAAGCUGGAGCCUGC hsa-mir-1254-2 hsa-mir-1254-2 1058 cUGAGCCUGGAAGCUGGAGCCUGCagUg agcUaUgaUcaUgUcccUgUacUcUagc cUgggca  765 CGGGCGUGGUGGUGGGGGUG hsa-mir-1268b hsa-mir-1268b 1059 accCGGGCGUGGUGGUGGGGGUGggUgc cUgUaaUUccagcUagUUggga  766 UCGAGGAGCUCACAGUCUAGA hsa-miR-151-5p-2  hsa-mir-151b 1060 agUcUcUcUUcagggcUcccgagacaca gaaacagacaccUgcccUCGAGGAGCUC ACAGUCUAGAca  767 UAAGGUGCAUCUAGUGCAGUU hsa-mir-18b-2 hsa-mir-18b 1061 UcUUgUgUUAAGGUGCAUCUAGUGCAGU UagUgaagcagcUUagaaUcUacUgccc UaaaUgccccUUcUggcacaggc  768 GAGGGUUGGGUGGAGGC hsa-miR-296-2 hsa-miR-296-2 1062 cUgccUccaccccgccUggccUgaccca gccagggcUcUagGAGGGUUGGGUGGAG GCaa  769 AUCAUAGAGGAAAAUCCAUGUU hsa-mir-376b-2 hsa-mir-376b 1063 UaaaacgUggaUaUUccUUcUaUgUUUa cgUgaUUccUggUUaAUCAUAGAGGAAA AUCCAUGUUUUc  770 AACAUAGAGGAAAUUCCACGU hsa-mir-376c-2 hsa-mir-376c 1064 UaaaaggUggaUaUUccUUcUaUgUUUa UgUUaUUUaUggUUaAACAUAGAGGAAA UUCCACGUUUUc  771 ACUGGACUUGGAGUCAGAAA hsa-mir-378b-1 hsa-mir-378d-1 1065 acUgUUUcUgUccUUgUUcUUgUUgUUa UUACUGGACUUGGAGUCAGAAAcagg  772 ACUGGACUUGGAGUCAGAAA hsa-mir-378b-2 hsa-mir-378d-2 1066 aggagagaacACUGGACUUGGAGUCAGA AAacUUUcaUccaagUcaUUcccUgcUc UaagUcccaUUUcUgUUcca  773 ACUGGACUUGGAGUCAGGA hsa-miR-378c hsa-mir-378e 1067 cUgacUccagUgUccaggccaggggcag acagUggacagagaacagUgcccaagac cACUGGACUUGGAGUCAGGAcaU  774 AGGCAGUGUAUUGCUAGCGGCU hsa-mir-449c hsa-mir-449c 1068 UcaggUAGGCAGUGUAUUGCUAGCGGCU gUUaaUgaUUUUaacagUUgcUagUUgc acUccUcUcUgU  775 UGCACCCAGGCAAGGAUUCUGC hsa-mir-500-2 hsa-mir-500b 1069 gUUcccccUcUcUaaUccUUgcUaccUg ggUgagagUgcUUUcUgaaUgcagUGCA CCCAGGCAAGGAUUCUGCaagggggagU  776 UAAUCCUUGCUACCUGGGUGAG hsa-mir-500-2* has-mir-500b 1070 gUUcccccUcUcUAAUCCUUGCUACCUG GGUGAGagUgcUUUcUgaaUgcagUgca cccaggcaaggaUUcUgcaagggggagU  777 AAAAGUAAUCGCGGUUUUUGUC hsa-mir-548h-5 hsa-mir-548h-5 1071 acAAAAGUAAUCGCGGUUUUUGUCaUUa cUUUUaacUgUaaaaaccacggUUgcUU UUgc  778 AAAAGUAAUUGUGGAUUUUGCU hsa-mir-548r-1 hsa-mir-548ab 1072  aUgUUggUgcAAAAGUAAUUGUGGAUUU UGCUaUUacUUgUaUUUaUUUgUaaUgc aaaacccgcaaUUagUUUUgcaccaacc  779 AAAAGUAAUUGUGGAUUUUGCU hsa-mir-548r-2 has-mir-548ab 1073 UgUUggUgcAAAAGUAAUUGUGGAUUUU GCUaUUacUUgUaUUUaUUUgUaaUgca aaacccgcaaUUagUUUUgcaccaacc  780 UGUCUUACUCCCUCAGGCACAU hsa-miR-550-3* pending 1074 cUggUgcagUgccUgagggagUaagagU ccUgUUgUUgUaagaUagUGUCUUACUC CCUCAGGCACAUcUccaa  781 GGUGGGCUUCCCGGAGGG hsa-mir-2221 hsa-mir-4417 1075 gaaaacaaccaGGUGGGCUUCCCGGAGG GcggaacacccagccccagcaUccaggg cUcaccUaccacgUUUg  782 GAAGCGGUGGCUGGGCUG hsa-mir-2222 pending 1076 gaggcggcccUagcgccaUUUUgUggga gcGAAGCGGUGGCUGGGCUGcgcUUg  783 CACUGCAGGACUCAGCAG hsa-mir-2223 hsa-mir-4418 1077 UggUUUUUgcUcUgagUgaccgUggUgg UUgUgggagUCACUGCAGGACUCAGCAG gaaUUc  784 UGAGGGAGGAGACUGCA hsa-mir-2224 hsa-mir-4419a 1078 UggUggUgUgUgccUgUagUcUUagcUa cUcgggaggcUGAGGGAGGAGACUGCAg UgagUggaggUcacgccacUg  785 ACUGGACUUGGAGCCAGAAG hsa-mir-2225 hsa-mir-378f 1079 gUcaggUccUggacUcccaUagUUUUca ggcUgcUaaacaacagaacgagcACUGG ACUUGGAGCCAGAAGUcUUggg  786 GUCACUGAUGUCUGUAGCUGAG hsa-mir-2226 hsa-mir-4420 1080 cUcUUggUaUgaacaUcUgUgUgUUcaU gUcUcUcUgUgcacaggggacgagaGUC ACUGAUGUCUGUAGCUGAGac  787 GAUGAGGAUGGAUAGCAAGGAA hsa-mir-2227 hsa-mir-3605 1081 cUggccUcUgUgccUggaUacUUUaUac gUgUaaUUgUGAUGAGGAUGGAUAGCAA GGAAgccgc  788 ACCUGUCUGUGGAAAGGAGCUA hsa-mir-2228 hsa-mir-4421 1082 cUgggUcUccUUUcUgcUgagagUUgaa cacUUgUUgggacaACCUGUCUGUGGAA AGGAGCUAccUac  789 AAAAGCAUCAGGAAGUACCCA hsa-mir-2229 hsa-mir-4422 1083 agUUcUUcUgcagacAAAAGCAUCAGGA AGUACCCAccaUgUaccagUgggcccUU cUUgaUgcUcUUgaUUgcagaggagcc  790 UGCCUGGAACAUAGUAGGGACU hsa-mir-2230-1 hsa-mir-3116-2 1084 UccUUUaUUgagUcccUacUaUgUUcca ggcaccUacgaUacccagUGCCUGGAAC AUAGUAGGGACUcaaUaaagU  791 UGCCUGGAACAUAGUAGGGACU hsa-mir-2230-2 hsa-mir-3116-1 1085 ccUUUaUUgagUcccUacUaUgUUccag gcaccUacgaUacccagUGCCUGGAACA UAGUAGGGACUcaaUaaagU  792 UGGAUUAAAAACAAUGGAGG hsa-mir-2231 pending 1086 cgccUccaUgUUUcagcaUcUaUgUcaU gggcUUggUccUggagUGGAUUAAAAAC AAUGGAGGU  793 AUAGGCACCAAAAAGCAACAA hsa-mir-2232 hsa-mir-4423 1087 aUcaUgUacUgcagUUgccUUUUUgUUc ccaUgcUgUUUaagccUagcAUAGGCAC CAAAAAGCAACAAcagUaUgUgaa  794 ACUGGGCUUGGAGUCAGAAG hsa-mir-2233 hsa-mir-378g 1088 cACUGGGCUUGGAGUCAGAAGaccUggc UccagcccagcUc  795 CAAAAACCGGCAAUUACUUUUG hsa-mir-2234 hsa-mir-548ac 1089 gUaUUaggUUggUgcaaaagUUaUUgUg gUUUUUgcUaUUUUUUUUUaaUggCAAA AACCGGCAAUUACUUUUGcacUaaccUa gUag  796 GUCAAAUGAAGGGCUGAUCACG hsa-mir-2235 pending 1090 aaagUGUCAAAUGAAGGGCUGAUCACGa aaUagcgcaUUagcUcUUUUUUUgaaaa cUUg  797 AAAGGGAGGAUUUGCUUAGAAGG hsa-mir-2236 pending 1091 gacUggcUacgUagUUcgggcaaaUccU AUGG ccaaaagggAAAGGGAGGAUUUGCUUAG AAGGAUGGcgcUcc  798 AGAGUUAACUCAAAAUGGACUA hsa-mir-2237 hsa-mir-4424 1092 cUUacaUcacacacAGAGUUAACUCAAA AUGGACUAaUUUUUccacUagUUagUcc aUUUcaagUUaacUcUgUgUgUgaUgUa gU  799 UGUUGGGAUUCAGCAGGACCAU hsa-mir-2238 hsa-mir-4425 1093 gUgcUUUacaUgaaUggUcccaUUgaaU cccaacagcUUUgcgaagUgUUGUUGGG AUUCAGCAGGACCAUUcgUgUaaagUaa  800 UAAAUAGAGUAGGCAAAGGACA hsa-mir-2239 hsa-mir-3121 1094 UaaaUggUUaUgUccUUUgccUaUUcUa UUUaagacacccUgUaccUUAAAUAGAG UAGGCAAAGGACAgaaacaUUUU  801 AGAGUCGAGAGUGGGAGAAGAG hsa-mir-2240 pending 1095 gcAGAGUCGAGAGUGGGAGAAGAGcgga gcgUgUgagcagUacUgcggccUccUcU ccUcUccUaaccUcgcUcUc  802 GAAGAUGGACGUACUUU hsa-mir-2241 hsa-mir-4426 1096 agUUGAAGAUGGACGUACUUUgUcUgac UacaaUaUUcaaaaggagUcUacUcUUc aUcUUg  803 UCUGAAUAGAGUCUGAAGAGU hsa-mir-2242 hsa-mir-4427 1097 gaagccUcUUggggcUUaUUUagacaaU ggUUUcaUcaUUUcgUCUGAAUAGAGUC UGAAGAGUcUUU  804 CAAGGAGACGGGAACAUGGAGC hsa-mir-2243 hsa-mir-4428 1098 UUggcaggUgccaUgUUgccUgcUccUU acUgUacacgUggcUggCAAGGAGACGG GAACAUGGAGCcgccaU  805 AAGAGGAAGAAAUGGCUGGUUC hsa-mir-2244 hsa-mir-3916 1099 aggaagAAGAGGAAGAAAUGGCUGGUUC UcaggUgaaUgUgUcUgggUUcagggga UgUgUcUccUcUUUUcU  806 UUCGCGGGCGAAGGCAAAGUC hsa-mir-2245 hsa-mir-3124 1100 ggcgggcUUCGCGGGCGAAGGCAAAGUC gaUUUccaaaagUgacUUUccUcacUcc cgUgaagUcggcg  807 AAAAGCUGGGCUGAGAGGCG hsa-mir-2246 hsa-mir-4429 1101 agggagAAAAGCUGGGCUGAGAGGCGac UggUgUcUaaUUUgUUUgUcUcUccaac UcagacUgccUggccca  808 AUGGCCAAAACUGCAGUUAUUU hsa-mir-2247 hsa-mir-548s 1102 cUgcaaaaaUaaUUgcagUUUUUgccaU UaUUUUUaaUaaUUaUaaUaAUGGCCAA AACUGCAGUUAUUUUUgcac  809 UAGUGGAUGAUGCACUCUGUGC hsa-mir-2248 hsa-mir-3681 1103 cUacUUccagUAGUGGAUGAUGCACUCU GUGCagggccaacUgUgcacacagUgcU UcaUccacUacUggaagUgU  810 AGGCUGGAGUGAGCGGAG hsa-mir-2249 hsa-mir-4430 1104 gUgAGGCUGGAGUGAGCGGAGaUcgUac cacUgcacUccaaccUggUga  811 GAAAACGACAAUGACUUUUGCA hsa-mir-2250 hsa-mir-548ad 1105 cUgUUaggUUggUgcaaaagUaaUUgUg gUUUUUgaaagUaacUUggcGAAAACGA CAAUGACUUUUGCAccaaUcUaaUac  812 GCGACUCUGAAAACUAGAAGGU hsa-mir-2251 hsa-mir-4431 1106 UggUUUGCGACUCUGAAAACUAGAAGGU UUaUgacUgggcaUUUcUcacccaaUgc ccaaUaUUgaacUUUcUagUUgUcagag UcaUUaaccc  813 AGAAGGCUGGAGCGCGGCGGU hsa-mir-2252 pending 1107 gcacUgcggUUcUgaggccgUUacUccg gcUUcUccaUagagggcggAGAAGGCUG GAGCGCGGCGGUga  814 AAAGACUCUGCAAGAUGCCU hsa-mir-2253 hsa-mir-4432 1108 gcaUcUUgcagagccgUUccaaUgcgac accUcUagagUgUcaUccccUagaaUgU caccUUggAAAGACUCUGCAAGAUGCCU  815 ACAGGAGUGGGGGUGGGACAU hsa-mir-2254 hsa-mir-4433 1109 caUccUccUUacgUcccaccccccacUc cUgUUUcUggUgaaaUaUUcaaACAGGA GUGGGGGUGGGACAUaaggaggaUa  816 AGGAGAAGUAAAGUAGAA hsa-mir-2255 hsa-mir-4434 1110 UcacUUUAGGAGAAGUAAAGUAGAAcUU UggUUUUcaacUUUUccUacagUgU  817 AUGGCCAGAGCUCACACAGAGG hsa-mir-2256 hsa-mir-4435-1 1111 aggcagcaaAUGGCCAGAGCUCACACAG AGGgaUgagUgcacUUcaccUgcagUgU gacUcagcaggccaacagaUgcUa  818 GCAGGACAGGCAGAAGUGGAU hsa-mir-2257 hsa-mir-4436 1112 gccUcacUUUUccacUUaUgccUgcccU gccccUcgaaUcUgcUccacgaUUUggG CAGGACAGGCAGAAGUGGAUaagUgagg a  819 AUCAGGGCUUGUGGAAUGGGAA hsa-mir-2258 hsa-mir-3127 1113 ggcccAUCAGGGCUUGUGGAAUGGGAAg gagaagggacgcUUccccUUcUgcaggc cUgcUgggUg  820 AUGGCCAGAGCUCACACAGAGG hsa-mir-2259 hsa-mir-4435-2 1114 gcaaAUGGCCAGAGCUCACACAGAGGga UgagUgcacUUcaccUgcagUgUgacUc agcaggccaacagaUgcU  821 UGAGGAUAUGGCAGGGAAGGGG hsa-mir-2260 hsa-mir-3679 1115 acgUggUGAGGAUAUGGCAGGGAAGGGG agUUUcccUcUaUUcccUUccccccagU aaUcUUcaUcaUgc  822 AGGAGGUUGGUGUGGAUU hsa-mir-2261 pending 1116 UaUgAGGAGGUUGGUGUGGAUUcUgUUg aagaaaaagaaggggaacacUaaUUUUc caUU  823 UUGGAAGACAUGGAGCAUGAGG hsa-mir-2262 pending 1117 UUUUGGAAGACAUGGAGCAUGAGGUaag UgccUagaUccUcaaaccacUUgccUcc accUaUgcUUccaggU  824 UCUGGCAAGUAAAAAACUCUCA hsa-mir-2263 hsa-mir-3128 1118 cUUccUCUGGCAAGUAAAAAACUCUCAU UUUccUUaaaaaaUgagagUUUUUUacU UgcaaUaggaaa  825 UGGGCUCAGGGUACAAAGGUU hsa-mir-2264 hsa-mir-4437 1119 acUUUgUgcaUUgggUccacaaggaggg gaUgacccUUgUGGGCUCAGGGUACAAA GGUU  826 CAAAAACUGCAAUUACUUUCA hsa-mir-2265-1 hsa-mir-548ae-1 1120 gcagUUUUUgccaUUaagUUgcggUUUU UgccaUUaUaaUggCAAAAACUGCAAUU ACUUUCAcaccUgc  827 CAAAAACUGCAAUUACUUUCA hsa-mir-2265-2 hsa-mir-548ae-2 1121 UgUgcaaaagUaaUUgUggUUUUUgUca UUUaaaagUaaUggCAAAAACUGCAAUU ACUUUCAcacc  828 GCUGCACCGGAGACUGGGUAA hsa-mir-2266-1 hsa-mir-3130-1 1122 acUUgUcaUgUcUUacccagUcUccggU gcagccUgUUgUcaagGCUGCACCGGAG ACUGGGUAAgacaUgacaagc  829 GCUGCACCGGAGACUGGGUAA hsa-mir-2266-2 hsa-mir-3130-2 1123 UgUcUUacccagUcUccggUgcagccUU gacaacagGCUGCACCGGAGACUGGGUA AgacaUgacaagUU  830 AUCCCCAGAUACAAUGGACAAU hsa-mir-2267 hsa-mir-2355 1124 cgUgUcAUCCCCAGAUACAAUGGACAAU aUgcUaUUaUaaUcgUaUggcaUUgUcc UUgcUgUUUggagaUaaUacU  831 AUUGUCCUUGCUGUUUGGAGAU hsa-mir-2267* pending 1125 cgUgUcaUccccagaUacaaUggacaaU aUgcUaUUaUaaUcgUaUggcAUUGUCC UUGCUGUUUGGAGAUaaUacU  832 CACAGGCUUAGAAAAGACAGU hsa-mir-2268 hsa-mir-4438 1126  UaagUgUaaacUUaaggacUgUcUUUUc UaagccUgUgccUUgccUUUccUUUggC ACAGGCUUAGAAAAGACAGUcUUUaagU UUacacUUc  833 UCGAGGACUGGUGGAAGGGCCU hsa-mir-2269 hsa-mir-3131 1127 UcUcagagUCGAGGACUGGUGGAAGGGC CUUUccccUcagaccaaggcccUggccc cagcUUcUUcUcagagU  834 GUGACUGAUACCUUGGAGGCAU hsa-mir-2270 hsa-mir-4439 1128 ccaGUGACUGAUACCUUGGAGGCAUUUU aUcUaagaUacacacaaagcaaaUgccU cUaaggUaUcagUUUaccaggcca  835 AGGGCUGGACUCAGCGGCGGAG hsa-mir-2271 pending 1129 gcgcagAGGGCUGGACUCAGCGGCGGAG cUggcUgcUggccUcagUUcUgccUcUg UccaggUccUUgUga  836 UGUCGUGGGGCUUGCUGGCUUG hsa-mir-2272 hsa-mir-4440 1130  cUcUcaccaagcaagUgcagUggggcUU gcUggcUUgcaccgUgacUcccUcUcac caagcaagUGUCGUGGGGCUUGCUGGCU UGcacUgUgaagaU  837 ACAGGGAGGAGAUUGUA hsa-mir-2273 hsa-mir-4441 1131  cagagUcUccUUcgUgUacagggaggag acUgUacgUgagagaUagUcagaUccgc aUgUUagagcagagUcUccUUcgUgUAC AGGGAGGAGAUUGUAc  838 ACUGGACUUGGAGGCAGAA hsa-mir-2274 hsa-mir-378b 1132 UggUcaUUgagUcUUcaaggcUagUgga aagagcACUGGACUUGGAGGCAGAAaga ccc  839 GCCGGACAAGAGGGAGG hsa-mir-2275 hsa-mir-4442 1133 gcgcccUcccUcUcUccccggUgUgcaa aUgUgUgUgUgcggUgUUaUGCCGGACA AGAGGGAGGUg  840 AUACACAUACACGCAACACACA hsa-mir-2276 hsa-mir-466  1134 aUgUgUgUgUaUaUgUgUgUUgcaUgUg UgUaUaUgUgUgUaUaUaUgUacacAUA CACAUACACGCAACACACAUaUaUacaU gcac  841 UUGGAGGCGUGGGUUUU hsa-mir-2277 hsa-mir-4443 1135 ggUgggggUUGGAGGCGUGGGUUUUaga accUaUcccUUUcUagcccUgagca  842 AAUUCCCUUGUAGAUAACCCGG hsa-mir-2278 hsa-mir-3938 1136 cgaUcacUagaUUaUcUacaagggaaUU UUUUUUUaaUUUaaaaAAUUCCCUUGUA GAUAACCCGGUggUca  843 AAGACUGGAGACAAAGUGGGAG hsa-mir-2279 pending 1137  CACCACCAAAAUCUCCAGGGGCAUCGUU GAAAUCGUAAGGGAUGUGCAGCUCAUUA AGACUGGAGACAAAGUGGGAG  844 CUGACUGAAUAGGUAGGGUCAU hsa-mir-2280 hsa-mir-3136 1138 aaaCUGACUGAAUAGGUAGGGUCAUUUU UcUgUgacUgcacaUggcccaaccUaUU cagUUagUUc  845 CUCGAGUUGGAAGAGGCG hsa-mir-2281 hsa-mir-4444 1139 gUgacgacUggccccgccUcUUccUcUc ggUcccaUaUUgaaCUCGAGUUGGAAGA GGCGagUccggUcUcaaa  846 AGAUUGUUUCUUUUGCCGUGCA hsa-mir-2282 hsa-mir-4445 1140 UUccUgcAGAUUGUUUCUUUUGCCGUGC AagUUUaagUUUUUgcacggcaaaagaa acaaUccagagggU  847 CACGGCAAAAGAAACAAUCCA hsa-mir-2282* has-mir-4445 1141 UUccUgcagaUUgUUUcUUUUgccgUgc aagUUUaagUUUUUgCACGGCAAAAGAA ACAAUCCAgagggU  848 CAGGGCUGGCAGUGACAUGGGU hsa-mir-2283 hsa-mir-4446 1142 cUggUccaUUUcccUgccaUUcccUUgg cUUcaaUUUacUccCAGGGCUGGCAGUG ACAUGGGUcaa  849 GGUGGGGGCUGUUGUUU hsa-mir-2284 hsa-mir-4447 1143 gUUcUagagcaUggUUUcUcaUcaUUUg cacUacUgaUacUUggggUcagaUaaUU gUUUgUGGUGGGGGCUGUUGUUUgcaUU gUaggaU  850 UGGGGAGGUGUGGAGUCAGCAU hsa-mir-2285 pending 1144 gggcaUGGGGAGGUGUGGAGUCAGCAUg gggcUaggaggccccgcgcUgacccgcc UUcUccgcagcUg  851 GCAGAGAACAAAGGACUCAGU hsa-mir-2286 hsa-mir-3919 1145 accUgagcaccaUUUacUgagUccUUUg UUcUcUacUagUUUgUagUagUUcgUaG CAGAGAACAAAGGACUCAGUaaaUggUg cUcagga  852 GGCUCCUUGGUCUAGGGGUA hsa-mir-2287 hsa-mir-4448 1146 aggagUgaccaaaagacaagagUgcgag ccUUcUaUUaUgcccagacagggccacc agagGGCUCCUUGGUCUAGGGGUAaUgc ca  853 CGUCCCGGGGCUGCGCGAGGCA hsa-mir-2288 hsa-mir-4449 1147 agcagcccUcggcggcccggggggcggg cggcggUgccCGUCCCGGGGCUGCGCGA GGCAcaggcg  854 AAAGGUAAUUGUGGUUUCUGC hsa-mir-2289-1 hsa-mir-548ag-1 1148 gUgcAAAGGUAAUUGUGGUUUCUGCUUU UaaaggUaaUggcaaaUaUUacaUUUac UUUUgcacca  855 AAAGGUAAUUGUGGUUUCUGC hsa-mir-2289-2 hsa-mir-548ag-2 1149 UgcAAAGGUAAUUGUGGUUUCUGCcaUU gaaagUaaaggcaagaaccUcaaUUacc UUUgcagc  856 UGGGGAUUUGGAGAAGUGGUGA hsa-mir-2290 hsa-mir-4450 1150 UgUcUGGGGAUUUGGAGAAGUGGUGAgc gcaggUcUUUggcaccaUcUccccUggU cccUUggcU  857 AAAAGUGAUUGCAGUGUUUG hsa-mir-2291 hsa-mir-548ah 1151 aggUUggUgcAAAAGUGAUUGCAGUGUU UGccaaUaaaagUaaUgacaaaaacUgc agUUacUUUUgcaccagccc  858 UGGUAGAGCUGAGGACA hsa-mir-2292 hsa-mir-4451 1152 UcUgUaccUcagcUUUgcUcccaaccaa ccacUUccacaUgUUUUgcUGGUAGAGC UGAGGACAgc  859 UUGAAUUCUUGGCCUUAAGUGAU hsa-mir-2293 hsa-mir-4452 1153 UggaUcacUUgaggccaagagUgcaagg cUgUagUgUgcacagccUUGAAUUCUUG GCCUUAAGUGAUccc  860 UAGGAGCUCAACAGAUGCCUGU hsa-mir-2294 hsa-mir-3139 1154 UcagagUAGGAGCUCAACAGAUGCCUGU UgacUgaaUaaUaaacaggUaUcgcagg agcUUUUgUUaUgU  861 AGCUUUUGGGAAUUCAGGUAG hsa-mir-2295 hsa-mir-3140 1155  UgUccUcUUgaggUaccUgaaUUaccaa aagcUUUaUgUaUUcUgaagUUaUUgaa aaUaagAGCUUUUGGGAAUUCAGGUAGU UcaggagUgacU  862 GAGCUUGGUCUGUAGCGGUU hsa-mir-2296 hsa-mir-4453 1156  UggaGAGCUUGGUCUGUAGCGGUUUccU UggggcaggUggggacUgcUccUUUggg aggaaggaggaggcccaggccgcgUcUU cagg  863 GGAUCCGAGUCACGGCACCA hsa-mir-2297 hsa-mir-4454 1157 ccGGAUCCGAGUCACGGCACCAaaUUUc aUgcgUgUccgUgUgaagagaccacca  864 CAAAAGUGAUCGUGGUUUUUG hsa-mir-2298 hsa-mir-548t 1158 gUggUgCAAAAGUGAUCGUGGUUUUUGc aaUUUUUUaaUgacaaaaaccacaaUUa cUUUUgcaccaa  865 AGGGUGUGUGUGUUUUU hsa-mir-2299 hsa-mir-4455 1159 agaAGGGUGUGUGUGUUUUUccUgagaa UaagagaaggaaggacagccaaaUUcUU ca  866 CCUGGUGGCUUCCUUUU hsa-mir-2300 hsa-mir-4456 1160 aUgaaCCUGGUGGCUUCCUUUUcUggga ggaagUUagggUUca  867 UCACAAGGUAUUGACUGGCGUA hsa-mir-2301 hsa-mir-4457 1161 ggagUacUccagUcaaUaccgUgUgagU UagaaaagcUcaaUUCACAAGGUAUUGA CUGGCGUAUUca  868 AGAGGUAGGUGUGGAAGAA hsa-mir-2302 hsa-mir-4458 1162 gagcgcacAGAGGUAGGUGUGGAAGAAa gUgaaacacUaUUUUaggUUUUagUUac acUcUgcUgUggUgUgcUg  869 CCAGGAGGCGGAGGAGGUGGAG hsa-mir-2303 hsa-mir-4459 1163 acCCAGGAGGCGGAGGAGGUGGAGgUUg cagUgagccaagaUcgUggcacUgacUc cagccUgggg  870 GUGGAGGACUGAGAAGGUGAG hsa-mir-2304 pending 1164 aUgaUGUGGAGGACUGAGAAGGUGAGgc agUUUUgccccgUgcUgccUUccaccgg UUaagaccUccaaaaUcga  871 ACUGACAGGAGAGCAUUUUGA hsa-mir-2305 hsa-mir-3660 1165 ggacaaaaUUaaaaUgcUcUUcUgUcaU UgUaaUagUUcaUaUgggcACUGACAGG AGAGCAUUUUGAcUUUgUca  872 AGCGCGGGCUGAGCGCUGCCAG hsa-mir-2306 hsa-mir-2277 1166 ggUUcacUggUcgUgcUUccUgcgggcU gAGCGCGGGCUGAGCGCUGCCAGUcagc g  873 AAGCUCGGGCGCUCCGGCUGU hsa-mir-2307 pending 1167 gcUcagUcagcUgggccgccUcagcUcU cggagUaggAAGCUCGGGCGCUCCGGCU GUaaggagcc  874 AUAGUGGUUGUGAAUUUACCUU hsa-mir-2308 hsa-mir-4460 1168 gUUUUUUgcccAUAGUGGUUGUGAAUUU ACCUUcUccUcUUUgcagUgaUaaagga ggUaaaUUcacaaccacUgUgggcagaa ac  875 GAUUGAGACUAGUAGGGCUAGGC hsa-mir-2309 hsa-mir-4461 1169 gagUaggcUUaggUUaUgUacgUagUcU aggccaUacgUgUUggaGAUUGAGACUA GUAGGGCUAGGCcUacUg  876 CUACCCCAGGAUGCCAGCAUAG hsa-mir-2310 pending 1171 aUagcUggUUggcaUUcUggcccUggUU caUgccaacUcUUgUgUUgaCUACCCCA GGAUGCCAGCAUAGUUgc  877 ACUGGACUUGGUGUCAGAUGG hsa-mir-2311 hsa-mir-378h 1171 acaggaacACUGGACUUGGUGUCAGAUG GgaUgagcccUggcUcUgUUUccUagca gcaaUcUgaUcUUgagcUagUcacUgg  878 GACAAUGAUGAGAAGACCUGAG hsa-mir-2312 pending 1172 gggGACAAUGAUGAGAAGACCUGAGgaU UUgcagcccccagcccUgggUUcaagUc ccagcUcUaccccUUcUUggcccc  879 ACCGCUCGAUCUUGGGACC hsa-mir-2313 pending 1173 gUUUcACCGCUCGAUCUUGGGACCcacc gcUgcccUcagcUccgagUccagggcga ggUaagggcUggagUcgggcagga  880 UAGUGGAUGAUGGAGACUCGGU hsa-mir-2314 hsa-mir-3691 1174 aUUgaggcacUgggUAGUGGAUGAUGGA GACUCGGUacccacUgcUgagggUgggg accaagUcUgcgUcaUccUcUccUcagU gccUcaaa  881 CUCGGGAGCGUUAGAGAUGGA hsa-mir-2315 pending 1175 gUCUCGGGAGCGUUAGAGAUGGAgacUa acgUcUUccaagggagaUUgcgUcUcca cUUUcacccUggUacUgagag  882 GGCUGGAGCGAGUGCAGUGGUG hsa-mir-2316 hsa-mir-3135b 1176 UgcccaGGCUGGAGCGAGUGCAGUGGUG cagUcagUccUagcUcacUgcagccUcg aacUccUgggcU  883 UCAGGUGUGGAAACUGAGGCAG hsa-mir-2317 hsa-mir-3934 1177 UUUUCAGGUGUGGAAACUGAGGCAGgag gcagUgaagUaacUUgcUcaggUUgcac agcUgggaagU  884 UGACACGGAGGGUGGCUUGGGAA hsa-mir-2318 hsa-mir-4462 1178 cUUcccagcUgcccUaagUcaggagUgg cUUUccUGACACGGAGGGUGGCUUGGGA Aa  885 GAAGAUGGUGCUGUGCUGAGGA hsa-mir-2319 pending 1179 ggUGAAGAUGGUGCUGUGCUGAGGAaag gggaUgcagagcccUgcccagcaccacc accUccUaUg  886 AAAGACUGCAAUUACUUUUGCG hsa-mir-2320 hsa-mir-548u 1180 aUggUgcaaaagUaaUgUggUUUUUUUc UUUacUUUUaaUggcAAAGACUGCAAUU ACUUUUGCGcca  887 GAGACUGGGGUGGGGCC hsa-mir-2321 hsa-mir-4463 1181 aaUagaUUaUUggUcaccaccUccagUU UcUgaaUUUgUGAGACUGGGGUGGGGCC UgagaaUUUgc  888 AAGGUUUGGAUAGAUGCAAUA hsa-mir-2322 hsa-mir-4464 1182 ggaaccUUagUAAGGUUUGGAUAGAUGC AAUAaagUaUgUccacagcUgaaaggac aUacUUUaUUgcaUgUaUccaaaccUUa cUaaUUca  889 AAAGGUAAUUGCAGUUUUUCCC hsa-mir-2323 hsa-mir-548ai 1183 gUaUUaggUUggUgcAAAGGUAAUUGCA GUUUUUCCCaUUUaaaaUaUggaaaaaa aaaUcacaaUUacUUUUgcaUcaaccUa aUaa  890 AGGGGACCAAAGAGAUAUAUAG hsa-mir-2324 hsa-mir-3144 1184 gaaacUacacUUUaAGGGGACCAAAGAG AUAUAUAGaUaUcagcUaccUaUaUacc UgUUcggUcUcUUUaaagUgUagUUUa  891 UAAAAACUGCAAUUACUUUUA hsa-mir-2325-1 hsa-mir-548aj-1 1185 aUUggUgUaaaagUaaUUgcaggUUaUg ccaUUaaaagUaaUggUAAAAACUGCAA UUACUUUUAcacUaac  892 UAAAAACUGCAAUUACUUUUA hsa-mir-2325-2 hsa-mir-548aj-2 1186 aaggUaUUaggUUggUgcaaaagUaaUU gcagUUUUUgcUaUUacUUUUaaUggUA AAAACUGCAAUUACUUUUAcaccaaccU aaUaUUUa  893 CUCAAGUAGUCUGACCAGGGGA hsa-mir-2326 hsa-mir-4465 1187 caUgUgUccccUggcacgcUaUUUgagg UUUacUaUggaacCUCAAGUAGUCUGAC CAGGGGAcacaUga  894 UCUGGCUGAGGAGGAAGUGGAG hsa-mir-2327-1 pending 1188 gcUcUagUagccacagccaUccccUaga gggaUCUGGCUGAGGAGGAAGUGGAGg  895 UCUGGCUGAGGAGGAAGUGGAG hsa-mir-2327-2 pending 1189 ccgccUcagUggcUUccUccacagccac cUccggagggaUCUGGCUGAGGAGGAAG UGGAGgUgUcacUgg  896 GGCGACAAAACGAGACCCUGU hsa-mir-2328 hsa-mir-1273c 1190 cUgGGCGACAAAACGAGACCCUGUcUUU UUUUUUUUcUgagacagagUcUcgUUcU gUUgcccaa  897 GGGUGCGGGCCGGCGGGG hsa-mir-2329 hsa-mir-4466 1191 acgcGGGUGCGGGCCGGCGGGGUagaag ccacccggcccggcccggcccggcga  898 CCUGCUGGUCAGGAGUGGAUAC hsa-mir-2330 hsa-mir-3692 1192 gccaUUCCUGCUGGUCAGGAGUGGAUAC UggagcaaUagaUacagUUccacacUga cacUgcagaagUgga  899 CAUGCUAGGAUAGAAAGAAUGG hsa-mir-2331 hsa-mir-3146 1193 aUUUUcUUUgcUaagUcccUUcUUUcUa UccUagUaUaacUUgaagaaUUcaaaUa gUCAUGCUAGGAUAGAAAGAAUGGgacU Uggccagggaagaa  900 AAUGUGGAAGUGGUCUGAGGCA hsa-mir-2332 pending 1194 gaaUagaaagAAUGUGGAAGUGGUCUGA GGCAUaUagagUaUaUgccaagaacacU accaUa  901 GCAAAGUGAUGAGUAAUACUGG hsa-mir-2333 hsa-mir-3609 1195 acagUaacUUUUaUUcUcaUUUUccUUU UcUcUaccUUgUagagaaGCAAAGUGAU GAGUAAUACUGGcUgg  902 UGGCGGCGGUAGUUAUGGGCUU hsa-mir-2334 hsa-mir-4467 1196 UggUGGCGGCGGUAGUUAUGGGCUUcUc UUUcUcaccagcagccccUgggccgccg ccUcccU  903 AGAGCAGAAGGAUGAGAU hsa-mir-2335 hsa-mir-4468 1197 agUcUUcUccUggggcUUUggUggcUaU ggUUgacUgggccacUcAGAGCAGAAGG AUGAGAUg  904 UGGAAUGGCCUGAAGGUGGA hsa-mir-2336 pending 1198 ccUggcagcccUcUggccUagUUcccac cacacaUgaggUggUGGAAUGGCCUGAA GGUGGAacaga  905 GCUCCCUCUAGGGUCGCUCGGA hsa-mir-2337 hsa-mir-4469 1199 ccgacgcggagagcggcUcUaggUgggU UUggcggcggcgaggacaccgccGCUCC CUCUAGGGUCGCUCGGAgcgUga  906 UGGCAAACGUGGAAGCCGAGA hsa-mir-2338 hsa-mir-4470 1200 cgagccUcUUUcggcUUUccagUUUgUc UcggUccUUUggaacgUGGCAAACGUGG AAGCCGAGAgggcUcU  907 UUUGUAUGGAUAUGUGUGUGUA hsa-mir-2339 hsa-mir-3149 1201 aUaUacaUacaUgUacacacacaUgUca UccacacacaUacaUaUaUaUaUgUUUG UAUGGAUAUGUGUGUGUAUgUgUgUgUa Uac  908 UGAGGAGAUCGUCGAGGUUGGC hsa-mir-2340 hsa-mir-3150b 1202 aaagcaggccaaccUcgaggaUcUcccc agccUUggcgUUcaggUgcUGAGGAGAU CGUCGAGGUUGGCcUgcUUc  909 UGGGAACUUAGUAGAGGUUUAA hsa-mir-2341 hsa-mir-4471 1203 ccaaaUUUaaaacUUaaaccUcUacUaa gUUUccaUgaaaagaacccaUGGGAACU UAGUAGAGGUUUAAgUUUUaaaUUUga  910 GGUGGGGGGUGUUGUUUU hsa-mir-2342-1 hsa-mir-4472-1 1204 UggcagacccUUgcUcUcUcacUcUccc UaaUggggcUgaagacagcUcaggggca gGGUGGGGGGUGUUGUUUUUgUUU  911 GGUGGGGGGUGUUGUUUU hsa-mir-2342-2 hsa-mir-4472-2 1205 UggUgggGGUGGGGGGUGUUGUUUUUgU UUUUgagacagagUcUUgcUccgUcgcc caggccggagU  912 CUAGUGCUCUCCGUUACAAGUA hsa-mir-2343 hsa-mir-4473 1206 aaggaacaggggacacUUgUaaUggaga acacUaagcUaUggacUgcUaUggacUg CUAGUGCUCUCCGUUACAAGUAUccccU gUUaccU  913 CACUUGUAAUGGAGAACACUAA hsa-mir-2344 pending 1207  aaaggaacaggggaCACUUGUAAUGGAG AACACUAAgcUaUggacUgcUaUggacU gcUagUgcUcUccgUUacaagUaUcccc UgUUaccUUg  914 UUGUGGCUGGUCAUGAGGCUAA hsa-mir-2345 hsa-mir-4474 1208 UUgccUaccUUgUUagUcUcaUgaUcag acacaaaUaUggcUcUUUGUGGCUGGUC AUGAGGCUAAcaaggUaggcac  915 CCCUGGGGUUCUGAGGACAUG hsa-mir-2346 pending 1209 aUgcUgCCCUGGGGUUCUGAGGACAUGc UcUgacUccccUgaUgUccUcUgUUccU caggUgcUgggcga  916 CAAGGGACCAAGCAUUCAUUAU hsa-mir-2347 hsa-mir-4475 1210 aUcUcaaUgagUgUgUggUUcUaaaUga cUcaUagUCAAGGGACCAAGCAUUCAUU AUgaa  917 CAGGAAGGAUUUAGGGACAGGC hsa-mir-2348 hsa-mir-4476 1211 aaaagccUgUcccUaagUcccUcccagc cUUccagagUUggUgcCAGGAAGGAUUU AGGGACAGGCUUUg  918 CUAUUAAGGACAUUUGUGAUUC hsa-mir-2349 hsa-mir-4477a 1212 UccUccUcccaUcaaUcacaaaUgUccU UaaUggcaUUUaaggaUUgCUAUUAAGG ACAUUUGUGAUUCacgggaggaggU  919 AUUAAGGACAUUUGUGAUUGAU hsa-mir-2350 hsa-mir-4477b 1213 accUccUcccgUgaaUcacaaaUgUccU UaaUagcaaUccUUaaaUgccAUUAAGG ACAUUUGUGAUUGAUgggaggagga  920 AAAAGGCAUAAAACCAAGACA hsa-mir-2351-1 hsa-mir-3910-2 1214 cUUUUUUUgUUgcUUgUcUUggUUUUaU gccUUUUaUgUgccUUgaUaUAAAAGGC AUAAAACCAAGACAagcaacagaaaaac  921 AAAAGGCAUAAAACCAAGACA hsa-mir-2351-2 hsa-mir-3910-1 1215 cUgUcagUUUUUcUgUUgcUUgUcUUgg UUUUaUgccUUUUaUaUcaaggcacaUA AAAGGCAUAAAACCAAGACAagcaacaa  922 GAGGCUGAGCUGAGGAG hsa-mir-2352 hsa-mir-4478 1216 ggccGAGGCUGAGCUGAGGAGccUccaa accUgUagacagggUcaUgcagUacUag gggcgagccUcaUccccUgcagcccUgg cc  923 CUGGGAGGUGUGAUAUUGUGGU hsa-mir-2353 hsa-mir-3689c 1217 gggaggUgUgaUaUcgUggUUccUggga ggUgUgaUaUcgUggUUcCUGGGAGGUG UGAUAUUGUGGUUccU  924 UAAAAACUGCAAUUACUUUC hsa-mir-2354-1 hsa-mir-548x-2 1218 aUgccaaaUaUUaggUUggcacaaaagU aaUUgUggcUUUUgccaUUaaaagUaaU ggUAAAAACUGCAAUUACUUUCgUgcca accUaaUaUUUgUgUg  925 UAAAAACUGCAAUUACUUUC hsa-mir-2354-2 hsa-mir-548x-1 1219 agUgcaaaagUaaUUgcagUUUUUgcgU UacUUUcaaUcgUAAAAACUGCAAUUAC UUUCacacc  926 UGUGAUAUCAUGGUUCCUGGGA hsa-mir-2355-1 hsa-mir-3689a 1220 gcUcccUgggaggUGUGAUAUCAUGGUU CCUGGGAggUgUgaUccUgUgcUUccUg ggaggUgUgaUaUcgUggUUccUgggag g  927 GGGAGGUGUGAUCUCACACUCG has-mir-2356-1 hsa-mir-3689d-1 1221 UGGGAGGUGUGAUCUCACACUCGcUggg aggUgUgcUaUcgUcUUccccgggaggU gUgaUccUgUUcUUccUg  928 CUGGGAGGUGUGAUAUUGUGGU mir-2355-2* has-mir-3689b-1 1222 gggaggUGUGAUAUCAUGGUUCCUGGGA ggUgUgaUcccgUgcUUcCUGGGAGGUG UGAUAUUGUGGUUccU  929 UGUGAUAUCAUGGUUCCUGGGA hsa-mir-2355-2 hsa-mir-3689b-1 1223 gggaggUGUGAUAUCAUGGUUCCUGGGA ggUgUgaUcccgUgcUUcCUGGGAGGUG UGAUAUUGUGGUUccU  930 GGGAGGUGUGAUCUCACACUCG has-mir-2356-2 hsa-mir-3689d-2 1224 acUGGGAGGUGUGAUCUCACACUCGcUg ggaggUgUgcUaUcgUcUUcccUgggag gUgUgaUccUgUUcUUccUgagcg  931 UGUGAUAUCAUGGUUCCUGGGA hsa-mir-2355-3 has-mir-3689b-2 1225 gggaggUGUGAUAUCAUGGUUCCUGGGA ggUaUgaUaUcgUggUUccUgggaggUg UgaUcccgUgcUcccU  932 UGUGAUAUCGUGCUUCCUGGGA hsa-mir-2355b hsa-mir-3689f 1226 aggUGUGAUAUCGUGCUUCCUGGGAcgU gUgaUgcUgUgCUUccUgggaggUgUga UcccacacUc  933 CGCGCGGCCGUGCUCGGAGCAG hsa-mir-2356 hsa-mir-4479 1227 gaaaccaagUccgagcgUggcUggcgcg ggaaagUUcgggaacgCGCGCGGCCGUG CUCGGAGCAGcgcca  934 CCAGGCUCUGCAGUGGGAACU hsa-mir-2357a hsa-mir-3155a 1228 ccUgUUccgggcaUcaccUcccacUgca gagccUggggagccggacagcUcccUUc CCAGGCUCUGCAGUGGGAACUgaUgccU ggaacagU  935 CCAGGCUCUGCAGUGGGA hsa-mir-2357b hsa-mir-3155b 1229 ccacUgcagagccUgggaagggagcUgU ccggcUccCCAGGCUCUGCAGUGGGAgU  936 AAAAGUAACUGCGGUUUUUGA hsa-mir-2358 hsa-mir-548ak 1230 gUgcAAAAGUAACUGCGGUUUUUGAgaa gUaaUUgaaaaccgcaaUUacUUUUgca g  937 AGCCAAGUGGAAGUUACUUUA hsa-mir-2359 hsa-mir-4480 1231 gcagaggUgagUUgaccUccacagggcc acccagggagUaagUAGCCAAGUGGAAG UUACUUUAccUcUgU  938 GGAGUGGGCUGGUGGUU hsa-mir-2360 hsa-mir-4481 1232 GGAGUGGGCUGGUGGUUUUUUaagagga agggagaccUaagcUagcacaUgagcac gcUc  939 GAGCGAUCCGAGGGACUG hsa-mir-2361 pending 1233 cggcUUcccgcggUccccggUgcUgagg agaGAGCGAUCCGAGGGACUGcgccgcc  940 AAGGGCUUCCUCUCUGCAGGAC hsa-mir-2362-1 hsa-mir-3158-2 1234 acaUUaUUcaggccggUccUgcagagag gaagcccUUccaaUaccUgUaagcagAA GGGCUUCCUCUCUGCAGGACcggccUga aUaaUga  941 AAGGGCUUCCUCUCUGCAGGAC hsa-mir-2362-2 hsa-mir-3158-1 1235 ggaUcaUUaUUcaggccggUccUgcaga gaggaagcccUUcUgcUUacaggUaUUg gAAGGGCUUCCUCUCUGCAGGACcggcc UgaaUaaUgUaaUca  942 AACCCAGUGGGCUAUGGAAAUG hsa-mir-2363 hsa-mir-4482 1236 agUgagcAACCCAGUGGGCUAUGGAAAU GUgUggaagaUggcaUUUcUaUUUcUca gUggggcUcUUacc  943 GGGGUGGUCUGUUGUUG hsa-mir-2364 hsa-mir-4483 1237 aaaaaacaacaUacUUagUgcaUaccca UaUaaUaUUaGGGGUGGUCUGUUGUUGU UUUUcU  944 AAAAGGCGGGAGAAGCCCCA hsa-mir-2365 hsa-mir-4484 1238 gggUUUccUcUgccUUUUUUUccaaUga aaaUaacgaaaccUgUUaUUUcccaUUg agggggaAAAAGGCGGGAGAAGCCCCA  945 UGGCUGUUGGAGGGGGCAGGCU hsa-mir-2366 pending 1239 ggagccagcccUccUcccgcacccaaac UUggagcacUUgaccUUUGGCUGUUGGA GGGGGCAGGCUcg  946 UAACGGCCGCGGUACCCUAA hsa-mir-2367 hsa-mir-4485 1240 agaggcaccgccUgcccagUgacaUgcg UUUAACGGCCGCGGUACCCUAAcUgUgc a  947 UAGGAUUACAAGUGUCGGCCAC hsa-mir-2368 hsa-mir-3159 1241 ccUAGGAUUACAAGUGUCGGCCACgggc UgggcacagUggcUcacgccUgUaaUcc cagc  948 GCUGGGCGAGGCUGGCA hsa-mir-2369 hsa-mir-4486 1242 gcaUGCUGGGCGAGGCUGGCAUcUagca caggcggUagaUgcUUgcUcUUgccaUU gcaaUga  949 AGAGCUGGCUGAAGGGCAG hsa-mir-2370 hsa-mir-4487 1243 acUgUccUUcagccAGAGCUGGCUGAAG GGCAGaagggaacUgUccUUcagccaga gcUggcUgaagggcaga  950 AGGGGGCGGGCUCCGGCG hsa-mir-2371 hsa-mir-4488 1244 ggUAGGGGGCGGGCUCCGGCGcUgggac cccacUagggUggcgccUUggccccgcc ccgccc  951 GCCGAGAGUCGUCGGGGUU hsa-mir-2372 pending 1245 UcGCCGAGAGUCGUCGGGGUUUccUgcU UcaacagUgcUUggacggaacccggcgc  952 UGGGGCUAGUGAUGCAGGACG hsa-mir-2373 hsa-mir-4489 1246 gggggUGGGGCUAGUGAUGCAGGACGcU ggggacUggagaagUccUgccUgacccU gUccca  953 UGUGACUUUAAGGGAAAUGGCG hsa-mir-2374 hsa-mir-3164 1247 UggaaacUGUGACUUUAAGGGAAAUGGC GcacagcagacccUgcaaUcaUgccgUU UUgcUUgaagUcgcagUUUccc  954 UCUCAGGAGUAAAGACAGAGUU hsa-mir-2375 hsa-mir-3664 1248 aacUUgaaggUagggaacUcUgUcUUca cUcaUgagUaccUUccaacacgagcUCU CAGGAGUAAAGACAGAGUUcccUaccUU caaUgU  955 AGGUGGAUGCAAUGUGACCUCA hsa-mir-2376 hsa-mir-3165 1249 caAGGUGGAUGCAAUGUGACCUCAacUc UUggUccUcUgaggUcacaUUgUaUcca ccUUa  956 AACGGCAAUGACUUUUGUACCA hsa-mir-2377 hsa-mir-548al 1250 ggUcggUgcaaaagUaaUUgcUgUUUUU gccaUUaaaaaUaaUggcaUUaaaagUa aUggcaaaAACGGCAAUGACUUUUGUAC CAaUcUaaUaUcU  957 UCUGGUAAGAGAUUUGGGCAUA hsa-mir-2378 hsa-mir-4490 1251 aUagUUUcUgcaaUgcUcaaaUcUcUgg ccaaagaccagaacUUaaUggUcUCUGG UAAGAGAUUUGGGCAUAUUagaaacUaa  958 AAUGUGGACUGGUGUGACCAAA hsa-mir-2379-1 hsa-mir-4491 1252 acaUUUggUcacaccagUccacaUUaac gUggaccagacaaUaUUAAUGUGGACUG GUGUGACCAAAa  959 AAUGUGGACUGGUGUGACCAAA hsa-mir-2379-2 pending 1253 accUggacaUUUggUcacaccagUccac aUUaacgUggaccagacaaUaUUAAUGU GGACUGGUGUGACCAAAagUccaggc  960 GGGGCUGGGCGCGCGCC hsa-mir-2380 hsa-mir-4492 1254 cUgcagcgUgcUUcUccaggccccgcgc gcggacagacacacggacaagUcccgcc aGGGGCUGGGCGCGCGCCagccgg  961 AGAAGGCCUUUCCAUCUCUGU hsa-mir-2381 hsa-mir-4493 1255 ccagagaUgggaaggccUUccggUgaUU aUcacagccaUgccUUUaccUccAGAAG GCCUUUCCAUCUCUGUc  962 CCAGACUGUGGCUGACCAGAGG hsa-mir-2382 hsa-mir-4494 1256 agUUUUagUUacccUggUcaUcUgcagU cUgaaaaUacaaaaUggaaaaUUCCAGA CUGUGGCUGACCAGAGGUaacUgaaacc  963 AGGAGAAGCAGGAGCUGU hsa-mir-2383 pending 1257 cUgAGGAGAAGCAGGAGCUGUcUUggUa caUUcaggUcacUg  964 AAUGUAAACAGGCUUUUUGCU hsa-mir-2384 hsa-mir-4495 1258 aagaAAUGUAAACAGGCUUUUUGCUcag UggagUUaUUUUgagcaaaaagcUUaUU UacaUUUcUg  965 GAGGAAACUGAAGCUGAGAGGG hsa-mir-2385 hsa-mir-4496 1259 ACAUCAGCUCAUAUAAUCCUCGAAGCUG CCUUUAGAAAUGAGGAAACUGAAGCUGA GAGGG  966 CUCCGGGACGGCUGGGC hsa-mir-2386 hsa-mir-4497 1260 acCUCCGGGACGGCUGGGCgccggcggc cgggagaUccgcgcUUccUgaaUcccgg ccggcccgcccggcgcccgUccgcccgc gggUc  967 UGGGCUGGCAGGGCAAGUGCUG hsa-mir-2387 hsa-mir-4498 1261 agggcUGGGCUGGCAGGGCAAGUGCUGc agaUcUUUgUcUaagcagccccUgccUU ggaUcUccca  968 GAGGCUGAAGGAAGAUGG hsa-mir-2388 hsa-mir-4419b 1262 cUcaggcUcagUggUgcaUgcUUaUagU cccagccacUcUgGAGGCUGAAGGAAGA UGGcUUgagccU  969 AAGACUGAGAGGAGGGA hsa-mir-2389 hsa-mir-4499 1263 AAGACUGAGAGGAGGGAacUggUgagUU gUacaUagaaaUgcUUUcUaacUccUUg UcUcagUcUgUUU  970 UGAGGUAGUAGUUUCUU hsa-mir-2390 hsa-mir-4500 1264 caggagagaaagUacUgcccagaagcUa aagUgUagaUcaaacgcaUaaUggcUGA GGUAGUAGUUUCUUgaacUU  971 CGGCUGGGAGCCGAGGCGUCGG hsa-mir-2391 pending 1265 ggCGGCUGGGAGCCGAGGCGUCGGUgca gaccUggagacgggcaUgggggggcUgc ggcUgcUggcUgUg  972 UAUGUGACCUCGGAUGAAUCA hsa-mir-2392 hsa-mir-4501 1266 UAUGUGACCUCGGAUGAAUCAcUgaaaU aUgUcUgagcUUcUgUUUcaUcagaUgU cacaUUUU  973 GCUGAUGAUGAUGGUGCUGAAG hsa-mir-2393 hsa-mir-4502 1267 agccUUUagcaagUUgUaaUcUUUUUgc UgaUggagggUcUUgccUccaUggggaU gGCUGAUGAUGAUGGUGCUGAAGgc  974 AGAUGUAUGGAAUCUGUAUAU hsa-mir-2394 hsa-mir-3171 1268 gAGAUGUAUGGAAUCUGUAUAUaUcUaU aUaUaUgUgUaUaUaUagaUUccaUaaa UcUa  975 UUUAAGCAGGAAAUAGAAUUUA hsa-mir-2395 hsa-mir-4503 1269 acaaUgUagaUaUUUAAGCAGGAAAUAG AAUUUAcaUaUaaaUUUcUaUUUgUUUc UaUUUccUgcUUaaaUaUcUacaUUgc  976 UGUGACAAUAGAGAUGAACAUG hsa-mir-2396 hsa-mir-4504 1270 cUaagaUaaUgUccUccaggUUcaUcUc UgUUgUcaUUUgUggcaUggaccaUUUG UGACAAUAGAGAUGAACAUGgaggaUaU UaUcUUaa  977 AGGCUGGGCUGGGACGGA hsa-mir-2397 hsa-mir-4505 1271 ggAGGCUGGGCUGGGACGGAcacccggc cUccacUUUcUgUggcaggUaccUccUc caUgUcggcccgccUUg  978 AAAUGGGUGGUCUGAGGCAA hsa-mir-2398 hsa-mir-4506 1272 UggccUcUgccaUcagaccaUcUgggUU caagUUUggcUccaUcUUUaUgAAAUGG GUGGUCUGAGGCAAgUggUcU  979 UAGGAUGGGGGUGAGAGGUG hsa-mir-2399 hsa-mir-2392 1273 aUggUcccUcccaaUccagccaUUccUc agaccaggUggcUcccgagccaccccag gcUgUAGGAUGGGGGUGAGAGGUGcUag  980 CUGGGUUGGGCUGGGCUGGG hsa-mir-2400 hsa-mir-4507 1274 UcUgggcUgagccgagcUgggUUaagcc gagCUGGGUUGGGCUGGGCUGGGU  981 AAGGGACUGGAGUGGAUUGGGU hsa-mir-2401 pending 1275 ggAAGGGACUGGAGUGGAUUGGGUacaU cUaUUaUagUgggagcaccUacUacaac ccgUcccUcaagagUcgagUcacc  982 AAGGGGCUGGAGUGGAUUGGGG hsa-mir-2402 pending 1276 cUggUgaaUcUgggUccgccagccccca gggAAGGGGCUGGAGUGGAUUGGGGaaa UccaU  983 GCGGGGCUGGGCGCGCG hsa-mir-2403 hsa-mir-4508 1277 aggacccaGCGGGGCUGGGCGCGCGgag cagcgcUgggUgcagcgccUgcgccggc agcUgcaagggccg  984 ACUAAAGGAUAUAGAAGGUUUU hsa-mir-2404-1 hsa-mir-4509-1  1278 cUUUaaUacUaUcUcaaACUAAAGGAUA UAGAAGGUUUUcccUUUcUcUUgcccUg aaaccUUcUgUaUccUUUaUUUUgagaU agUaUUagaa  985 ACUAAAGGAUAUAGAAGGUUUU hsa-mir-2404-2 hsa-mir-4509-2  1279 cUUUaaUacUaUcUcaaACUAAAGGAUA UAGAAGGUUUUcccUUUcUcUUgcccUg aaaccUUcUgUaUccUUUaUUUUgagaU agUaUUagaa  986 ACUAAAGGAUAUAGAAGGUUUU hsa-mir-2404-3 hsa-mir-4509-3  1280 cUUUaaUacUaUcUcaaACUAAAGGAUA UAGAAGGUUUUcccUUUcUcUUgcccUg aaaccUUcUgUaUccUUUaUUUUgagaU agUaUUagaa  987 AAGCAAUACUGUUACCUGAAAU hsa-mir-2405 hsa-mir-3942 1281 cUcaaagAAGCAAUACUGUUACCUGAAA UaggcUgcgaagaUaacagUaUUUcaga UaacagUaUUacaUcUUUgaa  988 UGAGGGAGUAGGAUGUAUGGUU hsa-mir-2406 hsa-mir-4510 1282 gUgUaUgUGAGGGAGUAGGAUGUAUGGU UgUUagaUagacaacUacaaUcUUUUcU cacaacagacag  989 GAAGAACUGUUGCAUUUGCCCU hsa-mir-2407 hsa-mir-4511 1283 aaaaaaaagggaaaGAAGAACUGUUGCA UUUGCCCUgcacUcagUUUgcacagggU aaaUgcaaUagUUcUUcUUUcccUUUUU UUa  990 CAGGGCCUCACUGUAUCGCCCA hsa-mir-2408 hsa-mir-4512 1284 cUcagcccgggcaaUaUagUgagaccUc gUcUcUacaaaaaaUUgagaCAGGGCCU CACUGUAUCGCCCAggcUgga  991 AGACUGACGGCUGGAGGCCCAU hsa-mir-2409 hsa-mir-4513 1285 aUUcUaggUggggAGACUGACGGCUGGA GGCCCAUaagcUgUcUaaaacUUcggcc cccagaUUUcUggUcUccccacUUcaga ac  992 ACAGGCAGGAUUGGGGAA hsa-mir-2410 hsa-mir-4514 1286 gUUgagACAGGCAGGAUUGGGGAAacaU cUUUUaccUcgUcUcUUgccUgUUUUag a  993 AGGACUGGACUCCCGGCAGCCC hsa-mir-2411 hsa-mir-4515 1287 gcgggaggUgUaacAGGACUGGACUCCC GGCAGCCCcagggcaggggcgUggggag cUggUccUagcUcagcgcUcccgga  994 UAGUGAGUUAGAGAUGCAGAGC hsa-mir-2412 hsa-mir-3174 1288 agcgUUaccUggUAGUGAGUUAGAGAUG CAGAGCccUgggcUccUcagcaaaccUa cUggaUcUgca  995 ACUGGCCUGGGACUACCGGGGG hsa-mir-2413 hsa-mir-3176 1289 UcUgcagcUcccggcagccUcgggccac acUcccgggaUccccagggACUGGCCUG GGACUACCGGGGGUggcggc  996 GGGAGAAGGGUCGGGGC hsa-mir-2414 hsa-mir-4516 1290 aGGGAGAAGGGUCGGGGCagggagggca gggcaggcUcUggggUggggggUcUgUg agUcagccacggcUcUgcccacgUcUcc cc  997 UGGGGCGGAGCUUCCGGAGGCC hsa-mir-2415-1 hsa-mir-3180-1 1291 agcUUccagacgcUccgccccacgUcgc aUgcgccccgggaacgcgUGGGGCGGAG CUUCCGGAGGCCcc  998 UGGGGCGGAGCUUCCGGAGGCC hsa-mir-2415-2 hsa-mir-3180-2 1292 agcUUccagacgcUccgccccacgUcgc aUgcgccccgggaacgcgUGGGGCGGAG CUUCCGGAGGCCcc  999 UGGGGCGGAGCUUCCGGAGGCC hsa-mir-2415-3 hsa-mir-3180-3 1293 agcUUccagacgcUccgccccacgUcgc aUgcgccccgggaacgcgUGGGGCGGAG CUUCCGGAGGCCcc 1000 UGGGGCGGAGCUUCCGGAGGCC hsa-mir-2415-4 hsa-mir-3180-4 1294 agcUUccagacgcUccgccccacgUcgc aUgcgccccgggaacgcgUGGGGCGGAG CUUCCGGAGGCCcc 1001 UGGGGCGGAGCUUCCGGAGGCC hsa-mir-2415-5 hsa-mir-3180-5 1295 agcUUccagacgcUccgccccacgUcgc aUgcgccccgggaacgcgUGGGGCGGAG CUUCCGGAGGCCcc 1002 CUCGUGGGCUCUGGCCACGGC hsa-mir-2416 hsa-mir-3677 1296 UggagggcaUUaggcagUggccagagcc cUgcagUgcUgggcaUgggcUUCUCGUG GGCUCUGGCCACGGCccUgagcUccUcc 1003 AGAAGGGGUGAAAUUUAAACGU hsa-mir-2417-1 hsa-mir-3179-1 1297 gccaggaUcacagacgUUUaaaUUacac UccUUcUgcUgUgccUUacagcagUAGA AGGGGUGAAAUUUAAACGUcUgUgaUcc Uggg 1004 AGAAGGGGUGAAAUUUAAACGU hsa-mir-2417-2 hsa-mir-3179-2 1298 gaUcacagacgUUUaaaUUacacUccUU cUgcUgUgccUUacagcagUAGAAGGGG UGAAAUUUAAACGUcUgUgaUccUggg 1005 AGAAGGGGUGAAAUUUAAACGU hsa-mir-2417-3 hsa-mir-3179-3 1299 gccaggaUcacagacgUUUaaaUUacac UccUUcUgcUgUgccUUacagcagUAGA AGGGGUGAAAUUUAAACGUcUgUgaUcc Ugg 1006 AAAUAUGAUGAAACUCACAGCUG hsa-mir-2418 hsa-mir-4517 1300 aggUAAAUAUGAUGAAACUCACAGCUGA AG GgagcUUagcaagUagcUaaggccagag cUUgUgUUUgggUggUgUggcUg 1007 GCUCAGGGAUGAUAACUGUGCUG hsa-mir-2419 hsa-mir-4518 1301 UgggggaaaagUgcUgggaUUgaUUagU AGA gaUgUcUgcUggggaaccgggGCUCAGG GAUGAUAACUGUGCUGAGAagcccccU 1008 CAGCAGUGCGCAGGGCUG hsa-mir-2420 hsa-mir-4519 1302 aaccUCAGCAGUGCGCAGGGCUGcacUg UcUccgUcUgcggccUgcagUaagcggg Ua 1009 UUGGACAGAAAACACGCAGGAA hsa-mir-2421 hsa-mir-4520 1303 gUgUgccaccUgcgUgUUUUcUgUccaa aUcagaaaaggaUUUGGACAGAAAACAC GCAGGAAgaaggaa 1010 GCUAAGGAAGUCCUGUGCUCAG hsa-mir-2422 hsa-mir-4521 1304 UcgGCUAAGGAAGUCCUGUGCUCAGUUU UgUagcaUcaaaacUaggaUUUcUcUUg UUac 1011 CUGGACUGAGCCAUGCUACUGG hsa-mir-2423 hsa-mir-1269b 1305 UgaggUUUCUGGACUGAGCCAUGCUACU GGcUUcUcUggUUcUccagcUUacagaU ggcUUaUcaUgggaccUcU 1012 UGACUCUGCCUGUAGGCCGGU hsa-mir-2424 hsa-mir-4522 1306 gcgggcgUUgccUgggggccUcgcaggg ggagaUccagcccaggcUggUUccgcUG ACUCUGCCUGUAGGCCGGUggcgUcUUc Ugg 1013 GACCGAGAGGGCCUCGGCUGU hsa-mir-2425 hsa-mir-4523 1307 gcggggGACCGAGAGGGCCUCGGCUGUg UgaggacUagaggcggccgaggcccggg ccggUUcccccga 1014 UAGAGGCUGGAAUAGAGAUUCU hsa-mir-2426 pending 1308 aUUUUAGAGGCUGGAAUAGAGAUUCUUg aggcUUggaagagUaaggaUcccUUUaU cUgUccUcUaggag 1015 UAGCCUUCAGAUCUUGGUGUUU hsa-mir-2427 hsa-mir-3614 1309 UggaUcUgaaggcUgccccUUUgcUcUc UggggUAGCCUUCAGAUCUUGGUGUUUU 1016 CCACUUGGAUCUGAAGGCUGCC hsa-mir-2427* has-mir-3614 1310 UgggCCACUUGGAUCUGAAGGCUGCCcc UUUgcUcUcUggggUagccUUcagaUcU UggUgUUUU 1017 AUAGCAGCAUGAACCUGUCUCA hsa-mir-2428 hsa-mir-4524 1311 gaacgAUAGCAGCAUGAACCUGUCUCAc UgcagaaUUaUUUUgagacaggcUUaUg cUgcUaUccUUca 1018 UGAGACAGGCUUAUGCUGCUAU hsa-mir-2428* has-mir-4524 1312 ggaacgaUagcagcaUgaaccUgUcUca cUgcagaaUUaUUUUGAGACAGGCUUAU GCUGCUAUccUUca 1019  GGGGGGAUGUGCAUGCUGGUU hsa-mir-2429 hsa-mir-4525 1313 gUcagaGGGGGGAUGUGCAUGCUGGUUg gggUgggcUgccUgUggaccaaUcagcg UgcacUUccccacccUgaa 1020  CAGGGAGGUGAAUGGUUCUGUC hsa-mir-2430 pending 1314 cUUagcUcccUggcUUcagcccUUUUUc CAGGGAGGUGAAUGGUUCUGUCUcgc 1021  GCUGACAGCAGGGCUGGCCGCU hsa-mir-2431 hsa-mir-4526  1315 UgcggUgacaUcagggcccagUcccUgc UgUcaUgccccaggUgacgUgcUggGCU GACAGCAGGGCUGGCCGCUaacgUcacU gUc 1022  UGGUCUGCAAAGAGAUGACUGU hsa-mir-2432 hsa-mir-4527 1316 ccagaagUGGUCUGCAAAGAGAUGACUG UgaaUccaagaUccacaUcagcUcUgUg cUgccUacaUcUga 1023  UCAUUAUAUGUAUGAUCUGGAC hsa-mir-2433 hsa-mir-4528  1317 UaUUcUacUgagagUacagaUcUUUaUa UaUaUgaUcaUUaUaUgUaUgaUgagaU CAUUAUAUGUAUGAUCUGGACacccagU agaaUc 1024  AUUGGACUGCUGAUGGCCCGU hsa-mir-2434 hsa-mir-4529 1318 aUgacaggccaUcagcagUccaaUgaag acaUgaagacccaaUgUcUUcAUUGGAC UGCUGAUGGCCCGUcacUggga 1025  UUGGAGGGUGUGGAAGACAUC hsa-mir-2435 pending 1319 cUccacaUUGGAGGGUGUGGAAGACAUC UgggccaacUcUgaUcUcUUcaUcUacc ccccaggacUggga 1026 CCCAGCAGGACGGGAGCG hsa-mir-2436 hsa-mir-4530 1320 cgaccgcacccgcccgaagcUgggUcaa ggagCCCAGCAGGACGGGAGCGcggcgc 1027 AUGGAGAAGGCUUCUGA hsa-mir-2437 hsa-mir-4531 1321 gccUaggagUccUUggUcagUggggacA UGGAGAAGGCUUCUGAgga 1028 AAAAGCUGGGUUGAGAA hsa-mir-2438 hsa-mir-320e 1322 gccUUcUcUUcccagUUcUUccUggagU cggggAAAAGCUGGGUUGAGAAggUgaa aaga 1029  UGGAAGGUAGACGGCCAGAGAG hsa-mir-2439 hsa-mir-3190 1323 ggUcaccUgUcUggccagcUacgUcccc acggcccUUgUcagUgUGGAAGGUAGAC GGCCAGAGAGgUgaccc 1030  UCUGGGAGGUUGUAGCAGUGGA hsa-mir-2440 hsa-mir-3192 1324 aggaagggaUUCUGGGAGGUUGUAGCAG UGGAaaaagUUcUUUUcUUccUcUgaUc gcccUcUcagcUcUUUccUUcUg 1031 CCCCGGGGAGCCCGGCG hsa-mir-2441 hsa-mir-4532 1325 acagaCCCCGGGGAGCCCGGCGgUgaag cUccUggUaUccUgggUgUcUga 1032  UGGAAGGAGGUUGCCGGACGCU hsa-mir-2442 hsa-mir-4533 1326 UgagaaUgUGGAAGGAGGUUGCCGGACG CUgcUggcUgccUUccagcgUccacUUc ccUUUcUcUcUcUcc 1033  CAAGAACCUCAAUUACCUUUGC hsa-mir-2443 pending 1327 cggUUggUgcaaaggUaaUUgUggUUUc UgccaUUgaaagUaaaggCAAGAACCUC AAUUACCUUUGCagcgaccU 1034  AAUCUGAGAAGGCGCACAAGGU hsa-mir-2444 has-mir-3200 1328 UcgagggAAUCUGAGAAGGCGCACAAGG UUUgUgUccaaUacagUccacaccUUgc gcUacUcaggUcUgcUcgUg 1035 CACCUUGCGCUACUCAGGUCUG hsa-mir-2444* hsa-mir-3200 1329 UcgagggaaUcUgagaaggcgcacaagg UUUgUgUccaaUacagUccaCACCUUGC GCUACUCAGGUCUGcUcgU 1036 GGAGGAACCUUGGAGCUUCGGC hsa-mir-2445 hsa-mir-3928 1330 ggcUgaagcUcUaaggUUccgccUgcgg gcaggaagcGGAGGAACCUUGGAGCUUC GGCa 1037 GGAUGGAGGAGGGGUCU hsa-mir-2446 hsa-mir-4534 1331 UgUgaaUgacccccUUccagagccaaaa UcaccagGGAUGGAGGAGGGGUCUUggg UacU 1038 ACUGGACUAGGAGUCAGAAGG hsa-mir-2447 hsa-mir-378i 1332 gggagcACUGGACUAGGAGUCAGAAGGU ggagUUcUgggUgcUgUUUUcccacUcU UgggcccUgggcaUgUUcUg 1039 GUGGACCUGGCUGGGAC hsa-mir-2448 hsa-mir-4535 1333 aacUgggUcccagUcUUcacagUUggUU UcUgacacGUGGACCUGGCUGGGACgaU gUg 1040 ACCUGGACCCAGCGUAGACAAA hsa-mir-2449 hsa-mir-3690 1334 ccACCUGGACCCAGCGUAGACAAAgagg UgUUUcUacUccaUaUcUaccUggaccc agUgU 1041 CAAAAACUGCAGUUACUUUUGU hsa-mir-2450 hsa-mir-548am 1335 agUUggUgcaaaagUaaUUgcggUUUUU gccgUcgaaaaUaaUggCAAAAACUGCA GUUACUUUUGUaccaaUg 1042 UUGGGCUGGGCUGGGUUGGG hsa-mir-2451 hsa-mir-1587 1336 UUUGGGCUGGGCUGGGUUGGGcagUUcU UcUgcUggacUcaccUgUgaccagc 1043 UGUGGUAGAUAUAUGCACGAU hsa-mir-2452 hsa-mir-4536 1337 aUgUgUggUagaUaUaUgcacUgUaUaU aaacaUaaUGUGGUAGAUAUAUGCACGA UaUag 1044 AGAAGGGAAAGAACAUCAA hsa-mir-2453 pending 1338 aUggUgUUUgccUccUUcaUccgcaagg caUcUgaUgcccacgaagUUaggaaggU ccUUggggAGAAGGGAAAGAACAUCAAa 1045 CUGUCCUAAGGUUGUUGAGUU hsa-mir-2454 hsa-mir-676 1339 cgcaUgacUcUUcaaccUcaggacUUgc agaaUUaaUggaaUgCUGUCCUAAGGUU GUUGAGUUgUgca 1046 AAAAGGCAUUGUGGUUUUUG hsa-mir-2455 hsa-mir-548an  1340 caUUaggUUggUgcAAAAGGCAUUGUGG UUUUUGccUaUaaaagUaaUggcaaaaa ccgcaaUUccUUUUgcaccaaccUaaU 1047 CGGGCGGCGGCUGUGUUGCGCA hsa-mir-2456 pending 1341 cacUcgcgcUgcggccagcgcccgggcc UgcgggccCGGGCGGCGGCUGUGUUGCG CAgUc 1048 UAUGGAAGGGAGAAGAGCUUUA hsa-mir-2457 hsa-mir-3202-1  1342 UUaUUaaUAUGGAAGGGAGAAGAGCUUU AaUgaUUggagUcaUUUUcagagcaUUa aagcUcUUcUcccUUccaUaUUaaUgU 1049 CGGCGGGGACGGCGAUUGGU hsa-mir-1908 hsa-mir-1908 1343 UgccgCGGCGGGGACGGCGAUUGGUccg UaUgUgUggUgccaccggccgccggcUc cgccccggcc 1050 CCUCCUGCCCUCCUUGCUGUAG hsa-mir-1976 pending 1344 gcaaagggUggcagcaaggaaggcaggg gUccUaaggUgUgUCCUCCUGCCCUCCU UGCUGUAGacUUUgg 1051 UGAGCCGAGCUGAGCUUAGCUG hsa-mir-2457 hsa-mir-4537 1345 UGAGCCGAGCUGAGCUUAGCUGggcUga gcUaaccagggcUgggcUgagcUgggcU gagcUgagcUgagc 1052 GAGCUUGGAUGAGCUGGGCUGA hsa-mir-2458 hsa-mir-4538 1346 GAGCUUGGAUGAGCUGGGCUGAacUggg cUgggUUgagcUgggcUgggcUgagUUg agccaggcUgaUcUgggcUgag 1053 GCUGAACUGGGCUGAGCUGGGC hsa-mir-2459 hsa-mir-4539 1347 UgagcUgggcUcUgcUgUgcUgUgcUga gcagggcUgaGCUGAACUGGGCUGAGCU GGGC 1054 CUGGGCUGAAUGACAGUGAUGAG hsa-mir-2460 pending 1348 gUcaagUcagaacagccaggUagagccc UUgUccaaacCUGGGCUGAAUGACAGUG AUGAG 1055 GGGAGCCGGGGCUGUGAGAGGA hsa-mir-2461 pending 1349 cUcUUUgagccUUggcUgccUUggUgca gcagggUcaUcUgUagggccaccccaca gcUcUUUccUUccccUccUcUcUccaGG GAGCCGGGGCUGUGAGAGGA 1056 UUAGUCCUGCCUGUAGGUUUA hsa-mir-2462 hsa-mir-4540 1350 aagcUgcaUggaccaggacUUggcaccU UUggccUUAGUCCUGCCUGUAGGUUUA

TABLE 33 Primers for Reverse Transcription for a subset of the known miRNAs identified by deep sequencing analysis. Putative SEQ ID Major/Minor Mature Sequence  Primer for reverse  SEQ ID NO. miRNA ID Captured transcription of miRNA NO.   7 hsa-mir-129-2* AAGCCCUUACCCCAAAAAGCAU AAGCCCTTACCCCAAAAAGCAT 1351  22 hsa-mir-25* AGGCGGAGACUUGGGCAAUUG AGGCGGAGACTTGGGCAATTG 1352  24 hsa-mir-30b* CUGGGAGGUGGAUGUUUACUUC CTGGGAGGTGGATGTTTACTTC 1353  26 hsa-mir-30c-2* CUGGGAGAAGGCUGUUUACUCU CTGGGAGAAGGCTGTTTACTCT 1354  27 hsa-mir-30e* CUUUCAGUCGGAUGUUUACAGC CTTTCAGTCGGATGTTTACAGC 1355  29 hsa-mir-342-3p UCUCACACAGAAAUCGCACCCGU TCTCACACAGAAATCGCACCCGT 1356  56 hsa-let-7a-2 UGAGGUAGUAGGUUGUAUAGUU TGAGGTAGTAGGTTGTATAGTT 1357  57 hsa-let-7a-3 UGAGGUAGUAGGUUGUAUAGUU TGAGGTAGTAGGTTGTATAGTT 1358  58 hsa-let-7c UGAGGUAGUAGGUUGUAUGGUU TGAGGTAGTAGGTTGTATGGTT 1359  63 hsa-mir-100 AACCCGUAGAUCCGAACUUGUG AACCCGTAGATCCGAACTTGTG 1360  64 hsa-mir-101-1 UACAGUACUGUGAUAACUGAA TACAGTACTGTGATAACTGAA 1361  65 hsa-mir-101-2 GUACAGUACUGUGAUAACUGAA TACAGTACTGTGATAACTGAA 1362  66 hsa-mir-103-1 AGCAGCAUUGUACAGGGCUAUGA AGCAGCATTGTACAGGGCTATGA 1363  67 hsa-mir-103-2 AGCAGCAUUGUACAGGGCUAUGA AGCAGCATTGTACAGGGCTATGA 1364  70 hsa-mir-106a AAAAGUGCUUACAGUGCAGGUAG AAAAGTGCTTACAGTGCAGGTAG 1365  71 hsa-mir-106b UAAAGUGCUGACAGUGCAGAU TAAAGTGCTGACAGTGCAGAT 1366  72 hsa-mir-107 AGCAGCAUUGUACAGGGCUAUCA AGCAGCATTGTACAGGGCTATCA 1367  73 hsa-mir-10a UACCCUGUAGAUCCGAAUUUGUG TACCCTGTAGATCCGAATTTGTG 1368  74 hsa-mir-10b UACCCUGUAGAACCGAAUUUGUG TACCCTGTAGAACCGAATTTGTG 1369  98 hsa-mir-128-1 UCACAGUGAACCGGUCUCUUU TCACAGTGAACCGGTCTCTTT 1370  99 hsa-mir-128-2 UCACAGUGAACCGGUCUCUUU TCACAGTGAACCGGTCTCTTT 1371 100 hsa-mir-129-1 CUUUUUGCGGUCUGGGCUUGC CTTTTTGCGGTCTGGGCTTGC 1372 101 hsa-mir-129-2 CUUUUUGCGGUCUGGGCUUGC CTTTTTGCGGTCTGGGCTTGC 1373 103 hsa-mir-1295 UUAGGCCGCAGAUCUGGGUGA TTAGGCCGCAGATCTGGGTGA 1374 119 hsa-mir-140-3p UACCACAGGGUAGAACCACGG TACCACAGGGTAGAACCACGG 1375 122 hsa-mir-143 UGAGAUGAAGCACUGUAGCUC TGAGATGAAGCACTGTAGCTC 1376 125 hsa-mir-146a UGAGAACUGAAUUCCAUGGGUU TGAGAACTGAATTCCATGGGTT 1377 126 hsa-mir-146b UGAGAACUGAAUUCCAUAGGCU TGAGAACTGAATTCCATAGGCT 1378 127 hsa-mir-148a UCAGUGCACUACAGAACUUUGU TCAGTGCACTACAGAACTTTGT 1379 130 hsa-mir-151-3p CUAGACUGAAGCUCCUUGAGG CTAGACTGAAGCTCCTTGAGG 1380 131 hsa-mir-152 UCAGUGCAUGACAGAACUUGG TCAGTGCATGACAGAACTTGG 1381 132 hsa-mir-155 UUAAUGCUAAUCGUGAUAGGGGU TTAATGCTAATCGTGATAGGGGT 1382 133 hsa-mir-15a UAGCAGCACAUAAUGGUUUGUG TAGCAGCACATAATGGTTTGTG 1383 134 hsa-mir-15b UAGCAGCACAUCAUGGUUUACA TAGCAGCACATCATGGTTTACA 1384 135 hsa-mir-16-1 UAGCAGCACGUAAAUAUUGGCG TAGCAGCACGTAAATATTGGCG 1385 136 hsa-mir-16-2 UAGCAGCACGUAAAUAUUGGCG TAGCAGCACGTAAATATTGGCG 1386 137 hsa-mir-17 CAAAGUGCUUACAGUGCAGGUAG CAAAGTGCTTACAGTGCAGGTAG 1387 138 hsa-mir-181a-1 AACAUUCAACGCUGUCGGUGAGU AACATTCAACGCTGTCGGTGAGT 1388 139 hsa-mir-181a-2 AACAUUCAACGCUGUCGGUGAGU AACATTCAACGCTGTCGGTGAGT 1389 140 hsa-mir-181b-1 AACAUUCAUUGCUGUCGGUGGGU AACATTCATTGCTGTCGGTGGG 1390 141 hsa-mir-181b-2 AACAUUCAUUGCUGUCGGUGGGU AACATTCATTGCTGTCGGTGGG 1391 142 hsa-mir-181c AACAUUCAACCUGUCGGUGAGU AACATTCAACCTGTCGGTGAGT 1392 143 hsa-mir-181d AACAUUCAUUGUUGUCGGUGGGU AACATTCATTGTTGTCGGTGGGTT 1393 147 hsa-mir-185 UGGAGAGAAAGGCAGUUCCUGA TGGAGAGAAAGGCAGTTCCTGA 1394 150 hsa-mir-18a UAAGGUGCAUCUAGUGCAGAUAG TAAGGTGCATCTAGTGCAGATAG 1395 151 hsa-mir-191 CAACGGAAUCCCAAAAGCAGCUG CAACGGAATCCCAAAAGCAGCTG 1396 152 hsa-mir-192 CUGACCUAUGAAUUGACAGCC CTGACCTATGAATTGACAGCC 1397 153 hsa-mir-193a-5p UGGGUCUUUGCGGGCGAGAUGA TGGGTCTTTGCGGGCGAGATGA 1398 159 hsa-mir-196b UAGGUAGUUUCCUGUUGUUGGG TAGGTAGTTTCCTGTTGTTGGG 1399 160 hsa-mir-197 UUCACCACCUUCUCCACCCAGC TTCACCACCTTCTCCACCCAGC 1400 163 hsa-mir-199b ACAGUAGUCUGCACAUUGGUUA ACAGTAGTCTGCACATTGGTTA 1401 164 hsa-mir-19a UGUGCAAAUCUAUGCAAAACUGA TGTGCAAATCTATGCAAAACTGA 1402 175 hsa-mir-20a UAAAGUGCUUAUAGUGCAGGUAG TAAAGTGCTTATAGTGCAGGTAG 1403 176 hsa-mir-20b CAAAGUGCUCAUAGUGCAGGUAG CAAAGTGCTCATAGTGCAGGTAG 1404 186 hsa-mir-221 AGCUACAUUGUCUGCUGGGUUUC AGCTACATTGTCTGCTGGGTTTC 1405 187 hsa-mir-222 AGCUACAUCUGGCUACUGGGU AGCTACATCTGGCTACTGGGT 1406 190 hsa-mir-23a AUCACAUUGCCAGGGAUUUCC ATCACATTGCCAGGGATTTCC 1407 194 hsa-mir-25 CAUUGCACUUGUCUCGGUCUGA CATTGCACTTGTCTCGGTCTGA 1408 195 hsa-mir-26a-1 UUCAAGUAAUCCAGGAUAGGCU TTCAAGTAATCCAGGATAGGCT 1409 196 hsa-mir-26a-2 UUCAAGUAAUCCAGGAUAGGCU TTCAAGTAATCCAGGATAGGCT 1410 197 hsa-mir-26b UUCAAGUAAUUCAGGAUAGGU TTCAAGTAATTCAGGATAGGT 1411 198 hsa-mir-27a UUCACAGUGGCUAAGUUCCGC TTCACAGTGGCTAAGTTCCGC 1412 203 hsa-mir-29a UAGCACCAUCUGAAAUCGGUUA TAGCACCATCTGAAATCGGTTA 1413 208 hsa-mir-30a UGUAAACAUCCUCGACUGGAAG TGTAAACATCCTCGACTGGAAG 1414 209 hsa-mir-30b UGUAAACAUCCUACACUCAGCU TGTAAACATCCTACACTCAGCT 1415 210 hsa-mir-30c-1 UGUAAACAUCCUACACUCUCAGC TGTAAACATCCTACACTCTCAGC 1416 211 hsa-mir-30c-2 UGUAAACAUCCUACACUCUCAGC TGTAAACATCCTACACTCTCAGC 1417 212 hsa-mir-30d UGUAAACAUCCCCGACUGGAAG TGTAAACATCCCCGACTGGAAG 1418 213 hsa-mir-30e UGUAAACAUCCUUGACUGGAAG TGTAAACATCCTTGACTGGAAG 1419 216 hsa-mir-320a AAAAGCUGGGUUGAGAGGGCGA AAAAGCTGGGTTGAGAGGGCGA 1420 217 hsa-mir-320b-1 AAAAGCUGGGUUGAGAGGGCAA AAAAGCTGGGTTGAGAGGGCAA 1421 218 hsa-mir-320b-2 AAAAGCUGGGUUGAGAGGGCAA AAAAGCTGGGTTGAGAGGGCAA 1422 227 hsa-mir-331 GCCCCUGGGCCUAUCCUAGAA GCCCCTGGGCCTATCCTAGAA 1423 231 hsa-mir-33a GUGCAUUGUAGUUGCAUUGCA GTGCATTGTAGTTGCATTGCA 1424 233 hsa-mir-340 UUAUAAAGCAAUGAGACUGAUU TTATAAAGCAATGAGACTGATT 1425 236 hsa-mir-34a UGGCAGUGUCUUAGCUGGUUGU TGGCAGTGTCTTAGCTGGTTGT 1426 239 hsa-mir-361-5p UUAUCAGAAUCUCCAGGGGUAC TTATCAGAATCTCCAGGGGTAC 1427 241 hsa-mir-363 AAUUGCACGGUAUCCAUCUGUA AATTGCACGGTATCCATCTGTA 1428 242 hsa-mir-365-2 UAAUGCCCCUAAAAAUCCUUAU TAATGCCCCTAAAAATCCTTAT 1429 246 hsa-mir-374a UUAUAAUACAACCUGAUAAGUG TTATAATACAACCTGATAAGTG 1430 250 hsa-mir-378 ACUGGACUUGGAGUCAGAAGG ACTGGACTTGGAGTCAGAAGG 1431 259 hsa-mir-423 UGAGGGGCAGAGAGCGAGACUUU TGAGGGGCAGAGAGCGAGACTTT 1432 265 hsa-mir-449a UGGCAGUGUAUUGUUAGCUGGU TGGCAGTGTATTGTTAGCTGGT 1433 287 hsa-mir-503 UAGCAGCGGGAACAGUUCUGCAG TAGCAGCGGGAACAGTTCTGCAG 1434 296 hsa-mir-532 CAUGCCUUGAGUGUAGGACCGU CATGCCTTGAGTGTAGGACCGT 1435 316 hsa-mir-576-3p AAGAUGUGGAAAAAUUGGAAUC AAGATGTGGAAAAATTGGAATC 1436 327 hsa-mir-625 AGGGGGAAAGUUCUAUAGUCC AGGGGGAAAGTTCTATAGTCC 1437 338 hsa-mir-7-1 UGGAAGACUAGUGAUUUUGUUGU TGGAAGACTAGTGATTTTGTTGT 1438 339 hsa-mir-7-2 UGGAAGACUAGUGAUUUUGUUGU TGGAAGACTAGTGATTTTGTTGT 1439 340 hsa-mir-7-3 UGGAAGACUAGUGAUUUUGUUGU TGGAAGACTAGTGATTTTGTTGT 1440 345 hsa-mir-874 CUGCCCUGGCCCGAGGGACCGA CTGCCCTGGCCCGAGGGACCGA 1441 351 hsa-mir-9-1 UCUUUGGUUAUCUAGCUGUAUGA TCTTTGGTTATCTAGCTGTATGA 1442 352 hsa-mir-9-2 UCUUUGGUUAUCUAGCUGUAUGA TCTTTGGTTATCTAGCTGTATGA 1443 353 hsa-mir-92a-1 UAUUGCACUUGUCCCGGCCUGU TATTGCACTTGTCCCGGCCTGT 1444 354 hsa-mir-92a-2 UAUUGCACUUGUCCCGGCCUGU TATTGCACTTGTCCCGGCCTGT 1445 356 hsa-mir-93 CAAAGUGCUGUUCGUGCAGGUAG CAAAGTGCTGTTCGTGCAGGTAG 1446 357 hsa-mir-9-3 UCUUUGGUUAUCUAGCUGUAUGA TCTTTGGTTATCTAGCTGTATGA 1447 364 hsa-mir-99a AACCCGUAGAUCCGAUCUUGUG AACCCGTAGATCCGATCTTGTG 1448 387 hsa-mir-570 AAAGGUAAUUGCAGUUUUUCCC AAAGGTAATTGCAGTTTTTCCCA 1449

TABLE 34 Primers for Reverse Transcription of a subset of novel miRNAs identified by deep sequencing analysis. Temporary SEQ ID Assigned Mature Sequence Primer for Reverse SEQ ID NO. miRNA ID Captured Transcription of miRNA NO.  773 hsa-miR-378c ACUGGACUUGGAGUCAGGA ACTGGACTTGGAGTCAGGA 1450  774 hsa-mir-449c AGGCAGUGUAUUGCUAGCGGCU AGGCAGTGTATTGCTAGCGGCTGT 1451  775 hsa-mir-500-2 UGCACCCAGGCAAGGAUUCUGC TGCACCCAGGCAAGGATTCTGC 1452  784 hsa-mir-2224 UGAGGGAGGAGACUGCA TGAGGGAGGAGACTGCA 1453  785 hsa-mir-2225 ACUGGACUUGGAGCCAGAAG ACTGGACTTGGAGCCAGAAG 1454  786 hsa-mir-2226 GUCACUGAUGUCUGUAGCUGAG GTCACTGATGTCTGTAGCTGAGACGG 1455  787 hsa-mir-2227 GAUGAGGAUGGAUAGCAAGGAA GATGAGGATGGATAGCAAGGAAG 1456  789 hsa-mir-2229 AAAAGCAUCAGGAAGUACCCA AAAAGCATCAGGAAGTACCCA 1457  796 hsa-mir-2235 GUCAAAUGAAGGGCUGAUCACG GTCAAATGAAGGGCTGATCACGAAATA 1458  798 hsa-mir-2237 AGAGUUAACUCAAAAUGGACUA AGAGTTAACTCAAAATGGACTA 1459  799 hsa-mir-2238 UGUUGGGAUUCAGCAGGACCAU TGTTGGGATTCAGCAGGACCATT 1460  800 hsa-mir-2239 UAAAUAGAGUAGGCAAAGGACA TAAATAGAGTAGGCAAAGGACA 1461  805 hsa-mir-2244 AAGAGGAAGAAAUGGCUGGUUC AAGAGGAAGAAATGGCTGGTTCTCAG 1462  809 hsa-mir-2248 UAGUGGAUGAUGCACUCUGUGC TAGTGGATGATGCACTCTGTGC 1463  814 hsa-mir-2253 AAAGACUCUGCAAGAUGCCU AAAGACTCTGCAAGATGCCT 1464  816 hsa-mir-2255 AGGAGAAGUAAAGUAGAA AGGAGAAGTAAAGTAGAA 1465  817 hsa-mir-2256 AUGGCCAGAGCUCACACAGAGG ATGGCCAGAGCTCACACAGAGG 1466  819 hsa-mir-2258 AUCAGGGCUUGUGGAAUGGGAA ATCAGGGCTTGTGGAATGGGAAG 1467  820 hsa-mir-2259 AUGGCCAGAGCUCACACAGAGG ATGGCCAGAGCTCACACAGAGG 1468  821 hsa-mir-2260 UGAGGAUAUGGCAGGGAAGGGG TGAGGATATGGCAGGGAAGGGGA 1469  825 hsa-mir-2264 UGGGCUCAGGGUACAAAGGUU TGGGCTCAGGGTACAAAGGTTC 1470  828 hsa-mir-2266-1 GCUGCACCGGAGACUGGGUAA GCTGCACCGGAGACTGGGTAA 1471  829 hsa-mir-2266-2 GCUGCACCGGAGACUGGGUAA GCTGCACCGGAGACTGGGTAA 1472  836 hsa-mir-2272 UGUCGUGGGGCUUGCUGGCUUG TGTCGTGGGGCTTGCTGGCTTG 1473  838 hsa-mir-2274 ACUGGACUUGGAGGCAGAA ACTGGACTTGGAGGCAGAA 1474  841 hsa-mir-2277 UUGGAGGCGUGGGUUUU TTGGAGGCGTGGGTTTT 1475  844 hsa-mir-2280 CUGACUGAAUAGGUAGGGUCAU CTGACTGAATAGGTAGGGTCAT 1476  846 hsa-mir-2282 AGAUUGUUUCUUUUGCCGUGCA AGATTGTTTCTTTTGCCGTGCA 1477  847 hsa-mir-2282* CACGGCAAAAGAAACAAUCCA CACGGCAAAAGAAACAATCCA 1478  848 hsa-mir-2283 CAGGGCUGGCAGUGACAUGGGU CAGGGCTGGCAGTGACATGGGT 1479  849 hsa-mir-2284 GGUGGGGGCUGUUGUUU GGTGGGGGCTGTTGTTT 1480  850 hsa-mir-2285 UGGGGAGGUGUGGAGUCAGCAU TGGGGAGGTGTGGAGTCAGCATG 1481  852 hsa-mir-2287 GGCUCCUUGGUCUAGGGGUA GGCTCCTTGGTCTAGGGGTA 1482  856 hsa-mir-2290 UGGGGAUUUGGAGAAGUGGUGA TGGGGATTTGGAGAAGTGGTGA 1483  857 hsa-mir-2291 AAAAGUGAUUGCAGUGUUUG AAAAGTGATTGCAGTGTTTGCC 1484  860 hsa-mir-2294 UAGGAGCUCAACAGAUGCCUGU TAGGAGCTCAACAGATGCCTGT 1485  861 hsa-mir-2295 AGCUUUUGGGAAUUCAGGUAG AGCTTTTGGGAATTCAGGTAG 1486  864 hsa-mir-2298 CAAAAGUGAUCGUGGUUUUUG CAAAAGTGATCGTGGTTTTTG 1487  865 hsa-mir-2299 AGGGUGUGUGUGUUUUU AGGGTGTGTGTGTTTTT 1488  871 hsa-mir-2305 ACUGACAGGAGAGCAUUUUGA ACTGACAGGAGAGCATTTTGA 1489  874 hsa-mir-2308 AUAGUGGUUGUGAAUUUACCUU ATAGTGGTTGTGAATTTACCTTC 1490  876 hsa-mir-2310 CUACCCCAGGAUGCCAGCAUAG CTACCCCAGGATGCCAGCATAGTT 1491  877 hsa-mir-2311 ACUGGACUUGGUGUCAGAUGG ACTGGACTTGGTGTCAGATGG 1492  880 hsa-mir-2314 UAGUGGAUGAUGGAGACUCGGU TAGTGGATGATGGAGACTCGGT 1493  888 hsa-mir-2322 AAGGUUUGGAUAGAUGCAAUA AAGGTTTGGATAGATGCAATA 1494  889 hsa-mir-2323 AAAGGUAAUUGCAGUUUUUCCC AAAGGTAATTGCAGTTTTTCCCA 1495  890 hsa-mir-2324 AGGGGACCAAAGAGAUAUAUAG AGGGGACCAAAGAGATATATAG 1496  896 hsa-mir-2328 GGCGACAAAACGAGACCCUGU GGCGACAAAACGAGACCCTGTC 1497  897 hsa-mir-2329 GGGUGCGGGCCGGCGGGG GGGTGCGGGCCGGCGGGGT 1498  899 hsa-mir-2331 CAUGCUAGGAUAGAAAGAAUGG CATGCTAGGATAGAAAGAATGG 1499  901 hsa-mir-2333 GCAAAGUGAUGAGUAAUACUGG GCAAAGTGATGAGTAATACTGG 1500  915 hsa-mir-2346 CCCUGGGGUUCUGAGGACAUG CCCTGGGGTTCTGAGGACATG 1501  917 hsa-mir-2348 CAGGAAGGAUUUAGGGACAGGC CAGGAAGGATTTAGGGACAGGC 1502  919 hsa-mir-2350 AUUAAGGACAUUUGUGAUUGAU ATTAAGGACATTTGTGATTGAT 1503  920 hsa-mir-2351-1 AAAAGGCAUAAAACCAAGACA AAAAGGCATAAAACCAAGACA 1504  921 hsa-mir-2351-2 AAAAGGCAUAAAACCAAGACA AAAAGGCATAAAACCAAGACA 1505  924 hsa-mir-2354-1 UAAAAACUGCAAUUACUUUC TAAAAACTGCAATTACTTTC 1506  926 hsa-mir-2355-1 UGUGAUAUCAUGGUUCCUGGGA TGTGATATCATGGTTCCTGGGA 1507  929 hsa-mir-2355-2 UGUGAUAUCAUGGUUCCUGGGA TGTGATATCATGGTTCCTGGGA 1508  931 hsa-mir-2355-3 UGUGAUAUCAUGGUUCCUGGGA TGTGATATCATGGTTCCTGGGA 1509  932 hsa-mir-2355b UGUGAUAUCGUGCUUCCUGGGA TGTGATATCGTGCTTCCTGGGA 1510  936 hsa-mir-2358 AAAAGUAACUGCGGUUUUUGA AAAAGTAACTGCGGTTTTTGA 1511  938 hsa-mir-2360 GGAGUGGGCUGGUGGUU GGAGTGGGCTGGTGGTT 1512  940 hsa-mir-2362-1 AAGGGCUUCCUCUCUGCAGGAC AAGGGCTTCCTCTCTGCAGGAC 1513  941 hsa-mir-2362-2 AAGGGCUUCCUCUCUGCAGGAC AAGGGCTTCCTCTCTGCAGGAC 1514  949 hsa-mir-2370 AGAGCUGGCUGAAGGGCAG AGAGCTGGCTGAAGGGCAG 1515  953 hsa-mir-2374 UGUGACUUUAAGGGAAAUGGCG TGTGACTTTAAGGGAAATGGCG 1516  954 hsa-mir-2375 UCUCAGGAGUAAAGACAGAGUU TCTCAGGAGTAAAGACAGAGTT 1517  955 hsa-mir-2376 AGGUGGAUGCAAUGUGACCUCA AGGTGGATGCAATGTGACCTCA 1518  977 hsa-mir-2397 AGGCUGGGCUGGGACGGA AGGCTGGGCTGGGACGGA 1519  979 hsa-mir-2399 UAGGAUGGGGGUGAGAGGUG TAGGATGGGGGTGAGAGGTG 1520  988 hsa-mir-2406 UGAGGGAGUAGGAUGUAUGGUU TGAGGGAGTAGGATGTATGGTT 1521  991 hsa-mir-2409 AGACUGACGGCUGGAGGCCCAU AGACTGACGGCTGGAGGCCCAT 1522  994 hsa-mir-2412 UAGUGAGUUAGAGAUGCAGAGC TAGTGAGTTAGAGATGCAGAGC 1523  996 hsa-mir-2414 GGGAGAAGGGUCGGGGC GGGAGAAGGGTCGGGGC 1524 1002 hsa-mir-2416 CUCGUGGGCUCUGGCCACGGC CTCGTGGGCTCTGGCCACGGCC 1525 1003 hsa-mir-2417-1 AGAAGGGGUGAAAUUUAAACGU AGAAGGGGTGAAATTTAAACGT 1526 1004 hsa-mir-2417-2 AGAAGGGGUGAAAUUUAAACGU AGAAGGGGTGAAATTTAAACGT 1527 1005 hsa-mir-2417-3 AGAAGGGGUGAAAUUUAAACGU AGAAGGGGTGAAATTTAAACGT 1528 1007 hsa-mir-2419 GCUCAGGGAUGAUAACUGUGCUGAGA GCTCAGGGATGATAACTGTGCTGAGA 1529 1011 hsa-mir-2423 CUGGACUGAGCCAUGCUACUGG CTGGACTGAGCCATGCTACTGG 1530 1017 hsa-mir-2428 AUAGCAGCAUGAACCUGUCUCA ATAGCAGCATGAACCTGTCTCA 1531 1018 hsa-mir-2428* UGAGACAGGCUUAUGCUGCUAU TGAGACAGGCTTATGCTGCTAT 1532 1022 hsa-mir-2432 UGGUCUGCAAAGAGAUGACUGU TGGTCTGCAAAGAGATGACTGTG 1533 1025 hsa-mir-2435 UUGGAGGGUGUGGAAGACAUC TTGGAGGGTGTGGAAGACATC 1534 1027 hsa-mir-2437 AUGGAGAAGGCUUCUGA ATGGAGAAGGCTTCTGA 1535 1028 hsa-mir-2438 AAAAGCUGGGUUGAGAA AAAAGCTGGGTTGAGAAG 1536 1029 hsa-mir-2439 UGGAAGGUAGACGGCCAGAGAG TGGAAGGTAGACGGCCAGAGAG 1537 1030 hsa-mir-2440 UCUGGGAGGUUGUAGCAGUGGA TCTGGGAGGTTGTAGCAGTGGA 1538 1036 hsa-mir-2445 GGAGGAACCUUGGAGCUUCGGC GGAGGAACCTTGGAGCTTCGGCA 1539 1038 hsa-mir-2447 ACUGGACUAGGAGUCAGAAGG ACTGGACTAGGAGTCAGAAGG 1540 1041 hsa-mir-2450 CAAAAACUGCAGUUACUUUUGU CAAAAACTGCAGTTACTTTTGT 1541 1046 hsa-mir-2455 AAAAGGCAUUGUGGUUUUUG AAAAGGCATTGTGGTTTTTG 1542

TABLE 35 miRNAs that differentiate ABC DLBCL vs. GCB DLBCL FoldChange pVal ABC vs. ABC vs. MicroRNA GCB GCB UGGUCUGCAAAGAGAUGACUGUG −4.30138 0.001335 (SEQ ID NO. 1565) CAAAAACUGCAGUUACUUUUGU −3.52085 0.022949 (SEQ ID NO. 1041) UGGGGAUUUGGAGAAGUGGUGA −2.8374 0.000753 (SEQ ID NO. 856) hsa-miR-129-3p −2.48708 7.39E−05 ACUGGACUUGGUGUCAGAUGG −1.3712 0.01173 (SEQ ID NO. 877) hsa-miR-196b −1.28463 0.032606 hsa-miR-9 −1.00737 0.003176 hsa-miR-28-5p −0.82319 0.00026 hsa-miR-365 −0.78573 0.032749 hsa-miR-185 −0.75345 0.044082 hsa-miR-199b-3p −0.74898 0.015518 hsa-miR-152 −0.67388 0.001282 hsa-miR-23a −0.65979 0.028732 hsa-miR-193a-5p −0.54233 0.031154 hsa-miR-27a −0.49729 0.027207 hsa-miR-331-3p −0.47573 0.0128 hsa-miR-301a −0.45261 0.014231 hsa-miR-128 −0.4224 0.024065 AGAUUGUUUCUUUUGCCGUGCA 0.557435 0.02141 (SEQ ID NO. 846) hsa-miR-625 0.747299 0.01813 hsa-miR-155 0.781901 0.024175 hsa-miR-20b 0.986918 0.000746 GGCUCCUUGGUCUAGGGGUA 1.945372 0.002596 (SEQ ID NO. 852) UAGUGAGUUAGAGAUGCAGAGC 2.347695 0.009081 (SEQ ID NO. 994) CAGGAAGGAUUUAGGGACAGGC 2.519326 0.04483 (SEQ ID NO. 917) *The 3′-end G of SEQ ID NO. 1565 is optionally omitted (providing SEQ ID NO. 1022).

APPENDIX A Average expression of the genes depicted in FIG. 6* Naive vs Germinal Center Germinal Center Germinal Center vs Plasma vs Memory Naive GC GC PC GC Memory ID Gene Name Average Average average Average Average Average 1 VPS37B 10.60 4.58 4.58 9.71 2 SCN3A 9.50 3.98 3 NT5E 10.76 5.69 4 TBC1D9 12.03 7.03 7.03 11.19 7.03 12.88 5 MAP7 1.64 8.03 6 SPRY1 10.40 5.72 7 TNFSF12 8.11 3.54 3.54 7.55 8 SOCS3 9.00 4.48 4.48 9.39 9 EDG1 11.43 6.91 6.91 8.69 10 CTGF 7.62 3.30 3.30 9.65 11 FAM46A 10.65 6.46 6.46 8.29 12 MOBKL2B 11.63 7.45 13 DNMT3A 10.56 6.44 6.44 7.85 14 BHLHB2 10.75 6.64 6.64 10.96 15 LAMC1 9.85 5.80 5.80 9.67 16 CD69 13.27 9.40 9.40 12.27 17 PLEKHA1 10.95 7.20 18 PTGDR 7.20 3.46 19 TXNIP 14.89 11.20 11.20 13.39 11.20 15.10 20 SIDT1 11.52 7.86 7.86 9.38 21 LY6E 8.57 4.92 4.92 7.39 22 IGF1R 8.73 5.13 23 PRICKLE1 11.68 8.09 8.09 9.69 24 CSDA 12.12 8.59 8.59 10.10 25 KLF2 12.61 9.10 9.10 11.70 26 ELOVL2 7.32 3.86 27 CCND2 12.06 8.61 8.61 11.53 28 LASS6 10.29 6.86 6.86 9.42 6.86 9.48 29 DUSP6 11.93 8.53 8.53 10.19 30 CUGBP2 14.28 10.93 10.93 14.29 31 PTPRO 9.64 6.32 6.32 8.63 32 PHF16 10.33 7.04 33 NR3C2 8.85 5.58 34 CRTC3 12.56 9.32 9.32 11.11 35 ADAMTS6 7.68 4.45 36 ETV6 10.36 7.14 7.14 8.89 7.14 10.43 37 LRRC17 3.10 7.49 38 FAM46C 12.18 8.98 8.98 14.76 8.98 10.54 39 SATB2 7.20 4.02 4.02 7.60 40 RNF125 9.00 5.83 41 ST6GALNAC3 8.12 4.96 42 LARGE 9.05 5.89 5.89 8.73 43 ZNF276 9.39 6.25 44 KCNA3 4.83 9.82 45 BCL2 10.89 7.76 7.76 11.41 46 MTSS1 12.92 9.82 9.82 12.05 47 NR6A1 9.10 6.03 6.03 7.62 48 BHLHB3 11.11 8.05 8.05 13.26 8.05 13.26 49 MYO10 7.22 4.19 50 ITM2C 6.44 13.85 51 C18orf1 9.49 6.47 6.47 8.63 52 FXYD7 7.36 4.35 53 DUSP8 7.96 4.96 4.96 8.41 4.96 7.75 54 BTBD3 7.41 4.42 55 TMEPAI 11.15 8.20 8.20 11.03 56 ANTXR2 9.90 6.97 57 FOSB 10.13 7.21 7.21 11.05 58 TMCC3 8.23 5.31 5.31 7.09 5.31 8.05 59 ARL4C 11.31 8.41 8.41 10.32 60 ZMYND11 11.33 8.43 8.43 11.34 8.43 11.68 61 RHOBTB1 7.33 4.48 62 JUN 12.14 9.34 9.34 12.70 63 SKI 10.46 7.67 7.67 10.68 64 TMEM121 7.07 4.29 65 IL13RA1 8.99 6.21 66 KIF13B 6.23 9.01 67 BHLHB5 4.26 7.39 68 PGM2L1 10.35 7.65 69 C14orf4 12.11 9.47 9.47 11.01 9.47 11.65 70 PDE4B 12.38 9.74 9.74 11.60 71 PDE7B 8.64 6.03 72 BCL9L 9.37 6.77 6.77 8.61 73 PCDH9 10.32 7.73 74 ARHGAP5 10.44 7.86 7.86 9.11 7.86 9.85 75 KIAA0802 9.18 6.61 6.61 7.91 6.61 7.89 76 ITGB4 7.48 4.91 77 NOTCH2NL 7.17 8.95 78 CDC42BPA 7.32 4.77 79 SPG20 9.25 6.73 80 KLF4 10.04 7.57 7.57 9.09 81 AHNAK 9.34 6.87 6.87 9.56 6.87 11.51 82 FCHSD1 9.15 6.69 83 KIAA1622 3.94 7.67 84 PLXNC1 10.92 8.48 85 TMEM150 8.39 5.96 86 ACVR2A 7.81 5.38 5.38 8.63 5.38 7.40 87 KALRN 5.61 7.64 88 ANK2 7.69 5.28 5.28 7.54 5.28 7.00 89 FLJ14213 7.61 5.21 5.21 7.97 90 CHPT1 10.92 8.52 91 TCF2 5.69 7.82 92 FGF5 5.41 7.52 93 SLC12A6 12.18 9.80 9.80 11.09 94 MGC17330 11.53 9.16 95 NR4A2 10.21 7.85 7.85 9.21 7.85 10.54 96 SLC39A10 11.06 8.70 97 LITAF 12.52 10.18 10.18 11.82 98 AKT3 9.32 6.99 6.99 9.25 99 PDCD4 12.89 10.57 10.57 13.33 100 STMN3 10.03 7.72 101 SIDT2 13.13 10.85 102 GRIA3 7.04 4.77 103 EML4 12.83 10.57 104 DIP2B 11.26 8.99 8.99 10.77 105 FBN1 4.89 8.17 106 FAM84B 9.21 6.96 107 EGR3 11.59 9.35 9.35 8.24 9.35 10.62 108 CTHRC1 4.25 11.94 109 RRAGD 7.69 5.46 110 MACF1 12.88 10.66 111 FOXF2 7.05 4.83 112 GAB1 8.01 5.81 5.81 10.91 113 ST18 4.42 7.40 114 ZFP36L2 13.78 11.59 11.59 13.43 11.59 14.05 115 GAB2 8.29 6.12 6.12 9.02 116 CHST11 11.17 8.99 8.99 10.28 117 CLOCK 9.85 7.68 7.68 9.91 7.68 9.62 118 PREX1 10.07 7.90 7.90 11.16 119 KLF11 8.08 5.94 5.94 8.39 120 PTGER4 11.66 9.53 121 KLF9 9.47 7.34 7.34 9.27 122 FLJ37078 7.55 5.42 5.42 7.49 123 ODZ2 7.20 5.08 5.08 7.25 5.08 7.22 124 SESN3 11.24 9.11 9.11 7.60 125 PDK4 7.22 5.09 126 CNTNAP3 7.35 5.23 5.23 7.10 127 DUSP1 13.34 11.22 128 MARCKS 11.19 9.07 9.07 11.05 9.07 12.21 129 SPRY4 7.02 4.91 130 LMO1 4.75 7.16 131 MTUS1 7.77 5.66 5.66 8.16 132 ADCY9 8.01 5.91 5.91 7.74 133 SLC17A6 3.80 7.06 134 NOX4 7.45 5.37 5.37 7.22 135 UTRN 9.46 10.97 136 ZBTB10 8.50 6.45 137 SLC26A7 8.37 6.32 6.32 7.89 138 PNRC1 13.14 11.09 139 LLGL2 6.83 9.29 140 CHST1 7.15 5.12 141 CREB3L2 10.53 8.51 8.51 13.30 142 DDIT4 12.69 10.68 143 C20orf108 8.82 6.80 6.80 10.19 144 CDH1 3.85 10.26 145 TFAP4 7.28 5.29 146 SLC38A2 13.57 11.58 11.58 13.74 11.58 13.17 147 SESN1 9.84 7.87 7.87 9.13 148 YPEL2 10.18 8.20 8.20 10.04 149 GRASP 8.47 6.50 150 TSC22D3 13.22 11.26 11.26 12.67 151 ATP11A 9.70 7.75 7.75 9.50 152 L3MBTL3 10.61 8.66 8.66 10.06 153 SORT1 7.61 5.67 5.67 8.11 154 CAV1 4.80 9.11 155 RXRA 9.07 7.15 7.15 8.81 156 CRELD1 8.40 6.48 6.48 8.26 157 RBMS1 12.40 10.49 10.49 8.80 158 LYST 10.90 8.99 159 PIP5K1B 9.61 7.70 7.70 9.97 160 JUNB 11.62 9.72 161 MBOAT1 4.80 7.27 162 IRF4 11.16 9.28 9.28 13.66 163 LIFR 4.62 7.08 164 MORC3 11.25 9.37 165 MBP 11.91 10.05 10.05 8.61 166 SRC 4.98 7.98 167 ALS2CR13 11.79 9.93 9.93 8.89 9.93 11.47 168 MYH1 4.40 7.37 169 DUSP3 9.36 7.50 7.50 9.16 170 HLX1 7.14 5.28 5.28 7.65 171 CDKN1A 9.09 7.23 7.23 8.97 7.23 8.43 172 SOCS5 10.00 8.15 173 PPP1R9A 5.14 7.35 174 TGFBR2 12.81 10.99 10.99 12.63 175 LRRC16 8.47 6.66 176 ZNF629 8.17 6.35 6.35 8.58 177 RPS6KA5 11.75 9.95 9.95 11.48 178 SATB1 12.79 10.99 10.99 9.06 179 SEMA4C 7.38 5.59 5.59 8.49 5.59 7.14 180 ULK1 7.79 5.99 5.99 8.72 5.99 8.06 181 STX3 8.88 7.09 7.09 8.91 182 BAMBI 4.81 7.26 183 MAP3K5 10.63 8.84 8.84 7.66 8.84 10.71 184 KIAA1147 11.70 9.91 9.91 11.53 185 SBK1 5.20 7.04 186 RYR3 7.80 6.02 6.02 8.27 187 ZNF238 13.05 11.27 11.27 10.08 11.27 12.54 188 IL12A 5.65 7.26 189 SLC2A3 12.00 10.23 10.23 11.89 190 GFPT2 3.39 7.18 191 G0S2 7.72 5.96 192 LYRM5 10.29 8.53 8.53 10.93 193 SSH2 11.67 9.91 9.91 11.85 194 NRP1 7.44 5.69 5.69 7.22 195 LMLN 8.92 7.19 196 UCP3 7.71 5.99 197 TMEM166 7.31 5.60 198 CACNA1I 7.46 5.76 5.76 7.06 199 PHOSPHO1 3.55 7.10 200 CRIM1 9.79 8.11 8.11 9.32 201 GATA6 5.41 7.59 202 SACS 10.06 8.39 8.39 10.54 203 CDKN1B 12.91 11.24 11.24 14.41 204 CACNA2D2 5.25 7.57 5.25 7.93 205 MKRN3 3.65 7.10 206 MTFR1 10.40 8.74 8.74 7.34 8.74 10.15 207 GALNT3 10.19 8.54 208 RPS6KA3 12.07 10.42 10.42 11.48 209 DTNA 5.47 7.86 210 MAGI2 7.04 5.40 5.40 7.42 211 FOXJ2 10.01 8.38 8.38 9.97 8.38 9.85 212 KIAA0513 5.29 8.44 5.29 7.36 213 NDRG1 7.75 10.02 214 AKAP7 10.16 8.54 215 CD72 13.74 12.12 216 IGFBP5 7.30 5.69 5.69 7.59 217 REPS2 7.51 5.92 5.92 7.60 218 PRDM12 7.17 5.57 219 ZNF3 8.86 7.27 7.27 8.75 220 TLL2 4.88 7.01 221 PCNX 9.77 8.19 222 ARHGAP24 11.31 9.73 9.73 8.65 9.73 11.32 223 THRAP2 11.31 9.73 224 RNF11 9.72 8.15 8.15 11.08 225 HOXC8 7.05 5.48 226 SCML2 10.33 8.76 227 BMPR2 9.70 8.14 8.14 10.06 228 STAC 5.27 7.20 229 C10orf54 9.12 7.56 7.56 10.16 230 FBXL17 9.51 7.95 7.95 9.36 231 CBX7 10.87 9.32 9.32 10.96 232 UBE2W 9.80 8.25 8.25 9.76 8.25 9.38 233 ProSAPiP1 4.12 7.54 234 UBL3 10.73 9.18 9.18 11.27 9.18 11.03 235 TTYH3 7.35 5.81 5.81 8.16 236 PUNC 5.39 8.85 5.39 7.30 237 GDF11 7.01 5.47 5.47 7.70 238 LMX1A 5.25 7.43 239 TIMP2 7.51 5.97 5.97 7.69 5.97 7.40 240 NHLH2 3.93 7.35 241 CLCF1 10.50 8.98 242 ITGB3 7.66 6.14 243 TMEM132E 3.93 7.20 244 KCTD17 7.45 5.94 5.94 7.33 245 ChGn 7.75 6.24 6.24 8.36 246 DIP2C 9.25 7.75 247 DKFZp667G2110 8.79 7.28 7.28 9.25 248 CSNK1G3 10.84 9.34 9.34 10.70 249 NRIP1 11.79 10.30 250 SMAD3 10.72 9.23 9.23 7.74 9.23 10.54 251 SHOX2 7.05 5.57 252 LDLRAP1 6.80 9.84 6.80 8.59 253 SUPT3H 7.77 6.30 6.30 8.05 254 KCNN2 7.18 5.70 255 DLL1 7.37 5.90 256 CEND1 7.72 6.26 257 NOTCH1 10.90 9.45 258 TLE1 7.74 9.63 259 FCHO2 8.75 7.30 260 JPH4 7.12 5.67 5.67 7.60 261 KCNMB2 7.16 5.72 262 KHDRBS2 7.17 5.73 263 LEFTY1 4.38 7.21 264 ST3GAL5 10.59 9.15 265 LGR4 5.30 7.29 266 FNDC8 4.25 8.01 267 NPTXR 5.87 7.65 268 PRICKLE2 5.47 7.47 269 GRIA4 5.19 7.04 270 RHOB 8.66 7.23 7.23 9.56 271 ZADH2 8.65 7.22 272 ZBTB41 9.73 8.31 8.31 9.42 273 GPRASP2 6.00 7.35 274 SYS1 10.79 9.36 275 RUNX1T1 7.37 5.95 276 DLX2 4.66 7.04 277 SLC30A7 11.58 10.17 278 PER1 8.82 7.40 279 NT5C3 12.67 11.25 280 PDE3A 11.62 10.21 281 OCRL 8.07 6.66 6.66 8.04 282 PSD3 7.99 6.60 283 LPHN1 7.80 6.41 284 TNRC6B 11.87 10.48 10.48 11.77 285 SNN 12.03 10.64 10.64 8.91 10.64 12.10 286 HERPUD2 11.56 10.18 287 UBQLNL 7.45 6.07 288 HES7 7.37 5.99 289 GALNT2 10.08 8.69 8.69 10.63 290 CAMKK1 8.45 7.07 291 ELN 5.44 7.18 292 ICK 8.09 6.72 6.72 8.01 293 POU4F2 7.09 5.72 5.72 7.21 294 GAS2 7.13 5.76 5.76 7.81 295 ARHGEF3 10.11 8.75 8.75 11.04 296 ZBTB4 11.45 10.09 10.09 11.78 297 CHD7 12.14 10.78 10.78 12.08 298 TMEM45B 5.97 7.61 299 CLDN11 5.74 7.22 300 PTPN1 10.85 9.51 301 PHF20 12.00 10.67 302 VAV3 10.44 7.84 303 CARKL 8.38 7.06 7.06 8.94 304 TRIM36 5.43 7.77 305 CTLA4 6.57 7.95 306 POLK 9.69 8.38 8.38 10.55 307 WSB1 13.22 11.91 11.91 13.02 308 ALS2CR2 9.87 8.57 8.57 10.14 309 PLK2 4.94 7.13 310 SRPK2 10.83 9.53 9.53 11.13 311 ARRDC2 10.86 9.55 312 IER5 13.10 11.80 313 EPN1 8.95 7.66 7.66 9.07 314 SLC20A2 9.45 8.16 315 DLG4 4.23 7.22 316 TMTC2 6.16 7.92 317 ETV1 8.19 6.90 318 JAZF1 11.93 10.65 10.65 7.49 319 VAV2 10.22 8.94 320 C15orf27 7.19 5.91 321 FYCO1 9.75 8.47 322 KIAA0789 7.27 6.00 323 OBFC2A 9.94 8.66 8.66 10.94 324 MCF2 7.19 5.92 325 KIAA2018 11.77 10.50 10.50 9.50 326 MTMR10 10.75 9.48 327 FAM63B 6.03 7.83 6.03 7.95 328 SNF1LK 10.20 8.93 8.93 10.18 329 ZNF385 8.89 7.63 330 SESTD1 11.05 9.78 331 SLC31A2 5.41 9.13 332 PCMTD1 12.03 10.76 10.76 12.44 333 NBEA 8.06 6.81 6.81 8.02 6.81 8.35 334 ZNF295 9.24 10.61 335 SIPA1L3 10.81 9.57 336 CC2D1B 9.11 7.87 337 PRKAG2 7.12 8.42 338 PKD1 9.04 7.81 339 CNTNAP2 7.54 6.32 340 FNBP1L 7.90 6.67 341 HEXIM1 10.27 9.05 9.05 10.24 342 C19orf2 12.29 11.07 343 MYLIP 11.62 10.41 10.41 11.81 344 SLC11A2 9.27 8.06 345 CLU 9.92 8.71 346 GCN5L2 10.18 8.97 347 DKFZP564J0863 10.85 9.65 9.65 11.11 348 CNNM2 7.85 6.64 6.64 8.07 349 CDC42SE1 12.07 10.87 10.87 12.18 350 HOXB9 6.20 8.41 351 NFATC3 11.39 10.19 352 UNC84B 11.12 9.93 9.93 8.59 353 DUSP5 6.23 9.44 354 ING1 11.35 10.17 355 ITM2B 11.23 13.62 356 FAM53B 11.67 10.49 357 ZFP36L1 14.07 12.89 12.89 10.09 358 NIPA1 9.75 8.57 8.57 10.07 359 GALNT1 10.93 9.76 9.76 11.12 360 MYPN 4.25 7.32 361 ITPK1 10.03 8.86 362 TTYH2 7.90 6.73 363 DOCK10 10.80 9.63 9.63 11.53 364 C14orf28 9.18 8.01 8.01 9.58 8.01 9.50 365 RP11-130N24.1 4.76 7.62 366 FGF12 5.82 7.33 367 ATP2B2 7.93 6.76 368 PPP1R9B 9.77 8.60 369 PPP3CA 13.50 12.33 12.33 13.86 370 TFAP2A 5.54 8.26 371 CYLD 10.91 9.75 372 PHF1 11.85 10.69 10.69 12.26 373 NEBL 7.98 6.82 6.82 8.08 374 ACIN1 12.04 10.89 10.89 11.99 375 SPTBN1 12.28 11.14 11.14 12.53 11.14 12.42 376 VAMP4 10.81 9.67 9.67 11.18 377 DNAJB9 10.80 9.66 9.66 15.21 9.66 11.03 378 ZDHHC2 11.55 10.42 379 TRIO 10.57 9.43 380 TMEM25 6.24 8.57 381 TAF9B 10.82 9.69 382 ARID3A 8.03 6.90 6.90 9.81 383 KIAA0182 10.68 9.55 384 RPS6KA2 8.61 7.49 385 C3orf58 11.47 10.34 386 CAST 11.94 10.82 387 SH3PXD2A 8.46 7.34 388 RAB6B 5.93 7.36 389 RNF141 11.47 10.35 390 SP4 11.26 10.14 391 ARMCX2 9.44 8.32 8.32 9.54 392 ZNF398 10.39 9.28 393 PBX3 9.69 8.58 8.58 7.00 394 FOS 12.35 11.25 11.25 13.34 395 FHOD3 6.40 7.94 396 C20orf59 10.11 9.01 9.01 10.92 397 FAM117A 11.67 10.57 10.57 12.06 10.57 11.64 398 ATP8B2 8.58 7.49 7.49 10.87 7.49 8.88 399 UXS1 9.53 8.43 400 GOLGA8A 12.84 11.74 11.74 13.14 11.74 13.05 401 SUFU 6.03 7.84 402 NAGPA 9.32 8.23 403 MLLT6 11.70 10.61 404 CPEB4 9.46 8.36 8.36 12.21 405 TMEM50B 10.67 9.58 9.58 11.41 9.58 10.63 406 AMPD3 11.65 10.56 10.56 8.76 407 SIX5 5.19 7.53 408 MMP16 5.66 7.47 409 LBH 11.87 10.79 10.79 8.83 410 POM121 9.60 11.26 411 ATP8B1 11.93 10.86 10.86 8.88 412 ARHGAP29 3.75 7.60 413 ZNF395 11.78 10.76 414 CRY2 6.50 8.01 415 BIN1 10.68 9.67 416 PSAP 11.24 13.41 11.24 12.71 417 ISL1 5.91 7.60 418 DNAJB5 8.04 6.97 419 KIAA0284 6.42 8.79 420 RBM35B 11.44 10.38 421 ADCY7 11.53 10.47 422 ARRDC3 9.46 10.68 423 MICAL1 11.72 10.67 424 MTHFR 10.31 9.26 425 HOOK3 8.57 7.53 7.53 6.52 426 EFNB3 5.16 7.79 427 ARHGAP12 9.86 8.82 428 LMBR1L 9.33 8.29 429 FGF7 5.88 7.86 430 USP2 5.50 7.52 431 SMARCA2 11.14 10.12 432 ELL2 8.23 13.60 433 C1orf26 7.06 10.01 434 CXCR4 14.61 13.45 435 HDGFRP3 5.58 7.39 436 BNC2 6.18 7.72 437 YPEL3 10.16 11.81 10.16 11.47 438 PPFIA3 4.58 8.06 439 DLGAP4 9.34 10.68 440 ZBTB7A 9.84 11.10 441 D4S234E 5.90 7.38 442 FNDC3A 9.41 13.60 443 FOXC1 5.84 7.39 444 KIF26B 5.55 7.30 445 NAV2 6.26 7.90 446 DDX3Y 8.07 10.38 447 FGD1 7.31 6.06 448 HTR4 7.26 9.01 7.26 8.40 449 C22orf31 5.67 8.10 450 RNF44 11.48 10.14 451 GALNAC4S-6ST 10.43 12.71 452 CCNT2 10.15 11.23 453 CHIC1 8.91 10.02 454 NNAT 5.97 8.19 5.97 7.84 455 CTDP1 6.81 8.26 456 BTG1 14.95 13.94 457 CMTM4 5.27 7.81 458 GOLGA8B 11.37 12.63 459 HBP1 10.07 12.13 460 GDPD1 6.35 7.61 461 CDYL 9.31 10.61 9.31 10.50 462 ZNF217 10.77 9.73 463 KIF5A 6.13 7.75 464 C1QL1 5.80 8.11 465 SOLH 7.88 9.03 466 ZC3H6 9.81 10.96 467 LATS2 7.61 10.19 468 COL18A1 6.46 7.85 469 C11orf24 9.89 11.07 470 SCUBE3 6.14 7.88 471 SEMA4G 5.57 7.81 472 FOXP1 12.31 10.84 473 TRIB2 10.62 9.61 474 LOC285382 5.35 7.20 475 RUNX2 7.91 10.22 476 LOC196463 4.16 7.52 477 LPGAT1 10.57 7.99 478 RASSF2 12.52 10.93 479 IRF1 9.86 11.60 480 RAB40B 7.31 10.89 481 CTDSPL 6.37 7.83 482 CLCN4 7.44 6.39 483 CACNB1 6.41 8.20 484 SYNGR1 8.45 10.40 485 ST8SLA4 10.67 11.81 486 PLD3 7.63 10.59 487 FOXO3A 10.17 12.41 488 TSPAN33 10.49 9.38 489 HIST1H4F 6.20 8.08 490 LAPTM4A 12.05 13.06 491 PRKCB1 12.14 10.50 492 PROX1 6.38 7.89 493 CDK5R1 10.12 7.78 494 MAP3K9 7.96 9.13 495 GPX3 5.92 7.61 496 GNS 8.79 11.06 497 ARL15 8.27 6.51 498 OXR1 9.21 11.17 9.21 10.25 499 AAK1 7.38 9.54 7.38 8.47 500 SH3PX3 6.72 8.58 501 MS4A7 10.55 8.35 502 FLJ20273 5.96 11.23 5.96 8.65 503 ISCU 12.01 13.55 504 ITGA2 5.70 7.60 505 ME1 5.87 7.89 506 LRP1 4.92 7.04 507 ZNF652 9.66 10.81 508 TRAK1 11.07 9.85 509 SLC8A1 6.27 7.83 510 C1orf119 10.76 11.98 511 KLF6 11.33 9.24 11.33 12.40 512 TRIM2 6.22 8.20 513 USP3 11.11 12.51 514 ARID5B 11.02 12.48 515 RASD1 6.15 9.32 516 ZCCHC2 10.63 8.93 517 LEFTY2 5.08 7.03 518 BACH1 9.97 11.76 519 IRAK1 11.48 12.80 520 RP11-217H1.1 10.76 13.04 521 HLCS 6.54 8.45 522 NAGK 10.94 12.14 523 CELSR2 6.26 7.89 524 PCBP4 7.75 9.08 525 FLJ25476 9.49 10.72 526 TPP1 12.10 11.06 527 ACVR1 7.95 9.31 528 EHD3 8.99 10.35 529 FAM80B 9.35 8.02 530 SPRYD3 8.19 9.51 531 PRDM4 9.81 10.83 532 C6orf134 7.92 5.60 533 HSP90B1 12.04 16.36 534 DYNC1I1 5.98 7.33 535 NFLX 7.43 8.67 536 DOCK4 5.96 7.97 537 ZNF287 7.09 8.47 538 XRN1 10.92 12.37 539 YES1 6.39 8.60 540 RBM35A 8.19 9.44 541 HOXB4 7.58 9.27 542 OTUD7B 7.24 8.57 543 CELSR3 6.83 8.39 544 RHOC 7.71 8.84 545 ZNF607 8.10 6.95 546 XYLT1 10.28 8.78 10.28 8.86 547 FAM89B 9.16 10.75 548 OSBPL8 12.99 11.66 549 SRCRB4D 6.82 8.67 550 RASL12 5.05 8.07 551 NAG8 8.39 9.78 552 MAN1A2 10.83 12.15 553 PPARA 8.59 9.65 554 CLDN12 6.66 8.39 555 ID4 5.93 7.79 556 HECTD2 7.98 6.80 557 EFCAB4A 5.93 8.96 558 CREBL1 6.97 8.09 559 SARM1 6.98 8.29 560 MIDN 8.48 7.29 561 EMB 10.48 8.65 562 FOXK2 8.40 9.63 563 INADL 6.87 8.44 564 KCNAB1 6.26 9.76 565 MAP3K8 10.92 9.60 566 C8orf58 7.89 5.62 567 SLC4A7 9.82 8.52 9.82 10.90 568 RAB8B 12.46 10.92 569 C10orf118 8.93 10.20 570 CRTC2 9.37 7.94 571 KLC2 7.31 9.19 572 SRCAP 8.06 6.96 573 CNTFR 7.15 8.67 574 SPTBN2 4.75 7.11 575 SMAD7 8.69 9.93 576 NDFIP1 9.10 10.95 577 BCL11A 14.03 10.63 578 SFXN5 7.26 8.87 579 RIMBP2 5.93 8.33 580 FUT8 8.62 11.08 581 PSEN2 5.86 9.17 582 MAP6 5.22 7.37 583 FOXO1A 11.53 10.14 584 BTG2 11.81 13.82 585 C10orf56 6.93 9.30 586 MAPK1 12.06 10.36 587 ZBTB47 6.63 8.12 588 GOSR2 9.73 11.07 589 ZFP90 10.15 8.92 590 RALGPS1 8.02 9.38 591 DGKI 4.77 7.39 592 RGL2 11.08 9.55 593 PAK6 5.90 8.55 594 DMXL1 11.85 10.31 595 TMEM113 12.28 11.03 596 SNX24 6.75 8.53 597 HOXA3 5.99 8.27 598 SAMD4A 9.84 8.36 599 WDR45 9.88 12.43 600 TLOC1 12.91 14.52 601 LARP2 7.64 11.50 602 DTX2 7.60 6.20 603 ITGA9 7.53 6.32 604 FASTK 10.04 11.22 605 TAOK2 7.47 6.37 606 CRTAP 9.78 11.08 607 SERTAD2 11.91 10.82 608 TBP 10.14 9.09 609 IQGAP2 7.26 11.19 7.26 8.93 610 RASGEF1B 6.23 8.01 611 PIP5K2B 9.69 8.53 612 PRRC1 10.32 11.92 613 RHPN2 6.73 8.21 614 DYRK1B 5.92 7.61 615 ADCY2 5.98 7.97 616 C12orf34 5.61 7.09 617 GMPR 5.35 8.15 618 PAK2 10.86 9.66 619 KIAA1539 8.12 9.49 620 PLAGL1 10.03 6.68 621 LCORL 9.74 11.29 622 BCL9 7.21 9.16 623 CPEB2 9.09 10.23 624 TMEM59 12.10 14.75 625 TRIP10 7.17 9.36 626 CCPG1 8.38 11.86 627 NDE1 10.71 9.30 628 ZDHHC21 9.38 8.11 629 STOX2 5.87 7.66 630 RAB4B 10.63 8.66 631 LRRFIP1 13.25 11.99 632 OSBP 10.10 11.39 633 RAB6A 10.76 12.27 634 RHOV 4.88 7.19 635 SLC39A14 8.80 11.00 636 ADARB1 10.05 7.69 637 ESPN 6.85 8.19 638 SEC31A 11.64 13.61 639 PJA2 10.85 11.99 640 SYNGR3 9.01 7.56 641 LOC339745 11.94 10.54 642 NEDD9 11.23 12.48 643 COL23A1 5.41 7.02 644 PIP5K3 11.93 10.79 645 PTPRG 7.30 8.49 646 DAB2IP 5.61 8.30 647 MAPRE3 5.80 8.60 648 SQSTM1 10.05 11.45 649 RAB6C 10.88 12.04 650 FAM57A 7.58 6.18 651 YPEL5 12.41 13.78 652 TTN 9.61 7.03 653 HTRA3 5.62 8.02 654 CHST2 7.80 12.49 655 BAZ1A 11.43 10.06 656 LRFN5 7.38 6.21 657 MBNL1 14.10 12.62 658 MLL2 10.93 9.89 659 SF1 11.44 10.36 660 FRMPD1 4.80 7.06 661 PPP2R5B 7.60 9.12 662 RNF43 10.04 8.01 663 GAP43 5.07 7.49 664 NOMO1 11.11 14.31 665 VEGFA 7.79 9.36 666 C22orf5 8.75 11.38 667 AKAP11 11.79 10.64 668 INSIG2 9.46 11.32 669 PDIK1L 9.11 10.72 670 TMEM4 10.93 13.32 671 LMNA 7.80 9.75 672 TP53INP1 11.84 14.14 673 NAV1 6.96 8.31 674 SPTY2D1 9.25 10.77 675 CREBL2 9.95 11.10 676 MFAP3L 5.90 7.46 677 REXO2 10.96 13.71 678 SPTBN4 6.77 8.22 679 NOMO2 9.74 12.94 680 PTEN 12.78 11.40 681 FBXL16 6.86 9.56 682 GPM6A 7.87 6.15 7.87 6.67 683 PRX 6.76 8.91 684 HOXC11 6.40 7.88 685 KIAA0329 8.27 9.87 686 PAFAH1B1 11.68 10.33 687 C20orf174 9.58 7.27 688 MTPN 13.87 12.17 689 TMED5 12.25 14.41 690 FURIN 8.03 9.54 691 ELAVL3 4.66 8.01 692 SH2B3 10.31 8.87 693 LIN28B 5.99 7.58 694 KIAA1033 12.65 11.38 695 TMEM28 4.95 7.14 696 TBC1D15 10.30 11.52 697 GOLGA4 10.11 11.71 698 STX1A 5.63 7.82 699 SLC40A1 6.87 8.27 700 KIAA1815 9.18 7.93 701 HNT 5.53 7.09 702 PDE11A 5.72 7.82 703 TGFBR3 7.84 9.52 704 MTF1 9.92 8.86 705 MAN1A1 9.99 13.65 706 THRA 7.26 8.48 707 CBLB 11.46 9.08 708 SLC35F1 6.29 8.16 709 FOXP4 8.52 7.30 710 ELOVL5 13.83 12.78 711 NMUR1 4.13 7.31 712 ITPR1 12.06 9.69 713 CDCA7L 11.95 10.33 714 RASSF1 9.35 10.69 715 IL1RAPL1 6.42 8.18 716 AUH 9.37 11.19 717 DIAPH1 11.52 9.74 718 ENSA 12.33 11.22 719 FAM43A 10.62 9.39 720 CSMD3 4.79 7.58 721 SLC25A37 10.10 8.69 722 SLC33A1 9.78 12.19 723 CNOT6 9.98 8.93 724 GRID1 7.05 8.80 725 C21orf91 11.51 10.18 726 ITPKB 11.28 8.91 727 CP 5.89 7.41 728 HMBOX1 10.05 8.50 729 ARID1A 12.22 11.11 730 C5orf5 11.86 10.38 731 TMSB4X 16.86 15.10 732 EPAS1 7.02 8.39 733 HPS3 11.65 10.16 734 DKK1 6.16 7.86 735 ZNF282 7.89 5.40 736 AP3D1 11.29 12.84 737 DERL1 11.69 13.43 738 C5orf13 9.89 7.62 739 CCNG2 13.32 11.64 740 PGRMC2 9.44 11.38 741 ARF6 13.60 12.55 742 TMEM110 7.75 9.24 743 FAM13A1 7.11 9.69 744 BRMS1L 8.58 10.18 745 TRAM1 12.52 15.17 746 CALU 9.42 11.20 747 GOLPH3 11.55 12.81 748 MAP3K7 11.14 10.06 749 ABCG4 6.90 8.22 750 NELF 8.75 7.70 751 ADIPOR1 9.67 10.92 752 INSR 8.48 11.62 753 GRM5 6.24 7.65 754 TFG 10.76 12.30 755 USP48 11.91 13.09 756 CLCN6 9.26 7.48 757 ZNF219 6.11 8.42 758 C7orf43 8.34 6.62 759 NFKB1 11.90 10.70 760 ARF3 11.11 9.87 761 JMJD1C 12.34 11.11 762 ROD1 13.13 11.42 763 OXSR1 10.69 9.15 764 ERGIC2 10.86 12.81 765 EIF4E3 7.61 9.87 766 SEC24A 10.05 12.85 767 SPRED1 7.19 5.77 768 HNRPH3 12.60 11.38 769 ZDHHC7 10.34 9.05 770 HNRPA1 16.14 15.14 771 TMED2 12.01 14.26 772 VASP 10.60 8.60 773 CHD4 11.40 10.31 774 RTN4RL1 5.48 8.36 775 PPP1R12A 12.03 10.97 776 SGK3 9.58 11.68 777 ARHGAP17 12.37 8.62 778 GORASP2 11.28 13.30 779 C2orf44 8.38 6.72 780 FAM116A 11.12 10.08 781 SSR1 12.75 14.73 782 MYH9 11.24 9.89 783 PIK3CD 12.99 10.03 784 DAZAP2 14.26 13.23 785 SEL1L 10.74 14.04 786 LOC388284 7.05 8.32 787 THRB 7.51 6.11 7.51 6.29 788 MGAT2 11.91 14.44 789 C8orf13 9.35 6.47 790 PDZD2 7.00 4.39 791 DERL2 10.74 12.75 792 ZCCHC5 7.39 6.27 793 NFYC 10.27 9.03 794 GLUD2 8.88 7.58 795 ESR1 7.55 9.88 796 NRP2 6.51 8.13 797 NUS1 10.01 11.53 798 BIRC6 12.15 10.94 799 ARID3B 7.83 9.22 800 STCH 10.16 13.88 801 SLC7A11 6.32 8.00 802 OSBPL5 7.91 9.22 7.91 6.62 803 IGFBP3 5.60 7.61 804 LNPEP 13.72 11.05 805 ZNRF1 8.18 9.68 806 DDAH1 7.96 5.87 807 ERG 4.07 7.49 808 APLP2 10.90 8.38 809 ZNFX1 10.14 8.93 810 GPM6B 8.66 6.69 811 BLCAP 11.49 10.10 812 SRP68 11.47 12.88 813 PIK3AP1 14.12 11.74 814 ANKRD28 11.00 12.46 815 KCNH8 8.27 4.80 816 KIAA0430 12.43 10.61 817 PPP2R1B 9.84 8.41 818 TMED9 11.62 13.82 819 CTNNBIP1 7.31 8.89 820 PPP2R5D 9.51 7.92 821 CBX4 12.36 13.69 822 AKAP6 7.38 5.55 7.38 4.93 823 C2orf30 10.72 13.84 824 DR1 11.97 10.65 825 MTDH 12.46 13.96 826 ETS1 14.40 12.62 827 EPHA8 6.12 8.10 828 ANKRD13B 7.23 5.85 829 C4orf16 8.83 7.70 830 SOX4 9.14 10.20 831 SLC12A2 10.23 9.01 832 IER3IP1 11.35 12.56 833 DST 7.02 8.34 834 WRNIP1 11.03 9.49 835 CLCC1 9.63 11.48 836 B4GALT6 7.90 6.82 837 BTBD10 10.12 8.07 838 SDC1 7.05 12.14 839 C10orf12 10.32 8.40 840 ZDHHC3 9.80 8.78 841 GNAI2 10.86 9.27 842 HNRPU 13.82 12.47 843 GNAZ 8.86 7.26 844 ALG9 8.93 10.97 845 FBXL10 11.75 10.43 846 ARID4B 12.19 10.96 847 PPP1R3F 6.19 7.79 848 EPB49 6.49 7.94 849 PCNP 12.91 11.74 850 PCYT1B 11.35 9.77 851 RAB14 11.64 10.41 852 TCERG1 12.50 11.46 853 MKNK2 14.87 12.67 854 COL4A3 8.78 12.23 855 HNRPA0 12.50 11.36 856 P2RX4 8.88 10.29 857 JUP 9.23 5.70 858 EGR2 10.43 8.07 859 SUPT16H 11.35 9.60 860 PNRC2 13.93 11.64 861 SRPR 11.87 13.89 862 BPTF 12.46 11.34 863 RBM16 12.05 10.52 864 YWHAZ 13.62 12.61 865 EDEM3 11.01 12.76 866 C12orf23 11.18 12.40 867 DOC2A 3.96 7.21 868 SETD2 11.54 10.39 869 FAM98A 10.91 12.10 870 C13orf18 13.25 9.86 871 BRP44L 10.48 11.91 872 CCDC6 11.25 9.82 873 GLCCI1 12.22 15.19 874 PLEKHH1 7.03 9.25 875 SMEK1 11.38 10.37 876 ANKRD9 4.70 8.61 877 CSNK1E 8.86 11.48 878 DCUN1D3 7.48 5.95 879 LTB 14.66 9.91 880 EOMES 7.30 6.14 881 PARP8 10.81 8.69 882 ABCD1 7.12 8.49 883 HOXA10 5.56 7.32 884 RNPS1 12.60 11.25 885 AYTL2 12.08 10.79 886 FLJ20699 5.74 8.80 887 SAPS1 11.43 9.76 888 SYNJ1 8.36 9.64 889 ZNF403 12.06 10.91 890 KPNB1 13.37 12.26 891 ISOC1 9.67 10.98 892 HYOU1 9.95 11.85 893 ZNF706 12.83 14.30 894 HDLBP 10.60 13.37 895 ELF1 12.70 11.34 896 TM9SF4 8.66 10.55 897 RAB8A 11.94 10.88 898 MORF4L2 12.94 14.69 899 SERP1 13.31 15.16 900 ADAMTS5 5.71 7.31 901 TRIOBP 11.23 10.18 902 ZNF664 11.32 12.57 903 RAB11FIP1 11.78 9.03 904 MYO18A 8.06 6.19 905 DUSP10 10.13 8.70 906 ATXN1 6.66 10.65 6.66 10.25 907 EPB41L4B 6.12 7.95 908 CNTNAP1 6.51 9.06 909 SLC17A7 6.47 8.01 910 SPCS2 13.75 15.53 911 CCNC 12.68 14.10 912 WDR77 10.67 8.83 913 GMFB 12.03 10.70 914 ITGA6 6.72 10.51 915 CASP8AP2 10.55 9.44 916 SEC24D 8.79 11.88 917 CBX1 12.16 10.96 918 TBX3 6.05 7.89 919 NFAT5 12.09 10.72 920 ATP6V1B2 10.73 9.53 921 ACTG1 16.72 14.81 922 RND3 7.31 5.65 923 HNRPUL1 11.97 10.58 924 TJP1 7.18 10.59 925 RAPGEF4 5.25 8.09 926 RGMA 5.65 7.42 927 NAP1L1 14.70 12.60 928 TARDBP 12.72 11.49 929 DAZAP1 12.74 11.30 930 ZNF609 8.26 6.94 8.26 9.52 931 ARL1 10.44 12.41 932 ERC2 7.03 5.97 933 PDE4A 7.65 9.22 934 CSK 12.83 10.59 935 IMPAD1 8.44 10.05 936 PNN 13.75 12.48 937 DCP2 13.06 10.74 938 PIK3R3 6.34 7.82 939 RAB1A 13.59 14.83 940 CENTB2 12.39 10.97 941 SPTAN1 11.48 9.79 942 DNAJC8 12.25 11.00 943 UNC13B 6.70 8.35 944 DHX15 14.19 12.99 945 VEZF1 11.45 9.94 946 DHDDS 8.74 10.05 947 FAM55C 8.19 9.74 948 USP37 8.89 7.60 949 MMD 11.68 10.32 950 HCLS1 14.42 13.12 951 KIAA1370 13.30 14.72 952 GANC 8.31 6.12 953 SSRP1 11.34 10.27 954 G3BP1 12.24 10.55 955 BAAT 4.91 7.24 956 FNDC3B 8.27 14.34 957 FBXW7 10.21 12.19 958 SPECC1L 10.27 7.66 959 YBX1 15.31 14.20 960 YAP1 7.23 5.61 961 ARF4 12.09 14.23 962 PNKD 10.86 9.79 963 CLEC2D 11.96 10.90 964 XPO1 13.81 11.82 965 TRAM2 9.38 12.80 966 MITF 8.05 6.41 967 CFL1 16.37 14.09 968 CREB5 5.46 7.24 969 GREM1 4.48 7.14 970 LONRF1 11.26 10.00 971 NME7 9.37 8.30 972 PMAIP1 12.26 10.75 973 KLHL14 11.89 10.84 974 AOF1 9.33 7.96 9.33 8.28 975 SMPD3 5.90 7.83 976 RGL1 6.66 8.04 977 LYPD6 5.38 7.39 978 STAT5B 10.95 9.73 979 C10orf6 10.04 8.44 980 CLDND1 10.72 12.01 981 DUSP9 5.59 7.70 982 SLC36A1 8.53 7.23 983 PAM 8.90 10.86 984 GHR 5.87 7.56 985 CBL 11.69 10.26 986 CENTG2 5.96 7.39 987 BACH2 13.68 9.35 13.68 11.88 988 NUP153 12.33 10.55 989 CPD 8.37 9.72 990 APLN 8.58 6.47 991 RFXDC2 11.67 10.00 992 GABRB2 5.58 8.10 993 NOMO3 5.39 7.39 994 RHOJ 6.41 7.75 995 PRDM1 9.15 14.10 996 IGSF3 7.62 5.91 997 UBE2A 12.47 11.47 998 KBTBD8 12.82 9.73 12.82 11.71 999 PRR15 7.27 5.94 7.27 4.67 1000 ILF3 11.94 10.71 1001 WIPF1 13.81 12.41 1002 GCNT2 11.01 8.49 1003 DBNL 10.43 8.48 1004 C14orf43 10.14 8.01 1005 MID1IP1 9.16 8.11 1006 LIMD2 10.43 8.88 1007 HNRPK 14.49 12.95 14.49 13.46 1008 ZNF697 5.74 8.07 1009 TSHZ3 7.31 5.32 1010 MBNL2 11.88 13.47 1011 ELL 7.83 9.17 1012 MAFB 7.30 8.56 1013 GGA2 13.25 10.77 1014 C20orf121 10.01 8.93 1015 CDC2L6 11.52 9.69 1016 TOB2 11.39 9.58 1017 MAP4K4 12.04 10.41 1018 FAM102A 11.41 10.18 1019 ITGB3BP 11.86 10.76 1020 HIVEP1 10.35 9.05 1021 NUDT21 12.51 11.11 1022 EIF4A1 14.02 12.98 1023 TSPAN14 8.38 6.31 1024 SLC2A4RG 8.98 7.40 1025 DGKZ 9.74 7.85 1026 PTPN9 9.30 7.85 1027 BCL7A 11.33 10.10 1028 LSM14A 12.74 11.19 1029 GNB2 11.50 10.12 1030 SLC6A6 11.35 8.51 1031 TACC1 13.21 11.62 1032 LIMK2 9.80 8.12 1033 ACVR2B 6.69 8.33 1034 SCC-112 12.25 10.55 1035 PTBP1 13.38 12.19 13.38 12.21 1036 CITED2 9.88 12.56 1037 SNX5 14.17 13.16 1038 ACTR2 15.12 13.32 1039 OSBPL3 10.59 12.84 1040 SFRS1 14.60 13.24 1041 ADM 7.24 11.10 1042 PFKFB3 11.91 10.01 1043 FNBP1 13.61 12.25 1044 MTMR2 10.53 9.06 1045 DDHD1 10.18 8.74 1046 HSPA5 13.70 16.32 1047 PTK2 12.12 8.33 1048 UBE2I 13.17 11.22 1049 SNAP23 13.78 12.23 1050 MTERFD2 10.53 8.59 1051 COTL1 13.89 10.14 1052 PHACTR2 8.65 6.86 1053 GLRA2 5.93 7.69 1054 NUTF2 10.39 9.26 1055 TSGA14 9.52 8.03 1056 FKBP1A 12.16 10.89 12.16 10.82 1057 LRRC1 8.82 7.68 1058 PDIA6 13.07 14.91 1059 YWHAQ 14.50 12.99 1060 ACHE 5.59 8.29 1061 KRAS 12.36 10.49 1062 FAM107B 13.87 12.55 1063 CCDC117 11.03 9.56 1064 WDR1 13.38 11.36 1065 HMGB1 16.36 14.98 16.36 14.97 1066 CCND3 12.69 9.79 1067 SUV39H1 9.28 8.07 1068 RANBP5 11.94 10.87 1069 SLC25A33 10.24 9.00 1070 EDNRA 5.94 7.12 1071 RAB11A 12.94 11.73 1072 DDEF1 11.98 10.54 1073 CXorf15 11.84 10.47 1074 C4orf34 13.65 10.16 1075 SLC44A1 11.10 13.50 1076 EIF2AK3 12.29 13.83 1077 RAP1B 14.21 13.21 1078 CDK2 10.20 8.73 10.20 9.01 1079 JDP2 7.94 5.97 1080 GSTCD 8.86 7.85 1081 TNKS2 10.95 9.62 10.95 9.62 1082 FUZ 7.15 8.96 7.15 8.19 1083 SYPL1 13.56 10.87 1084 EIF4H 13.07 12.02 1085 PIP5K2A 9.65 8.06 1086 RGS2 11.61 14.48 1087 ARF5 10.35 9.13 1088 JAKMIP2 8.57 6.96 1089 RABGAP1 12.19 9.65 12.19 10.85 1090 LRIG1 9.76 10.77 10.77 9.16 1091 CLTA 13.08 11.71 1092 APBB2 7.87 6.39 1093 SMC1A 12.88 11.33 1094 CDC27 9.86 10.88 1095 STT3A 8.64 9.66 1096 ZFAND6 12.01 13.04 13.04 11.95 1097 BZRAP1 8.43 7.15 1098 DPP3 9.41 10.44 10.44 8.39 1099 CNIH 11.94 12.98 1100 TMEM16F 9.42 10.46 1101 ARHGEF7 11.99 13.03 13.03 11.18 13.03 11.60 1102 CAMTA1 10.60 11.64 1103 PFN1 14.03 15.08 1104 USP12 10.18 11.23 1105 AZIN1 11.24 12.29 1106 GNA13 13.89 14.94 14.94 13.37 1107 RCOR1 10.46 11.51 11.51 9.96 1108 USP1 13.36 11.52 1109 VANGL1 7.47 9.15 1110 CAPZB 11.85 12.91 1111 CDV3 13.86 14.91 1112 ABI1 11.61 12.67 12.67 10.96 1113 ST5 7.21 8.28 1114 TTL 8.63 9.69 9.69 8.03 1115 ANP32E 12.76 13.82 13.82 12.19 1116 USP7 12.27 13.34 1117 BCL11B 7.20 8.27 8.27 9.68 1118 OAZ2 8.98 10.06 1119 PPP2CA 12.04 13.12 13.12 11.89 1120 TSC1 10.58 11.66 1121 CTDSPL2 9.81 10.90 10.90 9.51 10.90 9.68 1122 NEDD4L 7.81 8.90 1123 NAT13 12.06 13.16 1124 ASF1A 9.54 10.64 1125 DPF1 7.18 8.50 7.18 5.84 1126 RAN 13.46 14.57 14.57 12.39 1127 ELAVL1 11.66 12.77 12.77 11.43 1128 GRHL1 5.76 7.24 1129 SMAD2 10.45 11.57 1130 IQWD1 9.70 10.83 10.83 9.73 1131 ETS2 7.50 5.66 1132 CDC25B 10.04 11.18 1133 USP32 10.65 11.78 11.78 10.75 1134 EED 11.76 12.90 12.90 11.50 1135 CTNND2 5.93 7.81 1136 SHROOM3 7.86 9.01 9.01 6.05 1137 PSCD3 6.43 7.57 1138 ATF7 7.83 8.97 1139 CDK6 10.31 11.46 1140 GCH1 12.59 10.17 1141 AP3S1 11.95 13.12 1142 ARL6IP1 12.03 13.20 13.20 11.51 1143 TBC1D1 11.00 12.17 12.17 10.01 1144 ATP2A2 10.75 11.92 11.92 10.76 1145 SORL1 12.49 13.67 13.67 10.58 1146 SOX5 9.30 10.47 10.47 7.33 10.47 9.08 1147 KIAA1411 8.65 9.83 1148 KIAA0922 12.43 13.61 13.61 10.86 13.61 12.35 1149 SSX2IP 7.82 9.00 9.00 7.49 1150 SNRPD1 11.85 13.04 1151 EDD1 11.23 12.42 1152 BLMH 9.01 10.21 1153 PTPLB 11.32 12.52 1154 SLC25A27 7.44 3.28 1155 PGAM1 12.40 13.61 13.61 12.55 1156 HMGA1 11.26 12.47 12.47 10.36 1157 EDEM1 11.34 12.55 1158 PRPF38A 10.27 11.48 11.48 10.00 1159 DCUN1D1 9.82 11.03 1160 ROBO1 7.43 8.64 1161 LRRC59 11.26 12.65 1162 ZNF207 12.29 13.51 1163 GTDC1 9.19 10.42 10.42 9.35 1164 C1orf121 10.47 11.70 1165 NF1 9.23 10.46 1166 CUL3 12.98 14.21 14.21 12.80 14.21 12.99 1167 B4GALT5 8.74 9.97 9.97 8.08 9.97 8.71 1168 GADD45A 8.14 9.37 9.37 11.74 1169 RASD2 5.53 7.35 1170 CD4 6.76 8.01 8.01 6.11 1171 WWC1 6.16 7.88 1172 DUSP2 9.43 10.69 10.69 9.18 1173 TP53INP2 8.44 9.70 9.70 8.53 9.70 8.00 1174 NRAS 8.89 10.16 1175 TFRC 12.12 13.39 13.39 11.88 1176 MASTL 8.76 10.03 10.03 8.23 10.03 8.64 1177 USP6 9.12 10.39 10.39 9.25 1178 VGLL4 10.30 11.57 11.57 10.16 1179 C10orf78 8.93 10.21 1180 BTG3 9.87 11.16 1181 TMOD2 8.64 9.93 9.93 6.94 1182 HOXA5 7.03 8.32 1183 AK2 10.33 11.62 1184 MAP2K1 10.41 11.71 11.71 10.69 11.71 10.61 1185 CASP3 10.16 11.47 1186 STK40 9.30 10.60 10.60 8.13 1187 GRHL3 5.20 7.46 1188 SLC25A4 8.65 9.96 1189 KLHDC5 9.52 10.83 1190 SAMHD1 9.72 11.03 1191 PHLPP 7.93 9.24 9.24 7.58 1192 CCNE1 7.86 9.18 1193 EGR1 11.92 13.24 1194 PIM1 9.44 10.76 10.76 8.87 1195 HECW1 6.49 7.81 1196 CHAC1 6.73 8.76 1197 P4HA2 6.84 8.18 1198 PPM1E 6.59 7.92 1199 KIAA0746 13.65 14.98 1200 LOC401720 6.33 7.63 1201 CAPN5 5.90 7.24 1202 DYNLL1 12.69 14.03 1203 EHMT1 10.40 11.75 1204 RIC8B 7.54 8.89 1205 GRIN1 7.40 8.93 1206 DEK 12.73 14.09 14.09 10.29 1207 E2F1 7.01 8.37 8.37 7.21 1208 FAM45A 10.66 12.02 1209 VAMP1 11.10 12.47 1210 LTBP1 7.23 8.61 1211 SOCS1 9.18 10.56 10.56 9.25 1212 ZCCHC14 6.98 8.36 1213 KLHL3 8.04 9.43 1214 RET 5.90 7.29 7.29 5.99 1215 CUTL1 10.33 11.72 11.72 10.67 11.72 10.50 1216 RBL1 7.58 8.98 8.98 7.52 8.98 7.97 1217 TOP1 11.47 12.87 1218 GPD1L 7.94 9.35 1219 SAR1B 9.03 10.46 10.46 12.55 1220 MTF2 11.84 13.27 13.27 11.18 1221 ANP32B 15.53 14.21 1222 CIT 8.19 9.63 9.63 7.43 9.63 7.77 1223 POU3F1 6.08 7.52 1224 MTMR12 11.44 12.89 12.89 11.13 12.89 11.60 1225 MBOAT2 6.73 8.17 8.17 6.25 1226 DOCK9 9.28 10.73 1227 ZAK 8.60 10.05 10.05 8.21 1228 LOC152485 11.05 12.51 12.51 10.56 1229 HNRPA3 14.33 12.26 1230 LMNB1 10.63 8.78 1231 ZFYVE21 8.42 9.90 1232 TXNDC5 12.47 16.40 1233 UBE2G1 11.36 12.84 1234 KIF23 7.44 8.93 8.93 5.57 8.93 6.64 1235 DPYSL2 9.98 11.46 11.46 9.03 1236 ATP5G3 12.15 13.64 1237 GLRX5 10.08 11.57 1238 NLK 10.41 11.92 1239 ARL6IP6 10.51 12.02 12.02 10.43 1240 CNNM4 6.17 7.68 7.68 5.21 1241 TBC1D4 9.12 10.64 10.64 8.94 1242 CD163 5.49 7.00 1243 PKD2 8.17 9.71 9.71 7.48 1244 DIAPH3 8.23 9.77 9.77 8.34 1245 RAD23B 10.65 12.20 12.20 10.54 1246 DCAMKL2 5.53 7.08 7.08 5.88 1247 LMBR1 7.22 8.77 1248 RRAS2 11.24 12.79 12.79 11.03 1249 MYO1D 6.31 7.88 7.88 10.07 1250 KLHL5 10.57 12.15 12.15 10.43 12.15 10.80 1251 EPS15 12.32 13.91 13.91 12.70 1252 FASLG 5.47 7.06 1253 H2AFY 12.56 14.16 1254 LIMA1 8.47 10.07 10.07 9.06 1255 CDCA4 8.92 10.52 10.52 9.16 1256 HAS3 5.70 7.31 7.31 6.15 1257 HRBL 5.96 7.57 7.57 6.35 7.57 5.97 1258 SYAP1 9.71 11.32 11.32 9.76 1259 MDFIC 12.06 13.67 1260 FAM76B 11.27 12.89 12.89 10.52 1261 SNTB2 8.22 9.85 9.85 8.64 1262 ARL3 8.92 10.55 1263 GPR124 5.50 7.14 1264 BCL2L11 10.79 12.43 12.43 11.14 1265 RNF103 12.03 13.23 1266 MYB 6.97 8.62 8.62 5.61 1267 PKM2 11.21 12.87 1268 VCL 8.92 10.57 10.57 8.25 1269 RBBP7 12.45 14.11 14.11 12.96 14.11 12.70 1270 LBR 12.86 14.53 14.53 12.16 14.53 12.50 1271 RRBP1 6.97 8.64 8.64 11.94 1272 GABRB3 5.33 7.00 1273 SGCB 7.78 9.45 9.45 8.22 1274 FAM81A 6.61 8.30 8.30 5.44 1275 RAB15 5.75 7.44 1276 SOX9 6.72 8.42 1277 SAP30 8.22 9.91 1278 BRWD1 8.60 10.30 10.30 8.72 10.30 9.04 1279 KCNMA1 7.47 9.17 9.17 10.42 1280 WHSC1 9.67 11.37 11.37 9.60 1281 CCDC126 9.36 11.09 1282 GRAMD1C 7.83 9.57 1283 PHF19 8.98 10.73 10.73 9.18 1284 ADAM23 7.02 8.77 8.77 7.00 1285 C9orf150 5.38 7.13 1286 ZNF572 6.52 8.30 8.30 6.82 1287 STK39 9.38 11.15 11.15 9.40 1288 SMS 9.73 11.54 1289 DMD 8.96 10.77 10.77 9.32 1290 C1orf83 6.15 7.96 1291 MFHAS1 9.80 11.61 11.61 9.36 1292 STXBP1 6.57 7.79 1293 CPNE2 5.44 7.27 7.27 4.84 1294 MYH10 7.07 8.90 8.90 7.85 1295 CALM3 9.63 11.46 11.46 10.30 1296 EFNB2 7.01 8.85 1297 ACTN1 5.89 7.74 1298 RBMS3 5.67 7.51 1299 ACOT7 9.70 7.83 1300 RKHD1 5.92 7.77 1301 LRRK1 9.74 11.62 11.62 10.12 1302 PTCH1 7.70 9.58 1303 MGLL 7.30 9.18 9.18 10.57 9.18 8.06 1304 YWHAH 8.94 10.82 10.82 9.09 1305 PDE4D 6.78 8.66 1306 MAF 8.05 9.95 9.95 8.25 1307 PTGER3 5.18 7.09 7.09 6.06 1308 PRKCD 9.49 11.40 1309 CCDC64 8.15 10.07 10.07 7.55 1310 RASL11A 7.89 6.65 1311 KPNA2 11.18 13.09 13.09 11.78 13.09 11.55 1312 GPR137B 8.65 10.58 10.58 9.36 1313 TIAM1 6.97 8.90 1314 TFDP1 10.95 12.90 12.90 10.49 1315 SSBP2 10.47 12.42 12.42 10.32 1316 REEP1 5.64 7.61 1317 MAP2 7.85 9.83 9.83 7.75 1318 HOXA9 5.15 7.12 1319 SCRN1 11.81 9.54 1320 LOC129607 8.79 10.78 10.78 9.33 10.78 9.45 1321 SIAH2 10.35 12.34 12.34 10.57 1322 DKFZP564O0823 6.96 8.95 1323 POLQ 8.30 10.30 10.30 8.98 10.30 7.83 1324 KLF15 5.88 7.88 7.88 9.36 7.88 6.74 1325 PXDN 8.36 10.37 1326 BTBD12 8.06 10.08 10.08 8.56 1327 PHF6 11.19 13.21 13.21 11.96 13.21 12.09 1328 SLC41A2 5.67 7.68 1329 HN1 9.87 11.92 11.92 9.85 11.92 10.58 1330 ZNF608 8.98 11.07 11.07 9.74 1331 RNGTT 10.32 12.45 1332 RAP2A 10.35 12.47 1333 LIMK1 5.18 7.36 7.36 5.05 1334 SMAD1 5.91 8.10 8.10 6.34 1335 NCOA7 10.39 12.58 1336 PRDM15 10.29 12.49 1337 PELI1 10.67 12.88 1338 PLS1 5.43 7.65 7.65 4.53 1339 RAB23 6.14 8.36 1340 NAP1L5 7.40 9.63 9.63 8.30 9.63 8.34 1341 DNER 6.90 9.14 1342 LRRC42 7.58 9.83 1343 ID2 7.74 9.99 1344 IBRDC2 9.98 12.24 12.24 8.84 12.24 9.94 1345 DNMT1 11.21 13.50 1346 STAC3 5.74 8.02 8.02 7.01 1347 HMGB3 8.20 10.50 10.50 8.80 10.50 8.08 1348 BMPR1A 6.75 9.06 1349 SGK 10.06 12.37 1350 CBX2 6.06 8.37 8.37 6.38 1351 LRRC20 5.69 8.03 1352 LRRC4 4.81 7.15 7.15 5.05 1353 HOXA1 5.36 7.70 1354 LRRC62 4.95 7.30 1355 ATAD2 9.00 11.34 11.34 8.44 11.34 9.37 1356 MOBKL1A 9.73 12.08 12.08 9.13 12.08 10.12 1357 LOC220594 10.06 12.41 12.41 10.07 1358 ZNF804A 6.14 8.51 1359 C1orf113 5.99 8.36 8.36 5.74 1360 FMNL2 6.58 8.96 1361 H2AFX 12.49 10.60 1362 ATP1B1 5.60 8.03 1363 GPT2 6.54 8.97 1364 PSRC1 9.89 7.46 1365 SLC25A35 5.23 7.68 1366 LHFPL2 8.94 11.41 1367 UBE2J1 11.34 13.81 13.81 12.22 1368 TBC1D8B 5.43 7.91 7.91 6.89 1369 SGPP1 10.96 13.46 13.46 11.28 1370 C11orf9 4.74 7.24 1371 BCL6 12.29 14.82 14.82 10.60 14.82 11.78 1372 ANUBL1 8.12 10.66 10.66 8.78 1373 MTA3 8.37 10.92 1374 PGBD5 4.87 7.45 7.45 5.87 1375 LPP 11.00 13.59 13.59 10.07 13.59 10.89 1376 NDFIP2 7.39 9.99 1377 STMN1 11.76 9.03 1378 PITPNC1 8.77 11.42 11.42 10.00 1379 SH3RF1 7.37 10.05 10.05 8.10 1380 ASF1B 8.56 11.25 11.25 7.91 11.25 8.27 1381 FLJ20186 12.06 14.82 14.82 12.05 1382 SLC16A2 8.08 5.17 1383 PEX5 9.12 11.90 11.90 9.50 1384 ECT2 7.45 10.23 10.23 7.70 10.23 7.63 1385 MAML3 8.05 10.85 1386 TEAD1 4.42 7.24 1387 HMGB2 12.96 15.78 15.78 12.73 15.78 13.36 1388 NCALD 5.15 7.97 1389 RGC32 7.75 10.62 1390 PPP1R3C 4.18 7.06 1391 DEPDC1B 9.96 7.11 1392 WEE1 10.11 13.01 13.01 10.32 13.01 11.84 1393 FHL2 4.82 7.77 1394 ITGB8 4.70 7.66 1395 SLC1A1 10.86 8.88 1396 FAM83D 7.36 10.32 1397 UHRF1 12.22 8.72 1398 C7orf41 4.94 7.95 7.95 6.29 1399 ZBTB8 5.58 8.59 8.59 11.07 1400 ZNF367 7.97 10.99 10.99 8.04 10.99 8.22 1401 CDC25A 6.03 9.09 9.09 6.81 1402 CHEK1 7.59 10.68 10.68 7.72 1403 CDCA7 10.61 13.76 13.76 10.16 13.76 11.06 1404 FGF13 4.55 7.69 1405 SSBP3 6.20 9.35 1406 EZH2 9.40 12.57 12.57 10.22 1407 TNFSF11 5.18 8.36 8.36 5.91 8.36 9.78 1408 PACSIN1 5.16 8.35 1409 RRM2 10.59 13.82 13.82 9.47 13.82 10.79 1410 POU4F1 5.62 8.85 1411 MYBL2 9.07 12.41 12.41 9.12 1412 KIAA1212 8.46 11.81 11.81 8.55 1413 CCNE2 7.30 10.66 10.66 8.02 10.66 8.03 1414 IGF2BP3 7.92 11.34 11.34 9.93 11.34 9.55 1415 PRKAR2B 6.17 9.66 9.66 8.16 1416 CADPS 5.04 8.58 8.58 6.18 1417 ANKRD15 6.97 10.52 10.52 7.58 1418 DAAM1 9.33 12.92 1419 MAP1B 4.05 7.68 7.68 5.03 7.68 6.23 1420 AFF2 6.32 10.00 1421 E2F7 5.66 9.37 9.37 6.53 9.37 6.89 1422 PRC1 8.37 12.08 1423 ENPP5 3.54 7.26 7.26 4.97 1424 E2F8 7.68 11.41 1425 MED12L 7.82 11.59 11.59 7.46 11.59 10.57 1426 LOC162073 6.30 10.08 1427 LRRC32 4.14 7.93 7.93 6.61 7.93 4.95 1428 DMXL2 6.57 10.38 10.38 6.61 10.38 7.76 1429 FLJ20366 7.86 11.68 11.68 7.62 11.68 9.86 1430 TOX 9.05 12.88 12.88 11.27 1431 MME 11.56 10.33 1432 FGD6 7.63 11.73 11.73 9.12 1433 MYBL1 9.68 14.13 14.13 10.02 14.13 9.72 *Empty cells indicate values not appreciably measured.

TABLE 16 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from germinal center B-cell (GCB) DLBC Higher ABC vs GCB in hsa-miR-93/mmu-miR-93/rno-miR-93 GCB hsa-miR-331-3p/mmu-miR-331-3p/rno-miR-331 GCB hsa-miR-129* GCB hsa-miR-423-3p/mmu-miR-423-3p/rno-miR-423 GCB hsa-miR-28-5p/mmu-miR-28/rno-miR-28 GCB mghv-miR-M1-7-3p GCB hsa-miR-518b GCB ebv-miR-BHRF1-1 GCB hsa-miR-140-5p/mmu-miR-140/rno-miR-140 GCB hsa-miR-505* GCB hsa-miR-675 GCB hsa-miR-198 GCB hsa-miR-125b-1*/mmu-miR-125b-3p/rno-miR- GCB 125b-3p hsa-miR-361-5p/mmu-miR-361/rno-miR-361 GCB ebv-miR-BART8* GCB

TABLE 17 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from Burkitt lymphoma Higher ABC vs BL in hsa-miR-155 ABC hsa-miR-29c/mmu-miR- ABC 29c/rno-miR-29c hsa-miR-146b-5p/mmu-miR- ABC 146b/rno-miR-146b hsa-miR-29b/mmu-miR- ABC 29b/rno-miR-29b hsa-miR-22/mmu-miR- ABC 22/rno-miR-22 hsa-miR-21/mmu-miR- ABC 21/rno-miR-21 hsa-miR-768-3p ABC hsa-miR-145/mmu-miR- ABC 145/rno-miR-145 hsa-miR-29a/mmu-miR- ABC 29a/rno-miR-29a hsa-miR-30e/mmu-miR- ABC 30e/rno-miR-30e hsa-miR-26a/mmu-miR- ABC 26a/rno-miR-26a hsa-miR-101/mmu-miR- ABC 101a/rno-miR-101a hsa-miR-24/mmu-miR- ABC 24/rno-miR-24 hsa-miR-26b/mmu-miR- ABC 26b/rno-miR-26b hsa-miR-27a/mmu-miR- ABC 27a/rno-miR-27a hsa-miR-27b/mmu-miR- ABC 27b/rno-miR-27b hsa-miR-23b/mmu-miR- ABC 23b/rno-miR-23b hsa-miR-23a/mmu-miR- ABC 23a/rno-miR-23a hsa-miR-125b/mmu-miR- ABC 125b-5p/rno-miR-125b-5p hsa-miR-30a/mmu-miR- ABC 30a/rno-miR-30a hsa-miR-142-3p/mmu-miR- ABC 142-3p/rno-miR-142-3p hsa-let-7a/mmu-let-7a/rno-let- ABC 7a hsa-miR-30b/mmu-miR- ABC 30b/rno-miR-30b-5p hsa-miR-142-5p/mmu-miR- ABC 142-5p/rno-miR-142-5p hsa-miR-34b/mmu-miR-34b-3p ABC hsa-miR-16/mmu-miR-16/rno- ABC miR-16 hsa-miR-30c/mmu-miR- ABC 30c/rno-miR-30c hsa-let-7c/mmu-let-7c/rno-let- ABC 7c hsa-miR-550 ABC hsa-miR-921 BL hsa-miR-30c-2*/mmu-miR- BL 30c-2*/rno-miR-30c-2* hsa-miR-933 BL hsa-miR-658 BL hsa-miR-628-3p BL hsa-miR-503 BL hsa-miR-193a-5p BL hsa-miR-30b* BL hsa-miR-93/mmu-miR-93/rno- BL miR-93 hsa-miR-18b BL hsa-miR-18a/mmu-miR- BL 18a/rno-miR-18a hsa-miR-874/mmu-miR- BL 874/rno-miR-874

TABLE 18 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from chronic lymphocytic leukemia Higher Higher Higher ABC vs CLL in ABC vs CLL (con't) in ABC vs CLL (con't) in hsa-miR-125b/mmu-miR- ABC hsa-miR-142- CLL hsa-miR-340/mmu- CLL 125b-5p/rno-miR-125b-5p 5p/mmu-miR-142- miR-340-5p/rno-miR- hsa-miR-126/mmu-miR- ABC 5p/rno-miR-142-5p 340-5p 126-3p/rno-miR-126 hsa-miR-101/mmu- CLL hsa-miR-331- CLL hsa-miR-199a-3p/hsa- ABC miR-101a/rno-miR- 3p/mmu-miR-331- miR-199b-3p/mmu-miR- 101a 3p/rno-miR-331 199a-3p/mmu-miR- hsa-miR-185/mmu- CLL hsa-miR-151- CLL 199b/rno-miR-199a-3p miR-185/rno-miR-185 5p/mmu-miR-151- hsa-miR-145/mmu-miR- ABC hsa-miR-888* CLL 5p/rno-miR-151 145/rno-miR-145 hsa-miR-199a- CLL hsa-miR-636 CLL hsa-miR-143/mmu-miR- ABC 5p/mmu-miR-199a- hsa-miR-33a/mmu- CLL 143/rno-miR-143 5p/rno-miR-199a-5p miR-33/rno-miR-33 hsa-miR-637 ABC hsa-miR-668/mmu- CLL hsa-miR-486- CLL hsa-miR-371-5p ABC miR-668 5p/mmu-miR-486 kshv-miR-K12-6-3p ABC hsa-miR-549 CLL hsa-miR-150/mmu- CLL hsa-miR-628-3p ABC hsa-miR-801/mmu- CLL miR-150/rno-miR- hsa-miR-126*/mmu-miR- ABC miR-801 150 126-5p/rno-miR-126* hsa-miR-649 CLL hsa-miR-25/mmu- CLL hsa-miR-193a-5p ABC hsa-miR-625* CLL miR-25/rno-miR-25 hsa-miR-21/mmu-miR- ABC hsa-miR-140- CLL hsa-miR-331- CLL 21/rno-miR-21 3p/mmu-miR- 5p/mmu-miR-331-5p hsa-miR-24/mmu-miR- ABC 140*/rno-miR-140* hsa-miR-299- CLL 24/rno-miR-24 hsa-let-7f/mmu-let- CLL 5p/mmu-miR- hsa-miR-503 ABC 7f/rno-let-7f 299*/rno-miR-299 hsa-miR-23a/mmu-miR- ABC hsa-miR-768-5p CLL hsa-miR-891a CLL 23a/rno-miR-23a hsa-miR-24-1*/mmu- CLL hsa-miR-144* CLL hsa-miR-23b/mmu-miR- ABC miR-24-1*/rno-miR- hsa-miR-363*/rno- CLL 23b/rno-miR-23b 24-1* miR-363* hsa-miR-22/mmu-miR- ABC ebv-miR-BART13 CLL hsa-miR-93/mmu- CLL 22/rno-miR-22 hsa-miR-339- CLL miR-93/rno-miR-93 hsa-miR-665 ABC 5p/mmu-miR-339- hsa-miR-423- CLL hsa-let-7c/mmu-let-7c/rno- ABC 5p/rno-miR-339-5p 3p/mmu-miR-423- let-7c hsa-miR-20b/mmu- CLL 3p/rno-miR-423 hsa-miR-658 ABC miR-20b/rno-miR- hsa-let-7g/mmu-let- CLL hsa-let-7a/mmu-let-7a/rno- ABC 20b-5p 7g let-7a hsa-miR-335/mmu- CLL hsa-miR-28-5p/mmu- CLL mghv-miR-M1-4 ABC miR-335-5p/rno-miR- miR-28/rno-miR-28 hsa-miR-933 ABC 335 hsa-miR-20b* CLL hsa-miR-550 CLL mghv-miR-M1-8 CLL hsa-miR-140- CLL hsa-miR-30e/mmu-miR- CLL hsa-miR-30d/mmu- CLL 5p/mmu-miR- 30e/rno-miR-30e miR-30d/rno-miR-30d 140/rno-miR-140 hsa-miR-363/mmu- CLL hsa-miR-519d CLL miR-363/rno-miR-363 hsa-miR-147 CLL hsa-miR-361-3p CLL hsa-miR-487b/mmu- CLL hsa-miR-107/mmu- CLL miR-487b/rno-miR- miR-107/rno-miR-107 487b hsa-miR-154/mmu- CLL hsa-miR-361- CLL miR-154/rno-miR-154 5p/mmu-miR- hsa-miR-638 CLL 361/rno-miR-361 hsa-miR-186/mmu- CLL miR-186/rno-miR- 186 hsa-miR-32/mmu- CLL miR-32/rno-miR-32 hsa-miR-129* CLL hsa-miR-30e*/mmu- CLL miR-30e*/rno-miR- 30e* hsa-miR-196a*/mmu- CLL miR-196a*/rno-miR- 196a*

TABLE 19 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from follicular lymphoma Higher Higher Higher ABC vs FL in ABC vs FL (con't) in ABC vs FL (con't) in hsa-miR-938 ABC hsa-miR-518b FL hsa-miR-98/mmu- FL hsa-miR-183*/mmu-miR- ABC hsa-miR-194/mmu- FL miR-98/rno-miR-98 183* miR-194/rno-miR- hsa-let-7g/mmu-let-7g FL hsa-miR-197/mmu-miR- ABC 194 hsa-miR-302a/mmu- FL 197 hsa-miR-647 FL miR-302a hsa-miR-382/mmu-miR- ABC kshv-miR-K12-6-5p FL hsa-miR-625* FL 382/rno-miR-382 hsa-miR-622 FL hsa-miR-30b* FL hsa-miR-20b* ABC hsa-miR-516b FL hsa-miR-30b/mmu- FL hsa-miR-524-5p ABC hsa-miR-675 FL miR-30b/rno-miR- hsa-miR-337-3p ABC hsa-miR-526b FL 30b-5p hsa-miR-600 ABC hsa-miR-671- FL hsa-miR-377* FL hsa-miR-96/mmu-miR- ABC 5p/mmu-miR-671-5p hsa-miR-106b*/mmu- FL 96/rno-miR-96 hsa-miR-18a/mmu- FL miR-106b*/rno-miR- mghv-miR-M1-8 ABC miR-18a/rno-miR- 106b* hsa-miR-29c*/mmu-miR- ABC 18a hsa-miR-181a-2* FL 29c*/rno-miR-29c* hsa-miR-18b FL hsa-miR-887 FL hsa-miR-575 ABC hsa-miR-181b/mmu- FL hsa-miR-208a/mmu- FL hsa-miR-518a-3p ABC miR-181b/rno-miR- miR-208a/rno-miR- hsa-miR-361-5p/mmu-miR- ABC 181b 208 361/rno-miR-361 hsa-miR-215 FL ebv-miR-BART7* FL hsa-miR-193b* ABC hsa-miR-153/mmu- FL hsa-miR-7-2* FL hsa-miR-340*/mmu-miR- ABC miR-153/rno-miR- hsa-miR-155* FL 340-3p/rno-miR-340-3p 153 hsa-miR-513a-3p FL hsa-miR-708/mmu-miR- ABC hsa-miR-625 FL kshv-miR-K12-7 FL 708/rno-miR-708 hsa-miR-510 FL hsa-miR-299-3p FL hsa-miR-129* ABC hsa-miR-519d FL hsa-miR-218-2*/mmu- FL hsa-miR-525-5p ABC mghv-miR-M1-7-3p FL miR-218-2*/rno-miR- hsa-miR-497/mmu-miR- FL hsa-miR-485- FL 218* 497/rno-miR-497 3p/mmu-miR-485* hsa-miR-130b*/mmu- FL hsa-miR-22*/mmu-miR- FL hsa-miR-483-5p FL miR-130b* 22*/rno-miR-22* hsa-miR-140- FL hsa-miR-620 FL hsa-miR-130b/mmu-miR- FL 5p/mmu-miR- hsa-miR-33a/mmu- FL 130b/rno-miR-130b 140/rno-miR-140 miR-33/rno-miR-33 hsa-miR-551b* FL hsa-miR-921 FL hsa-miR-7/mmu-miR- FL hsa-miR-331-3p/mmu-miR- FL hsa-miR-186/mmu- FL 7a/rno-miR-7a 331-3p/rno-miR-331 miR-186/rno-miR- ebv-miR-BART6-3p FL ebv-miR-BART13 FL 186 hsa-miR-22/mmu- FL hsa-miR-877/mmu-miR- FL hsa-miR-196a*/mmu- FL miR-22/rno-miR-22 877/rno-miR-877 miR-196a*/rno-miR- hsa-miR-199b-5p FL hsa-miR-636 FL 196a* hsa-miR-768-3p FL hsa-miR-922 FL hsa-miR-381/mmu- FL hsa-miR-494/mmu- FL hsa-miR-198 FL miR-381/rno-miR- miR-494/rno-miR-494 hsa-miR-342-5p/mmu-miR- FL 381 hsa-miR-602 FL 342-5p/rno-miR-342-5p hsa-miR-620 FL hsa-miR-125b-2*/rno- FL hsa-miR-585 FL hsa-miR-152/mmu- FL miR-125b* ebv-miR-BART8* FL miR-152/rno-miR- hsa-miR-300 FL hsa-miR-617 FL 152 hsa-let-7e/mmu-let- FL hsa-miR-221* FL hsa-miR-766 FL 7e/rno-let-7e hsa-miR-125b-1*/mmu- FL mghv-miR-M1-7-5p FL hsa-miR-298 FL miR-125b-3p/rno-miR- hsa-miR-374b/mmu- FL hsa-miR-576-3p FL 125b-3p miR-374/rno-miR- hsa-miR-187* FL hsa-miR-93/mmu-miR- FL 374 hsa-miR-365/mmu- FL 93/rno-miR-93 hsa-let-7c/mmu-let- FL miR-365/rno-miR-365 hsa-miR-363*/rno-miR- FL 7c/rno-let-7c hsa-miR-518a-5p/hsa- FL 363* kshv-miR-K12-8 FL miR-527 hsa-miR-744/mmu-miR- FL mghv-miR-M1-3 FL hsa-miR-302d* FL 744 hsa-miR-920 FL hsa-miR-105 FL hsa-miR-659 FL hsa-miR-519e* FL hsa-miR-126/mmu- FL hsa-miR-490-3p/mmu-miR- FL hsa-miR-147 FL miR-126-3p/rno-miR- 490 hsa-miR-424 FL 126 hsa-let-7d/mmu-let-7d/rno- FL hsa-miR-193b FL hsa-miR-107/mmu- FL let-7d ebv-miR-BART19-3p FL miR-107/rno-miR-107 hsa-miR-361-3p FL hsa-miR-146b-3p FL hsa-miR-299-5p/mmu- FL ebv-miR-BHRF1-1 FL hsa-miR-30c/mmu- FL miR-299*/rno-miR- hsa-miR-92b/mmu-miR- FL miR-30c/rno-miR- 299 92b/rno-miR-92b 30c hsa-miR-28-3p/rno- FL hsa-miR-151-5p/mmu-miR- FL hsa-miR-30a/mmu- FL miR-28* 151-5p/rno-miR-151 miR-30a/rno-miR- hsa-miR-21/mmu- FL hsa-miR-144* FL 30a miR-21/rno-miR-21 hsa-miR-425/mmu-miR- FL hsa-miR-939 FL hsa-miR-27b/mmu- FL 425/rno-miR-425 hsa-let-7a/mmu-let- FL miR-27b/rno-miR-27b hsa-miR-138/mmu-miR- FL 7a/rno-let-7a hsa-miR-516a-5p FL 138/rno-miR-138 hsa-miR-122* FL hsa-miR-129-5p/mmu- FL hsa-miR-92a/mmu-miR- FL hsa-miR-206/mmu- FL miR-129-5p/rno-miR- 92a/rno-miR-92a miR-206/rno-miR- 129 hsa-miR-151-3p FL 206 hsa-miR-583 FL hsa-miR-25/mmu-miR- FL ebv-miR-BART18-3p FL hsa-miR-483-3p FL 25/rno-miR-25 hsa-miR-183/mmu- FL hsa-miR-326/mmu- FL hsa-miR-509-3-5p FL miR-183/rno-miR- miR-326/rno-miR-326 hsa-miR-30e*/mmu-miR- FL 183 hsa-miR-548d-5p FL 30e*/rno-miR-30e* hsa-miR-9*/mmu- FL hsa-miR-629 FL hsa-miR-28-5p/mmu-miR- FL miR-9*/rno-miR-9* ebv-miR-BART5 FL 28/rno-miR-28 kshv-miR-K12-1 FL hsa-miR-665 FL hsa-miR-200b*/mmu-miR- FL hsa-miR-34c- FL hsa-miR-493 FL 200b* 5p/mmu-miR- hsa-miR-484/mmu- FL hsa-miR-148b/mmu-miR- FL 34c/rno-miR-34c miR-484/rno-miR-484 148b/rno-miR-148b-3p hsa-miR-934 FL hsa-miR-645 FL hsa-miR-488 FL hsa-miR-890 FL hsa-miR-452 FL hsa-miR-99b/mmu-miR- FL hsa-miR-514 FL hsa-miR-518c* FL 99b/rno-miR-99b hsa-miR-297/mmu- FL hsa-miR-24-2*/mmu- FL hsa-miR-339-5p/mmu-miR- FL miR-297a miR-24-2*/rno-miR- 339-5p/rno-miR-339-5p hsa-miR-553 FL 24-2* hsv1-miR-H1 FL hsa-miR-765 FL hsa-miR-124/mmu- FL hsa-miR-32/mmu-miR- FL hsa-let-7b*/mmu-let- FL miR-124/rno-miR-124 32/rno-miR-32 7b*/rno-let-7b* hsa-miR-184/mmu- FL hsa-miR-885-5p FL hsa-miR-500* FL miR-184/rno-miR-184 hsa-miR-630 FL hsa-miR-601 FL hsa-miR-27a*/mmu- FL ebv-miR-BART16 FL ebv-miR-BHRF1-3 FL miR-27a*/rno-miR- hsa-miR-505* FL hsa-miR-296- FL 27a* hsa-miR-374b* FL 3p/mmu-miR-296- hsa-miR-25* FL hsa-miR-574-3p/mmu-miR- FL 3p/rno-miR-296 hsa-miR-34b/mmu- FL 574-3p hsa-miR-574- FL miR-34b-3p hsa-miR-874/mmu-miR- FL 5p/mmu-miR-574-5p ebv-miR-BART17-5p FL 874/rno-miR-874 hsa-miR-409- FL hsa-miR-658 FL hsa-miR-423-3p/mmu-miR- FL 5p/mmu-miR-409- hsa-miR-212/mmu- FL 423-3p/rno-miR-423 5p/rno-miR-409-5p miR-212/rno-miR-212 hsa-miR-889 FL hsa-miR-195* FL hsa-miR-99a/mmu- FL hcmv-miR-UL148D FL hsa-miR-635 FL miR-99a/rno-miR-99a hsa-miR-487b/mmu-miR- FL hsa-miR-542- FL hsa-miR-801/mmu- FL 487b/rno-miR-487b 3p/mmu-miR-542- miR-801 hsa-miR-552 FL 3p/rno-miR-542-3p hsa-miR-491-3p FL hsa-miR-220b FL hcmv-miR-US25-1* FL hsa-miR-551b/mmu- FL hsa-miR-551a FL mghv-miR-M1-2 FL miR-551b/rno-miR- hsa-let-7d*/mmu-let- FL hsa-miR-509-5p FL 551b 7d*/rno-let-7d* hsa-miR-340/mmu- FL hsa-miR-214/mmu- FL kshv-miR-K12-5 FL miR-340-5p/rno- miR-214/rno-miR-214 hsa-miR-629* FL miR-340-5p hsa-miR-30e/mmu- FL hsa-miR-99b*/mmu-miR- FL hsa-miR-891a FL miR-30e/rno-miR-30e 99b*/rno-miR-99b* hsa-miR-23a/mmu- FL hsa-miR-888* FL hsa-miR-615-3p/mmu-miR- FL miR-23a/rno-miR- hsa-miR-505/rno-miR- FL 615-3p 23a 505 hsa-miR-657 FL hsa-miR-19b/mmu- FL hsa-miR-27a/mmu- FL hsa-miR-301a/mmu-miR- FL miR-19b/rno-miR- miR-27a/rno-miR-27a 301a/rno-miR-301a 19b hsa-miR-15a/mmu- FL hsa-miR-515-5p FL miR-15a hsa-miR-23b/mmu- FL hsa-miR-20a/mmu- FL miR-23b/rno-miR- miR-20a/rno-miR-20a 23b kshv-miR-K12-3 FL hsa-miR-498 FL hsa-miR-455-3p FL hsa-miR-886-5p FL hsa-miR-486-5p/mmu- FL hsa-miR-220c FL miR-486 hsa-miR-10a/mmu- FL miR-10a/rno-miR- 10a-5p hsa-miR-32* FL hsa-miR-24/mmu- FL miR-24/rno-miR-24

TABLE 20 Predictor microRNAs that distinguish activated B-cell (ABC) DLBCL from Hodgkin's lymphoma Higher Higher Higher ABC vs HL in ABC vs HL (con't) in ABC vs HL (con't) in hsa-miR-19b/mmu-miR- ABC hsa-miR-934 HL hsa-miR-488 HL 19b/rno-miR-19b hsa-miR-328/mmu-miR- HL hsa-miR-125a- HL hsa-miR-30b/mmu-miR- ABC 328/rno-miR-328 3p/mmu-miR-125a- 30b/rno-miR-30b-5p hsa-miR-187* HL 3p/rno-miR-125a-3p hsa-miR-142-3p/mmu- ABC kshv-miR-K12-3 HL hsa-miR-24-2*/mmu- HL miR-142-3p/rno-miR-142- hsa-miR-373* HL miR-24-2*/rno-miR- 3p hsa-miR-96/mmu-miR- HL 24-2* hsa-miR-768-3p ABC 96/rno-miR-96 hsa-miR-484/mmu- HL hsa-miR-30c/mmu-miR- ABC hsa-miR-186/mmu-miR- HL miR-484/rno-miR- 30c/rno-miR-30c 186/rno-miR-186 484 hsa-miR-29b/mmu-miR- ABC hsa-miR-886-5p HL hsa-miR-106b*/mmu- HL 29b/rno-miR-29b hsa-miR-424 HL miR-106b*/rno-miR- hsa-miR-24/mmu-miR- ABC hsa-miR-147 HL 106b* 24/rno-miR-24 hsa-miR-340/mmu-miR- HL hsa-miR-600 HL hsa-miR-22/mmu-miR- ABC 340-5p/rno-miR-340-5p hsa-let-7b*/mmu-let- HL 22/rno-miR-22 hsa-miR-129-5p/mmu- HL 7b*/rno-let-7b* hsa-miR-30e/mmu-miR- ABC miR-129-5p/rno-miR-129 hsa-miR-302c* HL 30e/rno-miR-30e hsa-miR-25* HL hsa-miR-20b* HL hsa-miR-30a/mmu-miR- ABC hsa-miR-193b HL hsa-miR-524-5p HL 30a/rno-miR-30a hsa-miR-574-5p/mmu- HL hsa-miR-505* HL hsa-miR-26b/mmu-miR- ABC miR-574-5p hsa-miR-542- HL 26b/rno-miR-26b hsa-miR-589 HL 5p/mmu-miR-542- hsa-miR-26a/mmu-miR- ABC hsa-miR-339-5p/mmu- HL 5p/rno-miR-542-5p 26a/rno-miR-26a miR-339-5p/rno-miR- hsa-miR-557 HL hsa-miR-15a/mmu-miR- ABC 339-5p hsa-miR-183/mmu- HL 15a hsa-miR-34c-5p/mmu- HL miR-183/rno-miR- hsa-miR-16/mmu-miR- ABC miR-34c/rno-miR-34c 183 16/rno-miR-16 hsa-miR-891a HL hsa-miR-122* HL hsa-miR-142-5p/mmu- ABC hsa-miR-18a/mmu-miR- HL hsa-miR-675 HL miR-142-5p/rno-miR-142- 18a/rno-miR-18a hsv1-miR-H1 HL 5p hsa-miR-196a*/mmu- HL hsa-miR-99b/mmu- HL hsa-miR-29a/mmu-miR- ABC miR-196a*/rno-miR- miR-99b/rno-miR- 29a/rno-miR-29a 196a* 99b hsa-miR-101/mmu-miR- ABC hsa-miR-17*/rno-miR- HL hsa-miR-766 HL 101a/rno-miR-101a 17-3p hsa-miR-409- HL hsa-miR-126/mmu-miR- ABC hsa-miR-296-5p/mmu- HL 5p/mmu-miR-409- 126-3p/rno-miR-126 miR-296-5p/rno-miR- 5p/rno-miR-409-5p hsa-miR-451/mmu-miR- ABC 296* ebv-miR-BART20-3p HL 451/rno-miR-451 hsa-miR-25/mmu-miR- HL hsa-miR-129* HL hsa-let-7a/mmu-let-7a/rno- ABC 25/rno-miR-25 mghv-miR-M1-7-5p HL let-7a hsa-miR-509-5p HL hsa-miR-671- HL hsa-miR-23b/mmu-miR- ABC hsa-miR-550* HL 5p/mmu-miR-671-5p 23b/rno-miR-23b hsa-miR-708/mmu-miR- HL hsa-miR-629 HL hsa-miR-21/mmu-miR- ABC 708/rno-miR-708 hsa-miR-553 HL 21/rno-miR-21 hsa-miR-146b-3p HL hsa-let-7d*/mmu-let- HL hsa-miR-29c/mmu-miR- ABC hsa-miR-625* HL 7d*/rno-let-7d* 29c/rno-miR-29c hsa-miR-210/mmu-miR- HL hsa-miR-601 HL hsa-miR-20a/mmu-miR- ABC 210/rno-miR-210 hsa-miR-645 HL 20a/rno-miR-20a hsa-miR-93/mmu-miR- HL hsa-miR-221* HL hsa-miR-27b/mmu-miR- ABC 93/rno-miR-93 hsa-miR-874/mmu- HL 27b/rno-miR-27b hsa-miR-548b-3p HL miR-874/rno-miR- hsa-miR-23a/mmu-miR- ABC hsa-miR-652/mmu-miR- HL 874 23a/rno-miR-23a 652/rno-miR-652 hsa-miR-890 HL hsa-miR-27a/mmu-miR- ABC hsa-miR-153/mmu-miR- HL hsa-miR-492 HL 27a/rno-miR-27a 153/rno-miR-153 hsa-miR-629* HL hsa-miR-550 ABC mghv-miR-M1-3 HL hsa-miR-635 HL hsa-let-7c/mmu-let-7c/rno- ABC hsa-miR-194* HL hsa-miR-130b/mmu- HL let-7c hsa-miR-23a*/rno-miR- HL miR-130b/rno-miR- hsa-miR-34b/mmu-miR- ABC 23a* 130b 34b-3p hsa-miR-943 HL hsa-miR-197/mmu- HL hsa-miR-933 HL hsa-let-7d/mmu-let- HL miR-197 hsa-miR-30c-2*/mmu- HL 7d/rno-let-7d hsa-miR-654-5p HL miR-30c-2*/rno-miR-30c- hsa-miR-498 HL hsa-miR-518b HL 2* hsa-miR-381/mmu-miR- HL hsa-miR-889 HL hsa-miR-503 HL 381/rno-miR-381 hsa-miR-584 HL hsa-miR-765 HL hsa-miR-586 HL hsa-miR-198 HL hsa-miR-658 HL hsa-miR-137/mmu-miR- HL hsa-miR-636 HL hsa-miR-620 HL 137/rno-miR-137 hsa-miR-630 HL hsa-miR-921 HL hsa-miR-610 HL hsa-miR-490-5p HL hsa-miR-30b* HL hsa-miR-920 HL hsa-miR-663 HL mghv-miR-M1-4 HL hsa-miR-936 HL hcmv-miR-UL148D HL hsa-miR-939 HL hsa-miR-744/mmu-miR- HL hsa-miR-337-3p HL hsa-miR-494/mmu-miR- HL 744 hsa-miR-9*/mmu- HL 494/rno-miR-494 ebv-miR-BART5 HL miR-9*/rno-miR-9* hsa-miR-32* HL hsa-miR-21* HL hsa-miR-200b*/mmu- HL hsa-miR-491-3p HL hsa-miR-516a-5p HL miR-200b* hsa-miR-10a/mmu-miR- HL hsa-miR-576-5p HL ebv-miR-BART9* HL 10a/rno-miR-10a-5p mghv-miR-M1-6 HL hsa-miR-342- HL hsa-miR-33a/mmu-miR- HL hsa-miR-425/mmu-miR- HL 5p/mmu-miR-342- 33/rno-miR-33 425/rno-miR-425 5p/rno-miR-342-5p hsa-miR-99a/mmu-miR- HL hsa-miR-220c HL hsa-miR-206/mmu- HL 99a/rno-miR-99a hsa-miR-10a*/mmu-miR- HL miR-206/rno-miR- hsa-miR-199b-5p HL 10a*/rno-miR-10a-3p 206 hsa-miR-365/mmu-miR- HL hsa-miR-452 HL hcmv-miR-US25-1* HL 365/rno-miR-365 hsa-miR-345 HL hsa-miR-659 HL hsa-miR-520d-5p HL hsa-miR-29c*/mmu-miR- HL hsa-miR-514 HL hsa-miR-518c* HL 29c*/rno-miR-29c* kshv-miR-K12-6-5p HL hsa-miR-32/mmu-miR- HL hsa-miR-887 HL hsa-miR-508-5p HL 32/rno-miR-32 hsa-miR-7-2* HL hsa-miR-377* HL hsa-miR-214/mmu-miR- HL hsa-miR-363*/rno-miR- HL ebv-miR-BART16 HL 214/rno-miR-214 363* hsa-miR-181b/mmu- HL hsa-miR-98/mmu-miR- HL hsa-miR-22*/mmu-miR- HL miR-181b/rno-miR- 98/rno-miR-98 22*/rno-miR-22* 181b hsa-miR-302d* HL hsa-miR-922 HL hsa-miR-622 HL hsa-miR-30e*/mmu-miR- HL hsa-miR-92b* HL kshv-miR-K12-1 HL 30e*/rno-miR-30e* hsa-miR-526a/hsa-miR- HL hsa-miR-490- HL hsa-miR-374b/mmu-miR- HL 520c-5p/hsa-miR-518d- 3p/mmu-miR-490 374/rno-miR-374 5p hsa-miR-125b- HL hsa-miR-29a*/mmu-miR- HL hsa-miR-574-3p/mmu- HL 1*/mmu-miR-125b- 29a*/rno-miR-29a* miR-574-3p 3p/rno-miR-125b-3p hsa-miR-532-5p/mmu- HL hsa-miR-92a/mmu-miR- HL hsa-miR-124/mmu- HL miR-532-5p/rno-miR-532- 92a/rno-miR-92a miR-124/rno-miR- 5p hsa-miR-423-3p/mmu- HL 124 hsa-miR-149* HL miR-423-3p/rno-miR-423 hsa-miR-657 HL hsa-miR-422a HL hsa-miR-526b HL ebv-miR-BHRF1-3 HL ebv-miR-BHRF1-2 HL hsa-miR-526b* HL kshv-miR-K12-5 HL hsa-miR-634 HL ebv-miR-BART6-3p HL hsa-miR-487b/mmu- HL hsa-miR-143* HL hsa-miR-92b/mmu-miR- HL miR-487b/rno-miR- hsa-miR-620 HL 92b/rno-miR-92b 487b hsa-miR-660 HL hsa-miR-519e* HL hsa-miR-183*/mmu- HL hsa-miR-140-5p/mmu- HL hiv1-miR-H1 HL miR-183* miR-140/rno-miR-140 hsa-miR-623 HL hsa-miR-297/mmu- HL hsa-miR-28-5p/mmu-miR- HL hsa-miR-483-5p HL miR-297a 28/rno-miR-28 mghv-miR-M1-2 HL hsa-miR-885-5p HL hsa-miR-519c-5p/hsa- HL mghv-miR-M1-7-3p HL hsa-miR-296- HL miR-519b-5p/hsa-miR- hsa-miR-519e HL 3p/mmu-miR-296- 523*/hsa-miR-518e*/hsa- hsa-miR-361-5p/mmu- HL 3p/rno-miR-296 miR-522*/hsa-miR-519a* miR-361/rno-miR-361 ebv-miR-BART19-3p HL hsa-miR-505/rno-miR-505 HL hsa-miR-650 HL hsa-miR-617 HL hsa-miR-184/mmu-miR- HL hsa-miR-361-3p HL hsa-miR-519d HL 184/rno-miR-184 hsa-miR-374b* HL hsa-miR-195* HL hsa-miR-107/mmu-miR- HL kshv-miR-K12-8 HL hsa-miR-575 HL 107/rno-miR-107 hsa-miR-150*/mmu-miR- HL hsa-miR-208a/mmu- HL hsa-miR-298 HL 150* miR-208a/rno-miR- hsa-miR-455-3p HL hsa-miR-425*/mmu-miR- HL 208 hsa-miR-638 HL 425* hsa-miR-647 HL hsa-miR-502-3p HL hsa-miR-135a*/mmu- HL hsa-miR-525-5p HL hsa-miR-149/mmu-miR- HL miR-135a* ebv-miR-BART8* HL 149 hsa-miR-612 HL hsa-miR-340*/mmu- HL hsa-miR-583 HL hsa-miR-212/mmu-miR- HL miR-340-3p/rno-miR- hsa-miR-105 HL 212/rno-miR-212 340-3p hsa-miR-128/mmu-miR- HL hsa-miR-125b-2*/rno- HL hsa-miR-220b HL 128/rno-miR-128 miR-125b* hsa-miR-382/mmu- HL hsa-miR-656 HL hcmv-miR-UL112 HL miR-382/rno-miR- hsa-miR-497/mmu-miR- HL hsa-miR-500 HL 382 497/rno-miR-497 hsa-miR-502-5p HL hsa-miR-585 HL hsa-miR-152/mmu-miR- HL ebv-miR-BART18-3p HL hsa-miR-877/mmu- HL 152/rno-miR-152 hsa-miR-625 HL miR-877/rno-miR- hsa-miR-151-5p/mmu- HL hsa-miR-138/mmu-miR- HL 877 miR-151-5p/rno-miR-151 138/rno-miR-138 hsa-miR-99b*/mmu- HL hsa-miR-148b/mmu-miR- HL hsa-miR-500* HL miR-99b*/rno-miR- 148b/rno-miR-148b-3p hsa-miR-124*/mmu-miR- HL 99b* hsa-miR-300 HL 124*/rno-miR-124* ebv-miR-BHRF1-1 HL hsa-miR-144* HL hsa-miR-516b HL hsa-miR-326/mmu- HL hsa-miR-145*/mmu-miR- HL hsa-miR-30c-1*/mmu- HL miR-326/rno-miR- 145* miR-30c-1*/rno-miR- 326 hcmv-miR-UL70-3p HL 30c-1* ebv-miR-BART7* HL hsa-miR-28-3p/rno-miR- HL hsa-miR-331-5p/mmu- HL hsa-miR-615- HL 28* miR-331-5p 3p/mmu-miR-615-3p hsa-miR-27a*/mmu-miR- HL hsa-miR-510 HL mghv-miR-M1-8 HL 27a*/rno-miR-27a* hsa-miR-376a* HL hsa-miR-193b* HL hsa-miR-194/mmu-miR- HL hsa-miR-640 HL ebv-miR-BART13 HL 194/rno-miR-194 hsa-miR-331-3p/mmu- HL hsa-miR-433/mmu- HL hsa-miR-130b*/mmu-miR- HL miR-331-3p/rno-miR-331 miR-433/rno-miR- 130b* hsa-miR-602 HL 433 hsa-miR-548d-5p HL hsa-miR-485-3p/mmu- HL hsa-miR-202 HL hsa-miR-937 HL miR-485* hsa-miR-551b* HL hsa-miR-7/mmu-miR- HL hsa-miR-551a HL 7a/rno-miR-7a hsa-miR-542- HL hsa-miR-518a-5p/hsa- HL 3p/mmu-miR-542- miR-527 3p/rno-miR-542-3p hsa-miR-323-3p/mmu- HL hsa-miR-338- HL miR-323-3p/rno-miR-323 5p/mmu-miR-338- hsa-miR-215 HL 5p/rno-miR-338* hsa-miR-513a-3p HL hsa-miR-299-3p HL hsa-miR-595 HL hsa-miR-518a-3p HL hsa-miR-515-5p HL hsa-miR-181a-2* HL hsa-miR-483-3p HL hsa-miR-938 HL hsa-miR-330-5p/mmu- HL hsa-miR-509-3-5p HL miR-330/rno-miR-330 hsa-miR-552 HL hsa-miR-18b HL hsa-miR-509-3p HL hsa-miR-151-3p HL

TABLE 21 Predictor microRNAs that distinguish germinal center B-cell like (GCB) DLBCL from Burkitt lymphoma GCBvsBL Higher in GCB vs BL (con't) Higher in hsa-miR-129* GCB hsa-miR-140-3p/mmu-miR-140*/rno- GCB hsa-miR-28-5p/mmu-miR-28/rno- GCB miR-140* miR-28 hsa-miR-148a/mmu-miR-148a GCB hsa-miR-155 GCB hsa-miR-365/mmu-miR-365/rno-miR- GCB hsa-miR-196a*/mmu-miR-196a*/rno- GCB 365 miR-196a* hsa-miR-29c/mmu-miR-29c/rno-miR- GCB hsa-miR-146a/mmu-miR-146a/rno- GCB 29c miR-146a hsa-miR-30d/mmu-miR-30d/rno-miR- GCB hsa-miR-331-3p/mmu-miR-331- GCB 30d 3p/rno-miR-331 hsa-miR-214/mmu-miR-214/rno-miR- GCB hsa-miR-215 GCB 214 hsa-miR-600 GCB hsa-miR-146b-5p/mmu-miR-146b/rno- GCB mghv-miR-M1-7-3p GCB miR-146b hsa-miR-107/mmu-miR-107/rno- GCB hsa-miR-342-3p/mmu-miR-342-3p/rno- GCB miR-107 miR-342-3p hsa-miR-886-3p GCB hsa-miR-374a GCB hsa-miR-140-5p/mmu-miR-140/rno- GCB hsa-miR-223/mmu-miR-223/rno-miR- GCB miR-140 223 hsa-miR-154/mmu-miR-154/rno- GCB hsa-miR-29b/mmu-miR-29b/rno-miR- GCB miR-154 29b hsa-miR-103/mmu-miR-103/rno- GCB hsa-miR-21/mmu-miR-21/rno-miR-21 GCB miR-103 hsa-miR-29a/mmu-miR-29a/rno-miR- GCB hsa-let-7g/mmu-let-7g GCB 29a hsa-miR-222/mmu-miR-222/rno- GCB hsa-miR-23b/mmu-miR-23b/rno-miR- GCB miR-222 23b hsa-miR-221/mmu-miR-221/rno- GCB hsa-miR-24/mmu-miR-24/rno-miR-24 GCB miR-221 hsa-miR-26a/mmu-miR-26a/rno-miR- GCB hsa-miR-320/mmu-miR-320/rno- GCB 26a miR-320 hsa-miR-26b/mmu-miR-26b/rno-miR- GCB 26b hsa-miR-34b/mmu-miR-34b-3p GCB hsa-miR-503 BL hsa-miR-30b* BL

TABLE 22 Predictor microRNAs that distinguish germinal center B-cell like (GCB) DLBCL from chronic lymphocytic leukemia Higher Higher GCB vs CLL in GCB vs CLL (con't) in GCB vs CLL (con't) Higher in hsa-miR-181a/mmu- GCB hsa-miR-100/mmu- GCB hsa-miR-374a CLL miR-181a/rno-miR- miR-100/rno-miR-100 hsa-miR-142-5p/mmu- CLL 181a hsa-miR-371-5p GCB miR-142-5p/rno-miR- hsa-miR-886-5p GCB hsa-miR-193a-5p GCB 142-5p mghv-miR-M1-7-3p GCB hsa-miR-628-3p GCB hsa-miR-29c/mmu- CLL hsa-miR-934 GCB hsa-miR-185* GCB miR-29c/rno-miR-29c mghv-miR-M1-3 GCB hsa-miR-10b/mmu- GCB hsa-miR-140-3p/mmu- CLL hsa-miR-485- GCB miR-10b/rno-miR-10b miR-140*/rno-miR- 3p/mmu-miR-485* hsa-miR-665 GCB 140* hsa-miR-125b/mmu- GCB hsa-miR-503 GCB hsa-miR-30e/mmu- CLL miR-125b-5p/rno- hsa-miR-642 GCB miR-30e/rno-miR-30e miR-125b-5p hsa-miR-658 GCB hsa-miR-801/mmu- CLL hsa-miR-637 GCB hsa-miR-21/mmu- GCB miR-801 hsa-miR-365/mmu- GCB miR-21/rno-miR-21 hsa-miR-768-3p CLL miR-365/rno-miR- hsa-miR-23a/mmu- GCB hsa-miR-549 CLL 365 miR-23a/rno-miR-23a hsa-miR-199a-5p/mmu- CLL hsa-miR-505* GCB hsa-miR-125a- GCB miR-199a-5p/rno-miR- hsa-miR-199a- GCB 5p/mmu-miR-125a- 199a-5p 3p/hsa-miR-199b- 5p/rno-miR-125a-5p hsa-miR-223/mmu- CLL 3p/mmu-miR-199a- hsa-miR-24/mmu- GCB miR-223/rno-miR-223 3p/mmu-miR- miR-24/rno-miR-24 hsa-miR-101/mmu- CLL 199b/rno-miR-199a- hsa-miR-23b/mmu- GCB miR-101a/rno-miR- 3p miR-23b/rno-miR-23b 101a hsa-miR-675 GCB hsa-miR-620 GCB hsa-miR-888* CLL hsa-miR-424 GCB hsa-miR-933 GCB hsa-miR-24-1*/mmu- CLL ebv-miR-BHRF1-2 GCB hsa-miR-30b* GCB miR-24-1*/rno-miR-24- hsa-miR-519c- GCB hsa-miR-22/mmu- GCB 1* 5p/hsa-miR-519b- miR-22/rno-miR-22 hsa-miR-519d CLL 5p/hsa-miR- hsa-let-7e/mmu-let- GCB hsa-miR-154/mmu- CLL 523*/hsa-miR- 7e/rno-let-7e miR-154/rno-miR-154 518e*/hsa-miR- mghv-miR-M1-4 GCB hsa-miR-638 CLL 522*/hsa-miR- hsa-miR-149* GCB hsa-miR-668/mmu- CLL 519a* hsa-miR-765 GCB miR-668 hsa-miR-130a/mmu- GCB hsa-let-7c/mmu-let- GCB hsa-miR-891a CLL miR-130a/rno-miR- 7c/rno-let-7c hsa-miR-768-5p CLL 130a hsa-miR-423- CLL hsa-miR-140-5p/mmu- CLL hsa-miR-943 GCB 5p/mmu-miR-423-5p miR-140/rno-miR-140 hsa-miR-126/mmu- GCB hsa-miR-32* CLL hsa-miR-196a*/mmu- CLL miR-126-3p/rno- hsa-miR-34b/mmu- CLL miR-196a*/rno-miR- miR-126 miR-34b-3p 196a* hsa-miR-193b GCB hsa-miR-551b/mmu- CLL hsa-miR-150/mmu- CLL hsa-miR-198 GCB miR-551b/rno-miR- miR-150/rno-miR-150 hsa-miR- GCB 551b hsa-let-7g/mmu-let-7g CLL 200b*/mmu-miR- hsa-let-7i/mmu-let- CLL hsa-miR-363/mmu- CLL 200b* 7i/rno-let-7i miR-363/rno-miR-363 kshv-miR-K12-6-3p GCB hsa-miR-29a/mmu- CLL hsa-miR-486-5p/mmu- CLL hsa-miR-220c GCB miR-29a/rno-miR-29a miR-486 hsa-miR-374b* GCB hsa-miR-138- CLL hsa-miR-32/mmu-miR- CLL hsa-miR-518b GCB 1*/mmu-miR- 32/rno-miR-32 hsa-miR-920 GCB 138*/rno-miR-138* hsa-miR-147 CLL hsa-miR-125b- GCB hsa-miR-29b/mmu- CLL hsa-miR-20b* CLL 1*/mmu-miR-125b- miR-29b/rno-miR-29b hsa-miR-487b/mmu- CLL 3p/rno-miR-125b-3p hsa-miR-191/mmu- CLL miR-487b/rno-miR- ebv-miR-BART8* GCB miR-191/rno-miR-191 487b ebv-miR-BART16 GCB hsa-miR-26b/mmu- CLL hsa-miR-636 CLL hsa-miR-630 GCB miR-26b/rno-miR-26b hsa-miR-144* CLL hsa-miR-483-5p GCB hsa-miR-26a/mmu- CLL hsa-miR-186/mmu- CLL hsa-miR-422a GCB miR-26a/rno-miR-26a miR-186/rno-miR-186 hsa-miR-526b GCB hsa-miR-550 CLL hsa-miR-30e*/mmu- CLL hsa-miR-145/mmu- GCB miR-30e*/rno-miR- miR-145/rno-miR- 30e* 145 hsa-miR-331-5p/mmu- CLL hsa-miR-126*/mmu- GCB miR-331-5p miR-126-5p/rno- miR-126* hsa-miR-143/mmu- GCB miR-143/rno-miR- 143

TABLE 23 Predictor microRNAs that distinguish germinal center B-cell like (GCB) DLBCL from follicular lymphoma Higher Higher Higher GCB vs FL in GCB vs FL (con't) in GCB vs FL (con't) in hsa-miR-378/mmu- GCB hcmv-miR-UL148D FL hsa-miR-425/mmu- FL miR-378/rno-miR-378 hsa-miR-497/mmu-miR- FL miR-425/rno-miR-425 hsa-miR-20b/mmu- GCB 497/rno-miR-497 hsa-miR-99b*/mmu- FL miR-20b/rno-miR-20b- ebv-miR-BART13 FL miR-99b*/rno-miR- 5p ebv-miR-BART16 FL 99b* hsa-miR-19b/mmu- GCB hsa-miR-125b-2*/rno- FL hsa-miR-513a-3p FL miR-19b/rno-miR-19b miR-125b* hsa-miR-206/mmu- FL hsa-miR-106a GCB hsa-miR-490-3p/mmu- FL miR-206/rno-miR-206 hsa-miR-17/mmu-miR- GCB miR-490 hsa-miR-155* FL 17/rno-miR-17-5p/rno- hsa-miR-99b/mmu-miR- FL hsa-miR-181b/mmu- FL miR-17 99b/rno-miR-99b miR-181b/rno-miR- hsa-miR-93/mmu-miR- GCB hsa-miR-339-5p/mmu- FL 181b 93/rno-miR-93 miR-339-5p/rno-miR- hsa-miR-299-3p FL hsa-miR-20a/mmu- GCB 339-5p hsa-miR-218-2*/mmu- FL miR-20a/rno-miR-20a hsa-miR-574-3p/mmu- FL miR-218-2*/rno-miR- hsa-miR-23b/mmu- GCB miR-574-3p 218* miR-23b/rno-miR-23b hsa-miR-515-5p FL mghv-miR-M1-8 FL hsa-miR-23a/mmu- GCB hsa-miR-877/mmu-miR- FL ebv-miR-BART18-3p FL miR-23a/rno-miR-23a 877/rno-miR-877 hsa-miR-708/mmu- FL hsa-miR-22/mmu-miR- GCB hsa-miR-208a/mmu-miR- FL miR-708/rno-miR-708 22/rno-miR-22 208a/rno-miR-208 hsa-miR-409-5p/mmu- FL hsa-miR-19a/mmu- GCB hcmv-miR-US25-1* FL miR-409-5p/rno-miR- miR-19a/rno-miR-19a hsa-miR-326/mmu-miR- FL 409-5p hsa-miR-320/mmu- GCB 326/rno-miR-326 hsa-miR-553 FL miR-320/rno-miR-320 hsa-miR-488 FL hsa-miR-361-3p FL hsa-miR-106b/mmu- GCB hsa-miR-629 FL hsa-miR-296-3p/mmu- FL miR-106b/rno-miR- hsa-miR-24-2*/mmu- FL miR-296-3p/rno-miR- 106b miR-24-2*/rno-miR-24- 296 hsa-miR-103/mmu- GCB 2* ebv-miR-BHRF1-3 FL miR-103/rno-miR-103 hsa-miR-124/mmu-miR- FL hsa-miR-34c-5p/mmu- FL hsa-miR-30c/mmu- GCB 124/rno-miR-124 miR-34c/rno-miR-34c miR-30c/rno-miR-30c hsa-miR-493 FL hsa-let-7b*/mmu-let- FL ebv-miR-BHRF1-2 GCB hsv1-miR-H1 FL 7b*/rno-let-7b* hsa-miR-125a- GCB hsa-miR-484/mmu-miR- FL hsa-miR-301a/mmu- FL 5p/mmu-miR-125a- 484/rno-miR-484 miR-301a/rno-miR- 5p/rno-miR-125a-5p hsa-miR-483-3p FL 301a hsa-let-7a/mmu-let- GCB hsa-miR-27a*/mmu-miR- FL hsa-miR-122* FL 7a/rno-let-7a 27a*/rno-miR-27a* hsa-miR-183/mmu- FL hsa-miR-628-3p GCB hsa-miR-144* FL miR-183/rno-miR-183 hsa-let-7c/mmu-let- GCB hsa-miR-617 FL kshv-miR-K12-5 FL 7c/rno-let-7c hsa-miR-377* FL kshv-miR-K12-7 FL hsa-miR-423-5p/mmu- FL hsa-miR-363*/rno-miR- FL hsa-miR-552 FL miR-423-5p 363* hsa-miR-151-3p FL hsa-miR-24-1*/mmu- FL hsa-miR-148b/mmu-miR- FL hsa-miR-194/mmu- FL miR-24-1*/rno-miR- 148b/rno-miR-148b-3p miR-194/rno-miR-194 24-1* kshv-miR-K12-1 FL hsa-miR-585 FL ebv-miR-BART2-3p FL hsa-miR-7/mmu-miR- FL hsa-miR-340*/mmu- FL hsa-miR-138-1*/mmu- FL 7a/rno-miR-7a miR-340-3p/rno-miR- miR-138*/rno-miR- hsa-miR-193b* FL 340-3p 138* hsa-miR-542-3p/mmu- FL hsa-let-7d*/mmu-let- FL hsa-miR-768-5p FL miR-542-3p/rno-miR- 7d*/rno-let-7d* hsa-miR-30b* FL 542-3p hsa-miR-622 FL hsa-miR-494/mmu- FL hsa-miR-601 FL hsa-miR-575 FL miR-494/rno-miR-494 hsa-miR-106b*/mmu- FL hsa-miR-514 FL hsa-miR-583 FL miR-106b*/rno-miR- hsa-miR-92b/mmu- FL hsa-miR-185/mmu- FL 106b* miR-92b/rno-miR-92b miR-185/rno-miR-185 hsa-miR-7-2* FL hsa-miR-551a FL hsa-miR-765 FL kshv-miR-K12-6-5p FL hsa-miR-221* FL hsa-miR-34b/mmu- FL hsa-miR-645 FL hsa-miR-922 FL miR-34b-3p hsa-miR-524-5p FL hsa-miR-938 FL hsa-miR-921 FL hsa-miR-548d-5p FL hsa-miR-615-3p/mmu- FL hsa-miR-551b/mmu- FL hsa-miR-9*/mmu-miR- FL miR-615-3p miR-551b/rno-miR- 9*/rno-miR-9* hsa-miR-220b FL 551b hsa-miR-92a/mmu-miR- FL hsa-miR-744/mmu- FL hsa-miR-549 FL 92a/rno-miR-92a miR-744 hsa-miR-939 FL hsa-miR-22*/mmu-miR- FL hsa-miR-657 FL hsa-miR-302d* FL 22*/rno-miR-22* hsa-miR-382/mmu- FL ebv-miR-BART17-5p FL hsa-miR-500* FL miR-382/rno-miR-382 hsa-miR-801/mmu- FL hsa-miR-890 FL hsa-miR-518a-3p FL miR-801 hsa-miR-297/mmu-miR- FL hsa-miR-138/mmu- FL hsa-miR-888* FL 297a miR-138/rno-miR-138 hsa-miR-620 FL hsa-miR-197/mmu-miR- FL hsa-miR-636 FL hsa-miR-576-3p FL 197 hsa-miR-96/mmu- FL hsa-miR-32* FL hsa-miR-20b* FL miR-96/rno-miR-96 hsa-miR-574-5p/mmu- FL hsa-miR-629* FL hsa-miR-509-3-5p FL miR-574-5p hsa-miR-887 FL hsa-miR-337-3p FL hsa-miR-505/rno-miR- FL hsa-miR-342-5p/mmu- FL 505 miR-342-5p/rno-miR- hsa-miR-885-5p FL 342-5p hsa-miR-455-3p FL hsa-miR-152/mmu- FL miR-152/rno-miR-152 hsa-miR-200b*/mmu- FL miR-200b* mghv-miR-M1-2 FL

TABLE 24 Predictor microRNAs that distinguish germinal center B-cell like (GCB) DLBCL from Hodgkin's lymphoma Higher Higher Higher GCB vs HL in GCB vs HL (con't) in GCB vs HL (con't) in hsa-miR-19b/mmu-miR- GCB hsa-miR-130b/mmu- HL hsa-miR-744/mmu- HL 19b/rno-miR-19b miR-130b/rno-miR-130b miR-744 hsa-miR-19a/mmu-miR- GCB hsa-miR-671-5p/mmu- HL kshv-miR-K12-6-5p HL 19a/rno-miR-19a miR-671-5p hcmv-miR-US25-1* HL hsa-miR-106a GCB hsa-miR-525-5p HL hsa-miR-21* HL hsa-miR-20b/mmu-miR- GCB hsa-miR-505/rno-miR- HL mghv-miR-M1-6 HL 20b/rno-miR-20b-5p 505 mghv-miR-M1-8 HL hsa-miR-17/mmu-miR- GCB hsa-miR-488 HL hsa-miR-10a*/mmu- HL 17/rno-miR-17-5p/rno- hsa-miR-766 HL miR-10a*/rno-miR- miR-17 hsa-miR-20b* HL 10a-3p hsa-miR-15b/mmu-miR- GCB hsa-miR-339-5p/mmu- HL hsa-miR-345 HL 15b/rno-miR-15b miR-339-5p/rno-miR- hsa-miR-887 HL hsa-miR-20a/mmu-miR- GCB 339-5p hsa-miR-193b* HL 20a/rno-miR-20a hsa-miR-524-5p HL hsa-miR-122* HL hsa-miR-30b/mmu-miR- GCB hsa-miR-455-3p HL kshv-miR-K12-5 HL 30b/rno-miR-30b-5p hsa-miR-92a/mmu-miR- HL hsa-miR-92b* HL hsa-miR-142-3p/mmu-miR- GCB 92a/rno-miR-92a hsa-miR-526b* HL 142-3p/rno-miR-142-3p hsa-miR-502-3p HL hsa-miR-553 HL hsa-miR-30c/mmu-miR- GCB hsa-miR-210/mmu-miR- HL hsa-miR-601 HL 30c/rno-miR-30c 210/rno-miR-210 hiv1-miR-H1 HL hsa-miR-378/mmu-miR- GCB hsv1-miR-H1 HL hsa-miR-623 HL 378/rno-miR-378 ebv-miR-BART6-3p HL hsa-miR-519e HL hsa-miR-93/mmu-miR- GCB hsa-miR-490-3p/mmu- HL hsa-miR-650 HL 93/rno-miR-93 miR-490 hsa-miR-575 HL hsa-miR-106b/mmu-miR- GCB hsa-miR-149/mmu-miR- HL hsa-miR-629* HL 106b/rno-miR-106b 149 hsa-miR-890 HL hsa-miR-374a GCB hsa-miR-128/mmu-miR- HL hsa-miR- HL hsa-miR-24/mmu-miR- GCB 128/rno-miR-128 150*/mmu-miR- 24/rno-miR-24 hsa-miR-635 HL 150* hsa-miR-29b/mmu-miR- GCB hcmv-miR-UL148D HL hsa-miR- HL 29b/rno-miR-29b hsa-miR-373* HL 425*/mmu-miR- hsa-miR-22/mmu-miR- GCB hsa-miR-647 HL 425* 22/rno-miR-22 hsa-miR-197/mmu-miR- HL hsa-miR- HL hsa-miR-142-5p/mmu-miR- GCB 197 135a*/mmu-miR- 142-5p/rno-miR-142-5p hsa-miR-602 HL 135a* hsa-miR-30e/mmu-miR- GCB hsa-miR-656 HL hsa-miR-612 HL 30e/rno-miR-30e hsa-miR-874/mmu-miR- HL hsa-miR-636 HL hsa-miR-30a/mmu-miR- GCB 874/rno-miR-874 hsa-miR-500 HL 30a/rno-miR-30a ebv-miR-BART19-3p HL hsa-miR-502-5p HL hsa-miR-30d/mmu-miR- GCB hsa-miR-551b* HL hsa-miR-9*/mmu- HL 30d/rno-miR-30d hsa-miR-96/mmu-miR- HL miR-9*/rno-miR-9* hsa-miR-23b/mmu-miR- GCB 96/rno-miR-96 hsa-miR-500* HL 23b/rno-miR-23b hsa-miR-889 HL hsa-miR- HL hsa-miR-16/mmu-miR- GCB hsa-miR-425/mmu-miR- HL 124*/mmu-miR- 16/rno-miR-16 425/rno-miR-425 124*/rno-miR-124* hsa-miR-191/mmu-miR- GCB hsa-miR-34c-5p/mmu- HL hsa-miR-30c- HL 191/rno-miR-191 miR-34c/rno-miR-34c 1*/mmu-miR-30c- hsa-miR-15a/mmu-miR- GCB hcmv-miR-UL70-3p HL 1*/rno-miR-30c-1* 15a hsa-miR-27a*/mmu- HL hsa-miR- HL hsa-miR-26b/mmu-miR- GCB miR-27a*/rno-miR-27a* 99b*/mmu-miR- 26b/rno-miR-26b hsa-miR-194/mmu-miR- HL 99b*/rno-miR-99b* hsa-miR-23a/mmu-miR- GCB 194/rno-miR-194 hsa-miR-331- HL 23a/rno-miR-23a hsa-miR-17*/rno-miR- HL 5p/mmu-miR-331- hsa-let-7a/mmu-let-7a/rno- GCB 17-3p 5p let-7a hsa-miR-548d-5p HL hsa-miR-206/mmu- HL hsa-miR-103/mmu-miR- GCB hsa-miR-7/mmu-miR- HL miR-206/rno-miR- 103/rno-miR-103 7a/rno-miR-7a 206 hsa-miR-140-3p/mmu-miR- GCB hsa-miR-877/mmu-miR- HL hsa-miR-376a* HL 140*/rno-miR-140* 877/rno-miR-877 hsa-miR-585 HL hsa-miR-154/mmu-miR- GCB hsa-miR-22*/mmu-miR- HL hsa-miR-640 HL 154/rno-miR-154 22*/rno-miR-22* hsa-miR-377* HL hsa-miR-320/mmu-miR- GCB hsa-miR-323-3p/mmu- HL hsa-miR-125a- HL 320/rno-miR-320 miR-323-3p/rno-miR- 3p/mmu-miR-125a- hsa-miR-550 GCB 323 3p/rno-miR-125a-3p hsa-miR-125a-5p/mmu- GCB hsa-miR-708/mmu-miR- HL hsa-miR-24- HL miR-125a-5p/rno-miR- 708/rno-miR-708 2*/mmu-miR-24- 125a-5p hsa-miR-513a-3p HL 2*/rno-miR-24-2* hsa-let-7c/mmu-let-7c/rno- GCB hsa-miR-595 HL hsa-miR-484/mmu- HL let-7c hsa-miR-922 HL miR-484/rno-miR- hsa-miR-185/mmu-miR- HL hsa-miR-515-5p HL 484 185/rno-miR-185 hsa-miR-99b/mmu-miR- HL hsa-miR- HL hsa-miR-658 HL 99b/rno-miR-99b 106b*/mmu-miR- hsa-miR-549 HL hsa-miR-483-3p HL 106b*/rno-miR- hsa-miR-634 HL hsa-miR-330-5p/mmu- HL 106b* hsa-miR-551b/mmu-miR- HL miR-330/rno-miR-330 hsa-let-7b*/mmu- HL 551b/rno-miR-551b hsa-miR-509-3p HL let-7b*/rno-let-7b* hsa-miR-518c* HL hsa-miR-151-3p HL hsa-miR-302c* HL hsa-miR-888* HL ebv-miR-BART13 HL hsa-miR-542- HL hsa-miR-765 HL hsa-miR-617 HL 5p/mmu-miR-542- hsa-miR-423-5p/mmu-miR- HL hsa-miR-328/mmu-miR- HL 5p/rno-miR-542-5p 423-5p 328/rno-miR-328 hsa-miR-622 HL hsa-miR-30c-2*/mmu-miR- HL hsa-miR-361-3p HL ebv-miR-BHRF1-3 HL 30c-2*/rno-miR-30c-2* hsa-miR-138/mmu-miR- HL hsa-miR-181a-2* HL hsa-miR-503 HL 138/rno-miR-138 hsa-miR-183/mmu- HL hsa-miR-921 HL ebv-miR-BART7* HL miR-183/rno-miR- hsa-miR-520d-5p HL hsa-miR-589 HL 183 hsa-miR-574-5p/mmu-miR- HL hsa-miR-576-5p HL hsa-miR-409- HL 574-5p hsa-miR-452 HL 5p/mmu-miR-409- hsa-miR-32* HL hsa-miR-7-2* HL 5p/rno-miR-409-5p hsa-miR-939 HL hsa-miR-296-5p/mmu- HL ebv-miR-BART20- HL ebv-miR-BART2-3p HL miR-296-5p/rno-miR- 3p ebv-miR-BHRF1-2 HL 296* hsa-miR-629 HL hsa-miR-583 HL hsa-miR-550* HL hsa-let-7d*/mmu- HL hsa-miR-30b* HL hsa-miR-92b/mmu-miR- HL let-7d*/rno-let-7d* hsa-miR-149* HL 92b/rno-miR-92b hsa-miR-645 HL mghv-miR-M1-4 HL kshv-miR-K12-1 HL hsa-miR-492 HL hsa-miR-513a-5p HL hsa-miR-526a/hsa-miR- HL hsa-miR-654-5p HL hsa-miR-494/mmu-miR- HL 520c-5p/hsa-miR-518d- hsa-miR-208a/mmu- HL 494/rno-miR-494 5p miR-208a/rno-miR- hsa-miR-498 HL mghv-miR-M1-2 HL 208 hsa-miR-485-3p/mmu-miR- HL hsa-miR-548b-3p HL hsa-miR-584 HL 485* hsa-miR-297/mmu-miR- HL hsa-miR-382/mmu- HL hsa-miR-129-5p/mmu-miR- HL 297a miR-382/rno-miR- 129-5p/rno-miR-129 hsa-miR-195* HL 382 hsa-miR-25* HL hsa-miR-652/mmu-miR- HL hsa-miR- HL hsa-miR-923 HL 652/rno-miR-652 340*/mmu-miR- hsa-miR-519d HL hsa-miR-221* HL 340-3p/rno-miR- hsa-miR-516a-5p HL hsa-miR-194* HL 340-3p hsa-miR-99a/mmu-miR- HL hsa-miR-23a*/rno-miR- HL hsa-miR-490-5p HL 99a/rno-miR-99a 23a* hsa-miR-663 HL hsa-miR-943 HL hsa-miR-125b-2*/rno- HL hsa-miR-337-3p HL hsa-miR-885-5p HL miR-125b* hsa-miR-518a-3p HL ebv-miR-BHRF1-1 HL hsa-miR-212/mmu-miR- HL ebv-miR-BART9* HL hsa-miR-152/mmu-miR- HL 212/rno-miR-212 hsa-miR-342- HL 152/rno-miR-152 ebv-miR-BART18-3p HL 5p/mmu-miR-342- ebv-miR-BART8* HL hsa-miR-586 HL 5p/rno-miR-342-5p hsa-miR-200b*/mmu-miR- HL hsa-miR-137/mmu-miR- HL hsa-miR-514 HL 200b* 137/rno-miR-137 hsa-miR-508-5p HL hsa-miR-125b-1*/mmu- HL hsa-miR-610 HL hsa-miR-124/mmu- HL miR-125b-3p/rno-miR- hcmv-miR-UL112 HL miR-124/rno-miR- 125b-3p hsa-miR-181b/mmu- HL 124 hsa-miR-526b HL miR-181b/rno-miR-181b hsa-miR-657 HL hsa-miR-29a*/mmu-miR- HL hsa-miR-936 HL hsa-miR-938 HL 29a*/rno-miR-29a* hsa-miR-296- HL hsa-miR-532-5p/mmu-miR- HL 3p/mmu-miR-296- 532-5p/rno-miR-532-5p 3p/rno-miR-296 hsa-miR-183*/mmu-miR- HL hsa-miR-551a HL 183* hsa-miR-542- HL hsa-miR-659 HL 3p/mmu-miR-542- hsa-miR-145*/mmu-miR- HL 3p/rno-miR-542-3p 145* hsa-miR-220b HL mghv-miR-M1-7-5p HL hsa-miR-326/mmu- HL hsa-miR-143* HL miR-326/rno-miR- hsa-miR-660 HL 326 hsa-miR-615- HL 3p/mmu-miR-615- 3p hsa-miR-433/mmu- HL miR-433/rno-miR- 433 hsa-miR-202 HL hsa-miR-338- HL 5p/mmu-miR-338- 5p/rno-miR-338* hsa-miR-552 HL hsa-miR-299-3p HL hsa-miR-509-3-5p HL

TABLE 25 Predictor microRNAs that distinguish Burkitt lymphoma from chromic lymphocytic leukemia BL vs CLL Higher in hsa-miR-874/mmu- BL miR-874/rno-miR-874 hsa-miR-125b/mmu- BL miR-125b-5p/rno-miR- 125b-5p hsa-miR-126/mmu- BL miR-126-3p/rno-miR- 126 ebv-miR-BHRF1-2 BL hsa-miR-193b BL hsa-miR-371-5p BL hsa-miR-193a-5p BL hsa-miR-628-3p BL hsa-miR-185* BL hsa-miR-503 BL hsa-miR-199a-3p/hsa- BL miR-199b-3p/mmu- miR-199a-3p/mmu- miR-199b/rno-miR- 199a-3p hsa-miR-143/mmu- BL miR-143/rno-miR-143 hsa-miR-130a/mmu- BL miR-130a/rno-miR- 130a hsa-miR-145/mmu- BL miR-145/rno-miR-145 hsa-miR-30b* BL hsa-miR-665 BL hsa-miR-658 BL hsa-miR-933 BL hsa-miR-30c-2*/mmu- BL miR-30c-2*/rno-miR- 30c-2* hsa-miR-765 BL hsa-miR-620 BL hsa-miR-520d-5p BL hsa-miR-494/mmu- BL miR-494/rno-miR-494 hsa-miR-551b/mmu- CLL miR-551b/rno-miR- 551b hsa-miR-106b/mmu- CLL miR-106b/rno-miR- 106b hsa-miR-30c/mmu- CLL miR-30c/rno-miR-30c hsa-miR-16/mmu-miR- CLL 16/rno-miR-16 hsa-miR-27a/mmu- CLL miR-27a/rno-miR-27a hsa-miR-27b/mmu- CLL miR-27b/rno-miR-27b hsa-miR-550 CLL hsa-miR-30a/mmu- CLL miR-30a/rno-miR-30a hsa-miR-30b/mmu-miR- CLL 30b/rno-miR-30b-5p hsa-miR-34b/mmu-miR- CLL 34b-3p hsa-miR-801/mmu-miR- CLL 801 hsa-miR-26b/mmu-miR- CLL 26b/rno-miR-26b hsa-let-7b/mmu-let- CLL 7b/rno-let-7b hsa-miR-142-5p/mmu- CLL miR-142-5p/rno-miR- 142-5p hsa-miR-26a/mmu-miR- CLL 26a/rno-miR-26a hsa-miR-29a/mmu-miR- CLL 29a/rno-miR-29a hsa-miR-768-3p CLL hsa-miR-199a-5p/mmu- CLL miR-199a-5p/rno-miR- 199a-5p hsa-miR-30e/mmu-miR- CLL 30e/rno-miR-30e hsa-miR-29b/mmu-miR- CLL 29b/rno-miR-29b hsa-miR-101/mmu-miR- CLL 101a/rno-miR-101a hsa-miR-138-1*/mmu- CLL miR-138*/rno-miR-138* hsa-miR-195/mmu-miR- CLL 195/rno-miR-195 hsa-miR-549 CLL hsa-miR-103/mmu-miR- CLL 103/rno-miR-103 hsa-miR-649 CLL hsa-miR-335/mmu-miR- CLL 335-5p/rno-miR-335 hsa-miR-342-3p/mmu- CLL miR-342-3p/rno-miR- 342-3p hsa-miR-423-3p/mmu- CLL miR-423-3p/rno-miR- 423 hsa-miR-222/mmu-miR- CLL 222/rno-miR-222 hsa-miR-374a CLL hsa-miR-888* CLL hsa-miR-30d/mmu-miR- CLL 30d/rno-miR-30d hsa-miR-299-5p/mmu- CLL miR-299*/rno-miR-299 hsa-miR-107/mmu-miR- CLL 107/rno-miR-107 hsa-miR-105 CLL hsa-let-7f/mmu-let- CLL 7f/rno-let-7f hsa-miR-191/mmu-miR- CLL 191/rno-miR-191 hsa-miR-223/mmu-miR- CLL 223/rno-miR-223 hsa-miR-361-5p/mmu- CLL miR-361/rno-miR-361 hsa-miR-29c/mmu- CLL miR-29c/rno-miR-29c hsa-miR-147 CLL hsa-miR-361-3p CLL hsa-miR-140-3p/mmu- CLL miR-140*/rno-miR- 140* hsa-miR-486-5p/mmu- CLL miR-486 hsa-miR-33a/mmu- CLL miR-33/rno-miR-33 hsa-miR-636 CLL hsa-miR-24-1*/mmu- CLL miR-24-1*/rno-miR-24- 1* hsa-miR-144* CLL hsa-miR-668/mmu- CLL miR-668 hsa-miR-768-5p CLL hsa-miR-363/mmu- CLL miR-363/rno-miR-363 hsa-miR-150/mmu- CLL miR-150/rno-miR-150 hsa-miR-519d CLL hsa-miR-891a CLL hsa-miR-186/mmu- CLL miR-186/rno-miR-186 hsa-miR-331-5p/mmu- CLL miR-331-5p hsa-miR-28-5p/mmu- CLL miR-28/rno-miR-28 hsa-miR-154/mmu- CLL miR-154/rno-miR-154 hsa-miR-155 CLL hsa-miR-363*/rno-miR- CLL 363* hsa-miR-32/mmu-miR- CLL 32/rno-miR-32 hsa-miR-30e*/mmu- CLL miR-30e*/rno-miR- 30e* hsa-miR-140-5p/mmu- CLL miR-140/rno-miR-140 hsa-let-7g/mmu-let-7g CLL hsa-miR-20b* CLL hsa-miR-129* CLL hsa-miR-196a*/mmu- CLL miR-196a*/rno-miR- 196a* hsa-miR-487b/mmu- CLL miR-487b/rno-miR- 487b

TABLE 26 Predictor microRNAs that distinguish Burkitt lymphoma from follicular lymphoma BL vs FL Higher in hsa-miR-17/mmu-miR- BL 17/rno-miR-17-5p/rno- miR-17 hsa-miR-106a BL hsa-miR-19b/mmu-miR- BL 19b/rno-miR-19b hsa-miR-20a/mmu-miR- BL 20a/rno-miR-20a hsa-miR-19a/mmu-miR- BL 19a/rno-miR-19a hsa-miR-628-3p BL hsa-miR-503 BL hsa-miR-371-5p BL hsa-miR-106b/mmu- BL miR-106b/rno-miR-106b hsa-miR-30c-2*/mmu- BL miR-30c-2*/rno-miR- 30c-2* ebv-miR-BART2-3p FL hsa-let-7e/mmu-let- FL 7e/rno-let-7e hsa-miR-551b/mmu- FL miR-551b/rno-miR-551b hsa-miR-26b/mmu-miR- FL 26b/rno-miR-26b hsa-miR-26a/mmu-miR- FL 26a/rno-miR-26a hsa-miR-620 FL hsa-miR-801/mmu-miR- FL 801 ebv-miR-BART17-5p FL hsa-miR-29a/mmu-miR- FL 29a/rno-miR-29a hsa-miR-34b/mmu-miR- FL 34b-3p hsa-miR-32* FL hsa-miR-29b/mmu-miR- FL 29b/rno-miR-29b hsa-miR-649 FL hsa-miR-576-3p FL hsa-miR-302a/mmu- FL miR-302a hsa-miR-365/mmu-miR- FL 365/rno-miR-365 hsa-miR-148a/mmu- FL miR-148a hsa-miR-146b-5p/mmu- FL miR-146b/rno-miR-146b hsa-miR-505/rno-miR- FL 505 hsa-miR-33a/mmu-miR- FL 33/rno-miR-33 hsa-miR-455-3p FL hsa-miR-374b/mmu- FL miR-374/rno-miR-374 hsa-miR-214/mmu-miR- FL 214/rno-miR-214 hsa-miR-138-1*/mmu- FL miR-138*/rno-miR-138* hsa-miR-140-3p/mmu- FL miR-140*/rno-miR-140* hsa-miR-212/mmu-miR- FL 212/rno-miR-212 hsa-miR-29c/mmu-miR- FL 29c/rno-miR-29c hsa-miR-888* FL hsa-miR-222/mmu-miR- FL 222/rno-miR-222 hsa-miR-152/mmu-miR- FL 152/rno-miR-152 hsa-miR-183*/mmu- FL miR-183* hsa-miR-768-5p FL hsa-miR-107/mmu-miR- FL 107/rno-miR-107 hsa-miR-574-5p/mmu- FL miR-574-5p hsa-miR-154/mmu-miR- FL 154/rno-miR-154 hsa-miR-620 FL hsa-miR-886-5p FL hsa-miR-208a/mmu- FL miR-208a/rno-miR-208 hsa-miR-374b* FL hsa-miR-525-5p FL hsa-miR-363/mmu-miR- FL 363/rno-miR-363 hsa-miR-99b/mmu-miR- FL 99b/rno-miR-99b hsa-miR-148b/mmu- FL miR-148b/rno-miR- 148b-3p kshv-miR-K12-6-5p FL hsa-miR-125b-1*/mmu- FL miR-125b-3p/rno-miR- 125b-3p hsa-miR-526b FL hsa-miR-629 FL hsa-miR-617 FL hsa-miR-124/mmu-miR- FL 124/rno-miR-124 hsa-miR-493 FL hsa-miR-24-1*/mmu- FL miR-24-1*/rno-miR- 24-1* hsa-miR-200b*/mmu- FL miR-200b* hsa-miR-484/mmu- FL miR-484/rno-miR-484 hsa-miR-483-3p FL hsa-miR-516b FL hsa-miR-125b-2*/rno- FL miR-125b* hsa-miR-490-3p/mmu- FL miR-490 hsa-miR-140-5p/mmu- FL miR-140/rno-miR-140 hsa-miR-877/mmu- FL miR-877/rno-miR-877 hsa-miR-381/mmu- FL miR-381/rno-miR-381 hsa-miR-193b* FL hsa-miR-635 FL hsa-miR-542-3p/mmu- FL miR-542-3p/rno-miR- 542-3p hsa-miR-181a-2* FL hsa-miR-32/mmu- FL miR-32/rno-miR-32 hsa-miR-105 FL hsa-miR-488 FL hsa-miR-505* FL ebv-miR-BART16 FL hsa-miR-891a FL hsa-miR-221/mmu- FL miR-221/rno-miR-221 hsa-miR-7/mmu-miR- FL 7a/rno-miR-7a hsa-miR-299-3p FL hsa-miR-575 FL hsa-miR-585 FL hsa-miR-30e*/mmu- FL miR-30e*/rno-miR- 30e* hcmv-miR-US25-1* FL hsa-miR-708/mmu- FL miR-708/rno-miR-708 hsv1-miR-H1 FL hsa-let-7g/mmu-let-7g FL hsa-miR-146a/mmu- FL miR-146a/rno-miR- 146a ebv-miR-BART8* FL hsa-miR-106b*/mmu- FL miR-106b*/rno-miR- 106b* hsa-miR-601 FL hsa-miR-553 FL hsa-miR-518b FL hsa-miR-548d-5p FL hsa-miR-382/mmu- FL miR-382/rno-miR-382 hsa-miR-630 FL hsa-miR-144* FL hsa-miR-519d FL mghv-miR-M1-3 FL hsa-miR-497/mmu- FL miR-497/rno-miR-497 hsa-miR-524-5p FL hsa-miR-500* FL hsa-miR-920 FL hsa-miR-297/mmu- FL miR-297a hsa-miR-509-3-5p FL hsa-miR-340*/mmu- FL miR-340-3p/rno-miR- 340-3p hsa-miR-99b*/mmu- FL miR-99b*/rno-miR- 99b* hsa-miR-887 FL hsa-miR-331-3p/mmu- FL miR-331-3p/rno-miR- 331 hsa-miR-206/mmu- FL miR-206/rno-miR-206 hsa-miR-377* FL mghv-miR-M1-8 FL hsa-miR-513a-3p FL hsa-miR-146b-3p FL hsa-miR-155* FL hsa-miR-574-3p/mmu- FL miR-574-3p hsa-miR-615-3p/mmu- FL miR-615-3p hsa-miR-28-5p/mmu- FL miR-28/rno-miR-28 hsa-miR-934 FL hsa-miR-151-5p/mmu- FL miR-151-5p/rno-miR- 151 hsa-miR-885-5p FL hsa-miR-409-5p/mmu- FL miR-409-5p/rno-miR- 409-5p hsa-let-7d*/mmu-let- FL 7d*/rno-let-7d* hsa-miR-155 FL hsa-let-7b*/mmu-let- FL 7b*/rno-let-7b* hsa-miR-7-2* FL hsa-miR-221* FL hsa-miR-9*/mmu-miR- FL 9*/rno-miR-9* hsa-miR-122* FL hsa-miR-130b/mmu- FL miR-130b/rno-miR- 130b hsa-miR-183/mmu- FL miR-183/rno-miR-183 hsa-miR-92a/mmu- FL miR-92a/rno-miR-92a hsa-miR-890 FL hsa-miR-938 FL kshv-miR-K12-7 FL hsa-miR-629* FL hsa-miR-922 FL kshv-miR-K12-5 FL hsa-miR-197/mmu- FL miR-197 hsa-miR-552 FL hsa-miR-151-3p FL hsa-miR-194/mmu- FL miR-194/rno-miR-194 hsa-miR-218-2*/mmu- FL miR-218-2*/rno-miR- 218* hsa-miR-181b/mmu- FL miR-181b/rno-miR- 181b ebv-miR-BART18-3p FL hsa-miR-34c-5p/mmu- FL miR-34c/rno-miR-34c hsa-miR-622 FL hsa-miR-514 FL hsa-miR-657 FL hsa-miR-518a-3p FL hsa-miR-647 FL hsa-miR-22*/mmu- FL miR-22*/rno-miR-22* hsa-miR-196a*/mmu- FL miR-196a*/rno-miR- 196a* kshv-miR-K12-1 FL hsa-miR-425/mmu- FL miR-425/rno-miR-425 hsa-miR-361-3p FL hsa-miR-220b FL hsa-miR-744/mmu- FL miR-744 hsa-miR-551a FL hsa-miR-301a/mmu- FL miR-301a/rno-miR- 301a hsa-miR-92b/mmu- FL miR-92b/rno-miR-92b hsa-miR-487b/mmu- FL miR-487b/rno-miR- 487b hsa-miR-363*/rno-miR- FL 363* hsa-miR-337-3p FL hsa-miR-636 FL hsa-miR-600 FL hsa-miR-138/mmu- FL miR-138/rno-miR-138 hsa-miR-96/mmu-miR- FL 96/rno-miR-96 hsa-miR-20b* FL hsa-miR-342-5p/mmu- FL miR-342-5p/rno-miR- 342-5p hsa-miR-215 FL hsa-miR-129* FL

TABLE 27 Predictor microRNAs that distinguish Burkitt lymphoma from Hodgkin's lymphoma BL vs HL Higher in hsa-miR-19b/mmu-miR- BL 19b/rno-miR-19b hsa-miR-19a/mmu-miR- BL 19a/rno-miR-19a hsa-miR-17/mmu-miR- BL 17/rno-miR-17-5p/rno- miR-17 hsa-miR-106a BL hsa-miR-20a/mmu-miR- BL 20a/rno-miR-20a hsa-miR-106b/mmu-miR- BL 106b/rno-miR-106b hsa-miR-30c/mmu-miR- BL 30c/rno-miR-30c hsa-miR-551b/mmu-miR- HL 551b/rno-miR-551b hsa-miR-921 HL ebv-miR-BART2-3p HL hsa-miR-32* HL hsa-miR-494/mmu-miR- HL 494/rno-miR-494 hsa-miR-29c/mmu-miR- HL 29c/rno-miR-29c hsa-miR-923 HL hsa-miR-199b-5p HL hsa-miR-148a/mmu-miR- HL 148a hsa-miR-130a/mmu-miR- HL 130a/rno-miR-130a hsa-miR-154/mmu-miR- HL 154/rno-miR-154 hsa-miR-151-5p/mmu- HL miR-151-5p/rno-miR-151 hsa-miR-28-5p/mmu- HL miR-28/rno-miR-28 hsa-miR-365/mmu-miR- HL 365/rno-miR-365 hsa-miR-602 HL hsa-miR-222/mmu-miR- HL 222/rno-miR-222 hsa-miR-214/mmu-miR- HL 214/rno-miR-214 hsa-miR-144* HL hsa-miR-107/mmu-miR- HL 107/rno-miR-107 hsa-miR-497/mmu-miR- HL 497/rno-miR-497 hsa-let-7g/mmu-let-7g HL hsa-miR-146a/mmu-miR- HL 146a/rno-miR-146a hsa-miR-186/mmu-miR- HL 186/rno-miR-186 hsa-miR-886-5p HL hsa-miR-152/mmu-miR- HL 152/rno-miR-152 hsa-miR-29a*/mmu-miR- HL 29a*/rno-miR-29a* hsa-miR-140-5p/mmu- HL miR-140/rno-miR-140 hsa-miR-532-5p/mmu- HL miR-532-5p/rno-miR- 532-5p hsa-miR-145*/mmu-miR- HL 145* hsa-miR-515-5p HL hsa-miR-153/mmu-miR- HL 153/rno-miR-153 hsa-miR-513a-5p HL hsa-miR-516a-5p HL hsa-miR-660 HL hsa-miR-29c*/mmu-miR- HL 29c*/rno-miR-29c* hsa-miR-505/rno-miR- HL 505 hsa-miR-455-3p HL hsa-miR-519e* HL hsa-miR-502-3p HL hsa-miR-922 HL hsa-miR-524-5p HL hsa-miR-483-5p HL hsa-miR-708/mmu-miR- HL 708/rno-miR-708 hsa-miR-498 HL ebv-miR-BART19-3p HL hsa-miR-149/mmu-miR- HL 149 hsa-miR-574-3p/mmu- HL miR-574-3p hsa-miR-659 HL hsa-miR-331-3p/mmu- HL miR-331-3p/rno-miR-331 hsa-miR-105 HL hsa-miR-128/mmu-miR- HL 128/rno-miR-128 hsa-miR-200b*/mmu- HL miR-200b* hsa-miR-381/mmu-miR- HL 381/rno-miR-381 hsa-miR-766 HL hsa-miR-557 HL ebv-miR-BART16 HL hsa-miR-488 HL hsa-miR-516b HL mghv-miR-M1-2 HL hsa-miR-891a HL hsa-miR-221/mmu-miR- HL 221/rno-miR-221 hsa-miR-146b-3p HL hsa-miR-526b HL mghv-miR-M1-3 HL hsa-miR-505* HL hsv1-miR-H1 HL hcmv-miR-UL70-3p HL hsa-miR-24-2*/mmu- HL miR-24-2*/rno-miR-24- 2* hsa-miR-617 HL hsa-miR-194/mmu-miR- HL 194/rno-miR-194 hsa-miR-934 HL hsa-miR-220c HL hsa-miR-548d-5p HL hsa-miR-937 HL ebv-miR-BART13 HL hsa-miR-7/mmu-miR- HL 7a/rno-miR-7a hsa-miR-210/mmu-miR- HL 210/rno-miR-210 hsa-miR-490-3p/mmu- HL miR-490 hsa-miR-221* HL hsa-miR-92a/mmu-miR- HL 92a/rno-miR-92a hsa-miR-183*/mmu-miR- HL 183* hsa-miR-513a-3p HL hsa-miR-575 HL hsa-miR-595 HL hsa-miR-920 HL hsa-miR-483-3p HL hsa-miR-330-5p/mmu- HL miR-330/rno-miR-330 hsa-miR-525-5p HL hsa-miR-99b/mmu-miR- HL 99b/rno-miR-99b hsa-miR-509-3p HL hsa-miR-151-3p HL ebv-miR-BHRF1-1 HL hsa-miR-630 HL mghv-miR-M1-7-3p HL hsa-miR-328/mmu-miR- HL 328/rno-miR-328 hsa-miR-452 HL hsa-miR-635 HL ebv-miR-BART5 HL hsa-miR-373* HL hsa-miR-96/mmu-miR- HL 96/rno-miR-96 hsa-miR-382/mmu-miR- HL 382/rno-miR-382 hsa-miR-155 HL hsa-miR-197/mmu-miR- HL 197 kshv-miR-K12-6-5p HL hcmv-miR-UL112 HL hsa-miR-551b* HL hsa-miR-877/mmu-miR- HL 877/rno-miR-877 hsa-miR-589 HL hsa-miR-936 HL hsa-miR-34c-5p/mmu- HL miR-34c/rno-miR-34c hsa-miR-885-5p HL ebv-miR-BART6-3p HL hsa-miR-585 HL hsa-miR-302c* HL hsa-miR-196a*/mmu- HL miR-196a*/rno-miR- 196a* hsa-miR-195* HL hsa-miR-17*/rno-miR-17- HL 3p hsa-miR-296-5p/mmu- HL miR-296-5p/rno-miR- 296* hsa-miR-550* HL ebv-miR-BHRF1-3 HL hsa-miR-296-3p/mmu- HL miR-296-3p/rno-miR-296 hsa-miR-526b* HL hsa-miR-548b-3p HL hsa-miR-652/mmu-miR- HL 652/rno-miR-652 hsa-miR-297/mmu-miR- HL 297a hsa-miR-553 HL hsa-miR-194* HL hsa-miR-23a*/rno-miR- HL 23a* hsa-miR-130b/mmu-miR- HL 130b/rno-miR-130b hsa-miR-586 HL hsa-miR-137/mmu-miR- HL 137/rno-miR-137 hsa-miR-610 HL mghv-miR-M1-8 HL hsa-miR-193b* HL hsa-miR-519d HL hsa-miR-125b-1*/mmu- HL miR-125b-3p/rno-miR- 125b-3p hsa-miR-744/mmu-miR- HL 744 hsa-miR-138/mmu-miR- HL 138/rno-miR-138 hsa-miR-21* HL hsa-miR-576-5p HL hsa-miR-125a-3p/mmu- HL miR-125a-3p/rno-miR- 125a-3p mghv-miR-M1-6 HL hsa-miR-425/mmu-miR- HL 425/rno-miR-425 hsa-miR-10a*/mmu-miR- HL 10a*/rno-miR-10a-3p hsa-miR-215 HL hsa-miR-345 HL hsa-miR-887 HL hsa-miR-7-2* HL hsa-miR-122* HL hsa-miR-363*/rno-miR- HL 363* hsa-miR-22*/mmu-miR- HL 22*/rno-miR-22* hsa-miR-542-5p/mmu- HL miR-542-5p/rno-miR- 542-5p hsa-miR-92b* HL hsa-miR-526a/hsa- HL miR-520c-5p/hsa- miR-518d-5p kshv-miR-K12-5 HL hsa-miR- HL 340*/mmu-miR- 340-3p/rno-miR- 340-3p hsa-let-7d*/mmu- HL let-7d*/rno-let-7d* hsa-miR-92b/mmu- HL miR-92b/rno-miR- 92b hsa-miR-518b HL hiv1-miR-H1 HL hsa-miR-623 HL hsa-miR-645 HL hsa-miR-601 HL hsa-miR-519e HL hsa-miR-650 HL hsa-miR-361-3p HL hsa-miR- HL 150*/mmu-miR- 150* hsa-miR- HL 425*/mmu-miR- 425* hsa-miR- HL 135a*/mmu-miR- 135a* hsa-miR-518a-3p HL hsa-miR-612 HL hsa-miR-212/mmu- HL miR-212/rno-miR- 212 hsa-miR-125b- HL 2*/rno-miR-125b* hsa-miR-500 HL hsa-miR-663 HL hsa-miR-647 HL hsa-miR-502-5p HL ebv-miR-BART18- HL 3p hsa-miR- HL 99b*/mmu-miR- 99b*/rno-miR-99b* ebv-miR-BART7* HL hsa-miR-500* HL hsa-miR- HL 124*/mmu-miR- 124*/rno-miR-124* hsa-miR-206/mmu- HL miR-206/rno-miR- 206 hsa-miR-615- HL 3p/mmu-miR-615- 3p hsa-miR-30c- HL 1*/mmu-miR-30c- 1*/rno-miR-30c-1* hsa-miR-331- HL 5p/mmu-miR-331- 5p hcmv-miR-US25-1* HL hsa-miR-326/mmu- HL miR-326/rno-miR- 326 hsa-miR- HL 181b/mmu-miR- 181b/rno-miR-181b hsa-miR-376a* HL hsa-miR-433/mmu- HL miR-433/rno-miR- 433 hsa-miR-640 HL hsa-miR-938 HL hsa-miR-508-5p HL hsa-miR-484/mmu- HL miR-484/rno-miR- 484 hsa-miR- HL 106b*/mmu-miR- 106b*/rno-miR- 106b* hsa-miR-600 HL hsa-let-7b*/mmu- HL let-7b*/rno-let-7b* hsa-miR-20b* HL hsa-miR-622 HL hsa-miR-657 HL hsa-miR-183/mmu- HL miR-183/rno-miR- 183 hsa-miR-409- HL 5p/mmu-miR-409- 5p/rno-miR-409-5p ebv-miR-BART20- HL 3p ebv-miR-BART8* HL hsa-miR-129* HL hsa-miR-629 HL hsa-miR-890 HL hsa-miR-208a/mmu- HL miR-208a/rno-miR- 208 hsa-miR-492 HL hsa-miR-629* HL hsa-miR-654-5p HL hsa-miR-584 HL hsa-miR-636 HL hsa-miR-490-5p HL hsa-miR-337-3p HL hsa-miR-9*/mmu- HL miR-9*/rno-miR-9* ebv-miR-BART9* HL hsa-miR-509-3-5p HL hsa-miR-342- HL 5p/mmu-miR-342- 5p/rno-miR-342-5p hsa-miR-514 HL hsa-miR-377* HL kshv-miR-K12-1 HL hsa-miR-124/mmu- HL miR-124/rno-miR- 124 hsa-miR-542- HL 3p/mmu-miR-542- 3p/rno-miR-542-3p hsa-miR-220b HL hsa-miR-299-3p HL hsa-miR-181a-2* HL hsa-miR-202 HL hsa-miR- HL 487b/mmu-miR- 487b/rno-miR-487b hsa-miR-551a HL hsa-miR-338- HL 5p/mmu-miR-338- 5p/rno-miR-338* hsa-miR-552 HL

TABLE 28 Predictor microRNAs that distinguish chronic lymphocytic leukemia from follicular lymphoma CLL vs FL Higher in hsa-miR-331-5p/mmu- CLL miR-331-5p hsa-miR-144/mmu-miR- CLL 144/rno-miR-144 hsa-miR-150/mmu-miR- CLL 150/rno-miR-150 hsa-miR-140-5p/mmu- CLL miR-140/rno-miR-140 hsa-miR-335/mmu-miR- CLL 335-5p/rno-miR-335 hsa-miR-186/mmu-miR- CLL 186/rno-miR-186 hsa-miR-486-5p/mmu- CLL miR-486 hsa-miR-154/mmu-miR- CLL 154/rno-miR-154 hsa-miR-223/mmu-miR- CLL 223/rno-miR-223 hsa-miR-299-5p/mmu- CLL miR-299*/rno-miR-299 hsa-let-7g/mmu-let-7g CLL hsa-miR-32/mmu-miR- CLL 32/rno-miR-32 hsa-miR-30e*/mmu-miR- CLL 30e*/rno-miR-30e* hsa-miR-147 CLL hsa-miR-20b/mmu-miR- CLL 20b/rno-miR-20b-5p hsa-miR-101/mmu-miR- CLL 101a/rno-miR-101a hsa-let-7f/mmu-let-7f/rno- CLL let-7f hsa-miR-30e/mmu-miR- CLL 30e/rno-miR-30e hsa-miR-668/mmu-miR- CLL 668 hsa-miR-768-5p CLL hsa-miR-19a/mmu-miR- CLL 19a/rno-miR-19a hsa-miR-199a-5p/mmu- CLL miR-199a-5p/rno-miR- 199a-5p hsa-miR-638 CLL hsa-miR-196a*/mmu-miR- CLL 196a*/rno-miR-196a* hsa-miR-19b/mmu-miR- CLL 19b/rno-miR-19b hsa-miR-30d/mmu-miR- CLL 30d/rno-miR-30d hsa-miR-363/mmu-miR- CLL 363/rno-miR-363 hsa-miR-374a CLL hsa-miR-140-3p/mmu- CLL miR-140*/rno-miR-140* hsa-miR-185/mmu-miR- CLL 185/rno-miR-185 hsa-miR-106b/mmu-miR- CLL 106b/rno-miR-106b hsa-miR-106a CLL hsa-miR-191/mmu-miR- CLL 191/rno-miR-191 hsa-miR-17/mmu-miR- CLL 17/rno-miR-17-5p/rno- miR-17 hsa-let-7i/mmu-let-7i/rno- CLL let-7i hsa-miR-20a/mmu-miR- CLL 20a/rno-miR-20a hsa-miR-142-5p/mmu- CLL miR-142-5p/rno-miR-142- 5p hsa-miR-768-3p CLL hsa-miR-30b/mmu-miR- CLL 30b/rno-miR-30b-5p hsa-miR-891a CLL hsa-miR-24-1*/mmu-miR- CLL 24-1*/rno-miR-24-1* hsa-miR-29c/mmu-miR- CLL 29c/rno-miR-29c hsa-miR-28-5p/mmu-miR- CLL 28/rno-miR-28 hsa-miR-30a/mmu-miR- CLL 30a/rno-miR-30a hsa-miR-155 CLL hsa-miR-361-5p/mmu- CLL miR-361/rno-miR-361 hsa-miR-15a/mmu-miR- CLL 15a hsa-miR-26a/mmu-miR- CLL 26a/rno-miR-26a hsa-miR-30c/mmu-miR- CLL 30c/rno-miR-30c hsa-miR-541* CLL hsa-miR-26b/mmu-miR- CLL 26b/rno-miR-26b hsa-miR-519d CLL hsa-miR-15b/mmu-miR- CLL 15b/rno-miR-15b hsa-miR-550 CLL hsa-miR-29b/mmu-miR- CLL 29b/rno-miR-29b hsa-miR-29a/mmu-miR- CLL 29a/rno-miR-29a hsa-miR-103/mmu-miR- CLL 103/rno-miR-103 hsa-miR-423-3p/mmu- CLL miR-423-3p/rno-miR-423 hsa-miR-549 CLL hsa-miR-107/mmu-miR- CLL 107/rno-miR-107 hsa-miR-888* CLL hsa-miR-801/mmu-miR- CLL 801 hsa-miR-149* FL hsa-miR-634 FL ebv-miR-BART2-3p FL hsa-miR-921 FL hsa-miR-494/mmu-miR- FL 494/rno-miR-494 hsa-miR-933 FL mghv-miR-M1-4 FL hsa-let-7e/mmu-let-7e/rno- FL let-7e hsa-miR-939 FL hsa-miR-518c* FL hsa-miR-32* FL hsa-miR-491-3p FL hsa-miR-185/mmu-miR- FL 185/rno-miR-185 hsa-miR-765 FL ebv-miR-BART17-5p FL hsa-miR-576-3p FL hsa-miR-658 FL hsa-miR-503 FL hsa-miR-30b* FL hsa-miR-302a/mmu-miR- FL 302a hsa-miR-628-3p FL hsa-miR-642 FL hsa-miR-620 FL hsa-miR-99a/mmu- FL miR-99a/rno-miR- 99a hsa-miR-371-5p FL hsa-miR-452 FL hsa-miR-126*/mmu- FL miR-126-5p/rno- miR-126* hsa-miR-298 FL hsa-miR-193a-5p FL hsa-miR-583 FL hsa-miR-143/mmu- FL miR-143/rno-miR- 143 hsa-miR-665 FL hsa-miR-505/rno- FL miR-505 hsa-miR-199b-5p FL hsa-miR-28-3p/rno- FL miR-28* hsa-miR-422a FL hsa-miR-515-5p FL hsa-miR-455-3p FL hsa-miR-10a/mmu- FL miR-10a/rno-miR- 10a-5p hsa-miR-300 FL ebv-miR-BART5 FL hsa-miR-10b/mmu- FL miR-10b/rno-miR- 10b hsa-miR-212/mmu- FL miR-212/rno-miR- 212 hsa-miR-145/mmu- FL miR-145/rno-miR- 145 hsa-miR-187* FL ebv-miR-BHRF1-1 FL ebv-miR-BHRF1-2 FL hsa-miR-126/mmu- FL miR-126-3p/rno- miR-126 hsa-miR- FL 130b*/mmu-miR- 130b* hsa-miR-326/mmu- FL miR-326/rno-miR- 326 mghv-miR-M1-2 FL kshv-miR-K12-6-3p FL hsa-miR-516b FL hsa-miR-519e* FL mghv-miR-M1-7-3p FL hsa-miR-629 FL hsa-miR-24-2*/mmu- FL miR-24-2*/rno-miR- 24-2* hsa-miR-943 FL hsa-miR-124/mmu- FL miR-124/rno-miR- 124 hsa-miR-365/mmu- FL miR-365/rno-miR- 365 hsa-miR-493 FL hsa-miR-29c*/mmu- FL miR-29c*/rno-miR- 29c* hsa-miR-602 FL hsa-miR-484/mmu- FL miR-484/rno-miR- 484 hsa-miR-483-3p FL hsa-miR-125b- FL 2*/rno-miR-125b* hsa-miR-675 FL mghv-miR-M1-7-5p FL hsa-miR-152/mmu- FL miR-152/rno-miR- 152 hsa-miR-27a*/mmu- FL miR-27a*/rno-miR- 27a* hsa-miR-542- FL 3p/mmu-miR-542- 3p/rno-miR-542-3p hsa-miR-100/mmu- FL miR-100/rno-miR- 100 hsa-miR-208a/mmu- FL miR-208a/rno-miR- 208 hsa-miR-766 FL hsa-miR-637 FL hsa-miR-519c- FL 5p/hsa-miR-519b- 5p/hsa-miR- 523*/hsa-miR- 518e*/hsa-miR- 522*/hsa-miR-519a* hsa-miR-409- FL 5p/mmu-miR-409- 5p/rno-miR-409-5p hsa-miR-199a- FL 3p/hsa-miR-199b- 3p/mmu-miR-199a- 3p/mmu-miR- 199b/rno-miR-199a- 3p hsa-miR- FL 106b*/mmu-miR- 106b*/rno-miR- 106b* hsa-miR-130a/mmu- FL miR-130a/rno-miR- 130a hsa-miR-645 FL hsa-miR-548d-5p FL hsa-miR-671- FL 5p/mmu-miR-671-5p hsa-miR-574- FL 3p/mmu-miR-574-3p hsa-miR-125b/mmu- FL miR-125b-5p/rno- miR-125b-5p hsa-miR-500* FL hsa-miR-425/mmu- FL miR-425/rno-miR- 425 ebv-miR-BART8* FL hsa-miR-377* FL hsa-miR-513a-3p FL hsa-miR-181a-2* FL hsa-miR-938 FL hsa-miR-155* FL hsa-miR-218- FL 2*/mmu-miR-218- 2*/rno-miR-218* hsa-miR-198 FL hsa-miR-151-3p FL hsa-miR-299-3p FL hcmv-miR-US25-1* FL hsa-miR-708/mmu- FL miR-708/rno-miR- 708 hsa-miR-659 FL hsa-miR-600 FL hsa-miR-601 FL hsa-miR-296- FL 3p/mmu-miR-296- 3p/rno-miR-296 hsa-let-7b*/mmu-let- FL 7b*/rno-let-7b* ebv-miR-BART6-3p FL hsa-miR-7-2* FL hsa-miR-9*/mmu- FL miR-9*/rno-miR-9* hsa-miR-509-3-5p FL hsa-miR-518b FL hsa-miR-183*/mmu- FL miR-183* hsa-miR-125b- FL 1*/mmu-miR-125b- 3p/rno-miR-125b-3p hsa-miR-183/mmu- FL miR-183/rno-miR- 183 hsa-miR-890 FL hsa-miR-153/mmu- FL miR-153/rno-miR- 153 hsa-miR-874/mmu- FL miR-874/rno-miR- 874 hsa-miR-220c FL hsa-miR-99b*/mmu- FL miR-99b*/rno-miR- 99b* hsa-miR-193b* FL hsa-miR-629* FL hcmv-miR-UL148D FL ebv-miR-BART7* FL hsa-miR-99b/mmu- FL miR-99b/rno-miR- 99b hsa-miR-206/mmu- FL miR-206/rno-miR- 206 hsa-miR-381/mmu- FL miR-381/rno-miR- 381 hsa-miR-194/mmu- FL miR-194/rno-miR- 194 hsa-miR-525-5p FL hsa-miR-193b FL hsa-miR-497/mmu- FL miR-497/rno-miR- 497 ebv-miR-BART18- FL 3p hsa-miR-424 FL hsa-miR-553 FL hsa-let-7d*/mmu-let- FL 7d*/rno-let-7d* hsa-miR-34c- FL 5p/mmu-miR- 34c/rno-miR-34c ebv-miR-BHRF1-3 FL kshv-miR-K12-6-5p FL hsa-miR-551a FL hsa-miR-195* FL hsa-miR-551b* FL hsa-miR-514 FL hsa-miR-552 FL hsa-miR-122* FL hsa-miR-92b/mmu- FL miR-92b/rno-miR- 92b hsa-miR-22*/mmu- FL miR-22*/rno-miR- 22* hsa-miR-635 FL kshv-miR-K12-1 FL hsa-miR-483-5p FL hsa-miR-340*/mmu- FL miR-340-3p/rno- miR-340-3p hsa-miR-615- FL 3p/mmu-miR-615-3p hsa-miR-505* FL hsa-miR-622 FL hsa-miR-181b/mmu- FL miR-181b/rno-miR- 181b hsa-miR-886-5p FL hsa-miR-885-5p FL hsa-miR-220b FL hsa-miR-524-5p FL hsa-miR-382/mmu- FL miR-382/rno-miR- 382 hsa-miR-744/mmu- FL miR-744 hsv1-miR-H1 FL hsa-miR-526b FL hsa-miR-657 FL hsa-miR-130b/mmu- FL miR-130b/rno-miR- 130b hsa-miR-181a/mmu- FL miR-181a/rno-miR- 181a hsa-miR-301a/mmu- FL miR-301a/rno-miR- 301a hsa-miR-490- FL 3p/mmu-miR-490 hsa-miR-485- FL 3p/mmu-miR-485* hsa-miR-297/mmu- FL miR-297a hsa-miR-630 FL hsa-miR-877/mmu- FL miR-877/rno-miR- 877 kshv-miR-K12-5 FL hsa-miR-617 FL mghv-miR-M1-3 FL hsa-miR-920 FL hsa-miR-585 FL hsa-miR-374b* FL hsa-miR-215 FL hsa-miR-342- FL 5p/mmu-miR-342- 5p/rno-miR-342-5p hsa-miR-934 FL hsa-miR-575 FL hsa-miR-488 FL ebv-miR-BART16 FL hsa-miR-647 FL hsa-miR-138/mmu- FL miR-138/rno-miR- 138 hsa-miR-221* FL hsa-miR- FL 200b*/mmu-miR- 200b* hsa-miR-337-3p FL hsa-miR-922 FL hsa-miR-197/mmu- FL miR-197 hsa-miR-96/mmu- FL miR-96/rno-miR-96 hsa-miR-518a-3p FL

TABLE 29 Predictor microRNAs that distinguish Burkitt lymphoma from Hodgkin's lymphoma CLL vs HL Higher in hsa-miR-32/mmu-miR- CLL 32/rno-miR-32 hsa-miR-30e*/mmu-miR- CLL 30e*/rno-miR-30e* hsa-let-7g/mmu-let-7g CLL hsa-miR-144/mmu-miR- CLL 144/rno-miR-144 hsa-miR-140-5p/mmu- CLL miR-140/rno-miR-140 hsa-miR-19a/mmu-miR- CLL 19a/rno-miR-19a hsa-miR-154/mmu-miR- CLL 154/rno-miR-154 hsa-miR-150/mmu-miR- CLL 150/rno-miR-150 hsa-miR-28-5p/mmu- CLL miR-28/rno-miR-28 hsa-miR-363/mmu-miR- CLL 363/rno-miR-363 hsa-miR-101/mmu-miR- CLL 101a/rno-miR-101a hsa-miR-299-5p/mmu- CLL miR-299*/rno-miR-299 hsa-miR-768-5p CLL hsa-miR-19b/mmu-miR- CLL 19b/rno-miR-19b hsa-miR-30e/mmu-miR- CLL 30e/rno-miR-30e hsa-miR-20b/mmu-miR- CLL 20b/rno-miR-20b-5p hsa-miR-374a CLL hsa-let-7f/mmu-let-7f/rno- CLL let-7f hsa-miR-335/mmu-miR- CLL 335-5p/rno-miR-335 hsa-miR-142-5p/mmu- CLL miR-142-5p/rno-miR-142- 5p hsa-miR-486-5p/mmu- CLL miR-486 hsa-miR-33a/mmu-miR- CLL 33/rno-miR-33 hsa-miR-30b/mmu-miR- CLL 30b/rno-miR-30b-5p hsa-miR-768-3p CLL hsa-miR-668/mmu-miR- CLL 668 hsa-miR-15b/mmu-miR- CLL 15b/rno-miR-15b hsa-miR-196a*/mmu- CLL miR-196a*/rno-miR-196a* hsa-miR-140-3p/mmu- CLL miR-140*/rno-miR-140* hsa-miR-29b/mmu-miR- CLL 29b/rno-miR-29b hsa-miR-29c/mmu-miR- CLL 29c/rno-miR-29c hsa-miR-186/mmu-miR- CLL 186/rno-miR-186 hsa-miR-106a CLL hsa-miR-26a/mmu-miR- CLL 26a/rno-miR-26a hsa-miR-106b/mmu-miR- CLL 106b/rno-miR-106b hsa-miR-17/mmu-miR- CLL 17/rno-miR-17-5p/rno- miR-17 hsa-miR-191/mmu-miR- CLL 191/rno-miR-191 hsa-miR-20a/mmu-miR- CLL 20a/rno-miR-20a hsa-miR-30c/mmu-miR- CLL 30c/rno-miR-30c hsa-miR-26b/mmu-miR- CLL 26b/rno-miR-26b hsa-miR-147 CLL hsa-miR-15a/mmu-miR- CLL 15a hsa-miR-30d/mmu-miR- CLL 30d/rno-miR-30d hsa-miR-199a-5p/mmu- CLL miR-199a-5p/rno-miR- 199a-5p hsa-miR-29a/mmu-miR- CLL 29a/rno-miR-29a hsa-miR-223/mmu-miR- CLL 223/rno-miR-223 hsa-miR-30a/mmu-miR- CLL 30a/rno-miR-30a hsa-miR-16/mmu-miR- CLL 16/rno-miR-16 hsa-miR-451/mmu-miR- CLL 451/rno-miR-451 hsa-miR-24-1*/mmu-miR- CLL 24-1*/rno-miR-24-1* hsa-miR-550 CLL hsa-miR-342-3p/mmu- CLL miR-342-3p/rno-miR-342- 3p hsa-miR-195/mmu-miR- CLL 195/rno-miR-195 hsa-miR-801/mmu-miR- CLL 801 hsa-miR-541* CLL hsa-let-7i/mmu-let-7i/rno- CLL let-7i hsa-miR-155 CLL hsa-miR-185/mmu-miR- CLL 185/rno-miR-185 hsa-miR-891a CLL hsa-miR-138-1*/mmu- CLL miR-138*/rno-miR-138* hsa-miR-27b/mmu-miR- CLL 27b/rno-miR-27b hsa-miR-361-5p/mmu- CLL miR-361/rno-miR-361 hsa-miR-129* CLL hsa-miR-638 CLL hsa-miR-34b/mmu-miR- CLL 34b-3p hsa-miR-107/mmu-miR- CLL 107/rno-miR-107 hsa-miR-549 CLL hsa-miR-888* CLL hsa-miR-423-3p/mmu- CLL miR-423-3p/rno-miR-423 hsa-let-7e/mmu-let- HL 7e/rno-let-7e hsa-miR-125a-5p/mmu- HL miR-125a-5p/rno-miR- 125a-5p hsa-miR-576-3p HL hsa-miR-513a-5p HL ebv-miR-BART17-5p HL hsa-miR-185/mmu-miR- HL 185/rno-miR-185 hsa-miR-921 HL hsa-miR-518c* HL hsa-miR-520d-5p HL hsa-miR-939 HL hsa-miR-634 HL hsa-miR-491-3p HL ebv-miR-BART2-3p HL hsa-miR-30c-2*/mmu- HL miR-30c-2*/rno-miR-30c- 2* hsa-miR-765 HL hsa-miR-923 HL hsa-miR-620 HL hsa-miR-933 HL hsa-miR-143/mmu-miR- HL 143/rno-miR-143 hsa-miR-494/mmu-miR- HL 494/rno-miR-494 hsa-miR-665 HL hsa-miR-642 HL hsa-miR-126*/mmu-miR- HL 126-5p/rno-miR-126* hsa-miR-658 HL hsa-miR-149* HL hsa-miR-30b* HL mghv-miR-M1-4 HL hsa-miR-99a/mmu-miR- HL 99a/rno-miR-99a hsa-miR-193a-5p HL hsa-miR-498 HL hsa-miR-628-3p HL hsa-miR-185* HL hsa-miR-371-5p HL hsa-miR-199b-5p HL hsa-miR-126/mmu-miR- HL 126-3p/rno-miR-126 hsa-miR-503 HL hsa-miR-10a/mmu-miR- HL 10a/rno-miR-10a-5p hsa-miR-300 HL hsa-miR-583 HL hsa-miR-518a-5p/hsa- HL miR-527 hsa-miR-10b/mmu-miR- HL 10b/rno-miR-10b hsa-miR-145/mmu- HL miR-145/rno-miR- 145 hsa-miR-128/mmu- HL miR-128/rno-miR- 128 hsa-miR-532- HL 5p/mmu-miR-532- 5p/rno-miR-532-5p hsa-miR-143* HL hsa-miR-28-3p/rno- HL miR-28* hsa-miR- HL 130b*/mmu-miR- 130b* hsa-miR-505/rno- HL miR-505 hsa-miR-25* HL hsa-miR-574- HL 3p/mmu-miR-574-3p hsa-miR-455-3p HL kshv-miR-K12-3 HL hsa-miR-516b HL kshv-miR-K12-8 HL hsa-miR-502-3p HL kshv-miR-K12-6-3p HL hsa-miR-129- HL 5p/mmu-miR-129- 5p/rno-miR-129 hsa-miR-515-5p HL hsa-miR-199a- HL 3p/hsa-miR-199b- 3p/mmu-miR-199a- 3p/mmu-miR- 199b/rno-miR-199a- 3p hsa-miR-149/mmu- HL miR-149 hsa-miR-889 HL hsa-miR-637 HL hsa-miR-600 HL hsa-miR-151-3p HL hsa-miR-656 HL hsa-miR-497/mmu- HL miR-497/rno-miR- 497 hsa-miR-152/mmu- HL miR-152/rno-miR- 152 hsa-miR-100/mmu- HL miR-100/rno-miR- 100 hsa-miR-425/mmu- HL miR-425/rno-miR- 425 hsa-miR-145*/mmu- HL miR-145* hsa-miR-365/mmu- HL miR-365/rno-miR- 365 hsa-miR-422a HL hcmv-miR-UL70-3p HL hsa-miR-27a*/mmu- HL miR-27a*/rno-miR- 27a* hsa-miR-194/mmu- HL miR-194/rno-miR- 194 hsa-miR-548d-5p HL hsa-miR-187* HL hsa-miR-323- HL 3p/mmu-miR-323- 3p/rno-miR-323 hsa-miR-708/mmu- HL miR-708/rno-miR- 708 hsa-miR-29c*/mmu- HL miR-29c*/rno-miR- 29c* hsa-miR-513a-3p HL hsa-miR-595 HL hsa-miR-483-3p HL hsa-miR-330- HL 5p/mmu-miR- 330/rno-miR-330 hsa-miR-519e* HL hsa-miR-509-3p HL hsa-miR-328/mmu- HL miR-328/rno-miR- 328 hsa-miR-373* HL hsa-miR-96/mmu- HL miR-96/rno-miR-96 hsa-miR-215 HL hsa-miR-589 HL hsa-miR-34c- HL 5p/mmu-miR- 34c/rno-miR-34c hsa-miR-125b/mmu- HL miR-125b-5p/rno- miR-125b-5p hsa-miR-130a/mmu- HL miR-130a/rno-miR- 130a hsa-miR-519c- HL 5p/hsa-miR-519b- 5p/hsa-miR- 523*/hsa-miR- 518e*/hsa-miR- 522*/hsa-miR-519a* mghv-miR-M1-7-5p HL hsa-miR-516a-5p HL hsa-miR-424 HL hsa-miR-17*/rno- HL miR-17-3p hsa-miR-296- HL 5p/mmu-miR-296- 5p/rno-miR-296* hsa-miR-550* HL hsa-miR-210/mmu- HL miR-210/rno-miR- 210 hsa-miR-92b/mmu- HL miR-92b/rno-miR- 92b hsa-miR-548b-3p HL hsa-miR-652/mmu- HL miR-652/rno-miR- 652 hsa-miR-138/mmu- HL miR-138/rno-miR- 138 hsa-miR-194* HL hsa-miR-23a*/rno- HL miR-23a* hsa-miR-153/mmu- HL miR-153/rno-miR- 153 hsa-miR-586 HL hsa-miR-137/mmu- HL miR-137/rno-miR- 137 hsa-miR-610 HL hsa-miR-381/mmu- HL miR-381/rno-miR- 381 hsa-miR-936 HL hsa-miR-744/mmu- HL miR-744 ebv-miR-BART5 HL ebv-miR-BHRF1-1 HL hsa-miR-21* HL hsa-miR-576-5p HL mghv-miR-M1-6 HL hsa-miR-193b HL hsa-miR-10a*/mmu- HL miR-10a*/rno-miR- 10a-3p hsa-miR-524-5p HL hsa-miR-452 HL hsa-miR-345 HL hsa-miR-7-2* HL hsa-miR-409- HL 5p/mmu-miR-409- 5p/rno-miR-409-5p hsa-miR-557 HL hsa-miR-181a/mmu- HL miR-181a/rno-miR- 181a hsa-miR-22*/mmu- HL miR-22*/rno-miR-22* hsa-miR-922 HL hsa-miR-92b* HL hsa-miR-938 HL hsa-miR-526a/hsa- HL miR-520c-5p/hsa- miR-518d-5p hsa-miR-526b* HL ebv-miR-BHRF1-2 HL hiv1-miR-H1 HL hsa-miR-623 HL mghv-miR-M1-2 HL mghv-miR-M1-7-3p HL hsa-miR-519e HL hsa-miR-650 HL hsa-miR-766 HL hsa-miR-602 HL hsa-miR-425*/mmu- HL miR-425* hsa-miR- HL 135a*/mmu-miR- 135a* HL hsa-miR-612 HL hsa-miR-212/mmu- HL miR-212/rno-miR- 212 hsa-miR-125b- HL 2*/rno-miR-125b* hcmv-miR-UL112 HL hsa-miR-374b* HL hsa-miR-886-5p HL hsa-miR-500 HL hsa-miR-502-5p HL ebv-miR-BART18- HL 3p hsa-miR-198 HL hsa-miR-500* HL hsa-miR-342- HL 5p/mmu-miR-342- 5p/rno-miR-342-5p hsa-miR-124*/mmu- HL miR-124*/rno-miR- 124* hsa-miR-30c- HL 1*/mmu-miR-30c- 1*/rno-miR-30c-1* hsa-miR-220c HL hsa-miR-376a* HL hsa-miR-640 HL hcmv-miR-UL148D HL hsa-miR-659 HL hsa-miR-934 HL hsa-miR-125a- HL 3p/mmu-miR-125a- 3p/rno-miR-125a-3p hsa-miR-885-5p HL hsa-miR-24- HL 2*/mmu-miR-24- 2*/rno-miR-24-2* hsa-miR-484/mmu- HL miR-484/rno-miR- 484 hsa-miR- HL 106b*/mmu-miR- 106b*/rno-miR- 106b* hsa-miR-505* HL hsa-let-7b*/mmu-let- HL 7b*/rno-let-7b* hsa-miR-302c* HL hsa-miR-542- HL 5p/mmu-miR-542- 5p/rno-miR-542-5p hsv1-miR-H1 HL mghv-miR-M1-3 HL hsa-miR-183/mmu- HL miR-183/rno-miR- 183 hsa-miR-122* HL hsa-miR-183*/mmu- HL miR-183* hsa-miR-675 HL hsa-miR-99b/mmu- HL miR-99b/rno-miR- 99b hsa-miR-874/mmu- HL miR-874/rno-miR- 874 ebv-miR-BART20- HL 3p hsa-miR-483-5p HL hsa-miR-671- HL 5p/mmu-miR-671-5p hsa-miR-629 HL hsa-miR-553 HL hsa-let-7d*/mmu-let- HL 7d*/rno-let-7d* hsa-miR-601 HL hsa-miR-645 HL hsa-miR-920 HL hsa-miR-525-5p HL hsa-miR-221* HL hsa-miR-890 HL hsa-miR-492 HL hsa-miR-629* HL hsa-miR-635 HL hsa-miR-130b/mmu- HL miR-130b/rno-miR- 130b hsa-miR-197/mmu- HL miR-197 hsa-miR-654-5p HL hsa-miR-518b HL hsa-miR-382/mmu- HL miR-382/rno-miR- 382 hsa-miR-584 HL hsa-miR-99b*/mmu- HL miR-99b*/rno-miR- 99b* hsa-miR-630 HL hsa-miR-490-5p HL hsa-miR-663 HL hsa-miR-337-3p HL hsa-miR-9*/mmu- HL miR-9*/rno-miR-9* hsa-miR-202 HL ebv-miR-BART16 HL ebv-miR-BART9* HL hsa-miR-193b* HL ebv-miR-BART8* HL hsa-miR-206/mmu- HL miR-206/rno-miR- 206 hcmv-miR-US25-1* HL hsa-miR-514 HL kshv-miR-K12-6-5p HL hsa-miR-488 HL hsa-miR-508-5p HL hsa-miR-551b* HL hsa-miR-377* HL ebv-miR-BART6-3p HL hsa-miR-181b/mmu- HL miR-181b/rno-miR- 181b hsa-miR-526b HL hsa-miR-622 HL kshv-miR-K12-1 HL hsa-miR-485- HL 3p/mmu-miR-485* hsa-miR-490- HL 3p/mmu-miR-490 hsa-miR-125b- HL 1*/mmu-miR-125b- 3p/rno-miR-125b-3p hsa-miR-124/mmu- HL miR-124/rno-miR- 124 hsa-miR-657 HL ebv-miR-BHRF1-3 HL hsa-miR-542- HL 3p/mmu-miR-542- 3p/rno-miR-542-3p kshv-miR-K12-5 HL hsa-miR-943 HL hsa-miR-551a HL hsa-miR-297/mmu- HL miR-297a hsa-miR-296- HL 3p/mmu-miR-296- 3p/rno-miR-296 hsa-miR-617 HL hsa-miR-195* HL hsa-miR-575 HL hsa-miR-208a/mmu- HL miR-208a/rno-miR- 208 hsa-miR-647 HL hsa-miR-509-3-5p HL hsa-miR-340*/mmu- HL miR-340-3p/rno- miR-340-3p hsa-miR-220b HL hsa-miR- HL 200b*/mmu-miR- 200b* hsa-miR-585 HL hsa-miR-877/mmu- HL miR-877/rno-miR- 877 hsa-miR-326/mmu- HL miR-326/rno-miR- 326 ebv-miR-BART7* HL hsa-miR-615- HL 3p/mmu-miR-615-3p hsa-miR-433/mmu- HL miR-433/rno-miR- 433 hsa-miR-338- HL 5p/mmu-miR-338- 5p/rno-miR-338* hsa-miR-299-3p HL hsa-miR-518a-3p HL hsa-miR-181a-2* HL hsa-miR-552 HL

TABLE 30 Predictor microRNAs that distinguish follicular lymphoma from Hodgkin's lymphoma FL vs HL Higher in hsa-miR-301a/mmu-miR- FL 301a/rno-miR-301a kshv-miR-K12-7 FL hsa-miR-96/mmu-miR- FL 96/rno-miR-96 hsa-miR-151-5p/mmu- FL miR-151-5p/rno-miR-151 hsa-miR-28-5p/mmu-miR- FL 28/rno-miR-28 hsa-miR-302a/mmu-miR- FL 302a hsa-miR-215 FL hsa-miR-15b/mmu-miR- FL 15b/rno-miR-15b hsa-miR-29b/mmu-miR- FL 29b/rno-miR-29b hsa-miR-138/mmu-miR- FL 138/rno-miR-138 hsa-miR-363/mmu-miR- FL 363/rno-miR-363 hsa-miR-142-5p/mmu- FL miR-142-5p/rno-miR-142- 5p hsa-miR-19a/mmu-miR- FL 19a/rno-miR-19a hsa-miR-497/mmu-miR- FL 497/rno-miR-497 hsa-miR-144* FL hsa-miR-16/mmu-miR- FL 16/rno-miR-16 hsa-miR-138-1*/mmu- FL miR-138*/rno-miR-138* hsa-miR-768-5p FL hsa-miR-30c/mmu-miR- FL 30c/rno-miR-30c hsa-miR-129* FL hsa-miR-801/mmu-miR- FL 801 hsa-miR-34b/mmu-miR- FL 34b-3p hsa-miR-363*/rno-miR- FL 363* hsa-miR-20b* FL hsa-miR-550 FL hsa-miR-600 FL hsa-miR-196a*/mmu- FL miR-196a*/rno-miR-196a* hsa-miR-574-3p/mmu- FL miR-574-3p hsa-miR-620 FL hsa-miR-331-3p/mmu- FL miR-331-3p/rno-miR-331 hsa-let-7e/mmu-let- FL 7e/rno-let-7e hsa-miR-524-5p FL hsa-miR-197/mmu-miR- FL 197 hsa-miR-24-1*/mmu-miR- FL 24-1*/rno-miR-24-1* hsa-miR-519e* HL hsa-miR-628-3p HL mghv-miR-M1-7-5p HL hsa-miR-498 HL hsa-miR-525-5p HL hsa-miR-520d-5p HL hsa-miR-551b* HL hsa-miR-340*/mmu- HL miR-340-3p/rno- miR-340-3p hsa-miR-889 HL hsa-miR-494/mmu- HL miR-494/rno-miR- 494 hsa-miR-874/mmu- HL miR-874/rno-miR- 874 hsa-miR-30c- HL 2*/mmu-miR-30c- 2*/rno-miR-30c-2* hsa-miR-183*/mmu- HL miR-183* hsa-miR-25* HL hsa-miR-513a-5p HL hsa-miR-198 HL hsa-miR-659 HL mghv-miR-M1-4 HL hsa-miR-129- HL 5p/mmu-miR-129- 5p/rno-miR-129 ebv-miR-BART13 HL hsa-miR-193b* HL hsa-miR-422a HL hsa-miR-503 HL kshv-miR-K12-3 HL hsa-miR-766 HL hsa-miR-516a-5p HL hsa-miR-125b- HL 1*/mmu-miR-125b- 3p/rno-miR-125b-3p hsa-miR-149* HL ebv-miR-BART6-3p HL ebv-miR-BART19-3p HL hsa-miR-671- HL 5p/mmu-miR-671-5p ebv-miR-BART8* HL hsa-miR-509-3-5p HL hsa-miR-602 HL ebv-miR-BHRF1-1 HL mghv-miR-M1-7-3p HL mghv-miR-M1-2 HL hsa-miR-675 HL ebv-miR-BHRF1-2 HL hsa-miR-145*/mmu- HL miR-145* hsa-miR-296-5p/mmu- HL miR-296-5p/rno-miR- 296* hsa-miR-17*/rno-miR- HL 17-3p hsa-miR-452 HL hsa-miR-943 HL hsa-miR-326/mmu-miR- HL 326/rno-miR-326 hsa-miR-652/mmu-miR- HL 652/rno-miR-652 hsa-miR-623 HL hsa-miR-194* HL hsa-miR-557 HL hsa-miR-125a-3p/mmu- HL miR-125a-3p/rno-miR- 125a-3p hsa-miR-425*/mmu- HL miR-425* hsa-miR-10a*/mmu- HL miR-10a*/rno-miR-10a- 3p hsa-miR-323-3p/mmu- HL miR-323-3p/rno-miR- 323 hsa-miR-519e HL hsa-miR-502-5p HL hsa-miR-124*/mmu- HL miR-124*/rno-miR-124* hsa-miR-345 HL hsa-miR-584 HL hsa-miR-654-5p HL hsa-miR-331-5p/mmu- HL miR-331-5p hsa-miR-650 HL hsa-miR-202 HL hsa-miR-548b-3p HL hsa-miR-492 HL hsa-miR-135a*/mmu- HL miR-135a* ebv-miR-BART20-3p HL hsa-miR-586 HL hsa-miR-338-5p/mmu- HL miR-338-5p/rno-miR- 338* hsa-miR-92b* HL hiv1-miR-H1 HL hsa-miR-508-5p HL hsa-miR-542-5p/mmu- HL miR-542-5p/rno-miR- 542-5p hsa-miR-490-5p HL hsa-miR-663 HL hsa-miR-433/mmu-miR- HL 433/rno-miR-433 

We claim:
 1. A method of identifying a B cell malignancy in a subject as Hodgkin's Lymphoma, the method comprising: determining the level of expression of a microRNA corresponding to SEQ ID NO: 768 in a sample comprising a B cell taken from the subject relative to the level of expression of the microRNA corresponding to SEQ ID NO: 768 in a control sample; diagnosing the subject as having Hodgkin's Lymphoma when the expression of the microRNA in the sample is at least two-fold greater than the level of expression in the control; and administering a therapy to treat the subject identified as having Hodgkin's Lymphoma.
 2. A method of identifying a B cell malignancy in a subject as activated B cell-like (ABC) diffuse large B cell lymphoma (DLBCL), or germinal center-like (GCB) DLBCL, the method comprising: determining the level of expression of a microRNA corresponding to SEQ ID NO: 766 in a sample comprising a B cell taken from the subject relative to the level of expression of the microRNA corresponding to SEQ ID NO: 766 in a GCB DLBCL control sample; and administering a proteasome inhibitor to treat the subject identified as having ABC DLBCL, wherein the B cell malignancy is identified to be ABC DLBCL when the expression of the microRNA in the sample is 50% or less than the level of expression in the GCB DLBCL control.
 3. The method of claim 1, the method further comprising determining the level of expression of at least one additional microRNA in a sample taken from the subject relative to the level of expression of the at least one additional microRNA in a control sample, wherein the at least one additional microRNA corresponds to at least one of SEQ ID NOs: 763, 764, 765, 766, 767, 769, 770, 771, 772, and
 773. 4. The method of claim 1, wherein the control comprises normal cells, benign lymph nodes, or other B cell malignancy.
 5. A method of identifying a B cell malignancy in a subject as activated B cell-like (ABC) diffuse large B cell lymphoma (DLBCL), the method comprising: determining the level of expression of a microRNA corresponding to at least one of SEQ ID NO: 766 and SEQ ID NO: 1061 in a sample comprising a B cell taken from the subject relative to the level of expression of the microRNA in a control sample; and administering a proteasome inhibitor to treat the subject identified as having ABC DLBCL, wherein the B cell malignancy is identified to be ABC DLBCL when the expression of the microRNA in the sample is 50% or less than the level of expression in the control.
 6. The method of claim 5, wherein the control comprises normal cells, benign lymph nodes, or other B cell malignancy.
 7. The method of claim 6, wherein the other B cell malignancy is selected from germinal center-like diffuse large B cell lymphoma (GCB DLBCL), Burkitt lymphoma, follicular lymphoma, and Hodgkin's lymphoma. 